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Preface to “Recent Advances and Perspectives in 
Deoxynivalenol Research” 
Life is a battle and thus living organisms have developed strategies to win this war. Among the 
different strategies employed by micro-organisms to dominate their habitat is the production of toxins 
including bacteria and fungi and their use as bioweapons. Mycotoxins are secondary metabolites 
produced by molds that play such a role. 
For many years, one of these mycotoxins, the food-associated trichothecene Deoxynivalenol 
(DON or vomitoxin) has attracted the attention of scientists. This is due, in part, to its high prevalence 
in animal/human food and feed products, as demonstrated through the successful use of urinary 
biomarkers confirming the exposure of humans to substantial doses of this toxin. DON is also one of 
the most hazardous mycotoxins; it affects the functions of nerve, endocrine, immune and intestinal 
cells. In addition to its toxicity to animal cells (this could be considered as collateral damage), DON is 
also known to affect plant cell functions; such effects certainly play a role during the colonization of 
wheat and cereals by DON-producing fungi such as Fusarium species. The toxicity of DON seems to 
depend on the presence of an epoxide function which allows its binding to ribosomes, causing the so-
called “ribotoxic stress” effect, and the activation of specific kinases (including PKR and MAP kinases), 
eventually leading to the inhibition of the protein synthesis and to cell death. Due to its ability to 
activate PKR and MAP kinases, DON also acts as a proinflammatory signal at low doses whereas 
higher doses are immunosuppressive due to cellular toxicity. In animals, as well as affecting systemic 
and intestinal immunity, DON also impacts the functions of the brain and endocrine cells, causing 
anorexia and vomiting. Food not only contains native toxin, but also large amounts of plant and fungal 
derivatives of DON (including the fungal metabolites 3 and 15 acetyl-DON (3 and 15ADON) and the 
plant derivative 3-O-glucoside-DON (D3G)) and possibly, although no study has yet confirmed it, of 
animal derivatives (i.e., 3 and 15-glucuronide DON) potentially present in meat and animal-derived 
products. New DON derivatives were also recently found in plants and food products, including 
DON-oligoglycosides, DON-glutathione, DON-S-Cysteine, DON-S-Cysteinyl-glycine, and DON-
sulfonate. Although previous research has shed light on the mechanisms of action of DON, important 
questions remain. For example, little is known about the ability of the fungi to transmit from the soil to 
the cereals, and about the levels of DON and DON metabolites in different plant tissues during natural 
and experimental contamination. Data on the effects of DON and its metabolites on plant cells are also 
scarce. Similarly, how DON enters the cells (animal or plant cells) and how it binds/acts on ribosomes 
is not perfectly characterized. Finally, if ribosomes are the only target of DON, how the toxin could 
activate different kinases, depending on the toxin dose, remains a mystery. We hope that some of these 
questions will be answered in this Special Issue that focuses on one of the most studied and relevant 
food-associated mycotoxins. 
Marc Maresca 
Special Issue Editor 
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Abstract: Mycotoxins are fungal secondary metabolites contaminating food and causing toxicity
to animals and humans. Among the various mycotoxins found in crops used for food and feed
production, the trichothecene toxin deoxynivalenol (DON or vomitoxin) is one of the most prevalent
and hazardous. In addition to native toxins, food also contains a large amount of plant and fungal
derivatives of DON, including acetyl-DON (3 and 15ADON), glucoside-DON (D3G), and potentially
animal derivatives such as glucuronide metabolites (D3 and D15GA) present in animal tissues
(e.g., blood, muscle and liver tissue). The present review summarizes previous and very recent
experimental data collected in vivo and in vitro regarding the transport, detoxification/metabolism
and physiological impact of DON and its derivatives on intestinal, immune, endocrine and neurologic
functions during their journey from the gut to the brain.
Keywords: deoxynivalenol; mycotoxin; trichothecene; detoxification; intestinal absorption; intestine;
brain; endocrine; glial cells; immune cells
1. Introduction
Deoxynivalenol (DON, vomitoxin) belongs to a family of mycotoxins called trichothecenes.
Trichothecenes (including T-2 toxin, nivalenol, DON and satratoxins) are structurally related molecules
produced by fungi of Fusarium and Stachybotrys species [1]. They are small sesquiterpenoids all having
in common an epoxide group at position 12–13 that is critical for their toxicity [2–5] (Figure 1). It has
been proposed that the epoxide group allows them to bind to ribosomes, a mechanism known as the
ribotoxic stress effect, leading to the activation of various protein kinases, the modulation of gene
expression, the inhibition of protein synthesis and cell toxicity [5–8].
Analyses of the occurrence of DON in food and feed matrices have demonstrated that DON
is one of the most prevalent food-associated mycotoxins, particularly in cereals and cereal-derived
products [9]. In the US, 73% and 92% of wheat and corn samples, respectively, were found positive for
DON [10]. In Europe, a large-scale collaborative study conducted on more than 40,000 food samples
has shown that DON was present in 57% of all samples, with a percentage of positive samples
varying depending of the country (i.e., from 15% to 100% for Belgium and France, respectively) and
at levels ranging from 91 to 5000 μg/kg [11]. Similarly, another study conducted on 82 feed matrices
in Europe has demonstrated that 67 of them were contaminated with DON, 52 samples being highly
contaminated with levels of DON ranging from 74 to 9528 μg/kg [12]. DON is, moreover, resistant to
high temperature (up to 350 ◦C), thereby making it stable during processing and cooking, leading to
its persistence throughout the food chain [13].
Toxins 2013, 5, 784–820 1 www.mdpi.com/journal/toxins
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Figure 1. Chemical structure of DON and its major derivatives. DON and its derivatives were drawn
using Marvin software. Images on the right show an electrostatic map of the molecules, the blue
color indicating positive region, the red color indicating negative region and the gray color indicating
neutral region. The purple circles on the left images and yellow arrows on the right images indicate the
position of the epoxide or de-epoxide function in DON and its derivatives.
In addition to its prevalence, DON is one of the most hazardous food-associated
mycotoxins [4,7,8,13–16]. A provisional maximum tolerable daily intake (PMTDI) for DON of 1 μg/kg
of body weight and per day has been proposed by the Joint FAO/WHO Expert Committee on Food
Additives (JECFA) [14]. The ingestion of DON has been associated with alterations of the intestinal,
immune and nervous systems, thus leading, in cases of acute exposure, to illnesses characterized by
vomiting, anorexia, abdominal pain, diarrhea, malnutrition, headache and dizziness [4,7,8,17]. Toxicity
of DON relies on its ability to cross the biological barriers (i.e., the intestinal and blood-brain barriers)
and to affect the functions and viability of the cells forming such organ systems.
The present paper compiles experimental data collected in vivo and in vitro regarding: (i) the
transport of DON and DON derivatives from the gut to the brain; (ii) their detoxification; and (iii) their
impact on the animal and human physiology.
2. Transport and Metabolism of DON
2.1. Structure and Physicochemical Properties of DON and Its Derivatives
Food and feed are contaminated both by native DON and its derivatives. The structure and
partition coefficient (logD) of DON and its metabolites are given in Figure 1, Figure 2. The major
derivatives of DON correspond to metabolites formed either by fungi (i.e., the acetylated derivatives:
3- and 15-acetyl-DON or 3ADON and 15ADON), plants (i.e., 3-O-glucoside-DON or D3G), animals
(i.e., glucuronic acid derivatives: DON-3 and DON-15-glucuronide or D3GA and D15GA) or bacteria
(i.e., the de-epoxide diene derivatives of DON: DOM-1) [18,19]. Various studies have shown that food
contains large amounts of DON metabolites, mainly the fungal and plant derivatives 3/15ADON and
D3G, with up to 75% of the total amount of DON corresponding to DON metabolites [19]. In addition,
although no studies confirm it, animal derivatives of DON (i.e., D3/15GA) may be theoretically present
in food originated from animal tissues and blood. The amount of DON metabolites has not been
2
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considered in the regulatory limits fixed by food agencies for DON due to the lack of data regarding
their absorption and toxicity [19].
Calculation of the partition coefficient demonstrates that metabolic modifications of DON lead to
important changes in the polarity of the molecule (Figure 2). LogD of DON is −0.97 at pH 7, suggesting
a polar behavior. The presence of an acetyl moiety in the fungal metabolites 3ADON and 15ADON
or the absence of the oxygen linked to the epoxide function in the bacterial diene metabolite DOM-1,
result in a decrease in the polarity of the molecule compared to the native toxin (logD values of the
metabolites being less negative than the one of DON with a value at neutral pH of −0.35 and −0.53 for
DOM-1 and 3/15ADON, respectively).
 
Figure 2. LogD values of DON and its derivatives. LogD values of DON and its derivatives at various
pH values were calculated using Marvin software.
Conversely, the presence of a glucoside or a glucuronide moiety in the plant and animal
metabolites D3G, D3GA and D15GA leads to an increase in their polarity compared to DON (their logD
values being more negative than the one of the native toxin with a value at neutral pH of −2.74 and
−5.75 for D3G and D3/15GA, respectively). As discussed below, increase or decrease in the polarity of
DON metabolites may affect their ability to enter the cells and thus to be absorbed by the intestine
and/or to cause cell toxicity.
2.2. Cell Entry of DON and Its Derivatives
No studies have been conducted to characterize the exact mechanism of the cell entry of DON,
with only speculations being possible at present (Figure 3). One possibility is that cell entry of DON
does not occur at all and that cellular effects of DON described in part 3.1, such as activations of various
kinases, rely on its interaction with membrane receptors/proteins activating such signal pathways.
Although the direct effect of DON on membrane proteins could not be ruled out, data support the idea
that at least a part of DON enters the cells, i.e., the fact that: (i) DON binds to intracellular ribosomes;
and (ii) DON is substrate of intracellular detoxification enzymes (see part 2.4.). Studies using intestinal
cells have shown that the cell entry of DON does not saturate when the extracellular concentration of
toxin increases, suggesting that its entry takes place through a passive diffusion mechanism [20,21].
An important question is how DON, with its logD value of −0.97 at neutral pH that makes it behave
like a polar molecule, could diffuse across the cell membrane. Based on the fact that only molecules
bearing a logD value close to zero or positive are able to enter the cells through lipid diffusion [22],
the ability of DON to enter the cells through such a mechanism is theoretically low to nil. This leaves
only two possibilities for DON to cross the cell membrane: (i) a diffusion through an uncharacterized
membrane-associated passive transporter; and/or (ii) a bulk phase endocytosis/pinocytosis process
(Figure 3) [23,24].
3
Toxins 2013, 5, 784–820
Figure 3. Cell entry of DON and its derivatives. Although highly unlikely, cellular effects of DON
could rely on its ability to directly bind membrane receptor(s) (R) (1). However, the fact that DON
interacts with ribosomes and is substrate of intracellular detoxification enzymes rather suggests
that DON enters the cells. Cell entry of DON and its acetylated derivatives (3/15ADON) could
take place through membrane diffusion across lipids (2), through a membrane transporter (T) (3) or
through bulk phase endocytosis/pinocytosis (4) Once in the cell, 3/15ADON could be transformed in
DON by intracellular carboxyl-esterases. DON (and possibly 3/15ADON) reacts then with ribosomes
to cause cell effects. Detoxification of DON involves the production of glucuronide-metabolites by
UDP-glucuronosyltransferases. In addition, P-glycoproteins (PgP) are responsible for the efflux/excretion
of DON and possibly of its derivatives. The absence of cell effects of D3G and D3/15GA suggests either
that: (i) these derivatives do not cross the cell membrane (5); or (ii) that they efficiently enter the cell
but do not bind to ribosomes (6), the first hypothesis being more likely. Dashed lines/arrows and full
lines/arrows indicate unlikely/hypothetical and likely mechanisms, respectively.
As for DON, no data exists regarding the mechanism of cell entry of DON derivatives. As explained
in Section 3.1, alterations in their ability to enter the cells and/or to bind to ribosomes/receptors may
explain the difference of cell toxicity and toxicokinetics observed for DON derivatives compared to
the native toxin. One can suppose that DON derivatives with logD values closer to zero (i.e., DOM-1
and 3/15ADON) may have higher ability to diffuse across the lipids of the membrane. Conversely,
glucoside and glucuronide metabolites of DON (D3G, D3/15GA) bearing bigger molecular masses
and more polarity would have a reduced ability to enter the cells through lipid diffusion. Similarly,
modifications of DON (size, polarity) may also theoretically affect the ability of DON derivatives to
interact with membrane transporters if such transporters are involved. Future studies should help
identify the mechanism(s) that permit the entry of DON and its derivatives into the cells.
2.3. Bacterial Transformation and Intestinal Absorption of DON and Its Derivatives
Metabolism of DON in plants and fungi has been fully described recently [18,19] and thus will
not be elaborated upon in the present review focusing on modifications of DON by bacteria, animals
and humans.
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The first phase of the intoxication by DON and its derivatives corresponds to their passage
through the gut wall, such transport being possibly affected by bacterial metabolism. The intestinal
tract of animals and humans contains vast amounts of bacteria forming the commensal microbiota
that lives in symbiosis with the host. At present, the microbiota could be considered as an additional
organ system, playing important roles in the maturation of the intestinal and immune systems, in the
nutrition of the host, and finally in the protection of the host against pathogenic micro-organisms and
hazardous chemicals/xenobiotics, including DON and its derivatives [18,25–27].
Figure 4. Regional pH and bacterial densities in the digestive tract. pH and bacterial density (per mL
of intestinal fluid content) of the different segments of the digestive tract of humans, ruminants and
poultry are indicated in the figure. Values were obtained from publications [27–31].
The efficiency of the intestinal absorption and metabolism of DON greatly varies between
animal species due in part to the localization of bacteria along their intestine in relation to regional
pH (Figure 4) [27–31]. On this basis, animals could be divided into two groups: (i) those with a
high bacterial content located both before and after the small intestine such as polygastric animals
(i.e., ruminants that have bacteria in their rumen and in their colon) and birds (including poultry that
have bacteria in their crop and in their cecum); and (ii) those with high bacterial content located only
after the small intestine, in their colon, such as most of the monogastric species (including humans,
pigs and rodents). Localization of the gut bacteria prior or after the small intestine has a major effect
on the bioavailability of ingested DON and its metabolites (Figure 5, Figure 6).
In monogastric animals, large amounts of ingested DON can cross the intestinal epithelium
and reach the blood compartment (Figure 5). For example, in pigs, 54% to 89% of the ingested
toxin is absorbed in vivo after acute and chronic oral exposure to DON, respectively [32], possible
explanations for the higher oral bioavailability of DON after chronic exposure are discussed in the
following. After oral intoxication of pigs, DON starts to appear in the plasma after 30 min and its serum
concentration reaches a peak value within three to four hours post-ingestion, thereby suggesting a fast
and efficient absorption of the toxin through the proximal small intestine [32–34]. Accordingly, in vitro
experiments conducted with intestinal segments from pigs have shown that the intestinal absorption of
DON takes place mainly through the jejunum [35]. Similarities between the human and pig intestines
(also in terms of DON effects as described in part 3.2. suggest that humans could also efficiently absorb
ingested DON.
5
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Figure 5. Intestinal absorption, detoxification and excretion of DON and its derivatives in monogastric
species (e.g., humans/pigs/rodents). Humans and monogastric animals are exposed to DON and DON
derivatives through the ingestion of contaminated food. Details are given in the text (parts 2.3 and 2.4).
DOM-1-GA corresponds to glucuronide derivatives of DOM-1. Red arrows indicate transformation of
DON or DON derivatives, dashed arrows indicate excretion/elimination mechanisms.
 
Figure 6. Intestinal absorption, detoxification and excretion of DON and its derivatives in ruminants
and poultry. Poultry and polygastric animals are exposed to DON and DON derivatives through
the ingestion of contaminated food. Details are given in the text (parts 2.3. and 2.4.). DOM-1-GA
corresponds to glucuronide derivatives of DOM-1. Red arrows indicate transformation of DON or
DON derivatives, dashed arrows indicate excretion/elimination mechanisms.
6
Toxins 2013, 5, 784–820
Even though in vivo toxicokinetic data of DON in humans are not available, the intestinal
absorption of DON by humans has been elegantly evaluated using an in vitro model of human
intestinal epithelial cells (IEC), i.e., the Caco-2 cell line [20]. Caco-2 cells have been used for decades
to mimic the human IEC and to study the intestinal absorption of drugs and toxins, this cell line
giving apparent permeability coefficient (Papp) values predictive of the in vivo oral bioavailability
of molecules in humans [36]. Authors showed that DON has a Papp value of 5.02 × 10−6 cm/s in
Caco-2, corresponding to a potential in vivo oral bioavailability of 50% to 60% in human, a value in
accordance with the in vivo experiments conducted on pigs. The Papp of DON was also measured
in vitro in poultry, giving even higher values (i.e., 1.7 × 10−5 cm/s, corresponding to a predicted
in vivo oral bioavailability of 70%) [37]. As discussed below, the observed oral bioavailability of DON
in poultry is much lower (i.e., around 20%) than expected, in relation to the presence of intestinal
bacteria able to transform DON in DOM-1 before the small intestine in birds. Few data are available
regarding the mechanism of intestinal absorption of DON. Experiments conducted in vitro with Caco-2
cells [20] or with intestinal segments from poultry [37] showed that the intestinal absorption of DON
does not saturate but is proportionally dependent on the extracellular concentration of DON, thus
suggesting that the intestinal absorption of DON takes place through passive transcellular and/or
paracellular diffusion. As explained in part 2.2., based on its ability to target intracellular ribosomes
and to be substrate of intracellular detoxification enzymes, at least a part of the intestinal absorption
of DON has to take place through transcellular transport. Although the relative contribution of
transcellular and paracellular transport in DON absorption has not been evaluated yet, contribution of
the paracellular mechanism may massively increase and become predominant in the case of alterations
of intestinal permeability. Decreases in the intestinal tightness are observed in various conditions such
as inflammatory bowel disease (IBD) (including Crohn’s disease), intestinal infections by viruses, or
pathogenic bacteria and exposure to DON or other mycotoxins [14,38–44]. This could explain the
observed higher absorption of DON in pigs chronically exposed to oral DON compared to acute
exposure [32].
The rank order of sensitivity of animals to ingested DON is pigs > poultry/ruminants [4].
As mentioned above, intestinal explants from poultry and pigs possess a similar ability to intestinally
absorb DON, suggesting that the difference in their sensitivity to ingested DON does not rely on
their ability to intestinally absorb DON. In fact, the sensitivity of animals to oral DON relies on the
localization of the intestinal bacteria in their gut in relation to their ability to generate 9,12-diene DON
or DOM-1, the non-toxic de-epoxide derivative of DON [18,45].
The presence of high bacterial contents that are able to convert toxic DON into its non-toxic
de-epoxide metabolite DOM-1 before the small intestine in ruminants (rumen-associated bacteria) and
poultry (crop-associated bacteria) massively decreases the amount of native DON reaching the small
intestine, making such animal species almost insensitive to oral intoxication by DON (Figure 6) [4].
For example, only a small amount of the ingested DON reaches the small intestine as native toxin
in poultry and sheep (19.3% and 7.5% of the ingested DON being found in the blood of intoxicated
poultry and sheep, respectively) [46–48]. Similarly, in cows, 16% of ingested toxin reaches the small
intestine [49] and only 1% crosses the intestinal wall to reach the blood [50].
In monogastric animals, due to the high absorption of DON by the small intestine, bacterial
transformation of DON in DOM-1 could only be possible if a part of the ingested DON reaches the colon
and/or in the case of intestinal/hepatic excretion of absorbed DON (Figure 5). This explains why only
a low percentage of ingested DON is found in the feces of monogastric animals as DOM-1, with most
of the ingested DON being eliminated in the urine as glucuronide-DON, DON, glucuronide-DOM-1
and DOM-1 (Figure 5) [51,52].
No studies have looked at the intestinal absorption of DOM-1 in animals or humans. However,
based on the fact that DOM-1 is only formed by intestinal bacteria in the gut lumen and that a
percentage of ingested DON is found in urine as DOM-1, we could suppose that DOM-1 formed by
intestinal bacteria is efficiently absorbed by the gut (Figure 5, Figure 6) [53].
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Not all bacteria are able to transform DON in DOM-1 [18]. In pigs, it has been demonstrated
that only chronic oral exposure to DON leads to the formation of DOM-1 by the microbiota [54].
Experiments conducted with human feces coming from five volunteers showed that only one
spontaneously possesses bacteria able to transform DON in DOM-1 [53]. Taken together, experiments
conducted with pigs and humans suggest that naive intestinal bacteria naturally do not possess the
ability to detoxify DON and that pre-exposure of the microbiota to DON induces the appearance of the
bacterial detoxification activity, either through the induction of the expression of particular enzymes
and/or the selection of particular detoxifying bacterial species [18]. Initially, aerobic bacteria were
thought to be unable to form DOM-1 as they rather transform DON in 3-epi-DON and 3-keto-4-DON,
both having an intact epoxide function [18,55]. However, recent data suggested that some soil bacteria
are also able to form DOM-1 both in aerobic or anaerobic condition [56]. It has to be noted that although
some bacteria and micro-organisms were initially thought to be able to totally mineralize DON, data
suggest that adsorption of the toxin to the cell wall and bacterial uptake are in fact responsible for the
disappearance of the toxin from the medium [18], with such adsorption certainly playing an important
role in the neutralization of DON by the intestinal bacteria.
Fungal (i.e., 3/15ADON) and plant (i.e., D3G) metabolites of DON are also present in food and
could thus be absorbed by the intestine and/or metabolized by intestinal bacteria (Figure 5, Figure 6).
In addition, although no published studies describe it, animal derivatives of DON (i.e., D3/15GA)
could also be theoretically present in animal-derived food (animal tissues, blood) and thus be ingested
by humans or animals. In pigs, the ingestion of 3ADON leads to the appearance of DON (58%)
and DON metabolites (glucuronide-DON and DOM-1 (42%)) but not of 3ADON in the blood [52].
This result suggests either that: (i) 3ADON is not directly absorbed by IEC but requires its initial
transformation into DON by gut bacteria or by luminal intestinal lipases before its absorption; or
(ii) 3ADON is directly absorbed by IEC that transform it intracellularly into DON before its release
in the blood. Luminal intestinal lipases and microbial esterases/lipases could theoretically cut the
acetyl moieties of the fungal metabolites 3ADON and 15ADON to release DON in the intestinal
lumen [57,58]. Similarly, IEC possess intracellular carboxylesterases (CES) [59] potentially able to
transform absorbed 3ADON and 15ADON into DON. An in vitro study has shown that isolated IEC
are sensitive to 3/15ADON [60], proving that these derivatives could be directly absorbed by the IEC
without the requirement of intestinal lipases or microbial lipases/esterases. The relative contribution of
intestinal lipases, bacteria and IEC in the metabolism of acetyl-DON may depend of the animal species.
In monogastric animals, the significance of the transformation of 3/15ADON by colonic bacteria is
limited due to their high absorption by IEC [60], suggesting a major role of intestinal lipases and/or
epithelial CES in that case (Figure 5). To date, direct evidence of the transformation by intestinal CES of
3/15ADON in DON are unfortunately missing. In ruminants and poultry, bacterial de-acetylation of
3/15ADON could happen prior the small intestine and may theoretically impact their bioavailability.
Little is known regarding the intestinal absorption and bacterial metabolism of the more polar
metabolites of DON, i.e., D3G, D3GA and D15GA. On the basis of the hypothesis that DON enters IEC
by lipid diffusion, such polar metabolites should have lower intestinal absorption efficiency compared
to the native toxin. Similarly, one could suppose that addition of glucoside or glucuronide moiety
would impact the interaction of DON with its membrane transporter, affecting their cell entry through
this mechanism (see part 2.2.). No data exists regarding the intestinal absorption of D3/15GA, but
the lack of toxicity of these metabolites suggests that their oral bioavailability is certainly low to
nil [61]. Similarly, nothing is known regarding the bacterial metabolism of D3/15GA. One could
suspect that bacterial beta-glucuronidases would certainly transform them into DON with or without
consequences, depending if the transformation occurs prior to or after the small intestine. As with
D3/15GA, D3G is unable to cause toxicity [62]. Data have, however, shown that intestinal bacteria
are able to transform D3G into DON through the hydrolysis of its glucoside moiety [18,19,53,63,64].
Interestingly, the bacterial activity leading to the transformation of D3G in DON is spontaneously
present in the feces and does not seem to require its induction as observed for the transformation of
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DON in DOM-1 [53]. In monogastric animals, the transformation of D3G into DON after the small
intestine does not allow the absorption of the released DON since most of the toxin remains in the
feces, suggesting that D3G is not hazardous at least for these animals due to its limited intestinal
absorption (Figure 5) [64]. Again, the situation may be totally different in ruminants and poultry where
the transformation of D3G in DON would take place before the small intestine, potentially allowing
the absorption of the released toxin.
2.4. Metabolism and Excretion of DON and Its Derivatives by the Animals
The ingestion of native DON and its derivatives leads to the presence of a native toxin in the body
of intoxicated animals. As with many xenobiotics, DON is then subject to detoxification and excretion
(Figure 5, Figure 6).
Transport studies using Caco-2 cells have demonstrated that human IEC have the ability to apically
excrete DON [21]. Whereas the apical (AP) to basolateral (BL) transport of DON by human IEC is
insensitive to transporter’s inhibitors, its BL to AP excretion is sensitive to P-glycoprotein inhibitors,
particularly inhibitors of the multidrug resistance-associated protein (MRP-2) transporter [21]. In
addition to reduce the net absorption of ingested DON by IEC of the small intestine, net excretion by
IEC of the colon may account for the total excretion of DON (and possibly D3/15GA) by the body.
Detoxification of ingested xenobiotics generally takes place in the IEC, the liver and the kidneys.
Detoxification of DON certainly starts in IEC, directly after its intestinal absorption. Although the
detoxification metabolite DOM-1 is present in the blood of animals orally intoxicated with DON,
as mentioned above, the transformation of DON in DOM-1 is not related to animal detoxification
as it occurs in the intestinal lumen and corresponds to bacterial detoxification followed by the
intestinal absorption of DOM-1 [45,65]. Body detoxification of DON mostly involves the formation
of glucuronide metabolites (mainly D3GA and D15GA) by UDP-glucuronosyltransferases. Such
metabolites are less toxic than the parental toxin due to their lower logD value (Figure 2) making
them less efficient at crossing the cell membrane and/or at binding to ribosomes [61]. The amount
of glucuronide-DON formed greatly differs, depending of the animal species used. Thus, in sheep,
glucuronide metabolites correspond to 75% of the systemic DON [46], whereas in pigs, the percentage
of glucuronide metabolites varies from 5% to 58%, depending if the animals were exposed to DON or
3ADON, respectively [33,52]. This suggests that in addition to the animal species used, the form of the
ingested toxin, either native or conjugated, also impacts its detoxification, at least in pigs. The precise
site of the formation of the glucuronide-DON is not characterized at present, intestinal, liver and
kidney cells being theoretically able to form glucuronide metabolites. Liver microsomes extracted
from animals and humans have been shown to be able to transform DON in glucuronide-DON,
mainly D3GA and D15GA [66,67]. Experiments conducted with intestinal or renal microsomes are not
available to confirm that these tissues could also detoxify DON. However, the fact that in sheep the
amount of glucuronide-DON formed is higher after oral exposure to DON (75%) than after intravenous
injection (21%) suggests that IEC are responsible for a large part of the formation of such detoxification
products in case of oral intoxication [46].
Regarding the excretion of DON, it seems that most of the toxin is excreted in the urine as
glucuronide-DON, glucuronide-DOM-1, DON and DOM-1 (Figure 5, Figure 6). A study in humans
has shown that 91% of the DON excreted in urine is glucuronide-DON, D15GA being predominantly
found [68,69]. In pigs orally intoxicated by DON, 68% of the toxin is excreted in the urine as unchanged
DON and glucuronide-DON, the remaining being mostly eliminated in feces (20%) as DOM-1 and
DON (80% and 20% of total DON in feces, respectively) [32,34]. Similarly, oral exposure of pigs to
3ADON leads to the elimination of the toxin mainly in urine (up to 80%) as DON and glucuronide-DON
with only low amounts of toxin (2%) being present in the feces as DON and DOM-1 (48% and 52%,
respectively) [52]. As mentioned previously, intoxication of rats with D3G does not require body
detoxification since most of the D3G is not absorbed; 3.7% of the toxin is eliminated in the urine as
DON, glucuronide-DON and D3G, and all the rest is eliminated in feces as DON and DOM-1 [64].
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Mechanism(s) of excretion of DON/DOM-1 and glucuronide-DON/DOM-1 are unknown at present
and could involve both glomerular filtration of the metabolites present in the blood and their excretion
through P-glycoproteins expressed by intestinal, renal or hepatic epithelial cells, as demonstrated for
DON in IEC [21].
Overall, excretion of DON and its detoxification metabolites is quite efficient, half of plasmatic
DON being eliminated after 6 h in pigs and in sheep [34,46]. The fast elimination of DON suggests
a low binding of DON and its metabolites to serum albumin, at least in animals. Accordingly, the
in vitro toxicity of DON is not modified by the presence of bovine serum albumin (BSA) in the medium,
contrary to the toxicity of ochratoxin A, another mycotoxin with a strong affinity for serum albumin
and a longer plasmatic half-life (up to 840 h) [70,71]. It has to be noted that a recent study described the
interaction of DON with human serum albumin [72], indicating that in humans, DON could possibly
have a longer plasmatic half-life.
2.5. Transport of DON through the Blood-Brain Barrier (BBB)
As described in Section 3.4, DON is able to cause alterations of the brain functions. Although part
of these alterations could be attributed to peripheral effects, data suggest that neurologic effects of
DON rely in part to the direct action of DON on brain cells. This requires the crossing of the blood-brain
barrier (BBB) by the toxin. The BBB is formed by the close apposition of endothelial and glial cells,
forming a selective barrier controlling the passage of molecules from the plasma to the cerebro-spinal
fluid (CSF) [73]. In vivo studies have shown that DON crosses the BBB in various animal models. DON
transport across the BBB occurs rapidly, native toxins being detected in the brain of animals within a
few minutes (2 to 60 min, depending of the animal species) after exposure [74]. The ability of DON to
cross the BBB depends on the animal species. In pigs, 25% to 30% of the plasmatic DON is found in
the CSF, the toxin having a CSF half-life similar to its plasmatic one and being still detectable in the
CSF 20 h after the intoxication [74]. In mice, the BBB crossing of DON is lower, the concentration of
DON in the brain corresponding to 10% of the plasmatic concentration [75]. Finally, in sheep, only
5% of the plasmatic DON crosses the BBB [74]. Transport of DON across the BBB of other animal
species and humans has not yet been evaluated, though it would not be surprising that some animal
species may have higher or lower BBB permeability to DON. The best example of variation of BBB
permeability for a specific molecule between animal species comes from another family of mycotoxins:
the fumonisins. Indeed, BBB permeability to these toxins ranges from low/nil (for mice) to high (for
horses) [76,77]. Importantly, it was demonstrated that perturbations of the BBB permeability, caused
by LPS-induced neuro-inflammation, increase the brain accumulation of fumonisins in mice [78].
At present, no studies have looked at the effects of neuro-inflammation and perturbations of the
BBB on the brain accumulation of DON. Similarly, nothing is known regarding the mechanism(s)
responsible for the transport (absorption and excretion) of DON across the BBB. Regarding the ability
of DON derivatives to enter the brain, only native toxin is found in the CSF of intoxicated animals,
suggesting that neither DOM-1, nor D3/15GA are able to cross the BBB [74].
3. Pathophysiological Effects of DON
3.1. Cellular Effects of DON
As with other trichothecenes, DON is able to cause cellular effects through its ability to target
ribosomes and to cause ribotoxic stress [4–8]. Trichothecenes have all in common an epoxide group at
position 12–13 critical for their action on ribosomes, explaining why the de-epoxide diene metabolite
DOM-1 is non-toxic [2–5].
Binding of DON to the ribosomes could occur through the reaction of the epoxide moiety of
DON with the nucleotides forming ribosomal RNA (rRNA) [6–8]. Nucleotides contain amine groups
potentially able to react with epoxide (Figure 7) [79]. At present, nothing is known regarding the precise
nature of the chemical reaction(s) allowing DON to bind to rRNA. Surprisingly, no report has been
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made of the interaction of DON with other nucleotide-containing molecules, such as mRNA or DNA.
Aflatoxins (AFL), another family of mycotoxins with an epoxide function after their metaboliation
by CYP450, selectively bind to guanine and cytosine residues present both in DNA and RNA [80].
This suggests—if the absence of reaction between DNA/mRNA and DON is confirmed—either that
nucleotides from rRNA have a particular spatial organization allowing their specific interaction with
DON, or that the real target of DON in rRNA is not nucleotides.
 
Figure 7. Chemical reactivity of the epoxide moiety. Epoxide moiety of DON could theoretically react
with nucleophile functions present on the puric/pyrimidic bases of the nucleotides forming nucleic
acid (DNA and RNA) such as amine group and/or on the side chain of amino acids forming the
proteins such as: amine, hydroxyl, carboxyl and thiol groups.
Proteins possess amine, carboxyl, thiol and hydroxyl groups all potentially able to react with
the epoxide function of DON (Figure 7), as demonstrated for AFL that forms adduct with the amine
function of the lateral chain of lysine residues in serum albumin [81]. Thus, one could imagine that
the binding of DON to rRNA takes place through its interaction with rRNA-associated protein(s).
However, in that case again, it is not clear why DON only targets such rRNA-associated protein(s)
and not other cellular proteins. One could suppose that only rRNA possesses both the correct spatial
organization and chemical functions, present either on nucleotides or rRNA-associated proteins,
allowing their selective interaction with DON. What we know is that the binding of DON to rRNA
causes their cleavage and the activation of various cellular signaling pathways affecting cell functions
and potentially leading to cell apoptosis (Figure 8) [6–8,82,83]. Signal pathways activated by DON
correspond to the one generally activated by ribotoxins and ribotoxic stress, including: (i) two rRNA
associated protein kinases, i.e., the double-stranded RNA (dsRNA)-activated protein kinase (PKR)
and the hematopoietic cell kinase (Hck); and (ii) the MAP kinases (p38, ERK1/2, JNK), affecting the
expression of proteins involved in the innate immunity (through NFκB activation) and apoptosis
(through p53) [6–8].
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Figure 8. Cell effects of DON. Effects of DON on cell signal pathways in macrophages. Top image
shows the organization of eukaryotic ribosome. The small subunit (40S) on the left contains an RNA
molecule (cyan) and 20 proteins (dark blue); the large subunit (60S) on the right contains two RNA
molecules (grey and slate) and more than 30 proteins (magenta). The image also shows a transfer RNA
(orange) bound to the active site of the ribosome.
Initially, it was proposed that the binding of DON to rRNA cause their cleavage that in turn
activate PKR and Hck, leading to the downstream activation of MAP kinases, NFκB and apoptosis
pathways [6]. But recent elegant work from Pestka’s group has shown that, in fact, apoptosis activation
is not the consequence but is rather the cause of the rRNA cleavage through the activation of caspases
and RNases [82,83]. In accordance with this hypothesis, the authors showed that signaling pathway
activation occurs in minutes after exposure to low or high doses of DON, whereas rRNA cleavage
appears only after hours of exposure to high doses. In addition, authors demonstrated that inhibitors
of signal pathways and apoptosis inhibit rRNA cleavage caused by DON, thus definitively proving
that rRNA cleavage is the consequence of cell signaling induced by DON and not the opposite.
The actual hypothesis regarding DON effects is that after its cell entry, DON binds to rRNA
through the interaction of its epoxide moiety with functional group(s) present on the nucleotides
and/or rRNA-associated proteins (such as PKR and Hck) leading to the rapid activation of the
rRNA-associated protein kinases PKR and Hck which then activate MAP kinases, the type of MAP
kinases activated being different depending of the doses of DON used. Thus, in macrophages, low
doses (nM) activate preferentially ERK, causing cell survival and gene expression, whereas high doses
(μM) activate p38 leading to apoptosis, rRNA cleavage and protein synthesis inhibition (Figure 8).
At low doses, DON has been showed to regulate the expression of various genes involved in the
innate immunity and the inflammatory reactions through selective transcription, mRNA stabilization
and translational regulation [7,8,82,83]. In addition to PKR, Hck, MAP kinases and NFκB other proteins
participate in the transcriptional/translational effects of DON, including the HuR/Elav-like RNA
binding protein 1, the CCAAT/enhancer-binding protein (CHOP) homologous protein, the peroxisome
proliferator-activated receptor γ (PPARγ), the early growth response gene 1 (EGR-1), the activating
transcription factor 3 (ATF3), the histone methylase, and GRP78/BiP [84–89]. It will not be surprising
that additional signaling proteins participate in DON effects. Accordingly, a recent study from Pestka’s
group showed that DON affects the phosphorylation of 188 proteins, including proteins involved in
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transcription, epigenetic modulation, cell cycle, RNA processing, translation, ribosome biogenesis, cell
differentiation and cytoskeleton organization [90].
Few studies have looked at the cell effects of DON derivatives. It has been known for decades
that the loss of the epoxide moiety leads to the absence of cell effects of DOM-1 due to its inability
to bind to ribosome independently of its cell entry [18]. More polar derivatives of DON (D3/15GA
and D3G) are also non-toxic due either to their inability to cross the cell membrane and/or to bind
to ribosomes, the relative participation of each event being unknown at present [61,62]. Toxicity of
the less polar derivative (3/15ADON) depends of the organ and animal species, differences in their
ability to enter the cells and/or to bind to ribosomes compared to DON possibly being involved.
Using lymphocytes, 3ADON and 15ADON were found less toxic than DON [91–93]. Conversely,
using pig IEC and intestinal explants, Oswald’s group ranked the toxicity of DON and its acetylated
derivatives as follows: 3ADON < DON < 15ADON [60]. In vivo experiments on mice confirmed the
higher intestinal toxicity of 15ADON compared to DON in case of ingestion but not after i.p. injection,
suggesting a particular sensitivity of the intestinal epithelium to acetyl-DON [94]. Based on the fact
that ribosomes are theoretically the same in all cells, the difference of sensitivity of lymphocytes and
IEC to acetyl-DON suggests that acetylation may affect the cell entry of DON derivatives, IEC being
more efficient at transporting acetyl-DON than lymphocytes. Another attractive hypothesis would
be that DON and 3/15ADON have a similar ability to enter the cells, but that only DON, and not
3/15ADON, binds to ribosomes. In that case, the higher sensitivity of IEC compared to lymphocytes
could rely on the higher ability of IEC to transform 3/15ADON into DON through CES activity.
Overall, according to their ability to enter the cells, only DON and 3/15ADON have been
shown to affect the functions of intestinal, immune and brain cells; DON effects on these systems are
interconnected as described below.
3.2. Impacts of DON on the Intestinal Functions
Intestinal epithelial cells (IEC) are the first target of DON in case of natural exposure through
ingestion of contaminated food. Whereas only IEC of the small intestine are exposed apically to
ingested DON, IEC of the small intestine and colon are potentially exposed basolaterally to systemic
DON that has crossed the intestinal wall to reach the blood compartment. Numerous studies have
demonstrated that DON impacts IEC functions (Figure 9 and Table 1) (for review: [14,16,95]).
DON alters the proliferation and viability of animal and human IEC. In human IEC, the inhibition
of the cell proliferation is observed at low doses (IC50 = 1–5 μM), cytotoxic effects being observed at
higher doses (30–40 μM) [39,96]. Similarly, high doses of DON (IC50 = 10–50 μM) cause cell toxicity
and apoptosis in rat and pig IEC [97–100]. Importantly, studies conducted on pig IEC have shown
that the status of the cells (undifferentiated versus differentiated) and the site of DON exposure
(apical or basolateral) affect its toxicity, DON being more toxic to undifferentiated IEC and when
added basolaterally [97–99]. Whereas the higher sensitivity of undifferentiated cells compared to
differentiated cells (10-times more sensitive) may be explained by differences in their cell cycle, no
formal reasons explain the higher susceptibility of cells exposed basolaterally compared to apically
(4-times difference), especially on the basis of the supposed passive diffusion entry of DON in the
cells. No studies have been conducted to see if IEC absorb/accumulate more DON when the toxin is
added basolaterally, explaining such a difference. Experiments need to be performed to understand
how the site of exposure affects so much the effect of DON on IEC both in terms of toxicity and gene
expression [97,98,101].
In vitro and in vivo experiments have also shown that DON inhibits the intestinal absorption
of nutrients (at least glucose and amino acids) by human [39] and animal IEC [37,102–104].
The sodium-glucose dependent transporter (SGLT-1) activity is particularly sensitive to DON inhibition
with an IC50 of 10 μM [39]. In addition to nutritional consequences, inhibition of SGLT-1 could
explain the diarrhea associated with the ingestion of DON, since this transporter is responsible for
the daily absorption of 5 L of water by the gut [105]. How DON causes inhibition of SGLT1 and
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other nutrient transporters is unknown at present, this inhibition being possibly related either to
non-specific effects such as protein synthesis inhibition or ATP depletion, or to specific modulation of
the expression/membrane targeting/activity of the transporters. According to the second hypothesis,
activation of MAP kinases in IEC by proinflammatory signals causes the inhibition of the activity of
membrane inserted SGLT-1 without affecting its expression [106,107].
 
Figure 9. Effects of DON on the intestinal, immune and neuro-endocrine systems. Effects of DON
on the intestinal, immune and neuro-endocrine systems are explained in the text. Doses at which
the effects occur are schematically indicated at the bottom of the figure. It appears that the order of
sensitivity of the systems is as follow: immune > neuro-endocrine > intestinal (Intestinal microscopy
image courtesy of Cendrine Nicoletti).
Based on the ability of DON to activate MAP kinases in IEC, it would not be surprising that DON
inhibits glucose absorption through such a mechanism. Finally, although no data are available to
support such a hypothesis, one could speculate that D3G could act as a competitive inhibitor of SGLT-1
through its glucoside moiety.
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Table 1. Risk evaluation of the exposure to DON for humans. Risks associated to DON exposure in
humans were evaluated using the doses required to cause physiological alterations and PMTDI/higher
exposure of the human population. Intestinal, blood and CSF concentrations of DON were calculated
on the basis of a human adult weighting 70 kg, having a small intestinal volume of 1 L, a blood volume
of 5 L and assuming that humans behave like pigs regarding blood and CSF concentration of DON
[14,74]. The physiological alterations occurring at doses of DON with a safety factor inferior to 30
compared to the PMTDI/highest exposure-related concentrations are indicated in red.







INTESTINE Inhibition of the cell proliferation 1–5 μM 4.8–23 2–10
Increase in β-Defensin expression 2 μM 10 3.9
Decrease in nutrient absorption 10 μM 48 19PMTDI-related intestinal
concentration = 210 nM Decrease in mucin expression 10 μM 48 19
Increase in intestinal pathogenic
Th17 10 μM 48 19
Increase in bacterial translocation 10 μM 48 19
Increase in IL-8 secretion 1–20 μM 48–95 2 –39
Modification of the microbiota 20 μM 95 39Highest dose-related intestinal
concentration = 504 nM Increase in intestinal permeability 10–50 μM 48–245 19–99
Cytotoxicity >30 μM 142 59
Decrease in IL-8 secretion >30 μM 142 59
Increase in IgA secretion 500 μM 2 380 992
IMMUNE SYSTEM Increase in lymphocyte
proliferation 1–30 nM 0.6–20 0.3–8
Activation of macrophages 1–100 nM 0.6–66 0.3–28
PMTDI-related blood
concentration = 1.5 nM
Increase in proinflammatory
cytokines 0.1–1 μM 66–666 28 –277
Decrease in lymphocyte
proliferation >100 nM >66 >28
Inhibition of NK cells >150 nM >100 >41Highest dose-related blood
concentration = 3.6 nM Apoptosis of macrophages >300 nM >200 >83
Apoptosis of lymphocytes 10 μM 6666 2777
ENDOCRINE SYSTEM Steroid perturbations 0.3–3 μM 200–2 000 83–833
Increase in insulin secretion 1.44 μM 960 400
Decrease in IGF-1/IGFALS 1.8 μM 1200 500
PMTDI-related blood
concentration = 1.5 nM
Highest dose-related blood
concentration = 3.6 nM
Increase in secretion of PYY 7 μM 4666 1944
BRAIN Feed refusal 1.5–75 nM 3 –166 1.4 –69
Activation of microglia 10–100 nM 22 –222 9 –92PMTDI-related brain
concentration = 0.45 nM Inhibition of glutamate uptake 50 nM 111 46
Cell death/Inhibition of microglia >300 nM >666 >277
Vomiting 1.2 μM 2666 1111
Direct neuroinflammation 1.5 μM 3333 1388
Highest dose-related brain
concentration = 1.08 nM
Cell death of astrocytes 31 μM 68,888 28,703
In addition to directly affecting the activity of nutrient transporters, DON also affects the
permeability of the intestinal epithelium through modulation of the tight junction complexes (IC50 = 10
to 50 μM) [20,39,40,60,97,98,100,108]. Studies have demonstrated that activation of MAP kinases
(particularly ERK) by DON affects the expression and cellular localization of proteins forming or
being associated with the tight junctions such as claudins, ZO-1, resulting in an increase in the
paracellular permeability of the intestine [20,60,97,98,108]. Acetylated DON derivatives are also able
to affect the tight junctions through activation of the MAP kinases pathway, a direct correlation
existing between their ability to activate MAP kinases and to open tight junctions, with the following
order 3ADON < DON < 15ADON [60]. In addition to affecting nutrient absorption and causing
intestinal inflammation [14,40], the increase in paracellular intestinal permeability may explain why
animals chronically exposed to the toxin have higher DON oral bioavailability [32]. Interestingly,
others in addition to us reported that incubation of IEC with doses of DON not able to affect the tight
junctions causes a transcellular bacterial translocation across the intestinal epithelium suggesting a
possible role of DON as risk factor for inflammatory bowel diseases (IBD) and intestinal bacterial
infections [14,40,99,109]. In addition to opening tight junctions and promoting bacterial translocation,
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DON also modifies the production of the intestinal mucus. Thus, in vivo studies with pigs have shown
that ingestion of DON causes a decrease in the number of goblet cells and in the production of
mucus [110,111], potentially explaining the observed perturbations of the microbiota in pigs exposed
to DON [14,112]. Accordingly, we have preliminary in vitro data showing that DON modifies the
expression/production of mucins by human cells exposed to 10 μM of toxin (personal communication).
Finally, innate immunity related to IEC is also affected by DON both directly (through the
activation of signal pathways by the toxin) and indirectly (through the crossing of luminal bacterial
antigens caused by the bacterial translocation, mucus alteration and the opening of the tight
junctions) [14,40]. Thus, DON (1 to 20 μM) affects the expression of proteins involved in the epithelial
innate immunity, including COX-2 and β-defensins [113–115]. Similarly, numerous studies using
animal and human cells have demonstrated that DON stimulates the expression and secretion of
interleukin-8 (IL-8), a chemoattractant cytokine causing the recruitment/activation of circulating
immune cells and thus potentially participating indirectly in the central effects of DON in terms of
feed refusal and emesis. Induction of the intestinal inflammation by DON takes place through the
activation of PKR/Hck/MAP kinases/NFκB pathways [40,86,89,99,114,116,117]. Study with human
IEC has shown that DON has a biphasic effect on the secretion of IL-8, low doses of toxin (1 to
25 μM, non-cytotoxic) causing a massive increase in the secretion of IL-8, whereas higher doses (50 to
100 μM, cytotoxic) inhibit it [40]. Similarly, as described for immune cells, low doses (10–20 μM) of
DON potentate the effects of pro-inflammatory molecules such as cytokines or bacteria components
(flagella, LPS) on intestinal IL-8 secretion, whereas higher doses of DON inhibit it [40,116]. Taken
together, such a biphasic effect explains why DON acts: (i) as a proinflammatory toxin leading to
intestinal inflammation at low doses; and (ii) as an inhibitor of the intestinal immunity leading to
higher susceptibility of animals to intestinal infections at higher doses [14,40,118,119].
Taken together, the opening of tight junctions, the increase in the bacterial translocation, and the
decrease in the mucus production caused by DON may promote the passage across the intestinal
epithelium of xenobiotics (pharmaceutics, pesticides, others mycotoxins), harmful molecules (prion,
bacterial toxins, alimentary allergens) and pathogenic micro-organisms (bacteria, fungi, viruses)
present in food and water.
As detailed below, in addition to local effects, the alterations by DON of the intestinal functions,
including epithelial innate immunity, may have consequences on the systemic immunity (part 3.3.)
and on the brain functions (part 3.4.).
3.3. Impacts of DON on the Immune Functions
The second organ system targeted by DON once the toxin has crossed the intestinal epithelium
is the immune system. In vivo and in vitro studies have shown that immune cells (including
macrophages, B and T lymphocytes and natural killer (NK) cells) are very sensitive to DON and its toxic
derivatives (3/15ADON), exposure to the toxin leading either to immunostimulatory/inflammatory
or immunosuppressive effects depending of the dose, as demonstrated with IEC (Figure 9 and
Table 1) [5–8,12,93,120,121].
Due to their ability to phagocytose pathogens, to present antigens and to secrete cytokines
regulating B/T cells functions, monocytes/macrophages are critical in the immune system as they
link together the innate and the acquired immune responses [122]. Macrophages are highly sensitive
to DON exposure. Stimulation of macrophages with low doses of DON (nM range) causes their
activation, the secretion of inflammatory cytokines such as IL-1β, IL-2, IL-4, IL-5, IL-6 and TNFα
and the expression of intracellular proteins involved in the innate immunity such as COX-2 and
iNOS through the selective activation of ERK, NFκB and activator protein-1 (AP-1) [5–8,123–125]. In
addition to its direct stimulatory effect, DON at low doses also potentates the stimulatory effects of
cytokines/bacterial components on macrophages [124,125]. In parallel to macrophage activation, low
doses of DON also affect their ability to phagocytose and to kill bacteria, leading either to a decrease or
an increase in the phagocytosis depending of the type of bacteria used in the assay [109,126]. As shown
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with IEC, higher doses of DON (μM range) possess suppressive effects on macrophage activations
(cytokine secretion, phagocytosis, bacterial killing) and induce their apoptosis [124,125,127] such
deleterious effects certainly contributing to the observed increase in the susceptibility to infection
of animals exposed to DON [119,127,128]. As mentioned in part 3.1., it has to be noted that both
macrophage activation and apoptosis induced by DON depend on the type of MAP kinases activated,
i.e., ERK for the survival/activation signal and p38 for the inhibition/pro-apoptotic signal [6–8]. It is
interesting to note that macrophages are the most sensitive cells regarding DON toxicity, such cells
being 10 to 100-fold more sensitive compared to other cell types, including fibroblasts, lymphocytes,
IEC or astrocytes. Hypotheses could only be formulated regarding such differences, the higher
sensitivity of macrophages to DON toxicity relying either on: (i) a potential and unproved higher
ability of DON to enter/accumulate in these cells; and/or (ii) on a specific activation of JAK/STAT
pathway leading to apoptosis in these cells [129]. In addition to impacting the innate immunity,
alterations of the macrophage functions by DON also affect the acquired immune response. Thus, the
decrease in the phagocytosis/bacterial killing and cytokine production induced by DON may inhibit
the ability of macrophages to play their role as antigen-presenting cells (APC) and to activate B and T
cells. Accordingly, macrophage perturbation was proposed to play a role in the aberrant production of
IgA by the B cells of the intestinal Peyer’s patches [130,131].
Independently of the alterations of the macrophages, DON also affects the proliferation and
functions of lymphocytes, including B, T and NK cells.
Natural killer (NK) cells are effector lymphocytes of the innate immunity playing an important
role in the immune surveillance against tumors and microbial infections [132]. Low doses of DON
(150–300 nM) are able to inhibit the activity of human NK cells suggesting that DON exposure could
indirectly favor the emergence of tumors through a decrease in the immune vigilance associated to NK
cells, at least in humans [93].
DON also affects lymphocytes of the acquired immunity (B and T cells). At high doses (superior
to 10 μM), DON causes the apoptosis of lymphocytes, leading to immuno-suppression, increased
susceptibility to infection, reactivation of latent infections and decreased vaccine efficiency [6–8,119,128,
133,134]. At lower doses, DON has a biphasic effect on the mitogen-induced proliferation of human
and animal lymphocytes, 1 to 30 nM of toxin stimulating the proliferation, whereas 100 to 600 nM
of DON suppress it [134,135]. At low doses (nM), DON also increases the expression of cytokines by
lymphocytes, including IL-2, IL-4, IL-6, IL-8 and TNFα [136]. Alterations of the lymphocyte proliferation
and of the secretion of particular cytokines may explain the imbalance in the Th1/Th17/Th2 immune
responses observed after intoxication of the animals with DON. In mice, DON exposure results in a
parallel suppression and stimulation of the systemic Th1 and Th2 immune responses, respectively [119].
Similarly, exposure of intestinal explants from pigs to DON at 10 μM causes a profound alteration of
the intestinal Th17 immune response with a selective increase in the expression of genes associated to
the pathogenic/inflammatory Th17 cells (i.e., IL-23A, IL-22, IL-21) without affecting the expression
of the genes associated to the regulatory/protective Th17 cells (i.e., the anti-inflammatory cytokine
IL-10 and TGF-β) [117]. Modification of the secretion of cytokines by T cells and macrophages located
in the Peyer’s patches could also explain how DON modifies the production of antibodies by the B
cells, the exposure to DON being characterized by an increase in the production of IgA and a parallel
decrease in the production of IgM and IgG [130,131,134,137]. Importantly, part of the IgA produced
after exposure to DON reacts with self-antigens and gut bacteria as observed in IBD [138]. Based on
the ability of DON to cause intestinal and immune alterations mimicking the one found in IBD, we
proposed in 2010 that DON could play a role in such diseases, our hypothesis being now defended by
others and, more importantly, being confirmed by the recent work conducted on pigs by Oswald’s
group showing the activation of intestinal pathogenic Th17 at 10 μM of DON [14,117].
The effects of DON derivatives on immune cells have been studied. As observed with other
cell systems, DOM-1 and glucuronide-DON have been found non-toxic to immune cells [61,139],
no studies having tested the effect of D3G. Regarding acetyl-DON derivatives, it has been shown
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that 3ADON and 15ADON are less toxic than DON to human and mouse lymphocytes [91–93,120],
difference compared to DON in their ability to enter the cells and/or to bind to ribosomes potentially
explaining it (see part 3.1.).
In addition to affecting the immunity, alterations of the immune cells by DON could affect the
intestinal and the brain functions. Indeed, local activation of intestinal immune cells by DON could
reinforce the direct proinflammatory effect of DON on IEC through a vicious circle in which IEC
and immune cell-mediated inflammations potentate each other as described in IBD [14]. In addition,
intestinal and systemic production of cytokines could affect the endocrine system and the brain
functions and thus participate in the growth retardation, feed refusal and emesis caused by DON as
explained below.
3.4. Impacts of DON on the Brain and Endocrine Functions
Studies have demonstrated that DON affects the nervous and the endocrine systems (Figure 9
and Table 1).
Regarding the endocrine perturbations, it was shown that DON (at 0.3–3 μM) modifies the gene
expression, viability and synthesis/secretion of steroid hormones by human adrenocortical cells,
causing an increase in the secretion of progesterone and a parallel decrease in the production of
testosterone, estradiol and cortisol [140]. Stimulatory effect of DON on the secretion of progesterone
was furthermore confirmed in animals, such endocrine perturbation potentially leading to reproductive
toxicity [141,142]. Systemic inflammation induced by nanomolar doses of DON also causes the
production of suppressors of cytokine signaling (SOCS) able to inhibit the induction by the growth
hormone of the hepatic secretion of IGF-1 and IGF acid labile subunit (IGFALS) eventually resulting
in growth retardation [143,144]. Finally, DON increases the secretion of insulin and of the gut satiety
hormone peptide YY (PYY), two hormones with anorexic action [145,146]. Importantly, antagonist of
the PYY receptor partially prevents the anorexigenic effect of DON, showing that PYY plays a role in
the anorexia induced by DON [146].
In addition to endocrine perturbations, DON causes perturbations of brain cells. As mentioned
in Section 2.5, part of the plasmatic DON is able to cross the BBB to directly act on neurons and
glial cells forming the brain [74,75]. An in vitro study conducted on brain cells isolated from newborn
rats has shown that DON affects the viability and functions of astrocytes and microglial cells [147].
The sensitivity of astrocytes to DON toxicity is similar to the one observed with epithelial cells or
lymphocytes (IC50 of 31 μM on the cell viability). Microglial cells, in accordance with their origin
(monocytes) are much more sensitive to DON toxicity with an IC50 of 259 nM on cell survival (more
than 100-fold difference compared to astrocytes). Whether or not the higher sensitivity of microglia to
DON toxicity relies on JAK/STAT pathway activation as observed for monocytes/macrophages [129]
remains to be determined. In addition to affect their viability, DON is also able to modify the functions
of glial cells. DON has a biphasic effect on the microglia-associated neuro-inflammation [147]. At doses
inferior or equal to 100 nM, DON potentates the neuro-inflammation caused by LPS in terms of iNOS
induction and TNF-α secretion. Conversely, at doses superior to 300 nM, DON dose-dependently
inhibits the neuro-inflammation induced by LPS certainly through a general cytotoxic effect of DON
on microglia [147]. We also found that DON, at doses not causing toxicity to astrocytes, inhibits their
ability to reabsorb the excitatory neurotransmitter glutamate through EAAT1/2 transporters (IC50
= 50 nM, total inhibition at 1 μM) [147]. Surprisingly and contrarily to what we found with another
mycotoxin, ochratoxin A [148], such inhibition is associated to a massive increase in the membrane
expression of EAAT1/2 through an unidentified mechanism. Inhibition induced by DON of the
glutamate uptake by astrocytes may have major consequences since this activity prevents neuronal
damage caused by high excitotoxic extracellular glutamate concentrations [149] and that perturbation
of glutamate clearance by astrocytes could also contribute to brain tumor progression [150], pain
hypersensitivity [151] and to alterations in learning and memory consolidation [152]. Although very
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interesting, these in vitro data showing the perturbation of glial cells by DON now need to be confirmed
by in vivo studies.
In vivo studies have shown that DON affects the activity of brain neurons, particularly in relation
to anorexia and emesis; exposure of pigs to 10–75 or >150 μg of DON/kg BW (body weight)/day
causing partial/total feed refusal or vomiting, respectively (for review: [153]). Importantly, higher
doses of DON are required in mice, i.e., 0.5 to 5 mg/kg of BW causing anorexia, suggesting that pigs
are more sensitive to brain effects than mice [153]. This could be related to the higher ability of DON to
cross the BBB in pigs compared to mice (30% versus 10% of the plasmatic DON reaching the CSF in pigs
and mice, respectively [74,75]) and/or to a higher sensitivity of pigs to emetic/anorexigenic stimuli,
the important question being whether or not humans are closer to pigs or mice regarding the brain
effects of DON. Regarding the mechanism involved in feed behavior effects of DON, it was first shown
that emesis and anorexia induced by DON rely on central serotoninergic activities, as demonstrated for
other emetic molecules [154–156]. An in vivo study conducted on rats next identified a role of neurons
from the area postrema in the DON-induced conditioned taste aversion [157]. More recently, in vivo
studies proved that oral exposure to DON at 1 mg/kg of BW and at 6 to 25 mg/kg of BW in pigs and
mice, respectively, activates central anorexigenic neurocircuitries, including POMC and nesfatin-1
neurons present in specific area of the brain controlling the food intake and the vomiting [158–160].
Furthermore, it was demonstrated that, in addition to systemic/peripheral inflammation, DON also
causes a central neuro-inflammation with an increased expression of proinflammatory molecules
in the brain, including IL-1β and TNF-α and the anorexigenic prostaglandin PGE2 synthesized by
mPGES-1 [159]. Although it was initially proposed that central and/or peripheral inflammation may
cause the DON-induced anorexia as observed with LPS [161], in vivo data do not support such a
hypothesis. Indeed, inhibition of the TNF-α signaling does not affect DON-induced anorexia [162].
Similarly, the section of the vagus nerve known to prevent the anorexigenic effect of peripheral
inflammation induced by LPS does not affect DON-induced brain activation [158]. Finally, DON still
causes anorexia in mPGES-1 knock-out mice that are resistant to anorexia induced by LPS, showing
that peripheral and central inflammations caused by DON are not involved in the DON-induced
anorexia and that, although LPS and DON activate a similar brain area, they use different mechanisms
to do so [159]. At present, the exact mechanism involved in DON-induced anorexia is still a mystery.
One could speculate, based on an antagonist study, that the intestinal secretion of PYY induced by DON
is totally responsible for its anorexigenic action [146]. However, the fact that the direct injection of DON
in the CSF leads to activation of the anorexigenic neurons and to anorexia rule out such a hypothesis.
Accordingly, although peripheral secretion of PYY could play a role, DON-induced anorexia certainly
also depends on the central effect of the toxin independently of its neuro-inflammatory effect [159].
We could propose that DON either activates neurons directly involved in feed refusal and/or affects
glial cells regulating anorexigenic neuronal circuitries [163]. Future studies should help confirm such
a hypothesis.
Not a lot of studies have looked at the brain effects of DON derivatives. 3ADON and 15ADON
possess similar anorexic effects compared to DON, potentially in accordance with the fast and efficient
conversion of such derivatives in DON when they enter the body [164]. The absence of DOM-1 and
D3/15GA in the CSF of intoxicated animals suggests that such metabolites are not able to cross the
BBB or to enter the brain [74].
4. Conclusions: Global View of the Effects of DON and Risk Assessment for Humans Exposed
to DON
In vivo and in vitro studies have demonstrated that DON is able to alter the functions of the gut,
the immune system, the endocrine system and the brain, modifications of each system happening
at specific doses of DON and potentially affecting the functions of the others (Figure 9 and Table 1).
DON-induced perturbations of the intestinal functions and of the intestinal immunity are observed
at micromolar doses. Although the intestine is thus the less sensitive organ system regarding DON
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toxicity, we have to remember that the intestine is also the organ system exposed to the higher
doses of DON, making DON-induced perturbation of the gut likely in case of ingestion of the toxin.
In addition to affecting the gut functions, intestinal effects of DON also lead to alteration of the systemic
immunity and of the endocrine/brain systems through the release of proinflammatory cytokines and
of gut-associated hormones, such as the anorexigenic hormone PYY. Alterations of the immune system
observed at nanomolar to micromolar concentrations of DON, in addition to affecting the immunity,
may impact the intestinal and the neuro-endocrine functions through a vicious cycle, as observed in
IBD or in the case of the peripheral inflammation caused by LPS [14,161]. Finally, perturbations of the
neuro-endocrine system, in addition to causing modifications of the behavior including appetite, in
turn affect the gut and the immune system functions through the release of neuro-endocrine mediators.
Importantly, DON-induced inflammation of the intestine and brain could increase the permeability of
the intestinal and blood-brain barriers and thus increase the crossing of these barriers by DON (and
others toxins), ultimately affecting its bioavailability and its toxicity.
The use of highly innovative and promising methods based on the measurement of exposure
biomarkers has shown that humans are significantly exposed to DON and its derivatives [165–167].
Although DON-induced perturbations have been demonstrated both in vivo and in vitro, one major
question remains: are the doses causing such alterations realistic? To be as straightforward as possible,
are the doses causing intestinal/immune/neuro-endocrine effects susceptible to be reached in humans
exposed to food contaminated by DON? To address this question, we compare in Table 1: (i) the
concentrations of DON potentially found in the intestinal lumen, the blood and the CSF, based on
its provisional maximum tolerable daily intake (PMTDI) and the higher range of exposure in adult
and children to DON obtained from the Joint FAO/WHO Expert Committee on Food Additives
(JECFA) [14]; to (ii) the doses of DON required to cause alterations in the gut, the immune/endocrine
system or the brain. Concentrations of DON in the intestinal lumen, the blood and the CSF have been
estimated using the PMTDI/higher exposure of DON and assuming that: (i) a human adult has a
body weight of 70 kg, a global small intestinal volume of 1 L (considering the net intake/secretion
(around 9 L) and absorption (around 8 L) of water by the gut), and a blood volume of 5 L; and that (ii)
toxicokinetics data obtained with pigs orally exposed to DON could be extrapolated to humans [14,74].
On the basis of a PMTDI of 1 μg/kg of BW per day for DON, toxin concentrations should be: 210, 1.5
and 0.45 nM in the intestinal lumen, the blood and the CSF, respectively. On the basis of the worldwide
higher exposure in adult and children to DON obtained from the Joint FAO/WHO Expert Committee
on Food Additives (JECFA) (0.78 to 2.4 μg/kg of BW per day), DON concentrations would reach
maximal values of 504, 3.6 and 1.08 nM in the intestine, the blood and the CSF, respectively.
From the analysis of Table 1, it clearly appears that, as suggested by others and us [14,168],
DON represents a risk to human health based on the presence of a low safety factor (inferior to
30) between the doses of DON affecting cell functions and the doses of DON susceptible to be
present in relation to its actual PMTDI. The risk concerns mainly the intestinal and immune systems
and the brain; DON effects on the endocrine system are being unlikely to be observed in humans
exposed to DON at doses close to its PMTDI. Importantly, the risk could be even higher than
supposed since the toxicokinetic profile (intestinal absorption, detoxification, excretion, BBB crossing)
and/or the cellular effects of DON could be affected by factors not considered in our calculation.
This includes: (i) the concomitant presence in food of others xenobiotics and toxins such as drugs,
heavy metals, pesticides, bacterial/plant toxins or others mycotoxins [169]; and (ii) the exposure of
particular populations to DON, including: vegans/macrobiotics, children and patients suffering from
bacterial/viral infection, renal/hepatic diseases, IBD, compromised immunity, neurological disorders
or cancers, these populations being at higher risk regarding DON effects [14,170].
Taken together, such observations should alert food agencies and potentially lead to the
reevaluation of the actual PMTDI for DON, particularly as new DON metabolites have been found
in plants and food products, including DON-oligoglycosides, DON-glutathione, DON-S-Cysteine,
DON-S-Cysteinyl-glycine, DON-sulfonate. Such derivatives represent new “masked” toxins not yet
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considered in the total intake of DON and for which few or no data are available regarding their
intestinal transformation/absorption and their cellular toxicity [139,171,172].
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Abstract: Fourier-transform-near infrared (FT-NIR) spectroscopy has been used to develop
quantitative and classification models for the prediction of deoxynivalenol (DON) levels in durum
wheat samples. Partial least-squares (PLS) regression analysis was used to determine DON in wheat
samples in the range of <50–16,000 μg/kg DON. The model displayed a large root mean square error
of prediction value (1,977 μg/kg) as compared to the EU maximum limit for DON in unprocessed
durum wheat (i.e., 1,750 μg/kg), thus making the PLS approach unsuitable for quantitative prediction
of DON in durum wheat. Linear discriminant analysis (LDA) was successfully used to differentiate
wheat samples based on their DON content. A first approach used LDA to group wheat samples
into three classes: A (DON ≤ 1,000 μg/kg), B (1,000 < DON ≤ 2,500 μg/kg), and C (DON > 2,500
μg/kg) (LDA I). A second approach was used to discriminate highly contaminated wheat samples
based on three different cut-off limits, namely 1,000 (LDA II), 1,200 (LDA III) and 1,400 μg/kg DON
(LDA IV). The overall classification and false compliant rates for the three models were 75%–90% and
3%–7%, respectively, with model LDA IV using a cut-off of 1,400 μg/kg fulfilling the requirement
of the European official guidelines for screening methods. These findings confirmed the suitability
of FT-NIR to screen a large number of wheat samples for DON contamination and to verify the
compliance with EU regulation.
Keywords: deoxynivalenol; FT-NIR; rapid method; wheat; LDA; PLS
1. Introduction
Deoxynivalenol (DON), also known as vomitoxin, is a type B trichothecene mycotoxin. It is
one of the major secondary metabolites produced by fungi of the Fusarium genus, mainly Fusarium
graminearum and Fusarium culmorum, and occurs predominantly in grains, such as wheat, maize, barley,
oats and rye [1]. DON inhibits the synthesis of DNA, RNA and proteins and has a hemolytic effect on
erythrocytes. DON can cause feed refusal, vomiting, reduced weight gain, diarrhea, hemorrhage, skin
lesions, growth depression and immunosuppression, which have a negative impact on human and
animal health [2–6]. In order to protect consumers from exposure to DON through the consumption
of cereal-based food products, the European Commission has set maximum permitted levels for
DON ranging from 200 μg/kg for processed cereal-based food for infants and young children up to
1,750 μg/kg for unprocessed durum wheat, maize and oats [7].
Analytical methods for rapid, sensitive and accurate determination of DON in foods and feeds
are highly demanded for exposure risk assessment studies and to enforce regulatory requirements
issued by governments and international organizations. A number of analytical methods, such
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as gas chromatography (GC) with electron-capture or mass spectrometric (MS) detection and
high-performance liquid chromatography (HPLC) based on UV or MS detection have been developed
to quantitatively measure DON concentration in cereals and derived products [8–10]. Although these
traditional methods are sensitive and accurate, most of them involve expensive and time-consuming
steps, including sample cleanup and detection, being unsuitable for screening purposes. Large amounts
of cereals are processed in the food and feed industry each year, and frequent checks are required
to verify the compliance of raw materials with regulation, resulting in a large number of samples
to be analyzed. Factors, like promptness and low cost of analysis, minimal sample preparation and
environmentally-friendly methods, are of paramount importance to rapidly respond to the demands
of the market. In the last few decades, a variety of rapid methods based on competitive enzyme-linked
immunosorbent assays (ELISA) or on novel technologies, including lateral flow devices (LFD),
membrane-based flow-through enzyme immunoassay, fluorescence polarization (FP) immunoassay,
molecularly imprinted polymers (MIP) and surface plasmon resonance (SPR) biosensors, have been
reported for the rapid analysis of DON [8,11,12]. However, these methods are destructive, require
an extraction step and, in some cases, a clean-up procedure. Recently, a rapid, easy to-perform and
non-invasive method using an electronic nose based on metal oxide sensors to distinguish the quality
of durum wheat samples based on the content of DON has been reported [13]. Infrared spectroscopy
(IR) has gained wide acceptance within food and feed analysis as a rapid analytical tool that requires
minimal or no sample preparation, and in contrast with traditional chromatographic analysis, it does
not require reagents, nor does it produce chemical waste. Near-infrared (NIR) or mid-infrared (MIR)
spectroscopy techniques, both in combination or not with Fourier-transform (FT), are commonly
used in a remarkably wide range of applications for the analysis of moisture, oil, fiber, starch,
lipids, protein, yeast and bacteria in agricultural products [14,15]. In recent years, the potential
of using IR spectroscopy for the detection of mycotoxins, including DON, ochratoxin A, fumonisins
and aflatoxins, and mycotoxigenic fungal contamination in cereals and cereal products has been
also demonstrated [16–37]. Among mycotoxins, the most investigated one was DON, mainly in
Fusarium-damaged wheat kernels and ground wheat [16,18–20,22–24,34] and to a lesser extent in
maize, barley and oat [17,21,32,33]. The majority of these IR methods for the determination of DON in
wheat is based on NIR or UV-Vis-NIR spectroscopy. The feasibility of using FT-NIR spectroscopy for
the qualitative and quantitative prediction of DON in unprocessed ground durum and common wheat
was reported for the first time by our research group [19]. Performance results suggested the use of
FT-NIR as a sorting tool for screening purposes; however, both qualitative and quantitative models
merited further implementation in a larger study involving more wheat samples with a homogeneous
distribution of DON levels around the EU maximum limit (i.e., 1,750 μg/kg) for unprocessed durum
wheat in order to make the model more robust and reliable [19]. Moreover, the classification model
included both common and durum wheat samples and used a cut-off level (300 μg/kg) far from the
EU maximum limit (ML) to distinguish the two classes of wheat samples [19]. FT-NIR spectroscopy for
DON determination in whole wheat kernels was also reported by some authors [23,34]. The advantages
of FT include improvement in the spectral reproducibility and the accuracy and precision of wavelength
discrimination [28].
The objective of this research was to develop a robust, rapid and inexpensive FT-NIR method for
the analysis of DON-contaminated ground durum wheat samples and to verify the compliance with
European regulations. Both quantitative and classification models were developed and validated to
establish the most suitable approach to estimate DON in unprocessed durum wheat. The proposed
FT-NIR classification method as a first screening step for DON detection in samples could provide a
high-throughput analysis platform that could improve food and feed safety at mills and could be used
for monitoring programs.
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2. Results and Discussion
DON levels in the 464 durum wheat samples varied from <50 μg/kg (quantification limit of the
HPLC method) to 16,000 μg/kg, with mean and median values of 2,390 and 1,100 μg/kg, respectively.
This concentration range covered the majority of DON concentrations found in the routine surveillance
samples in wheat supply chains and was appropriate for the scope of the study to develop calibration
and classification models. Although the positive skewness and kurtosis values of DON concentrations
indicated that the number of highly-contaminated wheat samples was less than that of wheat samples
with no or low values of DON contamination, there was an approximately fifty-fifty distribution of
DON levels around the EU ML for unprocessed durum wheat (1,750 μg/kg); in particular, 57% of the
tested samples contained DON levels less than ML, whereas the remaining 43% of samples exceed
this threshold.
Wheat samples were analyzed by FT-NIR spectroscopy, and spectra were recorded as absorbance
between 10,000–4,000 cm−1. Figure 1 shows the FT-NIR raw spectra of five different unprocessed
ground wheat samples contaminated in the range of <50 μg/kg to about 10,000 μg/kg DON. From the
comparison of these spectra, it appears that wheat samples contaminated with low DON levels have
FT-NIR bands in common with those containing high DON levels, thus indicating that the major



























Figure 1. FT-NIR spectra of five different ground unprocessed durum wheat samples contaminated
with increasing levels (from <50 to 9,960 μg/kg) of deoxynivalenol (DON) (as measured by the reference
HPLC method).
2.1. Quantification of DON in Contaminated Wheat Sample
In our previous work, we evaluated the ability of using FT-NIR spectroscopy for the determination
of DON in durum wheat at levels between <50 μg/kg and 2,700 μg/kg by using the statistical approach
of partial least squares (PLS) regression [19]. The performance results provided good evidence of the
feasibility of using FT-NIR spectroscopy as a screening tool for the determination of DON in wheat
samples. However, the inhomogeneous distribution of DON levels around the EU ML for unprocessed
durum wheat (i.e., 94% of samples with DON levels <1,750 μg/kg) made the model poorly robust [19].
Based on these findings, we further implemented the PLS model in a larger study involving more
calibration and validation samples with a larger concentration range of DON. The resulting PLS model
35
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(PLS I) covered the range of DON concentration from <50 to 16,000 μg/kg and included 232 samples
for the calibration set and 232 for the validation one. The model was developed with eight PLS factors,
explaining 80% of the total variance of the entire set of calibration data. The slope and the coefficient of
determination (r2) values (both 0.802) of the calibration regression curve indicated that the PLS model
can be used for screening and approximate calibrations with a root mean squares error of calibration
(RMSEC) value of 1,473 μg/kg DON. However, the r2 value of the validation regression curve was
0.630, indicating that the PLS model was only usable for a rough screening of wheat samples and
showed a root mean squared error of prediction (RMSEP) of 1,977 μg/kg DON that was considered
very large with respect to the EU ML. Furthermore, based on the residual predictive deviation (RPD)
(1.72) and range error ratio (RER) (6.89) values, the model had a very poor classification ability and
was not recommended for any purpose. Figure 2 shows the PLS validation plot of the measured data
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Figure 2. Partial least squares (PLS) regression plot of measured (by HPLC) and estimated (by FT-NIR)
DON concentrations in the validation set (model PLS I).
It is well known that fungal infections of kernels cause multiple changes of kernel composition
and pigmentation, thus causing spectral variability [38]. To evaluate if high contamination levels of
DON were responsible for the poor classification ability of PLS I, samples containing DON levels
between 6,000 and 16,000 μg/kg DON were excluded from the dataset, and another PLS model was
developed (PLS II). The model included 204 samples for the calibration set and 204 for the validation
one with 65% of wheat samples with DON levels less than 1,750 μg/kg. With respect to PLS I, similar
results were obtained for PLS II in terms of slope (0.749) and intercept (427 μg/kg), whereas the values
of RMSEC and RMSEP were 753 μg/kg and 868 μg/kg, respectively. Although the RMSEP value
36
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of model PLS II was lower than that obtained with model PLS I, in both cases, it corresponded to
approximately 14% of the entire range of DON concentration in the samples used in the models. As for
model PLS I, the RPD value (1.66) indicated that model PLS II was not recommended for any purpose.
PLS results obtained in the present study were in agreement with those reported by Dvoracek et al. [23],
which applied the FT-NIR spectroscopy to the determination of DON in wheat kernels in the range of
0–13,000μg/kg and 0–5,000μg/kg DON. Based on these observations we concluded that the PLS approach
was unsuitable for the aim of the study; therefore, the classification one was used.
2.2. Classification of DON Contaminated Wheat Samples
The classification LDA models proposed herein have been developed on a huge number of durum
wheat samples with a broad range of DON contamination levels. The resulting models covered the
range of DON concentration from <50 to 16,000 μg/kg and included 232 samples for the calibration set
and 232 for the validation one. Initially, the spectra were treated using principal components analysis
(PCA). The first 10 principal components, accounting for more than 99% of the total variance, were
selected as input variables for the LDA. Two different approaches were used to develop LDA models in
order to find the most suitable one to estimate DON in durum wheat samples. With the first approach
(LDA I), wheat samples were classified into three groups based on DON contamination levels: Class A
(DON content less than 1,000 μg/kg), Class B (DON content ranging from 1,000 to 2,500 μg/kg) and
Class C (DON content more than 2,500 μg/kg). A discriminant model was then developed to classify
ground wheat samples into the three DON contamination groups. The overall classification rate was
82% during the calibration process. In particular, 77% of acceptable samples were correctly classified
into Class A; 75% of wheat samples with DON levels to be confirmed with a reference method were
correctly classified as Class B; and 94% of rejectable samples were correctly classified into Class C.
The model was then validated by using an independent dataset. Results are reported in Table 1.
Table 1. Validation results of the linear discriminant classification model (LDA I). The first column
indicates the class (A, B and C) assigned by the HPLC reference analysis, whereas the other three
columns refer to the class predicted by LDA analysis.
Assigned class a
(by HPLC reference analysis)
Number of samples classified in the predicted classes (by FT-NIR analysis)
A B C
A 92 22 4
B 6 18 13
C 2 12 63
Overall classification rate (%) 75
FC samples (%) b 3
FNC samples (%) c 7
a A: DON ≤ 1,000 μg/kg; B: 1,000 μg/kg < DON ≤ 2,500 μg/kg; C: DON > 2,500 μg/kg; b FC, false compliant;
c FNC, false, not compliant. .
The validated model achieved an overall classification rate of 75% with a comparable classification
rate for Class A and Class C (approximately 80%) and lower for Class B (49%). In particular, wheat
samples belonging to Class B were classified as either Class A (16%) or Class C (35%) (Table 1). From
Figure 3, showing the LDA score plot of wheat samples naturally contaminated with DON and
classified into three contamination groups, a scattered distribution of samples of Class A and a partial
overlapping of Class B to the contiguous Classes A and C is clearly evident. By looking inside these
overlapped samples, five of 22 samples of Class A that were incorrectly classified as Class B had DON
levels close to the cut-off of 1,000 μg/kg (i.e., from 700 to 1,000 μg/kg). Similarly, nine of 13 samples of
Class B that were incorrectly classified as Class C were contaminated with DON levels close to the
cut-off of 2,500 μg/kg (i.e., from 1,900 to 2,500 μg/kg). The low discrimination ability of the model
around the cut-off limits was probably due to the lower number of samples representing Class B as
37
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compared to the other two classes in the calibration set, thus making the model poorly balanced for
wheat samples with contamination levels in the range of 1,000–2,500 μg/kg DON. The European
official guidelines for analytical methods recommend that only those validated methods that have a
false compliant (FC) rate <5% at the level of interest shall be used for screening purposes, whereas
suspected non-compliant results shall be confirmed by a confirmatory method [38]. Despite the low
discrimination ability of the model LDA I for samples belonging to Class B, the amount of FC samples
(eight out of 232) accounted for 3% and fulfilled the requirement of the European official guidelines for




























Figure 3. Linear discriminant analysis score plot for FT-NIR spectra of wheat samples naturally
contaminated with varying DON content (validation set). Class A: DON ≤ 1,000 μg/kg; Class B:
1,000 μg/kg < DON ≤ 2,500 μg/kg; Class C: DON > 2,500 μg/kg.
With the second approach, wheat samples were classified into two groups based on a cut-off
level of DON to distinguish them. Three different LDA models were developed using cut-off levels of
1,000, 1,200 and 1,400 μg/kg DON (LDA II–IV, respectively), in order to find the optimal threshold
allowing the highest classification rate of wheat samples. The overall classification rate in the calibration
processes was in the range of 91%–92% with FC values of 3%–7%. When the models were validated, the
overall classification rates were still good (89%–90%, Table 2) and in agreement with those obtained in
the calibration process, indicating the good robustness of the developed LDA models. Moreover, model
LDA IV using a cut-off of 1,400 μg/kg fulfilled the requirement of the European official guidelines
for analytical methods [38] and was considered the most reliable one for the screening of DON in
unprocessed durum wheat. Good results in terms of repeatability (<2%) and within-laboratory
reproducibility (<3%) were also obtained for all LDA models, indicating the robustness of the
measurements and the instrumental stability over a period of time.
Considering that wheat samples used in the calibration and validation sets belonged to different
cultivars or mixtures of cultivars and were obtained in different periods from field crops located in
different Italian regions, it was unrealistic to expect 100% correct classification. Although a slight
misclassification occurred, advantages in terms of costs and the rapidity of analysis makes classification
model LDA IV a useful screening tool for the analysis of a large number of durum wheat samples and
to verify the compliance with legislation by reducing the number of samples to be confirmed with a
reference method.
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Table 2. Validation results of the linear discriminant classification models (LDA II-IV) using different
cut-off levels of DON.
Classification results
Discrimination models (cut-off DON, μg/kg)
LDA II (1,000) LDA III (1,200) LDA IV (1,400)
Overall classification rate (%) 89 90 90
FC samples (%) a 7 6 5
FNC samples (%) b 4 4 5
a FC, false compliant; b FNC, false, not compliant.
Classification results obtained in the present paper represent a great improvement in terms of the
robustness of the model and DON correct prediction as compared to those reported in our previous
work [19]. These findings are also better than those reported by Dvoracek et al. [23], which applied the
LDA to classify 400 intact wheat grain samples into two classes using four different cut-off levels in the
range of 1,250 to 30,000 μg/kg DON. Although performance indexes were 89%–93%, the number of
misclassified samples increased with the decreasing of the cut-off level, with the model using a cut-off
of 1,250 μg/kg DON giving approximately 40% of misclassified samples. These results were probably
related to the use of intact wheat kernels, which made the use of FT-NIR spectroscopy perform poorly
at contamination levels close to the EU ML [23]. On the other hand, our findings indicate that the
grinding step of unprocessed wheat is a useful step that helps to overcome the inhomogeneity problem
and allows one to obtain a representative sample to be analyzed by FT-NIR spectroscopy.
3. Experimental Section
3.1. Chemicals
Acetonitrile of HPLC grade was purchased from Mallinckrodt Baker (Milan, Italy). Ultrapure
water was produced by a Millipore Milli-Q system (Millipore, Bedford, MA, USA). Deoxynivalenol
(DON) standard was purchased from Sigma-Aldrich (Milan, Italy). DON immunoaffinity columns
(DONtest™ HPLC) were obtained from Vicam, a Waters Business (Milford, MA, USA), glass microfiber
filters (Whatman GF/A) and paper filters (Whatman No. 4) from Whatman (Maidstone, UK). The PTFE
syringe filters with a diameter of 25 mm and a pore size of 0.45 mm were bought from Teknokroma
(Barcelona, Spain).
3.2. Durum Wheat Samples
A total of 500 samples (1 kg each) of naturally contaminated durum wheat of several different
cultivars or mixtures of cultivars was obtained from field crops located in different Italian regions
during the period 2008–2013. After manual homogenization, an aliquot of each wheat sample
(about 200 g) was finely ground by the Tecator Cyclotec 1093 (International PBI, Hoganas, Sweden)
laboratory mill equipped with a 500-μm sieve and analyzed by FT-NIR spectroscopy and then by
HPLC. An additional laboratory quality control (QC) sample of unprocessed durum wheat naturally
contaminated with 1,420 ± 39 μg/kg DON was used to evaluate the repeatability and intra-laboratory
reproducibility of the best prediction model.
3.3. HPLC Analysis
DON quantitative determination was performed according to the method described by Visconti
et al. [39], with minor modifications. Briefly, 25 g of ground sample was extracted with 100 mL of
phosphate buffer solution (PBS, 10 mM sodium phosphate, 0.85% sodium chloride, pH = 7.4) by
blending at high speed for 2 min with a Sorvall Omnimixer (Sorvall Instruments, Norwalk, CN,
USA). The extract was filtered through both filter paper (Whatman No. 4) and glass microfiber filter
(Whatman GF/A), and 2 mL of the filtered extract were loaded onto the DONtest™ immunoaffinity
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column. After washing the column by passing 5 mL of water through it, DON was recovered by eluting
1.5 mL of methanol. The eluate was dried under an air stream at 50 ◦C, re-dissolved into 250 μL of the
mobile phase (acetonitrile/water, 8:92; v/v), and 50 μL were injected onto the HPLC system (Agilent
1100 Series, Agilent Technology, Palo Alto, CA, USA) with the diode array detector set at 220 nm.
3.4. FT-NIR Analysis
FT-NIR spectra were recorded using an Antaris II FT-NIR spectrophotometer (Thermo Electron
Corporation, Madison, WI, USA) equipped with an interferometer, an integrating sphere working in
diffuse reflection and an indium and gallium arsenide (InGaAs) detector. A sample-cup spinner
allowed the automatic collection of several sub-scans from each sample that were averaged to
obtain representative spectra. The integrating sphere’s internal reference was also used to collect
the background spectrum. Approximately 30 g of ground wheat samples were placed on the rotary
sample-cup spinner, and 64 interferometer sub-scans in ranges from 10,000 to 4,000 cm−1, with a
resolution of 8 cm−1, were applied for the collection of each spectrum sample by means of the software,
Results Integration v3.0.197 (Thermo Electron Corporation, Madison, WI, USA, 2006).
3.5. Spectral Data Preprocessing and Outlier Identification
The final spectral data were imported as SPA/SPG (Omnic) format into The Unscrambler® X,
v10.1 (CAMO Software AS, Oslo, Norway, 2011) software in order to perform multivariate statistical
analysis. Some preliminary descriptive analyses were performed by both graphic tools (histogram or
spectra visualization) and numerical results (mean, minimum, maximum, standard deviation, number
of missing data, etc.). Then, to remove the spectral baseline shift, noise and light scatter influence,
some spectral preprocessing methods were investigated before linear discriminant analysis (LDA)
or partial least squares (PLS) regression analysis. In particular, the spectra were firstly treated by
multiplicative scatter correction (MSC), then by de-trending and, finally, smoothed by a 15-point
Savitzky–Golay (2nd derivative, 2nd polynomial order) function [40]. Prior to proceeding to LDA or
PLS analysis, a principal components analysis (PCA) was also applied to the 500 wheat samples to
detect outliers or any clustering of the data. Sample outliers were detected by using the graphical tools
of the Unscrambler® X software, i.e., the Hotelling T2 line plot using a critical limit of p-value <5%
and the influence plot, displaying samples with high leverage. Samples suggested as outliers were
removed from the entire set, because their inclusion would have a detrimental effect on the model.
This procedure was repeated several times, until a total of 36 samples were considered as outliers, and
the remaining 464 samples were used for LDA and PLS model development.
3.6. Development and Validation of DON Quantitative Models
Quantitative calibration models were developed using partial least squares (PLS) regression
algorithms by correlating the DON results from HPLC reference measurements with the FT-NIR
spectra results. The PLS is a spectral decomposition technique, which finds the most relevant factors
to explain the variance in the dataset and compares the covariance between the spectral data and
DON concentration. Two PLS models were developed (PLS I and II). PLS I was developed on 464
samples in the range of concentrations of ≤50 to 16,000 μg/kg DON, whereas PLS II was developed
on 408 samples in the range of concentrations of ≤50 to 6,000 μg/kg DON. In both cases, sample
spectra were randomly divided into a calibration set (50% of samples) and a validation set (50%
samples) for developing and testing the model, respectively. Performance of the PLS models was
evaluated by calculating the coefficient of determination (r2), the slope of the calibration regression
curve and the root mean squared error of calibration (RMSEC). The final PLS models were validated
using an independent validation dataset, and the performance was evaluated according to the slope
and coefficient of determination of the validation regression curve (r2) and the root mean standard
error of prediction (RMSEP). The models’ accuracy ability was categorized as follows: r2 = 0.50–0.64,
usable for rough screening; r2 = 0.66–0.81, usable for screening and some “approximate” calibrations;
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r2 = 0.83–0.90, usable with caution; r2 = 0.92–0.96, usable in most applications; r2 > 0.98, usable in
any applications [41]. The prediction accuracy of models was also evaluated based on the residual
predictive deviation (RPD), defined as the ratio of the standard deviation of the reference DON values
in the validation set to the RMSEP [42]. The RPD evaluates how well the developed model can predict
the DON in the validation set, and the higher is its value, the greater is the prediction ability of the
model. Values of RPD from 3.1 to 4.9 are considered fair, and the model is recommended for very
rough screening purposes; values from 5.0 to 6.4 indicate that the model is good for quality control;
values from 6.5 to 8 indicate that the model is very good for process control; values higher than 8.1
indicate that the model is excellent and usable for any application [43]. Finally, the range error ratio
(RER), calculated by dividing the range of the reference DON values in the validation set by the RMSEP,
was used as a useful indicator to assess the practical utility of the calibration as a predictive model.
Both the RER and RPD standardize the RMSEP value of the model against the range and standard
deviation, respectively, of the reference data in the validation set.
3.7. Development and Validation of DON Classification Models
In order to develop a chemometric calibration model for the classification of DON-contaminated
samples, a linear discriminant analysis (LDA) was applied to the preprocessed spectral measurements.
The LDA was carried out assuming equal prior probability for each class; moreover, the first 10 principal
components (PCs) of the spectra were used as the explanatory variables to evaluate how wheat classes
were separated from each other in the spectral space. Two different approaches were followed to
develop LDA models. With the first approach (LDA I), three different classes of samples with different
DON content as determined by HPLC analysis were defined: samples with DON content less than or
equal to 1,000 μg/kg (Class A); samples with DON content ranging from 1,000 to 2,500 μg/kg (Class B);
samples with DON content higher than 2,500 μg/kg (Class C) (LDA I). The DON contamination
range for Class B was established by adding and subtracting an arbitrary measurement uncertainty
of 750 μg/kg with respect to the EC ML for DON in unprocessed durum wheat (i.e., 1,750 μg/kg).
These three classes were chosen to represent three different conditions in terms of DON contamination:
compliant samples with DON levels lower than EU ML (Class A), samples with DON concentration
to be confirmed by HPLC analysis (Class B) and rejectable (or not compliant) samples with high
DON levels (Class C). With the second approach, wheat samples were distinguished into two groups
using a cut-off limit to classify them. In particular, three classification models (LDA Models II–IV)
were developed by using three different cut-off levels of DON, i.e., 1,000 μg/kg, 1,200 μg/kg and
1,400 μg/kg. Compliant samples were considered those with DON concentrations ≤ the cut-off level
(Class A), whereas rejectable (or non-compliant) samples to be confirmed by HPLC analysis were
considered those with DON concentrations > the cut-off level (Class B). For each classification model,
a total of 464 samples spectra were randomly divided into calibration and validation sets by randomly
subdividing the available spectral data into two equal sets (i.e., 50% calibration and 50% validation)
(Table 3). The two sets covered the same concentration range of DON.
Table 3. Number of durum wheat samples in Classes A, B and C used for Model I and in Classes A
and B used for Models II–IV. For each model, the number of samples in the calibration and validation
sets was the same.
Model
Number of samples (DON, μg/kg)
Class A Class B Class C
I 118 (≤1,000) 37 (1,000–2,500) 77 (>2,500)
II 113 (≤1,000) 119 (>1,000) -
III 118 (≤1,200) 114 (>1,200) -
IV 123 (≤1,400) 109 (>1,400) -
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The LDA used pooled covariance matrices in calculating the Mahalanobis squared distance [44].
In this algorithm, a sample is assigned into one of the DON concentration groups when the squared
distance between the sample and the group is minimized. The Mahalanobis squared distances were
then calculated to classify an unknown sample from the validation data set into the DON group with
the lowest corresponding distance. The prediction ability of the chemometric models was expressed in
terms of overall discrimination rate, false compliant rate and false non-compliant rate, according to the
following equations:












where TC, TNC, FC and FNC denote the number of true compliant, true, not compliant, false compliant
and false, not compliant, respectively. Ntot denotes the number of samples in the considered class and
in the entire set (calibration or validation), respectively. The best classification model was determined
as the one with the highest overall discrimination rate and lowest false compliant samples.
The repeatability of the classification models was estimated by analyzing by FT-NIR spectroscopy
the laboratory QC sample of ground unprocessed durum wheat. The sample was analyzed ten
times under repeatability conditions, and DON levels were predicted by each LDA model (I–IV). For
each model, the repeatability was calculated as the coefficient of variation (CV) of the Mahalanobis
squared distances in the PCA of the ten measurements. The within-laboratory reproducibility of
the classification models was estimated by analyzing the same quality control sample ten times on
three different days under within-laboratory reproducibility conditions. For each model the CV was
calculated by considering the 30 measurements.
4. Conclusions
Classification and calibration methods using Fourier-transform near-infrared (FT-NIR) spectroscopy
have been developed to predict DON levels in unprocessed durum wheat samples. The quantitative PLS
models showed a very poor classification ability and were not recommended for any purpose. On the
other hand, the classification models showed good predictive performance with high overall classification
rates and low misclassification of wheat samples and fulfilled the requirement of the European official
guidelines for screening methods when a cut-off value of 1,400 μg/kg of deoxynivalenol was used.
The proposed classification model may have practical applications for screening durum wheat
samples for deoxynivalenol content, making FT-NIR spectroscopy a powerful and robust tool for
monitoring safety programs. Moreover, the speed of the procedure allows the analysis of a large
number of samples and reduces the number of samples to be confirmed with a reference method to
verify the compliance with regulation.
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Abstract: Human exposure assessment to deoxynivalenol (DON), aflatoxin B1 (AFB1), fumonisin
B1 (FB1), zearalenone (ZEA) and ochratoxin A (OTA) can be performed by measuring their urinary
biomarkers. Suitable biomarkers of exposure for these mycotoxins are DON + de-epoxydeoxynivalenol
(DOM-1), aflatoxin M1 (AFM1), FB1, ZEA + α-zearalenol (α-ZOL) + β-zearalenol (β-ZOL) and OTA,
respectively. An UPLC-MS/MS multi-biomarker method was used to detect and measure incidence
and levels of these biomarkers in urine samples of 52 volunteers resident in Apulia region in Southern
Italy. The presence of ZEA + ZOLs, OTA, DON, FB1 and AFM1 were detected in 100%, 100%, 96%,
56% and 6%, of samples, respectively. All samples contained biomarkers of two or more mycotoxins.
The mean concentrations of biomarkers ranged from 0.055 ng/mL (FB1) to 11.89 ng/mL (DON).
Urinary biomarker concentrations were used to estimate human exposure to multiple mycotoxin.
For OTA and DON, 94% and 40% of volunteers, respectively exceeded the tolerable daily intake (TDI)
for these mycotoxins. The estimated human exposure to FB1 and ZEA was largely below the TDI for
these mycotoxins for all volunteers.
Keywords: mycotoxins; biomarker; urine; UPLC-MS/MS; immunoaffinity cleanup; exposure
1. Introduction
Aflatoxins, deoxynivalenol (DON), zearalenone (ZEA), fumonisins and ochratoxin A (OTA) are
recognized as the principal mycotoxins occurring in agricultural products and their levels in food
commodities are constantly inspected worldwide. Humans can be daily exposed to mixtures of these
mycotoxins through consumption of foods contaminated with several mycotoxins or consumption
of different foods contaminated by a single mycotoxin. Data on the co-occurrence of the principal
mycotoxins in foods and beverages are increasing due to the availability and use of modern and
sensitive LC-MS/MS methodologies suitable for simultaneous determination of mycotoxins and other
fungal metabolites [1,2]. In a recent survey on 265 samples of cereal-based products commercialized
in Spain, Italy, Marocco and Tunisia, 14% of the analyzed samples were contaminated with at least
two mycotoxins and 18% of the analyzed samples were contaminated by more than two mycotoxins
simultaneously [3]. The co-occurrence of DON, ZEA and nivalenol (NIV) in winter wheat produced
in Sweden has been recently reported [4]. The presence of mixtures of aflatoxin B1 (AFB1), ZEA and
OTA was reported in samples of breakfast cereals commercialized in Spain [5]. The majority of food
commodities consumed in Cameroon were found contaminated with mixtures of mycotoxins, 21%
contained DON, ZEA and fumonisin B1 (FB1), 11% DON, AFB1, FB1 and ZEA [6]. Recently, the
co-occurrence of DON, FB1, fumonisin B2 (FB2), fumonisin B3 (FB3) and ZEA in good and moldy
maize and DON, FB1, FB2, ZEA and OTA in samples of maize based foods was reported in the former
Transkei region of South Africa [7,8].
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Exposure to mycotoxins can also originate from the ingestion of their masked forms (mycotoxins
covalently or non-covalently bound to matrix component) that are digested in the gastrointestinal tract
and released into the parent mycotoxins that become bioavailable. The occurrence of masked DON and
ZEA, either acetylated, conjugated with glucose or sulfate, has been reported in various cereals and
food samples [9]. The occurrence of masked fumonisins in processed food has also been reported but
the nature of the masking mechanism has not been fully clarified [10]. The formation of β-glucosides
of (4R)- and (4S)-5-hydroxy-OTA in germinating cereals and vegetables spiked with OTA has been
demonstrated but the occurrence of these compounds in naturally contaminated food has not been
reported [11]. The degree of human bioavailability of mycotoxins derived from their masked forms is
not known and could vary between individuals depending of the intestinal microbiota composition.
The assessment of human exposure to mycotoxins is usually performed by means of chemical
analysis of foods and beverages and results are correlated with the mean intake of analyzed
foods/beverages. The heterogeneous distribution of mycotoxins in food samples can affect the accuracy
of results obtained with this approach. Duplicate diet studies could avoid sampling issues but requires
suitable analytical methods for single or multi-mycotoxin determination and considerable commitment
from the participants.
The measurement of specific urinary mycotoxin biomarkers is a valid alternative to measure
exposure to mycotoxins providing that the excretion of biomarkers correlate well with mycotoxin intake.
Suitable urinary biomarkers for AFB1, FB1, ZEA, DON and OTA are aflatoxin M1 (AFM1), FB1, ZEA +
α-zearalenol (α-ZOL) + β-zearalenol (β-ZOL), DON + de-epoxydeoxynivalenol (DOM-1) and OTA,
respectively. These biomarkers are excreted as free and conjugated forms therefore urine samples are
usually digested with β-glucuronidase/sulfatase in order to deconjugate the conjugated forms and
increase the concentration and detectability of free analytes. Human pilot studies and epidemiological
studies based on biomarker approach have been performed for DON, AFB1, OTA and FB1. These
studies were conducted by using analytical methods tailored for determination of biomarker(s) of a
single mycotoxin [12–15]. LC-MS/MS is the ideal approach for simultaneous determination of analytes
and its use for multi-biomarker determination in human and animal urine is recently increased [8,16].
In vivo experiments demonstrated a good correlation between the amount of mixtures of DON, OTA,
ZEA, FB1 and AFB1 administered to piglets and the amount of relevant biomarkers excreted in 24 h post
dose urine. Linear dose-response correlation coefficients ranged between 0.68 and 0.78 for the tested
couples of mycotoxin/biomarker. Mean percentages of dietary mycotoxins excreted as biomarkers in
24 h post dose urine were 36.8% for ZEA, 28.5% for DON, 2.6% for FB1, 2.6% for OTA and 2.5% for
AFB1 [17]. In this paper, we report the results on the occurrence of biomarkers to DON, OTA, ZEA,
FB1 and AFB1 in urine samples of 52 volunteers resident in Apulia a region of Southern Italy.
2. Results and Discussion
The urinary concentrations of mycotoxin biomarkers could be very low for several reasons: (a) the
levels of mycotoxins in foods and beverages can be very low especially for AFB1, OTA and ZEA; (b) the
gastrointestinal absorption can be low as demonstrated for FB1, c) the serum half-life can be very high
as demonstrated for OTA. The purification protocol used in our study for simultaneous determination
of urinary DON, DOM-1, AFM1, FB1, ZEA, α-ZOL, β-ZOL and OTA was successfully validated in a
mini comparison study involving other laboratories that used either another multi-biomarker method
or single-biomarker methods for determination of DON and FB1 [18]. To improve the sensitivity of
the method we used an UPLC system coupled with a powerful and sensitive mass spectrometer (API
5000 MS/MS system with ESI interface). It was necessary to optimize the chromatographic conditions
for optimal biomarker separation on Acquity BEH phenyl column as well as the MS/MS conditions.
The optimized MS/MS conditions for each biomarker are reported in Table 1.
The main differences with the MS/MS parameters previously optimized on a QTrap system [19]
were: (a) the increase in number of daughter ions from 3 to 4 for FB1, α-ZOL and β-ZOL; (b) minor
modification in the clustering potential, entrance potential, collision energy and collision cell exit
47
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potential (Table 1). The use of the Acquity BEH phenyl column and the development of a new linear
gradient composition of the mobile phase permitted to reduce the run time from 46 min to 15 min.
However, each sample extract was analyzed twice in positive and negative mode. AFM1, FB1 and OTA
were detected and measured in positive mode whereas DON, DOM-1, ZEA, α-ZOL and β-ZOL were
detected and measured in negative mode. The use of an UPLC system permitted to use a 150 mm × 2.1
mm column with a 1.7 μm particles size of stationary phase that produced sharp peak thus increasing
peak high with consequent reduction of the limit of detection (LOD) and quantification (LOQ). The use
of a powerful mass spectrometer (API 5000 MS/MS system) produced a further increase in method
sensitivity. In particular, a marked increase in sensitivity (up to 114 times) was obtained, in descending
order, for ZEA, β-ZOL, α-ZOL, FB1, AFM1 and OTA with the new UPLC-MS/MS system as compared
to the previous one (Table 2). No increase of sensitivity was obtained for DON whereas for DOM-1 an
increase of LOQ value was observed probably due to ion suppression effect.
Table 1. MS/MS conditions for detection of target analytes by MRM method.






















































Notes: a Transitions used for quantitation; Q1: first quadrupole; Q3: third quadrupole; DP: declustering potential;
EP: entrance potential; CE. collision energy; CXP. collision cell exit potential
Table 2. LOQ values for DON, AFM1, FB1, β-ZOL,α-ZOL, ZEA and OTA in human urine samples obtained
with two different LC-MS/MS systems: LC-QTrap MS/MS system and UPLC-API 5000 MS/MS system.
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In Figure 1 are reported three chromatograms of a naturally contaminated urine sample containing




Figure 1. LC-MS/MS chromatograms obtained in negative ion mode (a,b) and in positive ion mode (c)
of a naturally urine sample (#4) containing 11.33 ng/mL of DON, 0.108 ng/mL of β-ZOL, 0.123 ng/mL
of α-ZOL, 0.082 ng/mL of ZEA, 0.26 ng/mL of FB1 and 0.06 ng/mL of OTA.
A summary of the results of the urine samples collected in this study are reported in Table 3.
All urine samples contained ZEA, α-ZOL and OTA whereas β-ZOL was found in 98% of samples.
DON, FB1 and AFM1 were found in 96%, 56% and 6% of urine samples, respectively. The highest
mean biomarker concentration was found for DON (11.89 ng/mL) followed by OTA (0.144 ng/mL),
β-ZOL (0.090 ng/mL), α-ZOL (0.077 ng/mL), AFM1 (0.068 ng/mL), ZEA (0.057 ng/mL) and FB1(0.055
ng/mL). The highest individual biomarker concentration was measured for DON (67.36 ng/mL)
followed by OTA (2.129 ng/mL), FB1 (0.352 ng/mL), α-ZOL (0.176 ng/mL), β-ZOL (0.135 ng/mL),
AFM1 (0.146 ng/mL) and ZEA (0.120 ng/mL). From this Table it is evident that urinary concentrations
of DON are much higher to those of the other biomarkers. Moreover, the highest inhomogeneous
distributions of concentrations was observed for OTA as demonstrated by the value of relative standard
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deviation (RSD) of the mean (217%) followed by FB1 (133%), AFM1 (99%), DON (84%), ZEA (40%),
α-ZOL (35%) and β-ZOL (16%).
Table 3. Results of mycotoxin biomarkers in human urine samples collected in Southern Italy and
estimated values of PDI for each mycotoxin
Biomarkers DON β-ZOL α-ZOL ZEA FB1 OTA AFM1
N. positive (%) 50 (96) 51 (98) 52 (100) 52 (100) 29 (56) 52 (100) 3 (6)
Mean, ng/mL 11.89 0.090 0.077 0.057 0.055 0.144 0.068
SD, ng/mL 10.05 0.014 0.027 0.023 0.073 0.312 0.067
Median, ng/mL 10.32 0.088 0.074 0.056 0.029 0.061 0.10
Max, ng/mL 67.36 0.135 0.176 0.120 0.352 2.129 0.146
Mycotoxins DON ZEA FB1 OTA AFB1
Mean PDIa, μg/kg body weight 1.03 0.015 0.053 0.139 0.068
Max PDIa, μg/kg body weight 5.90 0.029 0.338 2.047 0.142
% of PDIa values exceeding the TDI 40 0 0 94 0
Mean PDIb, μg/kg body weight 0.59 –c 0.274 –c –c
Max PDIb, μg/kg body weight 3.37 –c 1.759 –c –c
% of PDIb values exceeding the TDI 6 –c 0 –c –c
TDId, μg/kg body weight 1.0 0.2 2.0 0.017 –e
Notes: a calculated based on piglet excretion data; b calculated based on human excretion data (50% for DON, 0.5%
for FB1) reported in Shephard et al. [8]; c not estimated due to unavailability of human excretion rate; d TDI values
are reported in [19] and references therein; e there is no TDI value for AFB1 because it is a carcinogenic mycotoxin.
The results of the co-occurrence of multiple biomarkers in the tested urine samples are reported
in Table 4. The majority of urine samples (52%) contained biomarkers of DON, ZEA, FB1 and
OTA whereas 38% of samples contained biomarkers of DON, ZEA and OTA. The co-occurrence
of biomarkers of all mycotoxins was found in two urine samples. Moreover, no individual was found
unexposed or exposed to a single mycotoxin since all investigated urine samples contained biomarkers
of at least two mycotoxins. No important differences were observed for the results obtained for male
and female individuals with the exception that the two urine samples containing biomarkers of all
mycotoxins were from females. Mixtures of biomarkers of DON, ZEA, FB1 and OTA were found in
human urine samples collected in the former Transkei, South Africa [8]. Co-occurrence of biomarkers
of 2 to 5 mycotoxins was reported in human urine samples collected in Cameroon [20,21].
Table 4. Incidence of individuals exposed to mixtures of mycotoxins for a total of 52 volunteers
(26 males and 26 females).
Multiple mycotoxins exposure n. positive samples % of positive samples
DON, ZEA, FB1, OTA, AFB1 2 4
DON, ZEA, FB1, OTA 27 52
DON, ZEA, OTA 20 38
DON, ZEA, OTA, AFB1 1 2
ZEA, OTA 2 4
TOTAL 52 100
This is the first report on the simultaneous detection of biomarkers of the 5 principal mycotoxins
in Italy. The simultaneous presence of DON and OTA in human urine in Italy was previously
reported [19] whereas the presence of ZEA, α-ZOL, β-ZOL, FB1 and AFM1 is reported herein for the
first time. The presence of DON and OTA in almost all urinary samples is not surprising because these
mycotoxins are usually found in cereals and derived products, staple foods of Italian people [22,23].
Interestingly, 56% of urine samples contained FB1, a mycotoxin mainly found in maize and deriving
products. Although these products are not staple foods in Italy they are widely consumed as chips,
polenta, popcorn, beer, cornflakes, snacks, muesli and mixed cereals [22,24]. The consumption of these
products could explain the high percentage of urine samples containing FB1. The low concentrations
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of biomarkers of ZEA in all tested urine samples is also a new and interesting information and
demonstrate that all the 52 volunteers that participated in our study were exposed to low levels of
ZEA. On the other hand the results of a large survey conducted in Europe showed that only 32%
of 5018 samples of cereals and derived products, the main source for ZEA exposure, were found
contaminated with this mycotoxin [22]. A possible explanation of this apparent paradox could be
that the high sensitivity of the multi biomarker method used in the present study can detect urinary
biomarker deriving from the consumption of foods contaminated with very low levels of ZEA that
could not be detected with conventional analytical methods. The presence of AFM1 in only 3 urine
samples demonstrates that human exposure to AFB1 is quite limited in this area of Southern Italy.
In fact ground nuts and tree nuts, the main source of human AFB1 exposure in Italy, are occasionally
consumed in this Country. The absence of AFM1 in almost all urine samples suggests that maize and
derived products consumed in Southern Italy are probably not contaminated with AFB1 although it is
well known that maize is a major source of AFB1 in some countries. The absence of AFM1 in human
urine and AFB1 in maize based food was also reported in South Africa [8].
The urinary biomarker concentrations measured in this study were used to estimate the probable
daily intake (PDI) of each mycotoxin by each volunteer according to Equation (1).
 
(1)
PDI probable daily intake of mycotoxin (μg/kg body weight);
C human urinary biomarker concentration (μg/L);
V mean 24 h human urine volume (1.5 L);
W mean human body weight (60 kg);
E mean urinary excretion rate of mycotoxin in 24 h post dose in piglets (36.8% for ZEA, 27.9% for DON,
2.6% for FB1, 2.6% for OTA and 2.5% for AFM1 [17]).
Based on mean urinary concentration of each mycotoxin biomarker measured in the 52 human
urine samples and the mean urinary excretion rate in piglets for each mycotoxin, the estimated daily
mean intake of the 5 investigated mycotoxins were calculated and are reported in Table 3. Due to the
unavailability of human excretion rate for all the 5 mycotoxins considered in this study we used the 24 h
excretion rate measured in piglets [17] to estimate the PDI in human. However, since sufficient data of
human excretion rate of DON and FB1 have been reported [8], additional values of PDI, calculated
with human data, were added in Table 3. In this table, the values of max PDI for each mycotoxin
and the percentage of individuals that exceeded the tolerable daily intake (TDI) for each mycotoxin
are also reported. The estimated mean values of PDI were below or equal to the TDI or provisional
maximum TDI (PMTDI) for DON, FB1 and ZEA. Individual analysis of PDI values obtained for DON
revealed that 40% of volunteers exceeded the value of TDI of 1 μg/kg body weight established for this
mycotoxin with a maximum value of PDI of 5.90 μg/kg body weight. Previous studies conducted in
UK, France and Sweden using the urinary DON concentration to estimate DON exposure reported
mean values of PDI of 0.12–0.73, 0.61 and 0.16 μg/kg body weight, respectively [25–30]. Human
exposure to DON in our study seems to be higher to that estimated in UK since both mean values
of PDI and % of individuals that exceed TDI are higher as compared to UK where some 5% of the
adult population may exceed the TDI for DON intake [25]. The mean PDI values of DON derived
from food analyses in UK (0.14–0.23 μg/kg body weight) seems to be slightly lower as compared to
PDI values estimated from urinary DON in that Country [25–28,31]. The mean PDI values of DON
derived from food analysis in Europe and reported by SCOOP report [22] and FAO/WHO [32] were
0.34 and 1.4 μg/kg body weight, respectively. The results of our study obtained with the biomarker
approach fall within this interval and is more close to the PDI reported by FAO/WHO [32]. A lower
mean value of PDI (0.59 μg/kg body weight) was obtained by using the human excretion rate of 50%
reported by Shephard et al. [8] as well as the percentage of individuals (6%) that exceeded the value of
TDI for this mycotoxin.
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The mean value of PDI for FB1 calculated in our study with biomarker approach (0.053 μg/kg
body weight) is far below the TDI established for this mycotoxin (2 μg/kg body weight) and all
individual values are below the TDI for this mycotoxin with a maximum value of PDI of 0.338 μg/kg
body weight (Table 3). These results can only be compared with results obtained in Guatemala, South
Africa and Mexico because urinary FB1 in European population has not been performed yet. The mean
values of PDI estimated with biomarker approach in Guatemala, Mexico and South Africa were 0.45,
0.37 and 0.22 μg/kg body weight, respectively [15,33,34]. Comparison with these data shows that in
our study human exposure to FB1 is about 10 times lower to those estimated in Guatemala, Mexico
and South Africa. The mean PDI values of FB1 obtained in our study with biomarker approach
(0.053 μg/kg body weight) is quite similar to the PDI of 0.056 μg/kg body weight estimated with diet
approach by Brera et al. in Italy [24]. The estimated mean PDI value reported by FAO/WHO [32] for
Europe with the diet approach was 0.2 μg/kg body weight which is 3.8 times higher than the intake
estimated in our study. A much higher mean value of PDI (0.274 μg/kg body weight) was obtained
by using the human excretion rate of 0.5% reported by Shephard et al., [8]. However even with this
estimate all individuals resulted below the value of TDI for this mycotoxin.
The mean value of PDI of ZEA estimated with biomarker approach in our study (0.015 μg/kg
body weight) is about ten times below the TDI established for this mycotoxin (0.2 μg/kg body weight).
The maximum estimated value of PDI is 0.029 μg/kg body weight (Table 3). In Italy, the mean value of
PDI estimated with the diet approach was 0.0008 μg/kg body weight [22] whereas the PDI reported
by EFSA for Europe was 0.03–0.06 μg/kg body weight [35]. The mean value of PDI estimated in our
study is higher than the Italian value reported in the SCOOP report and lower than the lower limit of
the range reported by EFSA [35].
The occurrence of ZEA biomarkers in human urine was recently reported in USA and Cameroon.
Mixtures of ZEA, α-ZOL and β-ZOL were detected and measured in 55% of urine samples collected
from girls resident in New Jersey with mean concentrations ranging from 0.35 ng/mL (β-ZOL) to
1.82 ng/mL (ZEA) [36]. These concentrations are 4–32 times higher the mean concentrations found
in our study for these ZEA biomarkers which means that in New Jersey human exposure to ZEA is
higher as compared to Italy. Mixtures of ZEA, α-ZOL and ZEA-glucuronide were found in a low
percentage (5%) of human urine samples collected in Cameroon with a total mean concentration of
0.74 ng/mL [20].
As reported in Table 3 the mean value of PDI of OTA estimated with biomarker approach in our
study (0.139 μg/kg body weight) is about 8 times higher than the TDI (0.017 μg/kg body weight)
established for this mycotoxin [37]. The maximum value of PDI estimated in our study (2.047 μg/kg
body weight) is 147 times higher than the TDI and 94% of individuals participating in our study
exceeded the value of TDI (Table 3). Several studies reported the occurrence of OTA in human urine
with a high percentage of positive samples but the relevant values of PDI from these results were not
calculated nor reported. We used the human urinary concentrations of OTA reported in literature to
estimate values of PDI of OTA by using the Equation (1) reported above. Urinary concentrations of
OTA reported by Fazekas et al. [38] and Duarte et al. [14,39] produced values of PDI equal or below the
TDI, whereas from the results of Pena et al. [40], Manique et al. [41], Coronel et al. [42], Gilbert et al. [43]
and Domijan et al. [44] the estimated values of PDI were higher the TDI. Our result of estimated
mean PDI, though higher than the TDI, is lower than the mean PDI values estimated from the urinary
concentrations reported by Domijan et al. in Croatia [44] and Coronel et al. in Spain [42]. When
compared to the PDI values estimated with urinary concentrations reported by Fazekas et al. [38],
Duarte et al. [14,39], Pena et al. [40], Manique et al. [41] and Gilbert et al. [43] our estimated PDI values
were higher.
In Europe, the mean values of PDI of OTA estimated with the diet approach range from 0.0011 to
0.024 μg/kg body weight [23]. The mean value of PDI estimated with our biomarker study (0.139 μg/kg
body weight) is 5.8–127 times higher than the European PDI values estimated with diet approach.
All together, these data clearly show that the estimated human exposure to OTA is higher when using
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the biomarker approach as compared to the diet approach. Possible explanations of these differences
could be: a) the urinary excretion rate of OTA in piglets, used in this study to estimate PDI values,
is completely different from that in human, b) the food diet approach did not cover all sources of
OTA exposure due to the occurrence of this mycotoxin in a very high number of different foods and
beverages. It is well known that OTA is the mycotoxin more widespread in several different types of
foods and beverages [23,32].
The results shown in Table 3 indicate that AFM1 was detected and measured in only 3 urine samples
(6% of total samples) which confirm that human exposure to AFB1 was sporadic. The relevant mean
value of PDI of AFB1, calculated for the 3 positive subjects, is 0.068 μg/kg body weight. As reported
above, there is no TDI value for AFB1 because this is a carcinogenic mycotoxin. The incidence of
positive samples and mean urinary AFM1 concentration measured in positive samples in our study are
comparable to those reported by Hatem et al. from Marasmus, Egypt [45]. Polychronaki et al. reported,
for Guinea, a mean urinary concentration of AFM1 in positive samples similar to those found in
our study but a higher percentage of positive samples (64%) [13]. The mean value of PDI of AFB1
estimated with biomarker approach for the three volunteers participating in our study (0.068 μg/kg
body weight) is largely higher than the PDI of aflatoxin intake measured with the diet approach in
Europe (0.00016–0.00055 μg/kg body weight) [23].
3. Experimental Section
3.1. Chemicals and Reagents
Standard solutions were purchased from Romer Labs Diagnostic (Tulln, Austria). In particular,
solutions of DON (100 μg/mL), DOM-1 (50 μg/mL), AFM1 (0.5 μg/mL), ZEA (100 μg/mL), α-ZOL
(10 μg/mL), β-ZOL (10 μg/mL) and OTA (10 μg/mL) were prepared in acetonitrile (ACN) whereas
FB1 solution (50 μg/mL) were prepared in acetonitrile-water (50:50). β-glucuronidase/sulfatase type
H-2 from Helix pomatia (specific activity 130,200 units/mL β-glucuronidase, 709 units/mL sulfatase).
Chromatography-grade methanol (MeOH) and glacial acetic acid were obtained from Carlo Erba
(Milan, Italy). Ultrapure water was produced by use of a Milli-Q system (Millipore, Bedford, MA,
USA). Myco6in1® immunoaffinity columns were purchased from Vicam L.P (Watertown, MA, USA).
OASIS® HLB columns, 60 mg, 3 mL were purchased from Waters (Milford, MA, USA) and regenerated
cellulose filters (0.45 μm) were purchased from Sartorius Stedim Biotech (Goettingen, Germany).
3.2. Equipment and Conditions
LC-MS/MS analyses were performed on a triple quadrupole API 5000 system (Applied
Biosystems, Foster City, CA, USA), equipped with a ESI interface and an Acquity UPLC system
comprising a binary pump and a microautosampler from Waters (Milford, MA, USA). The analytical
column was an Acquity UPLC BEH phenyl column (2.1 mm × 150 mm, 1.7 μm particles; Waters).
The column oven was set at 40 ◦C. The flow rate of the mobile phase was 250 μL/min and the injection
volume was 10 μL. For multi-biomarker separation a multiple linear binary linear gradient of acidic
MeOH (containing 0.5% acetic acid) in water (containing 0.5% acetic acid) was developed and used
as mobile phase as follows: from 20% to 80% MeOH in 5 min, then maintained at 80% MeOH for
5 min, then brought to 20% MeOH in 0.5 min and left to equilibrate for 4.5 min before the next run.
For LC-MS/MS analyses, the ESI interface was used in positive ion mode for AFM1, FB1 and OTA and
in negative ion mode for DON, DOM-1, ZEA, α-ZOL and β-ZOL. The mass spectrometer operated in
MRM (multiple reaction monitoring) mode and the optimized MS/MS conditions for each analyte
are listed in Table 1. In particular, 4 transitions were monitored for confirmation of FB1, α-ZOL and
β-ZOL whereas the sum of the 4 transitions were used for quantification; for DON 3 transitions for
confirmation and the sum of 2 transition for quantification; for DOM-1, ZEA and OTA 3 transitions
for confirmation and 1 transition for quantification; for AFM1 2 transitions for confirmation and the
sum of 2 transition for quantification. Interface conditions were: TEM, 450 ◦C; CUR, nitrogen, 20 psi;
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GS1, air, 60 psi; GS2, air, 40 psi; ionspray voltage +5500 V or −4500 V. The signal of each compound
was preliminary optimized with each proposed ionization condition. The tuning procedure included
the optimization of source parameters during infusion of 1 μg/mL standard solution (0.1 μg/mL
for AFM1) of the individual toxins in MeOH-water (20:80) containing 0.5% acetic acid at 10 μL/min,
using an Harvard 11 plus infusion pump, into the UPLC mobile phase (50/50 water/methanol at
250 μL/min) by means of a minimum dead volume T-piece connected after the analytical column.
3.3. Participants and Urine Collection
For the evaluation of human exposure to DON, AFB1, FB1, ZEA and OTA 100 individuals residing
in 10 municipalities of Puglia region (Southern Italy) were invited to participate in the urine sampling.
Each individual was asked to provide a first morning urine sample and to fill out a questionnaire
concerning age, gender and health status. The majority of individuals gave oral informed consent
and donated a sample of first morning urine and the filled in questionnaire. Fifty-two individuals
(participation rate 52%), 26 males and 26 females, (mean age 41 years, range 3–85 years) were recruited
from municipalities of Bari, Triggiano, Mola di Bari, Monopoli, Adelfia, Conversano, Polignano a Mare,
Bitonto, Martina Franca and Statte. The remaining 48 individuals failed to donate their morning urine
samples. All participants collected their urine samples on 26 April 2011. Urine samples were stored at
−18 ◦C until analysis for identification and determination of DON, DOM-1, AFM1, FB1, ZEA, α-ZOL,
β-ZOL and OTA. Eleven volunteers declared to have health problems, in particular three individuals
with hypertension, three with allergies, three with diabetes, one with hyperthyroidism and one at risk
of thrombosis.
3.4. Calibration Curves
A mixed standard solution with a final concentration of 150 ng/mL DON, 20 ng/mL of DOM-1,
1.8 ng/mL AFM1, 28 ng/mL FB1, 35 ng/mL β-ZOL, 23 ng/mL α-ZOL, 12 ng/mL ZEA and 2 ng/mL
OTA was prepared by mixing appropriate volumes of commercially available standard solutions and
appropriate volume of ACN. Five standard calibration solutions covering appropriate range of analyte
concentrations were prepared by portioning adequate volumes of mixed standard solution that were
dried and reconstituted with 200 μL of initial LC-MS/MS mobile phase. In particular, the 5 standard
calibration solutions were prepared by drying 25, 125, 250, 375 and 1000 μL of mixed standard solution
that were reconstituted with 200 μL of initial LC-MS/MS mobile phase. Matrix-matched calibration
solutions were prepared in 5 purified urinary extracts. In particular, urine from 6 individuals were
pooled and mixed then 5 aliquots of 6 mL each were purified according to the protocol reported above.
The 5 eluates collected from OASIS® HLB and Myco6in1® columns were spiked with 5 aliquots of
the mixed standard solution (25, 125, 250, 375 and 1,000 μL), dried and reconstituted with 200 μL of
initial LC-MS/MS mobile phase. The ranges of mycotoxin concentrations in the calibration solutions
were, therefore: 18.75–750.00 ng/mL for DON, 2.50–100.00 ng/mL for DOM-1, 0.22–8.76 ng/mL for
AFM1, 3.50–140.00 ng/mL for FB1, 4.38–175.00 ng/mL for β-ZOL, 2.88–115.00 ng/mL for α-ZOL,
1.50–60.00 ng/mL for ZEA and 0.25–10.00 ng/mL for OTA.
3.5. Analysis of Urinary Biomarkers
Urine samples were hydrolyzed with β-glucuronidase/sulfatase enzyme to hydrolyse
glucuronide and/or sulfate conjugates of DON, DOM-1, ZEA, α-ZOL, β-ZOL and then purified
with a multi-antibody and OASIS® HLB columns according to the protocol reported elsewhere [19].
In brief, a 6 mL urine sample was hydrolyzed at 37 ◦C for 18 h with 300 μL of β-glucuronidase/sulfatase
type H-2 from Helix pomatia. Hydrolyzed sample was diluted with 6 mL of water and purified on a
Myco6in1® and OASIS® HLB columns connected in tandem. The OASIS® HLB column was previously
conditioned by passing 2 mL MeOH and 2 mL ultrapure water. After sample application and elution,
the two columns were separated, the Myco6in1® was washed with water (4 mL) and eluted with
methanol (3 mL) and water (2 mL) that were collected in a vial. The OASIS® HLB column was washed
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with methanol/water (20:80, 1 mL) and DON that had passed through the Myco6in1® and retained on
the OASIS® HLB was eluted with methanol/water (40:60, 1 mL). The separate eluates from the two
columns were combined, dried down and reconstituted in methanol/water (20:80, 200 μL) with 0.5%
acetic acid. Purified extract was filtered through a regenerated cellulose filter and a volume of 10 μL
(equivalent to 0.3 mL urine) was analyzed by UPLC-MS/MS.
4. Conclusions
The improved UPLC-MS/MS method for simultaneous determination of urinary biomarker for
DON, FB1, OTA, AFB1 and ZEA was suitable to detect and accurately measure the low mycotoxin
biomarker concentrations naturally occurring in the human urine samples collected in this study.
A multiple mycotoxin exposure was found for all tested volunteers participating in the study.
This is the first report on the occurrence of urinary AFM1, FB1, ZEA and ZOLs in Italy.
The estimated PDI values of OTA largely exceeded the TDI value for this mycotoxin in 94%
of volunteers.
The mean estimated PDI of DON is similar to the TDI value for this mycotoxin but in 40% of
volunteers it exceeded the value of TDI.
The values of PDI estimated herein with urinary biomarker approach matched quite well with the
intake estimated with the diet approach reported in the literature for DON, FB1 and ZEA whereas for
OTA and AFB1 the intake estimated with the biomarker approach was much higher than the intake
estimated with the diet approach reported in the literature.
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Abstract: Deoxynivalenol (DON) is a mycotoxin found in wheat that is infected with Fusarium fungus.
DON may also be converted to a type of “masked mycotoxin”, named deoxynivalenol-3-glucoside
(D3G), as a result of detoxification of the plant. In this study, DON and D3G were measured using
gas chromatographic (GC) and liquid chromatography-mass spectrometry (LC-MS) in wheat samples
collected during 2011 and 2012 in the USA. Results indicate that the growing region had a significant
effect on the DON and D3G (p < 0.0001). There was a positive correlation between both methods
(GC and LC-MS) used for determination of DON content. DON showed a significant and positive
correlation with D3G during 2011. Overall, DON production had an effect on D3G content and kernel
damage, and was dependent on environmental conditions during Fusarium infection.
Keywords: deoxynivalenol; deoxynivalenol-3-glucoside; wheat; USA
1. Introduction
One of the most predominant and economically important mycotoxins affecting small-grain
cereals, such as wheat, is deoxynivalenol (DON). DON is formed due to the presence of plant
pathogenic fungi Fusarium graminearum and F. culmorum; which are responsible for the disease known
as Fusarium head blight (FHB) [1]. The geographical distribution of these fungi is affected by climate.
F. culmorum occurs more commonly in Europe while F. graminearum is common in Europe and North
America [1,2]. The association between the FHB intensity level with DON accumulation in spring wheat
using a meta-analysis has been reported in multiple studies [3]. The most important environmental
factors causing FHB growth and biosynthesis of DON are water availability and temperature [4].
Minimum water activity values for growth and DON production appears to be limited at 0.93 under
optimum temperature conditions (25 ◦C) [4,5]. Also, higher disease severity occurs if the wheat has
been exposed to extended periods of wetness [1], which may result in higher DON production. On the
other hand, Fusarium growth and DON production depends on the growth stages of the plant; in wheat
higher damage occurs during flowering (anthesis) and shortly after flowering, the infection can also
continue during grain maturation stage [1,6].
The presence of DON in wheat decreases grain quality by rendering the crop unsuitable and
unsafe for food, feed and malting process. It is worthwhile noting that DON can have several side
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effects, such as feed refusal, vomiting, reduced weight gain, diarrhea, hemorrhage, skin lesions, growth
depression and immunosuppression [7–9], which have a negative impact on human and animal
health [6,10]. Also, DON affects the plant metabolism in wheat because it leads to the inhibition of
germination and decreases plant growth. The plant starts to develop a detoxification mechanism in
which DON is glycosylated into 3-β-D-glucopyranosil-4-deoxynivalenol (D3G) and stored inside the
vacuole or cell wall to combat this situation [11,12]. This product is known as a “masked” mycotoxin,
because one or more glucose molecules bind to the DON which reduces the toxicity in the plant and
makes it unable to be detected by traditional methods for DON detection. D3G is less active as a
protein biosynthesis inhibitor than DON [11]. There is a lack of information about the correlation
between the DON and D3G production in wheat. Rasmussen et al. [13] found that the concentration of
D3G is positively correlated with the increasing of DON content, which is similar to that observed by
Lemmens et al. [14].
The toxicity of D3G in mammals is currently unknown. Berthiller et al. [15] reported that this
“masked” mycotoxin resisted the in vitro acid conditions, indicating D3G cannot be hydrolyzed to
DON in the stomach of mammals; nevertheless, it can be hydrolyzed during fermentation process by
bacterial β-glucosidases in the colon. Later, it was demonstrated that D3G is partially absorbed in the
gastrointestinal system of rats, but the majority of the D3G ingested was hydrolyzed in the digestion
process and excreted in feces, which means that D3G is partially bioavailable in the gastrointestinal
system of rats [16]. In Europe, the DON content of food, feed and unprocessed grains of undefined
end-use collected in 21 European countries between 2007 and 2012 was recently published. It was
found that the levels of DON in wheat, maize and oat may exceed the maximum limits for food or
guidance values for feed. Due to the lack of data about D3G, this was not considered in the food safety
assessment [17]. However, it may be necessary to analyze the DON and D3G content in wheat to
have a clear idea about the total content of DON after the wheat is processed to different products.
After determination of DON and D3G levels the assessment must be made to determine if the levels
DON are within the permitted levels of DON approved by the Food and Drug Administration (FDA)
and also to assess the safety of wheat-based products consumed in USA. The objective of this research
was to analyze the DON and D3G content of hard red spring (HRS) wheat between 2011 and 2012
Crop Survey using gas chromatography (GC) and liquid chromatography-quadrupole time of flight
mass spectrometry (LC-QTOF-MS) and find the correlation between the DON and D3G production.
DON will be measured by both GC and LC-QTOF-MS to evaluate correlation between methods and
determine the feasibility of the LC-QTOF-MS methodology for simultaneous measurement of DON
and D3G.
2. Results and Discussions
2.1. Wheat Kernel Quality
The crop survey of HRS wheat was conducted in North Dakota (ND), South Dakota (SD), Montana
(MT) and Minnesota (MN), which make up the primary HRS wheat growing region in the United
States (US) (Figure 1). The Federal Grain Inspection Service (FGIS) use grading and non-grading
factors to evaluate the conditions and quality of wheat. The HRS wheat kernel quality of the 2011
and 2012 crop surveys is presented in Table 1. The mean dockage percentage was the same in both
survey crops. This factor does not affect the numerical grade but it is one important step in the grading
process to eliminate all the material that is not wheat prior to determining the rest of grading and
non-grading factors. Other than dockage, there were no differences observed in the grading factors
percent shrunken and broken kernels, percent dark hard and vitreous (DHV) and test weight. However,
the values of percent damage and percent total defects in the 2011 crop survey were higher than in the
2012 crop survey. According to the HRS wheat 2012 Regional Quality Report, there were differences in
the environmental factors during planting, growing and harvest of crops of both years [18]. Higher
temperatures and lower rainfall levels were observed in 2012, which decreased the disease pressure
59
Toxins 2013, 5, 2656–2670
and percent damaged kernels, compared to 2011. These environmental factors in turn affected the
wheat quality [19,20]. Among the non-grading factors (Table 1), the protein content is very important
to determine the suitability of wheat in different final products. The protein percentage of both crop
surveys was between the values established by the FGIS (13%–14%). HRS wheat is considered to
have high and excellent protein quality for use in bread-baking. The samples from 2011 crop survey
presented a lower falling number (386.3 s) compared to 2012 samples (429.3 s). Falling number is an
indirect measurement of the α-amylase activity to detect sprout damage in wheat. This is accomplished
by the measurement of changes in the physical properties of the starch portion of the wheat kernel
caused by this α-amylase. A high enzyme activity indicates faster liquefaction and lower falling
number. The falling number may be related to the higher percent damaged kernels and percent total
defects presented in samples from 2011. Nevertheless, the falling number of both years were at least
350 s, which is the level at which grain is considered to be sound by the FGIS. Also, the 1000 kernel
weight of 2011 crop survey samples was lower than 2012 crop survey samples. This means that the
environmental factors (temperature, rainfall and moisture) could increase the percent damaged kernels
and reduce the quality of wheat. Kernel quality was also affected by the production of mycotoxins,
such as DON and its “masked” mycotoxin D3G, related to the occurrence of the FHB.
 
Figure 1. Distribution of hard red spring (HRS) wheat samples from the 2011 and 2012 Crop Surveys
from Montana, North Dakota, Minnesota and South Dakota. A, B, C, D, E and F: regions in which the
samples were collected from each state. The numbers inside the parenthesis represent the number of
samples taken, from left to right: 2011 Crop Survey and 2012 Crop Survey.
Table 1. Mean, standard deviation (SD), minimum (MIN) and maximum (MAX) values for wheat
kernel quality characteristics for 2011 and 2012 crop survey samples.
Factors
2011 2012
Mean SD MIN MAX Mean SD MIN MAX
Dockage (%) a 1.1 1.4 0.0 13.4 1.1 1.2 0.0 13.3
Shrunken & broken a 1.6 1.4 0.0 10.0 1.2 1.1 0.0 10.1
Damage (%) a 0.5 0.8 0.0 10.6 0.1 0.2 0.0 2.8
Hard and vitreous kernel (%) a 75.8 21.9 5.0 99.0 74.5 28.4 2.0 99.0
Test weight (lbs/bu) a 60.0 2.4 52.5 65.7 60.9 1.9 53.9 65.1
Total defects (%) a 2.1 1.7 0.1 13.1 1.3 1.1 0.0 10.1
Protein (12% mb) b 14.8 1.3 10.2 18.6 14.6 1.4 10.3 20.1
Falling number (s) b 386.3 44.1 226.0 621.0 429.3 48.8 238.0 654.0
1000 kernel weight (g) b 26.7 4.1 16.8 40.0 29.1 4.1 16.6 44.1
Notes: a Grading factors used to evaluate the kernel quality to ensure general standards of acceptance in flour or
semolina production; b Non-grade factors used to evaluate the kernel quality; mb = moisture basis.
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2.2. Effect of the State and Region on DON, D3G and Damage Kernel
Least square means values of DON analyzed with GC and Liquid chromatography—mass
spectrometry (LC-MS), D3G determined with LC-MS, and percent damage kernels are given in Table 2.
These variables showed significant differences between state and region mean values, indicating that
HRS wheat samples collected from different state or regions might have different levels of DON and
D3G. Samples collected from ND presented higher values of DON (both GC and LC-MS methods),
D3G, and percent damaged kernels than other states in both years. Samples from MT presented the
opposite trend. The regional data showed more specifically that samples collected from ND contained
higher levels of DON, D3G and percent damaged kernels than the other states. DON, D3G and percent
damaged kernels presented higher values for samples collected from ND regions A, B, C, E and F
in 2011. For ND samples collected in 2012, DON, D3G and Kernel damaged showed higher values
only for samples from regions A and B. Among MN regions, samples collected in 2011 from region
B showed high DON and percent damaged kernels. Samples from SD region B in 2011 also showed
high levels of DON, D3G and percent kernel damage. For the 2012 samples, those collected from MN
region A and MT region B showed high D3G values. Specifically, samples from MT region B showed
high D3G content despite low DON content in 2012. The rest of the regions presented similar content
of DON, D3G and percent damaged kernels and the majority did not show significant differences.
The 2011 survey samples had high DON content, independent of the method used. Due to the high
levels of DON during this year, the percent damaged kernels were also higher compared to 2012
survey samples.
Table 2. Least square mean values for deoxynivalenol (DON), deoxynivalenol-3-glucoside (D3G) and
damage kernel in 2011 and 2012 survey.
Growing Area 2011 2012
State GC-DON LC-DON D3G Damage (%) GC-DON LC-DON D3G Damage (%)
MN 1.35 ** 1.74 ** 0.04 0.35 ** 0.89 0.78 0.128 ** 0.05
MT 0.03 0.03 0.00 0.03 0.18 0.18 0.090 0.00
ND 2.80*** 3.15 *** 0.24 *** 0.63 *** 1.93 *** 1.71 *** 0.142 *** 0.06 ***
SD 1.35 ** 1.72 * 0.12 0.36 * 0.37 0.33 0.085 0.03
Region
MN-A 1.07 1.21 0.01 0.23 0.82 0.72 0.124 * 0.08 *
MN-B 1.63 * 2.27 ** 0.06 0.47 * 0.96 0.84 0.133 0.02
MT-A 0.00 0.00 0.00 0.01 0.09 0.12 0.067 0.01
MT-B 0.00 0.00 0.00 0.05 0.04 0.05 0.176 ** 0.00
MT-C 0.13 0.13 0.00 0.03 0.11 0.20 0.105 0.00
MT-D 0.00 0.00 0.00 0.08 0.00 0.08 0.015 0.00
MT-E 0.04 0.00 0.00 0.00 0.65 0.47 0.088 0.00
ND-A 3.89 *** 4.26 *** 0.31 *** 0.75 *** 6.91 *** 5.97 *** 0.295 *** 0.15 ***
ND-B 3.77 *** 4.32 *** 0.30 *** 0.69 *** 2.48 *** 2.22 *** 0.174 *** 0.12 ***
ND-C 2.91 *** 3.36 *** 0.30 *** 0.61 *** 0.66 0.60 0.060 0.06
ND-D 1.08 1.10 0.02 0.61 *** 0.34 0.35 0.094 0.01
ND-E 2.19 ** 2.54 ** 0.09 0.66 *** 0.71 0.72 0.096 0.02
ND-F 3.00 ** 3.34 *** 0.39 *** 0.49 ** 0.47 0.38 0.133 0.01
SD-A 0.21 0.15 0.00 0.13 0.49 0.42 0.094 0.00
SD-B 2.41 *** 3.20 *** 0.29 ** 0.57 ** 0.22 0.23 0.097 0.00
SD-C 1.42 1.82 0.06 0.38 0.41 0.34 0.066 0.09
Notes: *, **, and *** means significant differences (H0: least square mean = 0) at p < 0.05, 0.01, and 0.001, respectively.
Values of DON and D3G are in mg/kg; gas chromatographic (GC).
D3G content in 2011 was not different among states except for ND, but in 2012, MN also showed
differences in D3G content. Also, the differences in DON content and D3G among regions and states
can be attributed to the environmental conditions presented in each year of survey. The analysis of
variance (ANOVA) indicates that state and region had significant effects on variation in DON and
D3G content and percent damaged kernels in 2011 survey samples (Table 3). The ANOVA for 2012
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survey samples showed slightly different results (Table 3). During 2012 the percent damaged kernels
was not affected by the state, region or their interaction. The ANOVA on DON and D3G for both years
indicates that the wheat growing environment greatly affects the variations in DON and D3G content.
Schmidt-Heydt et al. reported that the key genes in the biosynthetic pathway of mycotoxin production
could be influenced by the environmental factors and water activity [4]. Therefore, the gene expression
resulted in different effects, depending on their interaction with the abiotic conditions, on the DON
production levels. On the other hand, D3G is produced by the plant as a detoxification process in
response to the DON production [11]. So, it could be possible that the D3G content among states may
depends of the infection level of DON in the wheat.
Table 3. Mean square values of state (ST), region (Rga) and county (CTY) on DON, D3G and damaged
kernel in 2011 and 2012 survey.
Year Source Degrees of freedom
Mean square
GC-DON LC-DON D3G Damage
2011
ST 3 221.3 *** 282.8 *** 2.15 *** 10.19 ***
Rga (ST) 12 28.0 ** 40.4 *** 0.43 * 0.45
CTY (Rga × ST) 100 8.9 13.2 0.19 0.44
Residual 320 9.7 14.0 0.24 0.70
2012
ST 3 151.2 *** 111.2 *** 0.15 *** 0.22 **
Rga (ST) 12 104.3 *** 72.8 *** 0.12 0.12 ***
CTY (Rga × ST) 100 14.5 11.3 0.07 0.04
Residual 320 12.0 10.9 0.07 0.04
Notes: *, **, and *** means F values are significant at p < 0.05, 0.01, and 0.001, respectively.
2.3. Correlation among DON, D3G with Percent Damaged Kernels
The correlation between GC and LC-MS methods used to analyze DON during 2011 and 2012 is
shown in Figure 2a,b. DON was measured by both GC and LC-QTOF-MS to evaluate the correlation
between methods and determine the feasibility if the LC-QTOF-MS methodology for simultaneous
measurement of DON and D3G. The high coefficient of determination (R2) indicates strong, positive
and significant correlation between both methods in both years (Figure 2). When the GC and LC-MS
methods for both survey 2011 and 2012 were compared (Figure 2c), an R2 of 0.947 and mean square
error (MSE) of 0.90 were found. To identify relationships between mycotoxin contents and percent
damaged kernels, linear and rank correlation coefficients were estimated and given in Table 4. The
DON values determined GC and LC methods also showed very high and positive correlation for
2011 and 2012 data, individually (Table 4). These results mean that the LC method is as precise as
or better in evaluating DON concentration of HRS wheat lines when compared to the GC method.
The linear and rank correlations were significant (p < 0.01) and positive between DON concentration
data determined for 2011 and 2012 samples. This result indicates that year by region interaction might
not be strong, and the region that had higher DON concentration in 2011 samples also had higher
DON concentration than other regions in 2012. Specifically, ND regions A and B showed higher DON
concentration than other regions for both 2011 and 2012 samples. Further research may be needed to
verify this since current results are based on data collected from only 2 years. The correlation between
DON and D3G (Figure 3) in survey samples between 2011 and 2012 was significant with a moderate R2
= 0.521. This means that the D3G production is related positively to the DON content and increasing
DON levels also increase the D3G level in wheat. This is in agreement with the results from other
researchers [10,13]. However, the moderate R2 value indicates that DON concentration was partially
responsible for D3G variation in this sample set. This is due to the low correlation between DON and
D3G for 2012 samples (Table 4). To be more specific, 2012 samples from MN region A and MT region B
had high D3G concentrations despite low DON concentrations (Table 2). These results indicate that,
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for precise evaluation of mycotoxin in HRS wheat samples, the LC-MS method is better to use for
determination of DON and D3G content rather than the GC method which can only determine DON.
 
Figure 2. Correlation GC-DON and LC-MS DON content values. (a) 2011 survey samples; (b) 2012
survey samples and (c) 2011 and 2012 survey samples combined. *** Significantly different from 1 at
p < 0.001.
 
Figure 3. Correlation between DON and D3G levels in survey samples between 2011 and 2012; where
***, and * indicate that regression coefficients are significant at p < 0.001 and p < 0.05, respectively.
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Table 4. Pearson linear and Spearman rank correlation coefficients between DON, D3G and damage
kernel for regions.
Year Variables GC-DON LC-DON D3G Damage
Linear correlation
2011
GC-DON - 0.99 *** 0.91 *** 0.91 ***
LC-DON 0.99 *** - 0.91 *** 0.91 ***
D3G 0.94 *** 0.92 *** - 0.74 **




GC-DON - 1.00 *** 0.83 *** 0.79 ***
LC-DON 0.99 *** - 0.83 *** 0.79 ***
D3G 0.41NS 0.37NS - 0.60 *
Damage 0.72 ** 0.69 ** 0.28NS -
Rank correlation
Notes: *, **, and *** means correlation coefficient is significant at p < 0.05, 0.01, and 0.001, respectively. NS: Not
significant (p ≥ 0.05).
The correlation among DON and D3G with damage kernel during 2011 and 2012 is given in Table 4
and Figure 4. The percent damaged kernels had very highly significant correlation with GC-DON
and LC-DON (p < 0.001) in 2011; damage also had a very highly significant correlation at p < 0.01
with DON (GC and LC) in 2012. The positive correlations indicate that samples which were rated to
have higher percent damaged kernels had higher levels of DON in the sample. This was also shown
in Figure 4a,b, where the scatter plot between GC-DON and damage was depicted. D3G also had a
significant (p < 0.05) correlation with percent damaged kernels in 2011 and 2012. This indicates that as
the Fusarium infection progresses more kernel damage occurs. While DON levels rise which leads to
increased production of D3G as the plants detoxification mechanism.
 
Figure 4. Correlation between GC-DON and damage levels in survey samples from (a) 2011 and
(b) 2012.
3. Experimental Section
3.1. Standards and Chemicals
DON (100.2 μg/mL) and D3G (50.2 μg/mL) both in acetonitrile were purchased from Biopure
(Tulln, Austria). For the gas chromatography–electron capture detection (GC–ECD) method, 5 mg/L
DON working standard solution was used to make a standard curve prepared in a clean wheat
extract. In the LC-MS method, stock solutions were dissolved in acetonitrile and stored in the
refrigerator. Composite working standard solutions were prepared by dilution of the stock solutions
in a DON-free wheat matrix to prepare matrix-matched calibration standards in concentration of 0
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to 20 mg/L for DON and 0 to 10 mg/L for D3G. Acetonitrile was purchased from J. Baker. TMSI
(1-(trimethylsilyl)imidazole), TMCS (Chlorotrimethylsilane) and 2,2,4-trimethylpentane (ACS reagent)
were obtained from Sigma Aldrich.
3.2. Samples
The hard red spring (HRS) wheat between 2011 and 2012 Crop Survey samples were used as raw
material. A total of 441 and 436 samples were selected as wheat grader samples from the 2011 and
2012 HRS wheat crop surveys, respectively, and used in this study. The samples were collected based
on production data obtained from the National Agricultural Statistics Service for the 16 regions in the
4 state HRS wheat growing region (Figure 1). The Montana (MT), North Dakota (ND), South Dakota
(SD) and Minnesota (MN) state office of the National Agricultural Statistics Service obtained wheat
samples during harvest directly from growers either in the fields or farm bins and local elevators.
Samples from the 2011 Crop Survey represented a high FHB infection and incidence of DON, while
2012 Crop Survey samples represented wheat with low FHB infection.
3.3. Wheat Kernel Quality
The kernel quality based on non-grading factors consisted of the determination of the protein
content (expressed in 12% moisture basis, Method 39.10.01), falling number expressed in seconds
(Method 56.81.03), both approved methods of the AACC [21] and thousand kernel weight determined
on a 10 g sample of cleaned wheat (free of foreign material and broken kernels) counted by electronic
seed counter.
The wheat grade and class of the samples was determined by a licensed grain inspector for
the Official United States Standards for Grain. North Dakota Grain Inspection Service, Fargo, ND,
provided grades for composite wheat samples. The final grade of the samples was based on dockage
(elimination of all material other than wheat), shrunken and broken kernels and percent damaged
kernels, test weight measured as pounds per bushel (l b/bu) (Method 55-10, AACC) and percent
vitreous kernels (percentage of kernels having vitreous endosperm), as well as the summation of these
defects referred to as total defects using an official procedure of USDA (United Stated Department of
Agriculture).
3.4. Sample Preparation for GC–ECD and LC-MS
3.4.1. Free DON Analysis with GC–ECD
Free DON was determined using the methodology described by Tacke et al. [22] with some
modifications [2]. One g of sample was dispersed in 8 mL of acetonitrile:water mixture (84:16, v/v)
and shake for 1 h at 180 rpm. The extract (4 mL) was passed through cleanup column (Extract cleanTM
C18-Al, GRACE, Illinois, USA) and 2 mL of the filtrate were evaporated until dryness with nitrogen at
55 ◦C. Then, 100 μL of TMSI-TMCS (100:1, v/v) was added to the solution to residue. The samples
were vortexed for 10 s and allowed to react for 5 min at room temperature. The internal standard
solution (1 mL, 0.5 mg/L Mirex) was added and swirled. Immediately after which, 1 mL of water was
added and the tube was shaken for 5 min. The samples were left at room temperature until two layers
were observed. The top layer was transferred to vials for analysis by gas chromatography–electron
capture detection (GC–ECD) with a series of standards. The GC–ECD equipment was Agilent 6890
GC with dual injector, cool on-column inlet, HP-5 column (30 m, 0.25 mm and 0.25 μm) and ECD
detectors (Agilent Technologies, Wilmington, USA). Helium and argon-methane were used as carrier
and makeup gas, respectively. The DON recoveries as determined by Tacke et al. [22], were 100%, 94%
and 94% for 0.5, 4.0 and 20.0 mg/kg DON, respectively. The limit of detection (LOD) was determined
to be 0.05 mg/kg and the limit of quantitation (LOQ) was determined to be 0.2 mg/kg [22]. Figure 5a
shows a reference chromatogram of 2.0 mg/kg DON determined by GC–ECD.
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Figure 5. Representative chromatograms of a wheat sample containing approximately 2.0 mg/kg DON
and 1.0 mg/kg D3G. (a) gas chromatography–electron capture detection (GC-ECD) chromatogram
of DON * and Mirex ** (internal standard); (b) LC-MS extracted ion (m/z of (M + H) + ion
297.1333) chromatogram of DON; and (c) LC-MS extracted ion (m/z of the (M + Na) + ion 481.1680)
chromatogram of D3G.
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3.4.2. Free DON and D3G Analysis with LC-MS
The sample preparation was carried out according to Tacke et al. [22] with a few modifications.
The sample (2.5 g) was extracted with 20 mL of acetonitrile/water mixture (84:16; v/v) for 1 h on
an orbital shaker at 180 rpm. The samples were left 20–30 min to settle. One mL of the crude extract
was filtered with 0.2 μm nylon syringe filter into a glass vial. The sample was analyzed with a liquid
chromatographic coupled with a quadrupole time of flight system (LC-QTOF). A series of DON and
D3G standards were also prepared and analyzed with every set of samples run on the LC-QTOF. Matrix
matched calibration standards were prepared at several concentrations for DON and D3G to take into
consideration any matrix effects from compounds extracted from the wheat. The concentrations of
DON were 20.0, 10.0, 6.0, 4.0, 2.0, 1.0, 0.7, 0.5, 0.2 and 0.1 mg/kg and the D3G concentrations were
5.0, 3.0, 2.0, 1.0, 0.75, 0.5, 0.3 and 0.2 mg/kg. Figure 5b,c shows reference chromatograms of DON
(2.0 mg/kg) and D3G (1.0 mg/kg) determined by LC-MS.
3.4.3. LC-MS Instrumentation and Methodology
The analysis of mycotoxins by liquid chromatography mass spectrometry (LC-MS) was performed
according to the methods of Vendl et al. [23] and Simsek et al. [2] with some modifications. A 1290 UPLC
System (Agilent Technologies, Wilmington, DE, USA) was used for separation of analytes. The DON
and D3G separation was carried out with an Eclipse Plus C18 column (Zorbax Rapid Resolution
High Definition (RRHD), 2.1 × 100 mm, 1.8-Micron, Agilent Technologies, Wilmington, DE, USA).
The column temperature was set to 40 ◦C. The solvent system consisted of 0.1% formic/water (solvent
A) and 0.1% formic/acetonitrile (solvent B). Formic acid was used instead of acetic acid to improve
formation of the M+H ion rather than formation of M+Na ion found frequently when using acetic acid.
The purge was done with 100% A with a purge flow rate of 4 mL/min during 15 s and the isocratic
pump flow was 0.6 mL/min with 100% A. The solvent gradient was modified slightly to reduce run
time and improve chromatographic separation of DON and D3G. The gradient program started with
97% A and 3% B with a binary pump flow rate of 0.4 mL/min and was kept until 0.75 min. Afterwards,
the proportion of B was increased linearly to 100% within 4 min, followed by a hold time of 6 min at
100% B and 10 min re-equilibration at 97% A, followed by isocratic washout step for 2 min with 97% A.
Five μL was the volume injection used.
The analyte detection was determined with a mass spectrometer quadrupole time of flight (Agilent
6540 time-of-flight LC-MS, Agilent Technologies, Wilmington, DE, USA). The ESI interface was used
in positive-ionization mode at 300 ◦C with the following settings: 7 L/min gas flow, 30 psig nebulizer
gas, 225 sheath gas temperature and 12 of sheath gas flow. Acquisition mode MS1 parameters were
minimal range (m/z) 100, maximum range (m/z) 1700 and scan range of 2 spectra/s. The data analysis
was performed using a MassHunter Qualitative Analysis B.05.00 program (Agilent Technologies,
Wilmington, USA). Integration and calculation of DON and D3G were prepared by extracting the
ion chromatograms for DON and D3G from the total ion chromatogram (TIC) using a mass window
of 10 ppm. The DON extracted ion chromatogram used the m/z of the (M+H)+ ion (297.1333) and
the D3G EIC used the m/z of the (M+Na)+ ion (481.1680). Since the detection method was TOF-MS
without fragmentation the accurate mass and retention time of standards were used for identification
of compounds (DON and D3G) as determined by Vendl et al. [23]. The DON recovery was calculated
to be 107% whole the D3G recovery was 51% [23].
3.5. Statistics Analysis
Analysis of variance (ANOVA) was performed for individual years using the “MIXED” procedure
in SAS (V 9.2, SAS Institute Inc., Cary, NC, USA). The model for ANOVA was a nested fixed model
in which region was nested in state and city was nested in region. Least square mean values were
estimated using the “LSMEAN” option. Correlation and regression was performed using “CORR”
and “GLM” procedures in SAS, respectively.
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4. Conclusions
The results indicated that DON levels varied with the survey crop year and they have a
relationship with the kernel quality and D3G detected in wheat. Also, it was found that the growing
state cause a larger effect on DON and D3G, but not on percent damaged kernels. The D3G levels were
significantly correlated with the percent damaged kernels, but at lower levels than the DON content.
DON infection in wheat caused more effect on the kernel quality between years analyzed. Otherwise,
the ANOVA and correlation coefficient indicate that both GC and LC-MS can be used to determine
DON in HRS. However, due to the ease of the method (sample can be extracted and analyzed without
derivatization) and simultaneous determination of the D3G, LC-MS is more advantageous.
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Abstract: Deoxynivalenol (DON) is a mycotoxin affecting wheat quality. The formation of the
“masked” mycotoxin deoxinyvalenol-3-glucoside (D3G) results from a defense mechanism the plant
uses for detoxification. Both mycotoxins are important from a food safety point of view. The aim of
this work was to analyze DON and D3G content in inoculated near-isogenic wheat lines grown at
two locations in Minnesota, USA during three different years. Regression analysis showed positive
correlation between DON content measured with LC and GC among wheat lines, locality and year.
The relationship between DON and D3G showed a linear increase until a certain point, after which
the DON content and the D3G increased. Wheat lines having higher susceptibility to Fusarium
showed the opposite trend. ANOVA demonstrated that the line and location have a greater effect
on variation of DON and D3G than do their interaction among years. The most important factor
affecting DON and D3G was the growing location. In conclusion, the year, environmental conditions
and location have an effect on the D3G/DON ratio in response to Fusarium infection.
Keywords: fusarium; wheat; deoxinyvalenol; deoxynivalenol-3-glucoside
1. Introduction
Molds can infect almost every agricultural crop—including wheat—worldwide during plant growth
and/or after harvest. A great variety of these fungi can produce mycotoxins, which are poisonous
for humans and animals and can be found in a great variety of food and feed commodities [1,2].
Deoxynivalenol (DON) or vomitoxin is a trichothecene mycotoxin produced by fungal plant pathogens
Fusarium graminearum and F. culmorum. Both pathogens cause a disease known as Fusarium head
blight (FHB) [3]. The severity of FHB during individual seasons depends on precipitation during
flowering, and increased levels of DON are often observed in harvest years with frequent rainfall and
high humidity during flowering [4]. In determination of the tolerance to FHB in wheat, it has been
reported that quantitative trait loci (QTL)-Fhb1 governs resistance towards FHB [5]. In general, the
most important factors that influence germination of wheat, growth of Fusarium and biosynthesis of
DON are temperature and water activity (moisture amount and duration) [3,6]. DON is usually the
most prevalent of the trichothecenes found in small grains grown in temperate regions all over the
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world; the reason for which is extensively studied [4]. The European and Food Safety Authority [2]
reported that DON was found in 44.6%, 43.5% and 75.2% of unprocessed grains of undefined end-use,
food and feed samples, respectively, with maize, wheat and oat having the highest levels. Also, DON
levels were significantly higher in wheat bran than other wheat milling products, while DON levels in
processed cereals were significantly lower than the DON levels found in unprocessed grains. So, in the
interest of food health and safety, mycotoxin analysis represents a major challenge in the control and
inspection of foodstuffs, as a high proportion of cereal based foods are affected [7].
Another emerging food safety concern related to the topic of mycotoxins is their “masked”
forms. Deoxynivalenol-3-glucoside (D3G) which has been discovered relatively recently is one of
the most common forms of masked DON. D3G is formed as part of a detoxification process in the
plant through the glycosylation of DON and is stored in the plant vacuoles [4,8,9]. It has been reported
that D3G formation is connected with glycosyltransferases [7]. Poppenberger et al. found that the
UDP-glucosyltransferase AtUGT73C5 transferred glucose to the hydroxyl group at carbon 3 of DON
forming D3G in Arabidopsis [8]. Also, D3G has been found in wheat lines with low FHB susceptibility.
In this case, the DON is converted to D3G due to the presence of the quantitative trait locus (QTL)-Fhb1,
which encodes a glucosyltransferase or regulates the expression of such enzyme [10]. There was very
little data available for D3G content in samples of food, feed and unprocessed grains of undefined
end-use collected by 21 European countries between 2007 and 2012. D3G was found in approximately 5%
of the samples, almost always together with DON, representing 5.6% of the lower bound sum of DON
and D3G. Because of this, the “masked” mycotoxin D3G was not taken into account in the exposure
assessment [2]. However, D3G should be measured because it is unknown how this mycotoxin can be
reactivated in humans and animals. Berthiller et al. have shown that D3G is not affected by stomach
conditions, but when D3G is exposed to human lactic acid bacteria, the glucose is cleaved and DON is
released, reactivating its toxicity [11]. Therefore, knowledge about the natural occurrence and impact
on processing/manufacturing practices on toxin levels in the final products has become important for
assessment of potential health risks associated with mycotoxin contamination [12]. The aim of this
research was to analyze the DON and D3G content and determine if there is correlation between the
DON and D3G production in samples with variation in susceptibility to FHB grown in Minnesota,
USA at two locations and three years of study, using liquid chromatography-quadrupole time of flight
mass spectrometry (LC-MS).
2. Results and Discussions
2.1. Relationship between DON and D3G
The data obtained showed correlation between DON and D3G. LC-MS was chosen for mycotoxin
determination because it is more convenient due to the lack of derivitization step in sample preparation.
Another advantage of the LC-MS is that it was possible to determine the D3G content in wheat
simultaneously with the DON determination. The correlation between DON and D3G determined by
LC-MS is shown in Figure 1. The coefficient of determination was moderate and significant (R2 = 0.872).
The equation model obtained with this R2 value was a second-order curve. The D3G content rose as the
DON content increased in samples with DON content between 0 and 30 ppm. However, at higher DON
concentration, a decrease in the D3G content was seen. Sasanya et al. did not find correlation between
DON and D3G content in randomly selected hard red wheat samples, and they also observed that in
the samples with the highest DON levels D3G was not detected [13]. Lemmens et al. found that samples
without the presence of the quantitative trait loci (QTL)-Fhb1 (FHB resistance gene) showed high DON
and D3G content [5]. However, in the presence of Fhb1, the conjugation of DON to glucose occurred
to a larger extent as compared to the lines without the QTL-Fhb1 [5]. Our results showed the same
trend reported by these authors. Possibly, the type of inoculum used between locations to inoculate the
samples, and inoculation at slightly different growth stages could be causing the behavior observed in
the correlation of DON and D3G in this research. It has been reported that D3G is a “masked” mycotoxin,
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product of the detoxification of the plant due to DON production after Fusarium infection [8]. Such
transformation is catalyzed by plant enzymes [1,7], such as glycosyltransferases, which transfer sugars
to a wide range of plant receptors. In Arabidopsis cloned with HvUGT13248 (UDP-glucosyltranferase
(UGT) from barley, capable of detoxifying DON), FHB susceptibility decreased and the capacity to
convert DON into D3G increased [9]. Therefore, the results obtained in this study lead us to think that
the samples which presented lower FHB susceptibility (lower DON), will produce high levels of D3G;
whilst the samples with higher FHB susceptibility will have lower levels of this “masked” mycotoxin.
This means the DON and D3G formation exerted by the less FHB susceptible wheat lines is a response
towards Fusarium infection [14].
Figure 1. Correlation between liquid chromatography deoxynivalenol (LC-DON) and
deoxynivalenol-3-glucoside (D3G) values (combined 2008, 2009 and 2010). *** Significantly different
from 1 at p < 0.001.
2.2. Effect of the Line, Location and Their Interactions on DON and D3G Content
Table 1 shows the means of DON and D3G content of wheat lines grown in Minnesota collected
during 2008, 2009 and 2010. The values for 2008 ranged from 0.1 to 33.9 ppm and 0.1 to 1.9 ppm for
LC-DON and D3G, respectively. Overall, the mycotoxin contents for 2009 were lower and ranged from
0.0 to 23.6 ppm and 0.0 to 3.0 ppm, for LC-DON and D3G, respectively. The lowest mycotoxin contents
were observed in 2010 and ranged from 0.2 to 17.7 ppm and 0.0 to 2.2 ppm, for LC-DON and D3G,
respectively. The analysis of variance (ANOVA) for DON and D3G in the samples for individual years
is shown in Table 2. During 2008, DON and D3G contents were not statistically related to the main
effects [Line and Location (Loc)] or their interaction (Line × Loc). In 2009, it was observed that the
effects of Line and Loc on DON were statistically significant. This means that growing location is the
main influence of DON content among samples. Concerning the D3G, during 2009 only the Loc had a
significant effect. On the other hand, during 2010, the main effects were significantly related to the
DON and D3G content in the samples, whereas the interaction between factors was not significant.
These results indicated that genetic and environmental conditions play an important role in the DON
and D3G production in 2010. So, it can be concluded that the DON content, dependent on the growing
conditions in a particular season, is affected by the wheat line. However, the main influence on DON
production is the location where the wheat line is planted, which also showed the highest influence on
the D3G content. It has been reported that the environmental conditions affect the gene expression and
so affect the mycotoxin occurrence, in this case DON production [6]. Although, factors such as the stage
of plant development and concentration and delivery of the toxin may be important in determining
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when and where DON is relevant in the disease process [10]. As was found for the DON, the D3G
production will depend on the tolerance/susceptibility level of the wheat line to FHB and its response
to environmental conditions. Lemmens et al. found D3G in naturally infected wheat samples, and also
that wheat containing the Qfhs.ndsu-3BS QTL have the ability to convert DON to D3G, resulting in a
high D3G/DON ratio and a low FHB susceptibility level [10]. It seems that conjugation of DON to
glucose is the primary biochemical mechanism for resistance towards DON [10].
The results of this study on D3G could help to increase the data about its occurrence in hard red
spring wheat in the USA. For example, in Europe, D3G content is not taken into account in the food
safety assessment [2] and in the USA, there is not a statement about the maximum levels of D3G in
food and feed, due to the lack of data about this “masked” mycotoxin. Increased D3G content, due to
the detoxification process of the plant, should be taken into account in terms of food safety because
this “masked” mycotoxin might be converted back to the parental toxin in the end products made
from the wheat [9].
Table 1. Means of GC-DON, LC-DON and D3G of wheat samples collected during 2008–2010 in
Crookston, Saint Paul and Minnesota (MN).
Year Location Range DON a D3G a
2008
Crookston
Min (n = 22) 0.1 0.3
Max (n = 22) 24.2 1.8
Average (n = 22) 5.7 1.1
St. Paul
Min (n = 22) 0.7 0.1
Max (n = 22) 39.5 1.9
Average (n = 22) 11.1 0.9
MN
Min (n = 44) 0.1 0.1
Max (n = 44) 39.5 1.9
Average (n = 44) 8.4 1.0
2009
Crookston
Min (n = 35) 0.0 0.0
Max (n = 35) 25.7 3.8
Average (n = 35) 11.9 2.1
St. Paul
Min (n = 35) 0.2 0.0
Max (n = 35) 21.0 1.5
Average (n = 35) 4.8 0.5
MN
Min (n = 70) 0.0 0.0
Max (n = 70) 25.7 3.8
Average (n = 70) 8.3 1.3
2010
Crookston
Min (n = 88) 1.7 0.4
Max (n = 88) 20.2 2.6
Average (n = 88) 7.9 1.3
St. Paul
Min (n = 90) 0.2 0.0
Max (n = 90) 11.5 1.5
Average (n = 90) 4.2 0.5
MN
Min (n = 178) 0.2 0.0
Max (n = 178) 20.2 2.6
Average (n = 178) 6.1 0.9
Notes: a in ppm (parts per million); n = number of lines in each set.
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Table 2. ANOVA table for DON and D3G of wheat samples for 2008–2010.
Year Traits Source DF Sum of squares Mean square F Value Pr > F
2008
DON
Line 21 3369.6 160.5 2.9 0.0095
Loc 1 418.7 418.7 7.5 0.0122
Line × Loc 21 1169.0 55.7 3.5 0.015
Error 12 191.7 16.0
D3G
Line 21 12.7 0.60 3.8 0.0016
Loc 1 0.9 0.88 5.6 0.0275
Line × Loc 21 3.3 0.16 4.7 0.004
Error 12 0.4 0.03
2009
DON
Line 34 5314.4 156.3 5.3 <0.001
Loc 1 1013.4 1013.4 34.3 <0.001
Line × Loc 34 1004.5 29.5 1.3 0.177
Error 72 1639.7 22.8
D3G
Line 34 27.9 0.82 2.5 0.0048
Loc 1 49.3 49.28 149.0 <0.0001
Line × Loc 34 11.2 0.33 2.6 0.000
Error 72 9.0 0.13
2010
DON
Line 89 3479.0 39.1 8.0 <0.0001
Loc 1 650.1 650.1 132.5 <0.0001
Line × Loc 87 426.8 4.9 1.0 0.497
Error 88 419.0 4.8
D3G
Line 89 48.1 0.54 4.0 <0.0001
Loc 1 33.1 33.09 247.4 <0.0001
Line × Loc 87 11.6 0.13 1.0 0.497
Error 88 11.8 0.13
2.3. Correlation of DON and D3G Content between Locations
The Pearson and Spearman’s correlations were used to determine the correlation between DON
and D3G in wheat grown at two localities of Minnesota, and are shown in Table 3. During 2008, the
ANOVA did not show any significant effect of the Loc between these two parameters. However,
the Spearman’s correlation showed positive correlation coefficients with significant levels (p < 0.05,
0.01 and 0.001) among DON and D3G from Crookston and St. Paul (Table 3). With respect to D3G
from Saint Paul, the Pearson correlation indicated that there was significant (p < 0.001) correlation
with DON from Saint Paul for 2008, 2009 and 2010. However, the Spearman correlation determined
a correlation coefficient of 0.44 (p < 0.01) for DON. This may be related to the trend (second order
curve) observed among the DON and D3G content among localities and years of study obtained in
Figure 1. The low significance level could be due to the different kind of inoculum used to infect the
wheat lines, differences in the growth stage development of the plant when the inoculum was applied,
and the differences in the weather conditions between Crookston and St. Paul during the three years
of study. In the case of 2010, the correlation among the parameters between both localities showed
high and significant correlation (p < 0.001). This indicated that the year of study also influenced the
DON and D3G content in the wheat lines, probably because of differences in the rainfall or moisture,
relative humidity, temperature, factors that have a notable effect on Fusarium infection [3]. Incidentally,
the significant (p < 0.05) correlations that occurred between mycotoxin contents of samples collected
from two different locations supports the notion that the interaction of wheat line and location might
not have a strong effect on variation of mycotoxin contents as already suggested by ANOVA. These
results also indicate that selection of wheat lines that have resistance to mycotoxin production might
be possible in one location. Cowger et al. found that genetic differences among cultivars may reflect its
ability to resist DON under increasing moisture conditions [15], meaning that the higher the disease
with varying post-anthesis moisture durations (in this case a nursery), the greater the differential effects.
While it is well known that agronomic and climatic conditions play an important role in mycotoxin
formation in wheat, cultivar selection and breeding strategies are very important for identification of
wheat with low susceptibility to Fusarium on the basis of masked mycotoxin formation.
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Table 3. Pearson and Spearman’s correlation coefficients between DON and D3G of two localities of
Minnesota for 2008–2010.
Year Crk DON Stp DON Crk D3G Stp D3G
2008
Pearson Correlation
- 0.59 ** 0.56 ** 0.56 **
0.51 * - 0.47 * 0.90 ***
0.68 *** 0.46 * - 0.59 **




- 0.52 ** 0.66 *** 0.50 **
0.45 ** - 0.24 NS 0.75 ***
0.56 *** 0.44 ** - 0.41 *




- 0.63 *** 0.69 *** 0.41 ***
0.57 *** - 0.51 *** 0.67 ***
0.55 *** 0.45 *** - 0.48 ***
0.34 ** 0.61 *** 0.44 *** -
Spearman correlation
Notes: Crk: Crookston, Stp: Saint Paul, DON: deoxynivalenol, D3G: deoxynivalenol-3-glucoside; NS: No significant.
*, **, and *** means correlation coefficient is significant at p < 0.05, 0.01, and 0.001, respectively.
3. Experimental Section
3.1. Standards and Chemicals
DON (100.2 μg/mL) and D3G (50.2 μg/mL) both in acetonitrile were purchased from Biopure
(Tulln, Austria). The standard curve for both GC-ECD and LC-MS methods were prepared using
clean wheat extract (DON-free wheat matrix). Acetonitrile was purchased from J. Baker. TMSI
(1-(trimethylsilyl)imidazole), TMCS (Chlorotrimethylsilane) and 2,2,4-trimethylpentane (ACS reagent)
were obtained from Sigma Aldrich.
3.2. Samples
Different wheat lines ranging from moderately susceptible to susceptible to Fusarium head blight
(FHB) were analyzed. The samples were collected when the latest maturing lines were at harvest
ripeness (14% or less grain moisture content). The sample set is comprised of experimental spring
wheat lines from the University of Minnesota wheat breeding program, ranging from first year to third
year yield trial lines. The checks Alsen, BacUp, Roblin, Wheaton, and MN00269 are included for each
nursery and are represented 53–55 times each in the data set. Therefore, the checks represent a total of
272 samples. The experimental lines, each represented 1–4 times, totaled 287 samples.
All lines were grown under two field screening during 2008, 2009 and 2010 in two locations of
Minnesota, USA. The growing locations were St. Paul, MN (44.9441◦ N, 93.0852◦ W) and Crookson,
MN (47.7742◦ N, 96.6081◦ W). For both locations, the weather conditions in 2008 were cool and wet
during planting. The growing conditions were hot and slightly dry, but with adequate soil moisture
at both locations in 2008. The growing conditions in 2009 at both locations were cooler than average
with adequate precipitation. Both growing locations in 2010 had cooler growing temperatures and
adequate precipitation.
At the St. Paul location (StP), F. graminearum macronidia was applied by backpack sprayer at the
rate of 60 mL of a 100,000 conidia/mL per 2.4 m row at anthesis and 3–4 days later. At the Crookston
location (Crk), grain spawn inoculum was spread at the rate of 56 kg/ha at the jointing stage and with a
second application one week later. Both nurseries were misted periodically overnight to maintain high
humidity environments. In Crookston, the grain-spawn inoculum method used in Crookston mimics
more closely what happens in nature, and a constant supply of inoculum was possible. In St. Paul,
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conidia were spray applied to control timing and inoculum dose. The conidia spray method is not
subject to as great of a possibility of escapes, unless the climate conditions are particularly non-conducive
during inoculation and the 48 hours post inoculation (for example, very windy and dry conditions).
The samples were ground using a UDY mill with a 0.8 mm screen and conserved under
refrigeration until their analysis.
3.3. Sample Preparation
The sample preparation was carried out according to Tacke et al., with some modifications [16,17].
The sample (2.5 g) was extracted with 20 mL of acetonitrile/water mixture (84:16; v/v) for 1 h on
an orbital shaker at 180 rpm. The samples were left 20–30 min to settle. The crude extract (1 mL)
was filtered with 0.2 μm nylon syringe filter into glass vial. The sample was analyzed with a liquid
chromatography system coupled with a quadrupole time of flight system (LC-QTOF).
3.4. LC-MS Instrumentation and Methodology
A 1200 Series HPLC System (Agilent Technologies, Wilmington, DE, USA) was used for separation
of analytes. The DON and D3G separation was carried out with an Eclipse Plus C18 column
(Zorbax Rapid Resolution High Definition (RRHD), 2.1 × 100 mm, 1.8-Micron, Agilent Technologies,
Wilmington, DE, USA). The column temperature was set to 40 ◦C. The solvent system consisted of 0.1%
formic acid/water (solvent A) and 0.1% formic acid/acetonitrile (solvent B). The purge was done with
100% A with a purge flow rate of 4 mL/min during 15 s and the isocratic pump flow was 0.6 mL/min
with 100% A. The gradient program started with 97% A and 3% B with a binary pump flow rate of
0.4 mL/min and was kept until 0.75 min. Afterwards, the proportion of B was increased linearly to
100% within 4 min, followed by a hold time of 6 min at 100% B and 10 min re-equilibration at 97% A,
followed by isocratic washout step for 2 min with 100% A. The volume of injection used was 5 μL.
The analytes’ detection was determined with a mass spectrometer quadrupole time of flight
(Agilent 6500 series time-of-flight LC/MS, Agilent Technologies, Wilmington, DE, USA). The ESI
interface was used in positive-ionization mode at 300 ◦C with the following settings: 7 L/min gas flow,
30 psig nebulizer gas, 225 sheath gas temperature and 12 of sheath gas flow. Acquisition mode MS1
parameters were minimal range (m/z) 100, maximum range (m/z) 1700 and a scan range of 2 spectra/s.
The data analysis was performed using a MassHunter Qualitative Analysis B.05.00 program (Agilent
Technologies, Wilmington, DE, USA).
3.5. Statistics Analysis
Analysis of variance (ANOVA) was performed individually for three year data. The “GLM”
procedure in SAS (V 9.2, SAS Institute Inc., Cary, NC, USA) was used for ANOVA in which wheat line
and location were considered as fixed effects. The main effects of wheat line and location and their
interaction were tested for significance using the residual error terms. Correlation and regression was
performed using “CORR” and “GLM” procedures in SAS, respectively.
4. Conclusions
In conclusion, the relationship between DON and D3G fit a second order curve, indicating that the
tolerance of the wheat lines to the Fusarium infection is related to the ability of the wheat line to convert
the DON to D3G during the detoxification process. Also, the most important factor affecting the DON
and D3G formation is locality, which may be due to differences in gene expression of the wheat line in
different environmental conditions and its response to different inoculum and development stages of
the wheat during the inoculation process.
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Abstract: Four hundred and seventy-two pasta samples were collected from long retail distribution
chain sales points located in North, Central and South Italy. Representative criteria in the sample
collection were followed in terms of number of samples collected, market share, and types of pasta.
Samples were analysed by an accredited HPLC-UV method of analysis. The mean contamination
level (64.8 μg/kg) of deoxynivalenol (DON) was in the 95th percentile (239 μg/kg) and 99th percentile
(337 μg/kg), far below the legal limit (750 μg/kg) set by Regulation EC/1126/2007, accounting for
about one tenth, one third and half the legal limit, respectively. Ninety-nine percent of samples
fell below half the legal limit. On the basis of the obtained occurrence levels and considering the
consumption rates reported by the Italian official database, no health concern was assessed for all
consumer groups, being that exposure was far below the Tolerable Daily Intake (TDI) of 1000 ng/kg
b.w/day. Nevertheless, despite this, particular attention should be devoted to the exposure to DON
by high consumers, such as children aged 3–5 years, who could reach the TDI even with very low
levels of DON contamination.
Keywords: deoxynivalenol; pasta; exposure assessment; risk assessment; consumer groups;
children; cereals
1. Introduction
Deoxynivalenol (DON) is a natural-occurring mycotoxin produced at pre-harvest stage by
several Fusarium species, mainly F.graminearum and F. culmorum [1], and belongs to a wide family of
mycotoxins known as trichothecenes. It is also known as vomitoxin due to its strong emetic effects
after consumption, because it is transported into the brain where it runs dopaminergic receptors.
Chemically, DON (Figure 1) is a sesquiterpenoid polar organic compound, which belongs to the
type B trichothecenes since it contains carbonyl group in C-8. Its empirical formula is C15H20O6. DON
is highly hydrosoluble and stable at cooking temperatures (120 ◦C), and in storage conditions and
milling processes [2,3].
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Figure 1. Chemical structure of deoxynivalenol (DON).
DON is one of the most pervasive mycotoxins that predominantly colonize wheat ears and also
corn leaves. Fungi attack mainly occurs in the field before harvest [4].
The optimal range of temperatures for DON production is 21–29 ◦C at moisture levels >20%.
DON is considered as a marker for the presence of other mycotoxins such as zearalenone [5].
The fungus has two distinct growth cycles corresponding to mould growth during warm daytime
temperatures and toxin production during cool night-time temperatures [6].
Red ear rot caused by F. graminearum is favoured by warm wet weather after silking. This plant
disease tends to be more risky in conditions of no rotation between subsequent cultivations, and in
general when corn or wheat precedes wheat and corn crops respectively as a consequence of the
permanence of contamination in the debris. Reduced tillage situations, provides additional elements
for an increase of the probability of fungi attack.
To date, all animal species are susceptible to DON in the following order: pigs > mice > rats >
poultry ≈ ruminants [7]. Differences in metabolism, absorption, distribution, and elimination of DON
among animal species might account for this differential sensitivity.
Specifically in swine, DON intake reduces weight gain and hinders animal feeding. At high
concentrations (more than 10 ppm) typical signs are emesis and total feed refusal [8]. In terms of DON
bioavailability, sheep and cows show very low rates (10% for single-doses administered) [9] in contrast
with swine where approximately 95% of the administered dose was recovered as deoxynivalenol [10].
Acute exposure of pigs to DON causes abdominal distress, increased salivation, malaise, diarrhea,
and emesis [11,12].
DON is detectable also in blood and serum in high amounts immediately after ingestion, but is
rapidly cleared from the blood stream.
Although JECFA established that DON is a probable factor for acute pathologies in humans, there
is not enough data yet to set an Acute Reference Dose (RfD) [13].
In 1993, IARC classified DON in Group 3, corresponding to not classifiable for its carcinogenicity
to humans; in 2002 the Scientific Committee for Food set a tolerable daily intake of 1 μg/kg bw/d.
In humans, deoxynivalenol causes gastro-intestinal problems, immunosuppression and
interferences with reproduction and development [14–18]. DON effects in humans have not yet
been widely registered but new evidence that has led to a report of immunotoxicity in humans even
at low doses of contamination that could create proteomic changes in human B (RPMI1788) and T
(JurkatE6.1) lymphocyte cell lines is currently under consideration. These potential effects are to be
considered much more alarming if transferred to the fetus where, according to a Norwegian study,
21% of the toxin is transferred, with no activation of DON required and a very poor detoxification
route. More generally, a correlation between low sanitary quality of cereals and increase of abortions
during pregnancy was also noted [19–21].
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In vitro studies using human intestinal Caco-2 cells suggested that DON crosses the intestinal
mucosa through a para-cellular pathway, though contribution by passive trans-cellular diffusion could
not be ruled out [17,22].
From the above, this study provides an evaluation of the exposure to deoxynivalenol deriving
from the consumption of pasta by different groups of Italian consumers, with a focus to a very sensitive
subgroup such as children.
1.1. Legislation on DON
Almost 40 countries have established regulatory limits or guidelines for DON in wheat and other
cereal-based products. The guideline levels for cereals and finished cereal products for humans range
from 100 to 2000 μg/kg, depending on consumer age and stage of processing of the grain [23]; levels
in diets for swine, poultry, and cattle range from 500 to10.000 μg/kg [24].
The European Commission set maximum tolerable limits for DON in food products. EC
Regulation 1126/2007 applies to the unprocessed durum wheat and oat (1750 μg/kg), soft wheat (1250
μg/kg) and to milled intermediate products, e.g finished products (500 μg/kg), dry pasta, cereals
destined for direct human consumption, such as cereal flour, bran and germ (750 μg/kg) and processed
cereal-based baby foods and foods for young children (200 μg/kg) [25]. Currently, no legal limits but
only guidance values have been set by the EU Recommendation 576/2006 for complementary and
complete feeding stuffs at various levels depending on the animal species susceptibility such as pigs,
calves (<4 months), lambs and kids [26].
However, it should be considered that DON contribution to animal origin food products as
carried over from feeds is generally negligible since no residues in eggs, milk and edible tissues were
found in the literature. It was shown, in fact, that DON is rapidly metabolized by de-epoxydation and
glucuronization leading to the formation of reduced toxicity metabolites [27].
1.2. Exposure Assessment by DON in Humans
Generally, human exposure assessment derived from mycotoxin-contaminated diet is a more and
more challenging issue in the worldwide scenario. What is still pending is the real aetiological
role of these hazards in the development of pathologies such as cancer or mycotoxin-induced
immunodepression diseases or other pathologies not yet related, like autism or celiac disease [28,29].
From the data available in the literature, in humans, the emetic effects of this mycotoxin were
firstly described in Japanese men consuming mouldy barley containing Fusarium fungi in 1972 [30,31].
In China, between 1961 and 1985, about 35 outbreaks of acute human illness were reported.
The symptoms of nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, and fever were
attributed to DON and other trichothecenes contaminated cereals, with at least 7818 victims.
In an outbreak in 1984 in Xingtai County, 94% persons who ate moldy maize became ill. The range
of DON levels was from 3.8 to 93 mg/kg [13].
DON was detected in all 15 urine samples of female inhabitants of Linxian County and Gejiu,
two Chinese high and low, respectively, risk exposure regions for DON and oesophageal cancer, with
mean levels of 37 and 12 ng/mL, respectively [32].
In one-year-old Dutch children exposed to DON levels above the Provisional Maximum Tolerable
Daily Intake (PMTDI), reductions in body weight and relative liver weight were estimated at 2.2% and
2.7% (confidence interval: 0.2%–25%), respectively [33].
In a study performed in UK, DON was detected in the urine of 296 out of 300 healthy subjects
showing a strong association between the cereal intake and urinary DON concentrations (p < 0.0005).
From a multivariable analysis, wholemeal and white bread as well as other cereal-based food products
including pasta were consistently related to urinary DON excretion.
The geometric mean concentrations were 6.55, 9.63, and 13.24 μg DON/day for low-, medium-,
and high-cereal intake groups, respectively. Consumption of other grain-based foods such as cereal
products and pasta was also significantly associated with urinary DON concentrations [34].
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In another study by Hepworth et al., DON exposure assessment was evaluated in a group of
pregnant women aged 16–44 from Bradford, UK. The urinary DON was detected in all samples in a
range from 0.5 to 116.7 ng/mg creatinine. From a food questionnaire, bread, particularly chapattis in
South Asian women, was the major contributor to DON exposure [35].
In 2003, the study performed by the European Commission within the SCOOP task 3.2.10 revealed
that the total intake of DON calculated from data coming from 12 member States ranged from
14.45%–46.1% to 11.3%–95.9% of TDI for adults and children, respectively. The contribution deriving
from wheat and derived products accounted for 76%–90%. In this study, among foodstuffs, pasta
showed a lower rate in the overall contribution to DON intake (25%) compared to wheat flour and
bread [36].
Analogous results were obtained by Larsen et al. [37] where higher intakes were calculated
considering the 95th percentile of consumption data multiplied by the mean DON concentration
resulted in an intake very close to or even higher than TDI, with specific emphasis for children
and infants.
It should be noted that in another study performed on baby foods in Italy by Pietri et al. in 2004,
DON intakes higher than the TDI (121%) were observed. In this study, a consumption of 100 grams of
cereal-based products was considered [38].
Occurrence of DON in Wheat Products
So far, in order to estimate the real amount of DON ingested with human diet, a reliable assessment
should be made, taking into account (i) the metabolic pathways of DON leading to the formation
of various DON-metabolites, DOM-1, glucuronic-DON, 3-AcOH-DON and 15-AcOH-DON; (ii) the
lifecycle of DON from the raw kernel to the finished products such as flour or bread and pasta; and
(iii) the frequency and degree of the occurrence of DON contamination levels in the wheat products
ingested by the final consumer.
The results obtained in a recent study by Brera et al. [39] showed a significant DON reduction from
the caryopsis to cooked pasta, accounting for a mean DON contamination decrease of 78%. Moreover,
the overall DON reduction observed from wheat grain to dry pasta was 66%.
Another study conducted by Visconti et al. concluded that the retention level of DON from grains
on the market to cooked pasta on the plate can be conservatively assessed at 25% or less [40].
As far as DON bio-accessibility, a recent in vitro study has demonstrated differences in levels
of DON during the child digestion processes, attributable to different typologies of pasta and initial
contamination levels [41].
L. González-Osnaya et al. evaluated the occurrence of DON at a rate of 28% in bread whereas in
pasta the occurrence was higher, varying from 9.3% to 62.7%. The mean content of deoxynivalenol in
bread was 42.5 μg/kg while in pasta the content of deoxynivalenol was higher (137.1 μg/kg). The
estimated daily intake of deoxynivalenol from the consumption of the mentioned products represented
8.4% of the tolerable daily intake [42].
Bockhorn et al. analysed 29 pasta samples purchased from retail shops in Berlin in April and
May 2001 and were analysed for their content of deoxynivalenol. Ninety percent of the raw samples
contained less than 0.5 mg DON/kg, but three out of 29 samples had contamination of up to 0.84
mg/kg. The amount of DON decreased after cooking, resulting in 60%–80% lower DON levels in the
ready to eat products [43].
2. Results and Discussion
2.1. Exposure Assessment
Exposure of different population groups was calculated by a deterministic approach using the
following equation:
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(1)
As far as the calculation of DON intake derived from only pasta, three different parameters
were taken into account: the mean contamination value, the mean consumption rate expressed in
grams, and the body weight expressed in kg. The exposure was calculated as ng/kg body weight/day.
This unit was chosen to compare the resulting values with the TDI of DON that was set by the Scientific
Committee for Food at 1000 ng/kg bw/day [44].
2.2. Occurrence Values
The statistical description analysis of the obtained results is shown in Tables 1 and 2. The mean
(64.8 μg/kg) and median (35 μg/kg) DON values of all samples were far from the legal limit of 750 μg/kg.
Ninety-nine percent of samples did not exceed the threshold of 50% of the legal limit. A percentage
of 78.6% of samples was lower than the limit of quantification (70 μg/kg). Even the DON contamination
levels corresponding to the 95th percentile and 99th percentile were around 50% of the legal limit.
The contamination profile of a subgroup of pasta samples (N = 43), namely short shape typology,
more commonly consumed by elderly and children but not corresponding to baby foods, showed
slight different values for the mean (101.5 μg/kg) that were higher than the overall mean. All the
other values, i.e., median, 95th percentile, 99th percentile and the maximum contamination value,
overlapped with the overall scenario.
No cluster contamination was observed for a specific brand and generally the contamination was
equally distributed among the different brands.
The obtained contamination levels generally confirm previous findings cited before.
Table 1. Descriptive statistics of DON contamination in pasta samples.
Parameter Numerical value
Number of samples 472
Samples <LOQ 371 (78.6%)
Samples ≥LOQ 101 (21.4%)
Mean contamination (μg/kg) 64.8*
Median contamination (μg/kg) 35*
95th percentile of contamination (μg/kg) 239.4
99th percentile of contamination (μg/kg) 337.0
MAX contamination (μg/kg) 385.7
Note: *Mean and median values have been computed assigning to <LOQ results, the value of LOQ/2 = 35 μg/kg.
Table 2. Descriptive statistics of DON contamination in small size pasta samples.
Parameter Numerical value
Number of samples 43
Samples <LOQ 26 (60.5%)
Samples ≥LOQ 17 (39.5%)
Mean contamination (μg/kg) 101.5*
Median contamination (μg/kg) 35*
95th percentile of contamination (μg/kg) 279.6
99th percentile of contamination (μg/kg) 320.9
MAX contamination (μg/kg) 336.4
Note: *Mean and median values have been computed assigning to <LOQ results, the value of LOQ/2 = 35 μg/kg.
82
Toxins 2013, 5, 2293–2309
2.3. Consumption Rate
Mean consumption rates of pasta related to specific subgroups of population were taken by the
Italian official reference database published by Leclercq in 2009 [45]. The study was conducted randomly
selecting households after geographical stratification of the national territory. Food consumption
was assessed on three consecutive days through individual estimated dietary records. The study
sample encompassed 3323 subjects (1501 males and 1822 females) aged 0.1 to 97.7 years belonging to
1329 households.
In Table 3, mean, 95th percentile and 99th percentile consumption rates for total population,
consumers only, children, adolescents, adults and elderly, are reported. For children, the data are
reported combining males and females. Vice versa, for adolescents, adults and elderly, a distinction of
gender is provided.
The range of consumption rates is between 54.2 g/d and 161.7 g/d being this latter value the worst
in absolute terms since it corresponds to children 3–9.9 years whose body weight is to be considered
unfavorable for the intake.
For this reason, the exposure assessment was calculated considering in more detail the status only
for children.
Table 3. Mean, 95th percentile* and 99th percentile** of individual daily consumption of pasta in the
total population (TP), in consumers only (C) and in males (M) and females (F) of different ages (g/d).
Category Gender
Consumption (g/day)
Mean 95th percentile 99th percentile
Total population 54.2 108.7 140.1
Consumers only 59.5 110.7 141.9
Children (3–9.9 years) Total population 58.2 104.9 161.7
Consumers only 59.8 104.9 161.7
Adolescent (10–17.9 years) Total population M 63.6 128.0 133.3
F 56.6 105.3 133.3
Consumers only M 66.7 128.0 133.3
F 61.0 105.3 133.3
Adult (18–64.9 years) Total population M 60.3 118.4 156.1
F 47.7 100.0 134.8
Consumers only M 66.0 121.6 156.9
F 53.8 102.2 137.8
Elderly (≥65 years) Total population M 61.1 109.6 129.8
F 50.7 100.6 117.4
Consumers only M 64.3 116.5 131.2
F 54.5 110.9 121.5
2.4. Body Weights
Body weights of children between 3 and 5 years were taken from the WHO official database [46],
and between 6–14 years, 15–18 years and over 18 years values as reported from EFSA [47] were
considered. In Table 4, the corresponding values are reported.
Table 4. Mean weight (kg) in all groups of population between 3 and >18 years.
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2.5. DON Exposure in Adolescents and Adults
In all cases, considering mean DON occurrence levels as a fixed parameter and mean, 95th
percentile and 99th percentile consumption rates, the overall exposure of the Italian population
sub-groups has to be considered not at risk. For instance, for adolescents, even in the worst case,
i.e., 133.3 g/d corresponding to the 99th percentile consumption rate—a body weight of 45 kg
corresponding to the subgroup of adolescents aged 10–14 years and a mean DON contamination
level of 64.8 μg/kg—the exposure would account for 192 ng/kg bw/day corresponding to almost one
fifth of the TDI. By taking as a reference situation the exposure of adolescents, all the other population
subgroups—adults and elderly—accounted for an even lower exposure rate considering approximately
similar consumption rates and higher body weights. For instance, for adults with a 99th percentile
consumption rate of 156.1 g/d, a body weight of 70 kg and considering the DON mean contamination
level, the exposure resulted in 144.5 ng/kg bw/day.
2.6. DON Intakes in Children
As far as children, different scenarios for their exposure assessment were taken into consideration
consistently with different consumption rates (mean, 95th percentile and 99th percentile) and
contamination levels (mean level, threshold level, legal limit) (Table 5). By accounting for the daily
mean consumption rate of pasta corresponding to 59.8 g for children aged from 3 to 9.9 years, the
exposure, only related to the consumption of pasta, did not reveal any alarming situation, being quite
far below the TDI.
More specifically, the obtained exposure rates decreased from 3 year old children to 10 year old
children accounting for a mean value, combining male and female data, of 275 ng/kg bw/day (27% of
the TDI) to 123 ng/kg/bw/day (12% of TDI), respectively.
A second scenario was evaluated taking into consideration double the mean contamination level,
i.e., 130 μg/kg; also in this condition, the exposure equalled 50% of the TDI in the worst case (children
aged 3 years). No meaningful difference between male (543 ng/kg bw/day) and female (559 ng/kg
bw/day) groups was noted.
A third scenario considering the calculated DON contamination level leading to an exposure
corresponding to the TDI for every subgroup of children was also considered. The resulting levels
ranged from one third to two third of the legal limit, as set by the Regulation 1126/2007 [25].
Nevertheless, it must be considered that 99% of the results obtained from this study fell below
these contamination levels.
Table 5. DON exposure in children (males (M) and females (F)) assuming a mean consumption of pasta











64.8* 14.3/3 271 13.9/3 279
16.3/4 237 16.1/4 240
18.3/5 211 18.2/5 213
31.2/10 124 31.9/10 121
130 14.3/3 543 13.9/3 559
16.3/4 476 16.1/4 482
18.3/5 424 18.2/5 427
31.2/10 249 31.9/10 243
239 (M)–233 (F) 14.3/3 999 13.9/3 1002
273 (M)–269 (F) 16.3/4 1001 16.1/4 999
306 (M)–305 (F) 18.3/5 999 18.2/5 1002
522 (M)–533 (F) 31.2/10 1000 31.9/10 999
Note: *: DON contamination level (N = 472).
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In Table 6, the same scenarios were calculated but for consumption rates corresponding to the
99th percentile, i.e., 161.7 grams. Even in this case, the exposure corresponding to the mean occurrence
level obtained in the present study always fell below the TDI with a maximum value for the exposure
accounting for the 75% of the toxicological threshold in the worst case (females aged 3 years).
Table 6. DON exposure in children (males (M) and females (F)) assuming a 99th percentile consumption











64.8* 14.3/3 732 13.9/3 753
16.3/4 643 16.1/4 650
18.3/5 572 18.2/5 575
31.2/10 335 31.9/10 328
89 (M)–86 (F) 14.3/3 1006 13.9/3 1000
101 (M)–100 (F) 16.3/4 1002 16.1/4 1004
114 (M)–113 (F) 18.3/5 1007 18.2/5 1003
193 (M)–198 (F) 31.2/10 1000 31.9/10 1003
Note: *: DON contamination level (N = 472).
Analogously to the previous description of different scenarios, the DON concentration levels
leading to an exposure equal to the TDI were calculated resulting in all children subgroups as a higher
value than the DON mean contamination level obtained in this study.
A last scenario, shown in Figures 2 and 3, leads to a very challenging issue since if the legal limit
of 750 μg/kg is considered, for any consumption rate, both mean and high values (99th percentile),
and for all children subgroups, an increase of 1.5–8 times the TDI would be reached, respectively.
 
Figure 2. DON exposure for a consumption of pasta of 59.8 g (mean consumption of pasta by children
between 3 and 9.9 years old, [45]) at a contamination level of 750 μg/kg.
Figure 3. DON exposure for a consumption of pasta of 161.7 g (99th percentile of consumption of
children between 3 and 9.9 years old, [45]) at a contamination level of 750 μg/kg.
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3. Experimental Section
3.1. Sampling
In order to assess the level of DON contamination in pasta, 472 packages of commercially
produced pasta taken from four large-scale retail traders distributed in different geographical areas in
Italy were collected over a period between November 2010 and May 2011. Pasta samples were chosen
with the criterion to guarantee the maximum representativeness of the most diffused marketed and
consumed products. The selection was chosen on the basis of the market share and consumption rates
in the north, south and centre of Italy. Forty-one brands were sampled.
The collected samples had to meet the following characteristics:
- Typology of pasta products (dry, fresh (10%), whole (10%), not egg-pasta, not addressed to baby
food chain);
- Random selection among different shape of pasta products (spaghetti, medium size like rigatoni,
short size like penne);
- Only one 500 g package per lot, typology, shape and brand.
3.2. Principle of the Method
The analytical method used for the analysis of pasta samples got accreditation, number 0779, by
the national accreditation body ACCREDIA, for DON determination in wheat and derived products.
DON is extracted from the matrix by homogenizing the sample with water. After centrifugation,
the extract is cleaned-up step by immunoaffinity columns and the toxin is eluted with methanol, dried
under nitrogen and re-dissolved in an aqueous solution of methanol (9.5%). DON is quantified by
reversed-phase HPLC by UV detection.
According to the obtained linearity, the used analytical method for DON determination in pasta
samples is to be considered applicable in the range 70 μg/kg ÷ 2000 μg/kg.
3.3. Sample Preparation
The first step was to choose between a wet (slurry) and a dry homogenization of pasta samples.
The preparation of slurried samples by using a lab-scale 4-lt Waring Blender and adding to the sample
tap water in a ratio 1:1, led to very sticky products. For this reason, this approach was abandoned and
a processing of samples in dry conditions was preferred.
All pasta samples were ground with a laboratory mill (Retsch ZM 200, Retsch GmbH, Haan,
Germany) to obtain a particle size of at least 0.75 mm. After grinding and before drawing the test
aliquot, a thorough homogenization of the test portion was done.
3.3.1. Extraction
DON is extracted by weighing 20.0 g (±0.1 g) of the dry ground test portion directly in the blender.
One hundred and sixty milliliters of deionized water as extraction solvent was added. After 3 min of
blending, the extract is centrifuged at 8000 rpm per 10 min.
The extract is then transferred to the IAC.
3.3.2. Immunoaffinity Clean-Up
To clean samples, manufacturers’ instructions of IAC (DONPREP, R-Biopharm-Rhone, Glasgow,
UK) were followed. IAC columns were kept at room temperature before the conditioning.
Under slight vacuum conditions, 3 mL (equivalent to 0.375 grams of pasta) of the centrifuged
extract was pipetted into the syringe connected to the IAC. During the clean-up, the flow was
maintained at a constant flow of not more than 3 mL/min, (in any case, the flow speed must not exceed
5 mL/min).
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After the complete passage of the filtered sample, IAC was washed with 5 mL of de-ionized water.
The column was successively dried by flowing at least 2 volumes of air.
DON was eluted from the IAC in two steps: firstly, 750 μL of methanol were flown by gravity
and then, after 1 min, a second amount of 750 μL of methanol was applied to the IAC.
To collect the entire residual methanol, the elution is completed by pushing one volume of air
inside the IAC by a 10-mL syringe.
The eluate is taken to dryness with a nitrogen flow at a temperature of 40 ◦C. The residue is then
redissolved in 750 μL of the injection mixture MeOH:H2O (9.5%:90.5%, v:v), and mixed thoroughly by
vortex. The sample to be injected was stored at 4 ◦C until the HPLC analysis.
3.4. HPLC Analysis
One-hundred and fifty microliters (equivalent to 0.075 grams of pasta sample) out of 750 μL of
the reconstituted analytical sample were injected onto HPLC, by partial loop.
HPLC Operating Conditions
The following operating conditions were used:
- Chromatographic column: Symmetry® C18 (Waters, Milford, Massachusetts, UK) reversed phase,
5 μm, 4.6 mm × 150 mm, kept at constant temperature of 40 ◦C;
- Mobile phase: deionized water: methanol 85:15 v:v;
- Flow rate: 1.0 mL/min;
- UV spectrophotometer regulated at a wavelength of 220 nm;
- Injection Volume: 150 μL.
3.5. Spiking Procedure
To assess the recovery factors to be used for correcting the analytical results, six replicates of
fortified samples were prepared by weighing directly in the homogenizer 20.0 g ± 0.1 g of blank
pasta samples and pipetting proper volumes of working solution of DON reference standard to obtain
spiking concentration levels of 200 μg/Kg and 750 μg/Kg. The fortified samples were left under hood
for two hours before the successive processing.
3.6. Validation Study
With the aim to test the reliability of the analytical results, a single-laboratory validation study
was performed on the used method according to the IUPAC protocol [48].
All method performance characteristics, including precision and accuracy, were compliant with
the criteria set by the European Commission Regulation (CE) 401/2006 [49].
Limit of Quantification
The limit of quantification (LoQ) of the used method was calculated over replicate analyses of
blank samples and calculating mean values and standard deviation of the areas of the background.
The standard deviation was then multiplied by 10.
From this approach a LoQ of 70 μg/kg was calculated. In these analyses, a value of repeatability
≤10% was verified.
3.7. Calibration Curve
Fit for purpose calibration curve was built up by preparing six working solutions in 5-mL flasks.
Each level was injected in triple.
The stock solution of the primary certified standard material (Trilogy®, R-Biopharm: 100 μg/mL)
was diluted with a mixture water:methanol 90.5:9.5 (v:v) to 10 μg/mL, by pipetting 1000μL of it in
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10-mL flask. To prepare working solutions necessary for the building up of the calibration curve,
proper amounts of DON were drawn from the diluted solution.
4. Conclusions
Estimates of dietary exposure to DON based on the obtained occurrence data in pasta samples are
far below the TDI of 1000 ng/kg b.w. for populations of all age groups, and therefore do not represent
a health concern.
Just in some cases regarding population subgroups’ exposure to DON, some borderline situations
were noted. In fact, considering a DON contamination level slightly higher than the mean value
obtained in this study—like for instance 90–100 μg/kg, for children from 3 to 5 years with high
consumption rates (99th percentile)—the exposure levels would reach the TDI, considering pasta as
the only daily contribution to exposure.
However, it should be noted that the abovementioned concentration value would correspond
to almost one seventh of the legal limit; therefore, creating a quite challenging situation where even
for very low levels of DON contamination in a food product highly consumed such as pasta, a health
warning for some sensitive consumer groups could be raised.
It should be also noted that, due to the high DON hydro-solubility, the overall exposure assessment
should, however, be re-examined considering a loss of up to 20% of DON after cooking pasta, except
for when the cooking water remains in the meal as in the case of soups, consumed especially by the
elderly and young children.
The scientific information derived from this study can provide a basis for more strict consideration
of children’s exposure through diet, since even for contamination levels far lower than the legal limit,
borderline situations can arise.
This consideration is more pertinent if applied to DON that is present in the wide spectrum of
food products such as bread, breakfast cereals, pizza, biscuits and other cereal-based products.
For the above, reconsideration both of the maximum tolerable legal limit and of the toxicological
threshold could represent interesting and challenging topics to be examined with the aim to guarantee
an even higher level of safety for those population subgroups, such as children and adolescents, for
whom in some cases issues could arise.
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Abstract: The Fusarium mycotoxin deoxynivalenol (DON) can cause cell death in wheat (Triticum
aestivum), but can also reduce the level of cell death caused by heat shock in Arabidopsis (Arabidopsis
thaliana) cell cultures. We show that 10 μg mL−1 DON does not cause cell death in Arabidopsis cell
cultures, and its ability to retard heat-induced cell death is light dependent. Under dark conditions,
it actually promoted heat-induced cell death. Wheat cultivars differ in their ability to resist this
toxin, and we investigated if the ability of wheat to mount defense responses was light dependent.
We found no evidence that light affected the transcription of defense genes in DON-treated roots
of seedlings of two wheat cultivars, namely cultivar CM82036 that is resistant to DON-induced
bleaching of spikelet tissue and cultivar Remus that is not. However, DON treatment of roots led
to genotype-dependent and light-enhanced defense transcript accumulation in coleoptiles. Wheat
transcripts encoding a phenylalanine ammonia lyase (PAL) gene (previously associated with Fusarium
resistance), non-expressor of pathogenesis-related genes-1 (NPR1) and a class III plant peroxidase
(POX) were DON-upregulated in coleoptiles of wheat cultivar CM82036 but not of cultivar Remus,
and DON-upregulation of these transcripts in cultivar CM82036 was light enhanced. Light and
genotype-dependent differences in the DON/DON derivative content of coleoptiles were also
observed. These results, coupled with previous findings regarding the effect of DON on plants,
show that light either directly or indirectly influences the plant defense responses to DON.
Keywords: Arabidopsis; β-1,3-glucanase; cell death; Fusarium; light; non-expressor of pathogenesis-related
genes-1 (NPR1); peroxidase; phenylalanine ammonia lyase; wheat
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1. Introduction
Fusarium graminearum Schwabe [teleomorph Gibberella zeae (Schweinitz) Petch] and F. culmorum
(W.G. Smith) Saccardo cause diseases on the roots, stems and heads of cereal plants [1]. Fusarium
head blight (FHB) receives significant attention because of both the yield losses and mycotoxin
contamination of grain associated with this disease. F. graminearum and F. culmorum commonly
produce the trichothecene mycotoxin deoxynivalenol (DON) in infected plant tissue and this toxin acts
as an aggressiveness factor for the pathogen during the development of root rot and FHB disease [2,3].
DON inhibits protein synthesis and its effect on wheat (Triticum aestivum L.) head tissue is similar to
that of FHB disease, in that it bleaches the tissue [4,5]. Wheat genotypes differ in their response to
DON; resistance to DON-induced bleaching is associated with resistance to the spread of FHB disease
(type II resistance to FHB), but not with resistance to Fusarium infection (type I resistance to FHB) [4].
Studies have shown that DON treatment induces defense gene transcription in wheat [5–7], the
production of reactive oxygen species (ROS) and, thereafter, an increase in programmed cell death
(PCD) [6]. Diamond et al. [8], however, showed that lower levels of DON (10 vs. 100–200 μg mL−1) and
a DON-producing strain of F. graminearum did not cause cell death in Arabidopsis thaliana cell cultures,
but they did reduce the level of cell death caused by heat shock. The opposing effects of DON on cell
viability and death in Arabidopsis and wheat may be due to many factors, including the differences in
DON concentrations used. We postulated that it might in part be due to light-dependent signaling.
The Arabidopsis experiments were conducted using light-grown cell cultures (that contained mature
chloroplasts), while the wheat experiments were conducted using seedlings. Therefore, the light
exposure of cells was quite different, and it is known that DON-induced bleaching of barley tissue is
light dependent [9]. The opposing effects of DON on cell death in Arabidopsis vs. wheat may also
reflect host-dependent responses to the toxin, or a specific type of resistance to DON that is inherited
in a genotype-dependent manner. DON resistance inherent to some wheat genotypes is associated
with the capacity to convert DON to the less toxic DON-3-glucoside and co-segregated with the QTL
Fhb1 [4]. This may be in and of itself a light-dependent phenomenon, because, in Arabidopsis, a UDP
glucosyltransferase (UGT) catalyzes the glucosylation of DON [10] and an analysis of Arabidopsis
microarray experiments available in public repositories shows that the transcription of the encoding
gene is light regulated.
The first objective of this work was to try and determine if light plays a role in how DON influences
plant cell death. We show the ability of DON and DON-producing F. graminearum to retard cell death
caused by heat shock in Arabidopsis cell cultures is light dependent, and that DON actually enhanced
heat-induced cell death in dark-grown cells. The fact that the effect of DON and DON-producing Fusarium
on cell viability was light dependent, coupled with the previously reported light-dependent bleaching of
barley leaves by DON [9], indicated that light might be an important determinant of the plant response to
this toxin and its producer fungi. The second objective was to determine if light influences the ability
of wheat seedlings to mount defense in response to DON treatment. Using seedlings whose roots were
treated with DON, we show that light does enhance defense transcript accumulation in coleoptiles and
increases the DON metabolite content of coleoptiles. The extent to which light influences defense
transcript accumulation and DON metabolite translocation in DON-treated seedlings, however, is
wheat genotype-dependent. The implications of these results are discussed.
2. Results
2.1. The Effect of DON on the Viability of Heat-Shocked Arabidopsis Cell Cultures Is Light Dependent
We used heat as an abiotic cell death inducer and determined whether light was necessary
for DON-mediated inhibition of heat-induced cell death (a phenomenon previously discovered by
Diamond et al., [8]). We compared light- and dark-incubated Arabidopsis thaliana ecotype Landsberg
erecta cell cultures with respect to the effect of 10 μg mL−1 DON on heat-induced cell death.
Light-grown cultures contained mature chloroplasts, while dark-grown cultures contained plastids, as
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determined by electron microscopy [11]. Cell cultures were treated with 10 μg mL−1 DON or water
(controls) 24 h prior to heat treatment (55 ◦C for 10 min). Cells were treated with fluorescein diacetate
and cell fluorescence and morphology (epifluorescent microscopy) were used to distinguish between
viable and non-viable cells and to determine whether non-viable cells displayed apoptotic-like cell
death morphology or necrotic morphology (Figure S1) [8]. Results showed that the effect of DON
on cell death was light-dependent. When cells were incubated in the dark (Figure 1A, B), DON
pre-treatment did not enhance the viability of heat-shocked cells. Indeed, when comparing DON and
water-pretreated cells examined 5 h post-heat treatment, toxin treatment resulted in 2.6-fold higher
numbers of cells exhibiting apoptotic-like cell death morphology and reduced cell viability by 5.94-fold
(P ≤ 0.01). However, in light-grown cells harvested 5 h post-heat treatment, DON, as compared to
water, reduced cell mortality (6.2 and 2.8-fold reductions, respectively in cells exhibiting apoptotic-like
cell death and necrotic morphology) and enhanced the level of cell viability (by 5.0-fold; P ≤ 0.02;
Figure 1C). Another interesting observation was that the ability of DON to inhibit heat-induced cell
death in light-grown cultures was temporal. At 24 h post-treatment, the DON (relative to water)
pretreatment did not influence the viability of heat-shocked cells (P ≥ 0.31) (Figure 1D).
 
 
Figure 1. The effect of DON on the viability of heat-stressed Arabidopsis cells. Cells were cultured
under dark conditions (A and B) or light conditions (C and D) and were treated with DON (10 μg
mL−1) or water (controls) 24 h pre-heat treatment (55 ◦C, 10 min) and cells were examined at either
(A and C) 5 h, or (B and D) 24 h post-heat treatment. Cells were treated with fluorescein diacetate
and examined under phase contrast microscopy with or without UV fluorescence (490 nm) in order
to determine if cells were viable, or non-viable and exhibiting either programmed cell death (PCD)
or necrotic morphology. Results represent the mean percentage (+/− standard error) of cells in a
given state, based on five independent experiments, and in each experiment 200 cells were scored per
treatment per time point. In control, water-treated, non-heat shocked cells, ≥84% were viable and ≤14
and 3% respectively displayed PCD or necrotic morphology in dark-/light-grown cultures at the time
points analyzed.
95
Toxins 2014, 6, 679–692
Diamond et al. [8] showed that, like DON, pre-treatment with DON-producing F. graminearum
reduced the level of PCD caused by subsequent heat treatment in Arabidopsis cell cultures. We
conducted similar experiments, where light- and dark-incubated Arabidopsis cell cultures were
pre-treated with conidia of wild-type DON producing F. graminearum (strain GZ3639) or its DON-minus
mutant derivative (strain GZT40), 20 h prior to heat treatment (55 ◦C, 10 min). Cell viability was
assessed at 5 h post-heat treatment, as described above (Figure 2). For dark-grown cultures, neither the
wild type nor mutant Fusarium significantly affected either cell viability or the morphology of dead cells
(P ≥ 0.30) (Figure 2A). This contrasted with the DON which enhanced death under dark conditions
(Figure 1). In light grown cultures, the wild-type, but not the mutant, significantly enhanced cell
viability (by 2.5-fold) and reduced cell necrosis (by 1.6-fold; P ≤ 0.05; Figure 2B). Neither fungal strain
significantly influenced the level of apoptotic-like cell death morphology observed in heat-shocked
cells at this time point (P ≥ 0.27). Therefore we concluded that the effect of toxigenic F. graminearum on
plant cell death is light dependent, possibly dependent on chloroplasts, and under light conditions,
the ability of DON to prevent cell death caused by abiotic stress is temporal.
2.2. DON Induction of Defense Gene Expression in Wheat Is Light Enhanced and Genotype Dependent
The second objective was to determine if light influenced the wheat response to DON. In this study,
we used two wheat cultivars which differ with respect to the ability of their spikelets to resist DON; cv.
CM82036 is DON-resistant, while cv. Remus is susceptible [4,5]. The response analyzed was defense
gene expression, namely genes encoding POX, PAL, NPR1 and GLC1. These were analyzedbecause
a previous study showed that these were all DON-upregulated in wheat spikelets, and that NPR1
transcription was more highly DON-upregulated in the toxin-treated spikelets of cv. CM82036, as
compared to cv. Remus ([12]). Furthermore, the upregulation of the PAL gene is associated with two
quantitative trait loci (QTL) that confers spikelets of cv. CM82036 with enhanced resistance to both
FHB and DON [13]. In this study, the roots of seedlings grown under light or dark conditions were
treated with DON and defense gene transcription in both roots and coleoptile was analyzed at 4 and 24
h post-treatment. The localized effect of DON on defense gene expression in roots of the two cultivars
was not light enhanced (results not shown). In coleoptiles of cv. Remus, GLC1 was the only transcript
that was significantly DON-upregulated; this phenomenon was light-enhanced (3.1-fold higher in DON
vs. water treated, light-grown cells observed 24 h post-treatment; P = 0.02) (Figure 3). In coleoptiles of
dark-grown cv. CM82036 seedlings, POX was the only transcript significantly upregulated in response
to DON treatment (2.3-fold at 24 h, P = 0.05). But, under light conditions, and by 24 h post-root
treatment, DON had transcriptionally upregulated all four defense genes in coleoptiles of this cultivar
(2.0–4.3-fold upregulation; P ≤ 0.02) (Figure 3). Moreover, the highest transcript levels were detected
at 24 as compared to 4 h post-treatment.
2.3. Both Genotype and Light Affect the Movement of DON Metabolites within Wheat Seedlings
Using an ELISA test, we determined the level of DON and DON derivatives in coleoptiles 24 h
post-root treatment with toxin. The test used did not discriminate between DON and DON 3-glucoside
(and thus compounds detected are described as DON metabolites). Both the incubation conditions
(light/dark) and wheat genotype influenced the level of DON metabolites detected within coleoptiles
(Figure 4). Coleoptiles of cv. CM82036 contained more DON metabolites than those of cv. Remus,
irrespective of incubation conditions (≥1.7-fold more; P = 0.003) and coleoptiles of cv. CM82036, but
not of cv. Remus, accumulated significantly more DON metabolites by this time when incubated under
light as compared to dark conditions (1.4-fold more; P = 0.046). By 24 h post-DON treatment, neither
light nor cultivar-dependent differences in coleoptile dry weight were observed (mean = 32–35 mg;
P ≥ 0.20). However, coleoptiles of cv. CM82036 were more elongated than those of cv. Remus (results
not shown).
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Figure 2. The effect of DON production by Fusarium graminearum on the viability of heat-stressed
Arabidopsis cells. Cells were cultured under dark conditions (A) or light conditions (B) and were
treated with either water, or conidia of either wild type, DON-producing F. graminearum (strain GZ3639)
or its mutant, non-DON-producing derivative (strain GZT40). After 20 h, cells were incubated at
either 23 or 55 ◦C for 10 min, and thereafter at 23 ◦C. Cells were examined at 5 h post-heat treatment.
Cells were treated with fluorescein diacetate and examined under phase contrast microscopy with
or without UV fluorescence (490 nm) in order to determine if cells were viable, or non-viable and
exhibiting either programmed cell death (PCD) or necrotic morphology. Results represent the mean
percentage (+/− standard error) of cells in a given state, based on five independent experiments,
and in each experiment, a minimum of 200 cells were scored per treatment. In control, water-treated,
non-heat shocked cells, ≥94% were viable and ≤4.6 and 1.4% respectively displayed PCD or necrotic
morphology in dark-/light-grown cultures.
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Figure 3. Influence of light on deoxynivalenol (DON)-induced accumulation of defense transcripts
in coleoptiles of wheat cultivars CM82036 and Remus. (A) Visualization and (B–E) quantification
of the respective POX, PAL, NPR1 and GLC1 transcript (relative to Act1 transcript) levels. Results
represent the mean (+/− standard error), based on two independent experiments, each including
two replicates per treatment. The roots of germinated seedlings (48 h) were incubated in DON
(20 mgmL−1) or water under light or dark conditions at 20 ◦C. RNA extracted from coleoptiles at either
4 or 24 h post-treatment was used for RT-PCR analyses. Gene codes: Act1 = actin; POX = class III plant
peroxidase; PAL = phenylalanine ammonia lyase; NPR1 = a non-expressor of pathogenesis-related
genes-1; GLC = β-1,3-glucanase. Arrows indicate Act1, POX, PAL, NPR1 and GLC1 RT-PCR products
(270, 272, 241, 219 and 201 bp, respectively).
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Figure 4. The translocation of DON metabolites within seedlings of wheat cultivars CM82036 and
Remus. The roots of germinated seedlings (48 h) were incubated in DON (20 mg mL−1). Coleoptiles
were harvested 24 h post-treatment and DON was extracted and quantified by ELISA analysis. Results
represent the mean (+/− standard error), based on two independent experiments, each including two
replicates per treatment.
3. Discussion
This research has established that light is an important determinant of how plants cells respond
to the Fusarium mycotoxin DON and that wheat genotypes differ with respect to their ability to mount
light-dependent defense responses to DON. Plant defense responses against pathogens, including the
activation of PAL, the accumulation of SA, expression of PR proteins and the hypersensitive response,
are often light dependent [14–18]. Light can influence defense responses via its effects on chloroplast
metabolism, ROS generation and phytochrome signaling [19]. Light influences chloroplast function
and several lines of evidence point to the possible role of the chloroplast as an important determinant of
the plant response to DON. The light-grown Arabidopsis cells used in this study contained chloroplasts,
while the dark-grown did not. DON damage of chloroplasts is a light-dependent phenomenon [9].
This could result in the accumulation of photosensitive pigments, and these can directly generate
ROS in the light [20]. DON has been shown to induce ROS production in plants [6]. Excess energy
produced via the photosynthetic electron transport chain [19] may contribute to the DON-induced
ROS accumulation.
It is difficult to screen for the inhibition of cell death; such a phenomenon may be interpreted as a
null effect and would only be obvious in situations where cell death is induced by other factors, such as
heat stress. We thus used heat to induce PCD as it provided a means to activate this conserved pathway
in plants. The fact that DON and DON-production inhibits heat-induced PCD supports the previous
deduction from gene expression studies. Based on microarray studies, it was deduced that ROS
scavenging and the promotion of cell survival are key early defense strategies that are more effectively
employed by DON-resistant as compared to susceptible wheat genotypes [7]. It would be logical for
Fusarium-resistant plants to promote the survival, and hence the potential for defense, of cells that
are being attacked by necrotrophic Fusarium fungi that can colonize dead plant tissue. Babaeizad
et al. [21] showed that overexpression of a gene encoding a cell death suppressor, BAX inhibitor-1,
retarded F. graminearum colonisation of barley seedlings. While traditionally regarded as a necrotroph,
there is increasing evidence and belief that F. graminearum is actually a hemibiotrophic pathogen, with
a short biotrophic phase preceding the necrotrophic phase of disease spread. DON suppression of
death suggests that the role of DON may be to disable PCD during the initial biotrophic infection
stages in plant cells, with the accumulation of higher concentrations causing PCD and facilitating
nectrotrophism and disease spread. In the dark, DON enhanced the rate of apoptotic cell death.
However, the fungal DON-producing strain did not do so relative to the mutant strain. There are
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many possible reasons for these contradictory results, including the variation in DON concentrations
in toxin versus fungal studies and the fact that fungal factors other than DON are also very likely to
affect cell death.
This study showed that defense genes were light regulated and that NPR1, POX and PAL were
more DON responsive in seedlings of the DON-resistant cultivar CM82036, as compared to the
susceptible cultivar Remus. NPR1 and PAL genes have been associated with enhanced FHB resistance,
but not with enhanced DON resistance. NPR1 is a central regulator of plant defense responses,
including systemic acquired resistance (SAR), induced systemic resistance (ISR) and salicylic acid
(SA)/jasmonic acid (JA) cross-talk [22]. An Arabidopsis npr1-1 mutant was more susceptible to F.
graminearum and accumulated higher concentrations of DON in buds and flowers than did wild type
plants [23]. Overexpression of Arabidopsis NPR1 (AtNPR1) transcript in wheat conferred heritable
resistance to FHB disease spread, but not initial infection [24]. These data, together with the facts
that DON is associated with disease spread and that it induces the accumulation of NPR1 transcript
in wheat, suggest that the NPR1 protein is linked to Type II resistance to FHB (resistance to disease
spread). In rice, overexpression of a NPR1 homolog led to the constitutive expression of defense genes,
including POX and PAL [25].
Steiner et al. [13] showed that a PAL transcript was Fusarium responsive in wheat spikelets
and its responsiveness was associated with the presence of two quantitative trait loci that confer
enhanced resistance to FHB, namely Fhb1 and Qfhs-ifa-5A. This transcript is 100% homologous to
that used herein for PCR primer design. The results of Steiner et al. [13] and the higher accumulation
of cinnamic acid, benzoic acid, and glutamine in F. graminearum-infected spikelets of the FHB
resistant wheat cv. Sumai-3 (a parent of cv. CM82036 that carries QTL Fhb1) than in spikelets of
the susceptible cv. Roblin [26] provide evidence that the phenylpropanoid pathway plays a role in host
defense against DON-producing Fusaria. QTL Fhb1 also confers wheat with enhanced resistance to
DON-induced bleaching of spikelets [4]. It is therefore likely that components of phenylpropanoid
pathway play a light-dependent role in wheat resistance to DON. This is independent of DON
conversion to DON-3-glucoside as Gunnaiah et al. [27] recently showed that Fhb1 derived from
the wheat genotype Nyubai is mainly associated with cell wall thickening due to deposition of
hydroxycinnamic acid amides, phenolic glucosides and flavonoids, but not with the conversion of
DON to less toxic DON-3-glucoside.
The cv. CM82036 differs from cv. Remus in its enhanced ability to convert DON to DON-3-
glucoside [4]. This derivative is detected by the ELISA test [28] and, based on spikelet studies [4], it is
likely to be the predominant DON metabolite in cv. CM82036, though not in cv. Remus coleoptiles. It is
possible that light affects the conversion of DON to DON-3-glucoside in a genotype-dependent manner.
The light-enhanced translocation in cv. CM82036 may be an indirect consequence of enhanced sugar
availability for the formation of the DON-3-glucoside. Whether or not translocated DON metabolites
contributed to the light-enhanced defense transcript accumulation in coleoptiles is unknown.
4. Experimental Section
4.1. Maintenance, Growth and Treatment of Arabidopsis Cells
Arabidopsis thaliana (ecotype Landsberg erecta) cells were grown in liquid Murashige and Skoog
(MS) media ([29,30]. Cells were sub-cultured by pipetting 10 mL of culture into 100 mL of fresh media
every 7 days, and were grown on a rotary shaker at 100 rpm (5 cm rotation), a constant temperature
of 23 ◦C, and either in darkness or at a continuous light intensity of approximately 4 μmol photons
m−2 s−1. DON (Sigma, UK) was dissolved in water at a concentration of 2000 μg mL−1 and stored at
4 ◦C. Conidia of Fusarium graminearum strain GZ3639 and its trichothecene-minus mutant derivative
(strain GZT40) [31] were produced as described previously [32] and adjusted to a concentration of
5 × 104 mL−1 H2O (fresh conidia were prepared for each experiment). Arabidopsis cell samples
(10 mL) were transferred to sterile 100 mL conical flasks and were treated with 0.5 mL DON 24 h
100
Toxins 2014, 6, 679–692
prior to heat treatment or with 2 mL of conidial inoculum 20 h prior to heat treatment. Controls were
treated with equivalent volumes of water. For heat treatment, cell culture flasks were placed in a
shaking water bath (80 rpm) that was pre-equilibrated to either 23 or 55 ◦C, for 10 min. Between
DON/fungal and heat treatment, and subsequent to heat treatment, samples were returned to their
prior growth conditions (as above, either light or dark). Samples were morphologically analyzed at
either 5 or 24 h after heat treatment. Five independent experiments compared the effect of DON and
water on heat/non-heat-treated cells, and another five compared the effect of F. graminearum wild type,
mutant and water on heat/non-heat-treated cells. Each experiment included one flask per treatment
per harvest time point and 200 cells were morphologically analyzed per treatment per time point
per experiment.
4.2. Morphological Analysis of Arabidopsis Cells
Cells were examined under a Leica DM LB microscope with an attached fluorescence lamp and
camera (Leica Microsystems GmBH, Wetzlar, Germany). Cells were scored as being viable or non-viable
and exhibiting either necrotic or apoptotic-like cell death morphology. The vital stain fluorescein
diacetate (FDA) was used to assay for live cells [30]. When FDA is excited by light at a wavelength
of 490 nm, a bright green fluorescence is observed in viable cells whose plasma membrane is intact.
Cells that die by necrosis do not display the protoplast retraction associated with apoptotic-like cell death
and do not fluoresce, while cells that have undergone apoptotic-like cell death show a characteristic
retraction of the protoplast away from the cell wall and cannot cleave FDA [8] (Figure S1).
4.3. Growth and Treatment of Wheat Seedlings
Wheat (Triticum aestivum) cvs. CM82036 and Remus were used in this study. Cultivar CM82036
carries a major quantitative trait locus (QTL) on the short arm of chromosome 3B that is associated with
resistance to both FHB disease and DON-induced bleaching of spikelets (Fhb1; syn. Qfhs.ndsu-3BS) and
it carries another QTL on chromosome 5A that is associated with FHB resistance but not with DON
resistance [4,33]. Cultivar Remus is susceptible to FHB and DON-induced bleaching [4,33]. Seeds
were pre-germinated in the dark at 20 ◦C for 48 h in Petri dishes containing filter paper moistened
with 7 mL of sterile water (12 seeds per plate). Germinated seeds were then air-dried for 10 min on
filter paper and carefully placed in Petri dishes containing 7 mL of either water or DON (20 mgmL−1
water) (12 seeds per plate) such that coleoptiles were not in contact with the treatment solution. Wheat
seedlings are less sensitive to DON than Arabidopsis cell cultures ([34]), hence the reason for the higher
concentration as compared to the Arabidopsis studies. Plates were incubated at 20 ◦C under either
constant darkness or constant light (~110 mmol m−2 s−1). The roots and coleoptile were harvested at 4
or 24 h post-treatment, flash frozen in liquid N2 and stored at −70 ◦C prior to either RNA or DON
extraction. Seedling experiments conducted for RNA and DON analysis each included two replica
plates per treatment and each experiment was conducted twice.
4.4. Quantification of DON
Freeze-dried coleoptile tissue was homogenized as previously described [5]. DON/DON derivatives
was extracted from coleoptiles and quantified using the Ridascreen® DON Fast immunoassay
(R-Biopharm AG, Darmstadt, Germany) according to the manufacturer’s instructions. The antibodies
used in this assay detect DON and DON derivatives including the less phytotoxic DON-3-glucoside [27].
Values were based on the average obtained for two replicates per sample.
4.5. RNA Extraction and Gene-Specific RT-PCR Analyses
Freeze-dried root or coleoptile samples were homogenized and total RNA was extracted and
DNase1-treated as described by Ansari et al. [5]. Reverse transcription of total RNA was conducted
as described by Ansari et al. [5], except that the primer used was oligo dT12–18 (Life Technologies,
Paisley, UK). Both the genes of interest and wheat actin (Act1) were PCR-amplified (separately) using
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gene-specific primers (Supplemental Table S1 lists GenBank accession numbers, gene-specific primer
sequences and expected product sizes); Act1 served as a control gene that was constitutively expressed
in roots, coleoptile and head tissue. RT products were diluted to 100 mL and 3 mL was PCR-amplified
in a 10 mL reaction containing 1 unit of Taq DNA polymerase and 1× PCR buffer (Life Technologies,
Paisley, UK), 1.5 mM MgCl2, 150 mM each of dATP, dGTP, dCTP and dTTP, and 100 nM each of
forward and reverse transcript-specific primers. PCR reactions were conducted in a Peltier thermal
cycler DNA engine (MJ Research, St. Bruno, Canada) and the programme constituted 30 cycles of
94 ◦C for 30 s, 60 ◦C for 20 s and 72 ◦C for 45 s, with a final extension at 72 ◦C for 5 min. PCR
products were electrophoresed through 2% (w v−1) agarose gels containing 0.5 mg mL−1 ethidium
bromide and visualized using Imagemaster VDS and Liscap software (GE Healthcare Life Sciences,
Buckinghamshire, UK).
4.6. Data Analysis
All data analyses were conducted using Minitab (Minitab release 13©, 1994 Minitab Ltd, Coventry,
UK). No data set followed a normal distribution, as determined using the Normality test and none
could be transformed to fit a normal distribution using the Johnson Transformation tool. Non-normally
distributed data (cell viability and morphology data, gene expression data (transcript/Act1 levels in
DON relative to water-treated samples) and DON data) were analyzed using the Mann-Whitney Rank
sum test (confidence level 95%, alternatives of greater than, less than or equal chosen as appropriate).
5. Conclusions
We have shown that the effect of DON on the viability of abiotically stressed cells and on defense
gene expression in wheat is light enhanced. Future studies should investigate the role of cell death
suppression, cell survival pathways and light-regulated pathways in the resistance of wheat to Fusarium
fungi. The combination of DON and heat stress offers a valuable means by which to unravel some of
the complexity of plant programmed cell death.
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Abstract: This study comprises analyses of contents of mycotoxins, such as deoxynivalenol and
zearalenone, as well as the level of oxidative stress in ears of a susceptible wheat cultivar Hanseat and
cv. Arina, resistant to a pathogenic fungus Fusarium graminearum. Starting from 48 h after inoculation,
a marked increase was observed in the contents of these mycotoxins in ears of wheat; however, the
greatest accumulation was recorded in the late period after inoculation, i.e., during development of
disease. Up to 120 h after inoculation, in ears of both wheat cultivars, the level of deoxynivalenol
was higher than that of zearalenone. The susceptible cultivar was characterized by a much greater
accumulation of deoxynivalenol than the resistant cultivar. At the same time, in this cultivar, in the
time from 0 to 72 h after inoculation, a marked post-infection increase was observed in the generation
of the superoxide radical (O2•−). Additionally, its level, at all the time points after inoculation, was
higher than in the control. In wheat cv. Arina, a markedly higher level of O2•− generation in relation
to the control was found up to two hours after inoculation and, next, at a later time after inoculation. In
turn, the level of semiquinone radicals detected by electron paramagnetic resonance (EPR) increased at
later culture times, both in cv. Hanseat and Arina; however, in infested ears of wheat, it was generally
lower than in the control. Analysis of disease symptoms revealed the presence of more extensive
lesions in ears of a susceptible wheat cv. Hanseat than resistant cv. Arina. Additionally, ergosterol level
as a fungal growth indicator was higher in ears of susceptible wheat than in the resistant cultivar.
Keywords: deoxynivalenol; semiquinone radicals; Fusarium graminearum; oxidative stress; winter
wheat; zearalenone; ergosterol
1. Introduction
Interactions of plants and their pathogenic fungi now constitute an interesting and rapidly developing
field in plant science, with a significant impact on new strategies for plant protection. The plant response
to infection is determined by the genetic background of the host, as well as the pathogen [1]. The type
of induced response that is effective against a given pathogen varies, depending on the lifestyle of the
pathogen [2]. Pathogens have devised different strategies to invade a plant, as well as to feed on and
reproduce in the plant. Biotrophic pathogens need living tissue for growth and reproduction; in many
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interactions the tissue will die in the late stages of the infection (hemi-biotrophic pathogens). By contrast,
necrotrophic pathogens kill the host tissue at the beginning of the infection and feed on the dead tissue [3].
As plants are confined to the place where they grow, they have to develop a broad range of defense
responses to cope with pathogenic infections. Oxidative burst, a rapid, transient production of huge
amounts of reactive oxygen species (ROS), is one of the earliest observable manifestations of a plant’s
defense strategy [4–6]. Various aspects, mechanisms, and functions of the oxidative burst with generation
of superoxide anions (O2•−) in plant cells, which is stimulated by active defense-inducing fungal infection
or elicitor treatment, were reviewed mainly on the basis of experimental evidence obtained in different
pathosystems [7–9]. Free radicals, including ROS, may function in defense through their direct toxicity
to pathogens, or may activate various metabolic pathways. Enhanced generation of free radicals, such
as ROS, plays a significant role especially at the early plant-pathogen interaction, whereas, at a later
stage of the disease development—when not coordinated with an effective system of their removal—it
may enhance destructive changes in plants and facilitate the spread of a pathogen [6,10,11]. Recently,
concluding evidence suggests that the ROS network is essential to induce disease resistance [12]. On the
other hand, investigations show also that necrotrophic pathogens can use oxidative processes during
their attack and invasion of plant tissues [13]. Therefore, host cell death can occur through the action of
fungal toxins and an oxidative burst generated by both the pathogen and the host [14].
This study, next to oxidative stress indexes indicating early defense responses of plants, also
investigated the accumulation of mycotoxins formed by a pathogenic fungus Fusarium graminearum.
Reverberi and co-workers reported that several secondary metabolites are synthesized by fungi during
morphological and metabolic transitions when the accumulation of ROS occurs [15]. Plant compounds
involved in plant-fungi interactions are able to interfere with mycotoxin biosynthesis in host tissues [16].
Mycotoxins are harmful and often carcinogenic secondary metabolites produced by a range of widespread
fungi, including Fusarium. In general, they are low-molecular-weight compounds synthesized by
filamentous fungi and are capable of causing disease and death in plants, animals and humans [17]. While
in the literature there are many reports indicating high toxicity of mycotoxins, little is known about their
role in plant-pathogen interactions. The relationship between the decrease in cell proliferation, the presence
of oxidative stress generated by the enhancement of intracellular ROS production, and ROS-induced
lipid peroxidation by mycotoxins is a priority direction of research [18]. Fusarium mycotoxins, currently
considered of importance from the toxicological point of view, include zearalenone, trichothecenes and
fumonisins, and their occurrence is now regulated by legal limits in all developed countries [19,20].
Among trichothecenes, deoxynivalenol (DON) is the most popular mycotoxin formed mainly by Fusarium
graminearum and F. culmorum [19]. Fusarium graminearum is most common in moist and warm continental
climates, such as Central and South-Eastern Europe, whereas F. culmorum is found more often in
maritime and cooler European countries [21–23]. The primary sources of DON are cereals, including
wheat, barley, maize, and oat [24,25]. Toxicity is associated with the presence of both 9, 10 double
bond, 12, 13 epoxide group and varied substituent groups in the deoxynivalenol structure [26]. DON
is responsible for the inhibition of protein biosynthesis, reduction of enzymatic activity, disturbance in
cytoplasmic membrane permeability, and cell division disorders [26]. Another important mycotoxin,
similar to DON, produced mainly by the same fungi, is zearalenone (ZON) [27].
The aim of the present study was to examine the interdependence between the level of oxidative
stress and mycotoxin contents in ears of two winter wheat cultivars, i.e., the susceptible cv. Hanseat and
cv. Arina, resistant to a pathogenic fungus Fusarium graminearum. Therefore, the level of superoxide
anion radical generation and concentrations of free radicals, such as semiquinones, were estimated
in non-inoculated (control) and F. graminearum - inoculated ears of winter wheat. The semiquinone
radicals analyzed in this study using electron paramagnetic resonance (EPR) spectrometry are among
the relatively stable radicals that readily donate electrons to molecular oxygen (O2), forming O2•−.
Moreover, changes in mycotoxin contents, such as deoxynivalenol and zearalenone, were determined
in ears of the above-mentioned wheat cultivars. Additionally, disease symptoms were analyzed and
ergosterol level as a fungal growth indicator was estimated in both wheat cultivars.
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2. Results
2.1. Mycotoxin Contents
Starting from 48 h after inoculation with a pathogenic fungus F. graminearum a marked increase was
observed in the contents of mycotoxins, such as deoxynivalenol and zearalenone, in ears of wheat—both
the susceptible cv. Hanseat and the resistant Arina (Figure 1). The highest accumulation of mycotoxins
was recorded at late time points after inoculation (at 168 h and in week two), i.e., during development of
disease. Up to 120 h after inoculation in ears of both wheat cultivars, a higher level of deoxynivalenol
(DON) was found in comparison to zearalenone (ZON). Analysis of variance (ANOVA) results showed
that the differences in concentrations of DON and ZON in inoculated ears of wheat cultivars were
highly statistically significant. It needs to be stressed that the susceptible cultivar (Figure 1A,B) was
characterized by a much greater accumulation of deoxynivalenol than the resistant cultivar (Figure 1C,D).
In the susceptible cultivar, the level of deoxynivalenol ranged from 1.1 to 109.88 ng g−1 FW, while in the
resistant cultivar it was from 1.76 to 62.41 ng g−1 FW. Only at 168 h and in week two after inoculation
in ears of the resistant wheat cv. Arina, zearalenone level was higher than that of deoxynivalenol
(Figure 1C,D). ANOVA results showed that the differences in DON concentration in infected tissue of
cultivars Hanseat/Arina and the control plants at 72, 120, 168 h, and two weeks were highly statistically
significant (e.g., p = 0.00006/0.00005, p = 0.00016/0.00033, p = 0.00047/0.0069, p = 0.00005/0.00011,
respectively). Moreover, ANOVA results showed that the differences in ZON concentration in infected
tissue of cultivars Hanseat/Arina and the control plants at 168 h and two weeks were highly statistically
significant (e.g., p = 0.00027/0.00028 and p = 0.00006/0.00001, respectively).
(A) (B) 
(C) (D) 
Note: * significant differences on figures using asterisks are shown.
Figure 1. The effect of pathogenic fungus Fusarium graminearum on the content of mycotoxins, such
as deoxynivalenol and zearalenone, in ears of a susceptible wheat cv. Hanseat (A,B) and resistant cv.
Arina (C,D). Significant differences (p < 0.05) were observed between control and infected ears.
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2.2. Generation of Superoxide Anion
In the period from 0 to 72 h after inoculation in ears of wheat cv. Hanseat, a marked post-infection
increase was observed in the generation of superoxide anion (O2•−), while starting from 120 h after
inoculation it fluctuated (Figure 2A). Moreover, in the susceptible cv. Hanseat at all time points after
inoculation a higher post-infection level of O2•− generation was found in comparison to the control. In
turn, in the wheat resistant cv. Arina up to 2 h after inoculation a higher level of O2•− was recorded than
in the control and next at later time points after inoculation with F. graminearum, i.e., at 120, 168 h, and in
week two after inoculation, O2•− generation level was markedly higher than in the control (Figure 2B). It
is of interest that at 24 and 48 h after inoculation a strong increase was found in the generation of O2•−,
both in the control and in inoculated ears of wheat cv. Arina, whereas at 72 h a marked reduction of
O2•− was recorded in these tissues, while in inoculated ears the concentration of O2•− was lower than
in the control. Starting from 120 h after inoculation, the post-infection level of O2•− was much higher
than in the control. The significant differences in the level of superoxide anion were observed among
the experimental variants as analyzed by ANOVA. ANOVA results showed that the differences in the
concentration of O2•− in infected tissue of cultivar Hanseat and the control plants at 0.5, 4, 72, and 168
h were highly statistically significant (e.g., p = 0.0001, p = 0.0011, p = 0.0007 and p = 0.0005), while in
infected tissue of cultivar Arina and the control plants at 72, 120, 168 h, and two weeks they were
highly statistically significant (e.g., p = 0.005, p = 0.00016, p = 0.00006 and p = 0.00009, respectively).
(A) (B) 
Note: * significant differences on figures using asterisks are shown.
Figure 2. The effect of pathogenic fungus Fusarium graminearum on the generation of superoxide anion
radical in ears of a susceptible wheat cv. Hanseat (A) and resistant cv. Arina (B). Significant differences
(p < 0.005) were observed between control and infected ears.
2.3. Generation of Semiquinone Radicals
Levels of semiquinone radicals detected by electron paramagnetic resonance (EPR) increased
at later time points of culture both in cv. Hanseat and Arina; however, in inoculated ears of wheat
it was lower than in the control (Figure 3), except for 168 h after inoculation in ears of cv. Arina.
Moreover, in the period from 0 to 120 h of culture in both wheat cultivars, Hanseat and Arina, slight
fluctuations were observed in the concentration of semiquinone radicals both in the control and in
inoculated tissues. However, the range of generation of these radicals in 168-h and two-week-old
control tissues in the susceptible cv. Hanseat was two-fold greater than in the resistant cv. Arina.
ANOVA results showed that the differences in concentrations of semiquinone radicals both in the
control and in inoculated tissues were highly statistically significant. ANOVA results showed that
the differences in semiquinone radical concentrations in infected tissue of the susceptible cv. Hanseat
and the control plants at 168 h and two weeks were highly statistically significant (e.g., p = 0.0027 and
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p = 0.00064, respectively), while in the infected tissue of the resistant cv. Arina and the control plants at
two weeks they were highly statistically significant (e.g., p = 0.00378).
(A) (B) 
Note: * significant differences on figures using asterisks are shown.
Figure 3. The effect of pathogenic fungus Fusarium graminearum on the generation of semiquinone
radicals in ears of a susceptible wheat cv. Hanseat (A) and resistant cv. Arina (B). Significant differences
(p < 0.005) were observed between control and infected ears.
2.4. Analysis of Disease Symptoms and the Level of Ergosterol
Table 1 showed disease development in ears of the susceptible wheat cv. Hanseat and resistant cv.
Arina after inoculation with Fusarium graminearum. From 120 h after inoculation a pronounced severity
of disease development was observed in ears of the susceptible wheat cv. Hanseat, it was stronger than
in resistant cv. Arina. Symptoms first began as water-soaked brownish spots at the base of the glumes
and ultimately turned into bigger brown discolorations. Moreover, masses of black spores occurred
along the base of the glumes or over the infected head. In addition, from 120 h after inoculation the
level of ergosterol in infected tissue of the susceptible wheat cv. Hanseat was higher than the resistant
cv. Arina (Figure 4). ANOVA results showed that the differences in ergosterol concentration in infected
tissue of cultivar Arina/Hanseat and the control plants at 48, 72, 120, 168 h, and two weeks were
highly statistically significant (e.g., p = 0.03293/0.14943, p = 0.02159/0.06088, p = 0.01926/0.00921,
p = 0.00777/0.00048 and p = 0.0001/0.00091, respectively).
Table 1. Disease development in ears of a susceptible wheat cv. Hanseat and resistant cv. Arina after
inoculation with Fusarium graminearum (− lack of disease symptoms, + severity of disease symptoms,
i.e., strong discolorations and browning of ears where +++++ bigger brown discolorations in over 50%




Control Infected Control Infected
24 h − − − −
48 h − − − +
72 h − ++ − ++
120 h − ++ − ++++
168 h − +++ − ++++
2 weeks − ++++ − +++++
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(A) (B) 
Note: * significant differences on figures using asterisks are shown.
Figure 4. The level of ergosterol as a fungal growth indicator in ears of a susceptible wheat cv. Hanseat
(A) and resistant cv. Arina (B). Significant differences (p < 0.05) were observed between control and
infected ears.
3. Discussion
This study investigated the interdependence between the level of oxidative stress and contents of
mycotoxins, such as deoxynivalenol and zearalenone, in ears of two wheat cultivars, i.e., susceptible
Hanseat and Arina, resistant to a pathogenic fungus Fusarium graminearum. Our objective was to
understand the difference in the invasion process of the host plant by the pathogen and the differential
defense response in the resistant and susceptible cultivars. We detected changes in the redox status
of cells in wheat ears, associated with the generation of superoxide anion and semiquinone radicals
accompanying the accumulation of mycotoxins produced by the pathogenic fungus F. graminearum.
The pathogenic fungus F. graminearum produces a range of sesquiterpenoid mycotoxins, including
several types of B trichothecenes, such as DON and its acetylated derivatives 15Ac-DON and 3Ac-DON,
which are required for full virulence on wheat ears [28–31]. Bin-Umer and co-workers reported that
trichothecene toxins can inhibit mitochondrial translation independent of their effects on cytosolic
translation and mitochondrial membrane integrity [32].
As a consequence of contact between the pathogen and the plant cell, biochemical reactions
are initiated, limiting development of infection and disease. The first step of defense is the rapid
generation of free radicals, including reactive oxygen species (ROS) and the activation of pre-existing
components, such as the liberation of toxic compounds (e.g., phenolics and subsequent oxidative
reactions) [33]. Thus, in the present study, in wheat ears of the susceptible cultivar we observed a
marked post-infection increase in the generation of the superoxide anion radical (O2•−) in the period
from 0 to 72 h after inoculation (Figure 2A). Additionally, its level at all time points after inoculation
was higher than in the control. In turn, in wheat cv. Arina a markedly greater level of O2•− generation
in relation to the control was recorded at 2 h after inoculation and next at later time points after
inoculation, i.e., at the phase of disease development (Figure 2B). The difference in the level of O2•−
generation between the resistant wheat cultivar and the susceptible cultivar was connected with the
earlier reduction in the generation of O2•− in the resistant cultivar. In the resistant cultivar Arina
fluctuations were observed in its generation versus time after inoculation. Perhaps this is related to the
capture of electrons originating from superoxide anion (O2•−) by semiquinones.
Although superoxide anion (O2•−) is the proximal product generated, the more stable hydrogen
peroxide (H2O2) species is detected in many studies [34]. Oxidative burst could have a direct effect on
the pathogen or the defenses because of its reactivity. ROS could directly kill the pathogen, especially
in the case of the more reactive species such as hydroxyl radicals [35]. ROS could also contribute to the
establishment of physical barriers at the large papillae that are formed at the site of interaction of many
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pathogens by cross linking of cell wall glycoproteins [36] or via oxidative cross-linking of precursors
during the localized biosynthesis of lignin and suberin polymers [37]. Gupta and co-workers reported
that ROS are known to play pivotal roles in pathogen perception, recognition, and downstream defense
signaling [38]. However, how these redox alarms coordinate, in planta, into a defensive network is
still intangible.
Published literature sources comprise reports concerning modulation of the cellular redox status
by mycotoxins produced by pathogenic fungi, but it is mainly in cells of animals and the human
body, while there are scarce studies showing the above dependencies in plant cells. For example,
recent studies showed modulation of the cellular redox status in human body cells by toxins of a
pathogenic fungus, such as the Alternaria [39]. Therefore, the mycotoxins alternariol (AOH) and
alternariol monomethyl ether (AME) were found to modulate the redox balance of HT29 cells from the
human body, but without an apparent negative effect on DNA integrity. Additionally, Arunachalam
and Doohan reported that trichothecene mycotoxins inhibit eukaryotic protein synthesis and are
toxic to plants, humans and farm animals [40]. At the cellular level, they induce oxidative stress
cell-cycle arrest and apoptosis, and affect membrane integrity. In animals, trichothecenes can be
either immunostimulatory or immunosuppressive and induce apoptosis via mitochondria-mediated
or -independent pathways. In turn, in plants trichothecenes induce programmed cell death via
production of reactive oxygen species and they can induce genes involved in oxidative stress, cell
death, and plant defense signaling. Studies by Gilchrist revealed a connection of mycotoxins between
plants and animals in apoptosis and ceramide signaling [41]. Dobosz and co-workers showed also a
relationship between the increase of the free form of salicylic acid (SA), free radical (FR) concentration,
and propagation of F. proliferatum and F. oxysporum as a consequence mycotoxin formation, such as
moniliformin and fumonisin B1 in infected plants of Asparagus officinalis [42]. In plants, the use of
the Arabidopsis model system to understand molecular events in trichothecene-induced phytotoxicity
has identified the involvement of MAPK signaling pathways and downstream transcription factors
that manifest the toxicity effects [43,44]. Additionally, Desmond and co-workers demonstrated that
infusion of wheat leaves with DON induced hydrogen peroxide production within 6 h, followed
by cell death within 24 h that was accompanied by DNA laddering, a hallmark of programmed cell
death [45].
In this study with an enhanced post-infection generation of O2•− (Figure 2) a marked increase was
observed in the contents of mycotoxins, such as DON and ZON; however, the highest accumulation of
these toxins was recorded at the late period after inoculation in ears of both wheat cultivars, i.e., at
the disease development phase (Figure 1, Table 1). Up to 120 h after inoculation in ears of both wheat
cultivars, the level of DON was higher than that of ZON, while at later time points (168 h and two
weeks after inoculation) the resistant cultivar was characterized by a lower accumulation of DON
than the sensitive cultivar. In parallel, in the resistant cultivar the development of disease symptoms
(necrotic changes, discoloration of tissue) was limited (Table 1) and the level of ergosterol was lower
than in the sensitive cultivar (Figure 4). Ergosterol (ERG) is a specific component of the fungal cell
membrane [46]. It is also present in membranes in the cell walls and mitochondria in some yeasts,
but is not produced in significant quantities by higher plants, rust fungi, or phycomycetes, hence, it
can be used as a tool to estimate fungal biomass from any kind of mixtures [47,48]. A good positive
correlation has been established between ergosterol content and fungal growth in other studies [49–53].
At the same time in this study, next to the increased generation of O2•−, which may be one of the
lines of defense against F. graminearum, the concentration of free radicals, such as semiquinones was
also determined (Figure 3). These free radicals detected in ears of wheat give signals characterized by
g-value of 2.0037−2.0039 ± 0.0005, similarly as in previous reports [6,54–57], indicating that they are
semiquinone-derived radicals.
It should also be mentioned that quinones, which represent the largest group of redox cycling
compounds, are particularly active in ROS generation. Semiquinone radicals exhibit high reactivity
and cytotoxicity and are formed during the oxidation of phenols by phenolases, peroxidases, and
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also by polyphenol oxidase activity. Moreover, the semiquinone radicals analyzed in this study
using EPR spectrometry are among the relatively stable radicals. These oxidized phenolic species
have an enhanced antimicrobial activity and thus may be directly involved in stopping pathogen
development. During the pathogen-plant interaction, oxidation processes are stimulated, which
enhances the effectiveness of defense mechanisms [6,10,11,56].
Measurements of semiquinone radicals using electron paramagnetic resonance (EPR) showed
that the level of these radicals, in the period from 0 to 120 h, both in the control and in the infested ears
of the sensitive and resistant cultivars showed fluctuations and ranged from 0.9 to 2 × 1015 spins g−1
dry weight. In turn, at the time points the concentration of these radicals increased rapidly in tissues
both in cv. Hanseat and Arina, although, in infested ears of wheat, it was generally lower than in the
control. We assume that the lower level of these radicals in relation to the control may indicate their
involvement in the stimulation of defense mechanisms connected with strengthening of cell walls. It
is also possible that these radicals in plant cells may be incorporated into polymers, such as lignins
and by combining with reactive free radicals that propagate depolymerization through the lignin
matrix, these protective free radicals could prevent the breakdown of associated cell walls [11,58].
Additionally, in the resistant cultivar the concentration of semiquinone radicals was lower than in the
susceptible cultivar (Figure 3).
Summing up, recorded results indicate that the accumulation of mycotoxins produced by
F. graminearum in ears of winter wheat was accompanied by a markedly enhanced generation of
superoxide anion as an indicator of oxidative stress. A lower level of semiquinone radicals at later time
points after inoculation may probably indicate their incorporation into polymers, e.g., such as lignins,
by bonding with reactive oxygen species especially superoxide anion (O2•−) and, thus, strengthen the
cell wall. The resistant cultivar was characterized by a lower level of semiquinone radicals than the
sensitive cultivar especially at the late phase after inoculation. Development of disease was inhibited
in the resistant cultivar and ergosterol content was lower than in the sensitive cultivar. Additionally,
in the resistant cultivar production of the mycotoxin DON and the level of generation of superoxide
anion (O2•−) at the late phase after inoculation was lower than in the sensitive cultivar.
4. Experimental Section
4.1. Plant Material and Growth Conditions
Plant material comprised two popular winter wheat cultivars with different susceptibility to
Fusarium, i.e., —a susceptible cv. Hanseat and a resistant cv. Arina. The experiment was performed
in Cerekwica (Central West Poland, 30 km northwest of Poznań), in the randomized complete block
design in triplicate, with plot size of 1 m × 1 m. Seeds of both winter wheat cultivars were sown in
three independent plots both in the control and infected F. graminarum. Both cultivars, i.e., Hanseat
(susceptible) and the resistant Arina, originate from the Plant Breeding Company in Poznań, Poland.
4.2. Fusarium Strain and Inoculum Preparation
Fusarium graminearum strain KF 2870 (elsewhere referred to as F. graminearum) was obtained from
the Collection of Plant Pathogenic Fungi held by the Institute of Plant Genetics Polish Academy of
Sciences, Poznan. The pathogen was incubated in the dark at 25 ◦C in Petri dishes (+9 cm diameter) on
potato dextrose agar (PDA) medium (Difco; pH 5.5). After three weeks of growth the F. graminearum
spore suspension was prepared. The spore suspension was obtained by washing the mycelium with
sterile water and shaking with glass pearls. At mid-anthesis (Zadoks scale 65), 30 winter wheat
heads of each replication were inoculated individually (by brushing) with the conidial suspension
(2 × 106 spores) isolate of Fusarium graminearum (KF 2870). Non-inoculated plots of the same genotypes
were used as the control. Inoculated and control samples (heads) for the determination of superoxide
anion and semiquinone radicals were collected at 0, 0.5, 2, 4, 24, 48, 72, 120, 168 h, and two weeks
after inoculation. In turn, for the determination of mycotoxins and ergosterol content, and analyses
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of disease development plant samples were collected at 24, 48, 72, 120, 168 h and two weeks after
inoculation. To evaluate the disease, 50 ears of control plants and plants infected with F. graminearum
were collected for both varieties, i.e., resistant and sensitive.
4.3. Standards, Chemicals, and Reagents
Deoxynivalenol, zearalenone, and ergosterol standards and organic solvents (HPLC grade) were
purchased with a standard grade certificate from Sigma-Aldrich (Steinheim, Germany). All chemicals
used for extraction and purification of mycotoxins were purchased from POCh (Gliwice, Poland).
Water for the HPLC mobile phase was purified using a Milli-Q system (Millipore, Bedford, MA, USA).
4.4. Extraction and Purification Procedure for Mycotoxins
Samples of 10 g homogenized winter wheat ears were prepared for analyses. Both mycotoxins
(ZON and DON) were extracted and purified according to the detailed procedure described by
Wiśniewska et al. [19]. The eluate was evaporated to dryness at 40 ◦C under a stream of nitrogen. Dry
residue was stored at −20 ◦C until HPLC analyses.
4.5. HPLC Analysis of Mycotoxins
The chromatographic system consisted of a Waters 2695 high-performance liquid chromatograph
(Waters, Milford, PA, USA) with detectors:
• Waters 2996 Photodiode Array Detector with a Nova Pak C-18 column (300 mm × 3.9 mm) for
DON (λmax = 224 nm) analysis,
• Waters 2475 Multi λ Fluorescence Detector (λex = 274 nm, λem = 440 nm) and a Waters 2996
Photodiode Array Detector with a Nova Pak C-18 column (150 mm ×3.9 mm) for ZON analysis.
Quantification of mycotoxins was performed by measuring the peak areas at retention time
according to the relevant calibration curve. The presence of mycotoxins was confirmed by a comparison
of retention times with the external standard and by co-injection of every tenth sample with mycotoxin
standards. Limits of detection were 0.001 μg g−1 for ZON and 0.01 μg g−1 for DON.
4.6. Ergosterol Extraction, Purification, and HPLC Analysis
Plant samples (100 mg) were suspended in 2 mL methanol in a culture tube, treated with 0.5 mL
of 2 M aqueous sodium hydroxide, and sealed tightly. Samples were irradiated twice in a microwave
oven (370 W) for 20 s. After 15 min contents of cultures tubes were neutralized with 1 M aqueous
hydrochloric acid, then 2 mL methanol were added and samples were extracted with n-pentane
(3 × 4 mL). The combined pentane extracts were evaporated to dryness in a stream of nitrogen,
before analysis dissolved in 1 mL of methanol and 20 μL of thus prepared mixture were analyzed
by HPLC. The ergosterol separation was performed on a 3.9 mm Nova Pak C-18, 4 mm column with
methanol:acetonitrile (90:10, v/v) as the mobile phase at a flow rate of 1.0 mL min−1. EGR was detected
with a Waters 2996 Photodiode Array Detector (Waters Division of Millipore, Milford, MA, USA) set at
282 nm. The presence of ergosterol was confirmed by a comparison of retention times with the external
standard and by co-injection of every tenth sample with an ERG standard. The detection limit was 0.01
μg g−1 and standard deviation was below 7%.
4.7. Determination of Superoxide Anion Radical Content
Determination of superoxide anion radical (O2•−) content in biological samples was based on its
ability to reduce nitro blue tetrazolium (NBT) [59]. The superoxide anion was detected according to
Mai and co-workers [57], ears of wheat (0.30 g fr. wt) were cut into fragments (3 mm × 3 mm) and
immersed in 10 mM potassium phosphate buffer (pH 7.8) containing 0.05% NBT and 10 mM NaN3 in a
final volume of 3 mL and incubated for 1 h at room temperature. After incubation, 2 mL of the reaction
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solution were heated at 85 ◦C for 15 min and rapidly cooled. The levels of O2•− in ears of wheat were
expressed as absorbance at 580 nm per 1 g of fresh materials (A580.g−1 fr. wt). The measurement was
carried out in the Perkin Elmer Lambda 15 UV-Vis spectrophotometer (Norwalk, CT, USA).
4.8. Determination of Semiquinone Radicals
Samples of several g fresh weight of wheat ears were frozen in liquid nitrogen and lyophilized
in a Jouan LP3 freeze dryer. The lyophilized material was transferred to EPR-type quartz tubes of
6 mm in diameter. Electron paramagnetic resonance measurements were performed with a Bruker
ELEXSYS spectrometer operating at the X-band. The EPR spectra were recorded at room temperature
as derivatives of microwave absorption. A magnetic field modulation of about 2 Gs and a microwave
power of 5 mW were typically used for all experiments to avoid line saturation and deformation.
EPR spectra of free radicals were recorded in the magnetic field range of 3000–3650 Gs and with 4096
data points. In order to determine the number of paramagnetic centers (free radicals) in the samples,
the spectra were double-integrated and compared with the intensity of the monocrystal standard
chromium-doped corundum (Al2O3:Cr3+) with a known spin concentration [6,11,55,57,60,61]. Before
and after the first integration of the spectra, small background corrections were made to obtain a
reliable absorption signal before the second integration. Double integration of the free radicals was
performed separately and this value was subtracted from the value obtained for the full 3000–3650 Gs
scan range integration. As samples placed in quartz tubes were of equal volume, but of different
weights, EPR intensity data were recalculated per 1 g of dry sample.
4.9. Statistical Analysis
All determinations were performed in three independent experiments. Analysis of variance
(ANOVA) was applied to verify whether means from independent experiments within a given
experimental variant were significant. Data shown in the figures are means of triplicates for each
variant and standard errors of mean (SE). In individual figures significant differences are shown
using asterisks.
5. Conclusions
A marked increase was found for the contents of mycotoxins, such as deoxynivalenol and
zearalenone, in ears of both wheat cultivars in relation to the time after inoculation.
1. The susceptible cultivar was characterized by a much greater accumulation of deoxynivalenol
than the resistant cultivar.
2. In the susceptible cultivar a marked post-infection increase in O2•− level was found up to 120 h
after inoculation.
3. The level of O2•− generation in infested ears of both wheat cultivars was generally greater than
in the control.
4. An earlier reduction in the level of O2•− generation with the time after inoculation was observed
in the resistant rather than in the susceptible cultivar.
5. The concentration of semiquinone radicals, detected by EPR, increased at later culture times;
however, in infested ears of wheat it was generally lower than in the control.
6. The resistant cultivar was characterized by a lower level of semiquinone radicals than the sensitive
cultivar especially at the late phase after inoculation. It may probably indicate their incorporation
into polymers, such as lignins, and strengthening of the cell wall.
7. Development of disease was inhibited in the resistant cultivar and ergosterol content was lower
than in the sensitive cultivar.
8. Production of the mycotoxin DON and the level of generation of superoxide anion (O2•−) in the
resistant cultivar at the late phase after inoculation was lower than in the sensitive cultivar.
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Abstract: Deoxynivalenol (DON) is the most prevalent trichothecene in Europe and its occurrence is
associated with infections of Fusarium graminearum and F. culmorum, causal agents of Fusarium head
blight (FHB) on wheat. Resistance to FHB is a complex character and high variability occurs in the
relationship between DON content and FHB incidence. DON conjugation to glucose (DON-3-glucoside,
D3G) is the primary plant mechanism for resistance towards DON accumulation. Although this
mechanism has been already described in bread wheat and barley, no data are reported so far
about durum wheat, a key cereal in the pasta production chain. To address this issue, the ability
of durum wheat to detoxify and convert deoxynivalenol into D3G was studied under greenhouse
controlled conditions. Four durum wheat varieties (Svevo, Claudio, Kofa and Neodur) were assessed
for DON-D3G conversion; Sumai 3, a bread wheat variety carrying a major QTL for FHB resistance
(QFhs.ndsu-3B), was used as a positive control. Data reported hereby clearly demonstrate the ability
of durum wheat to convert deoxynivalenol into its conjugated form, D3G.
Keywords: masked mycotoxins; fusarium head blight; pasta; deoxynivalenol; virulence factor
1. Introduction
Fusarium head blight (FHB) is one of the most deleterious fungal diseases affecting wheat
worldwide: it is related to infection by pathogenic fungi of the Fusarium spp. and it is widely diffused,
especially in those areas with inductive climatic conditions (hot/warm temperatures and high/medium
high humidity) [1–3]. FHB causes severe yield losses (up to 70%), affecting the quality of grains which
show low protein content and color defects. Moreover, fungal infection may lead to the accumulation
of mycotoxins: depending on the chemotype of the fungus, the type B trichothecenes deoxynivalenol
(DON), nivalenol, 3-acetyldeoxynivalenol (3-ADON), and 15-acetyldeoxynivalenol (15-ADON) often
accumulate in the developing grain [4].
This contamination is especially critical for durum wheat, which is used primarily for human
consumption. Although the best economic and ecological strategy for reducing FHB damage is
the utilization of resistant cultivars, the attempts to define durum wheat resistant lines have been
unsuccessful so far.
In soft wheat, numerous QTL related to FHB resistance have been described [5]. In particular,
several studies performed using the high resistant Chinese Spring wheat line Sumai-3 showed that the
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two most effective QTLs related to FHB resistance are positioned on the short arm of chromosome 3B
(Fhb1) and on chromosome 5A (Qfhs.ifa-5A) [6–8].
Durum wheat cultivars were generally considered to be susceptible to FHB. Indeed, no variation
in resistance to FHB has been found within T. durum lines, even among large germplasm collections of
several thousand lines [9,10].
This fact may be due to several factors: a narrow genetic base compared to hexaploid wheat
might be linked to the fact that durum wheat is tretraploid and that limited breeding efforts have been
undertaken on this crop [11]. Attempts to transfer resistance from hexaploid into tetraploid wheat
have been met with limited success [12,13].
Several types of resistance to FHB are known in wheat, classified as type I (resistance towards
initial infection of spikelets), type II (resistance against spread of pathogen within spike) [14,15] and
type III (resistance to DON accumulation in grains) [16,17].
In particular, DON was proven to inhibit protein synthesis in eukaryotic cells and acts as a
virulence factor during fungal pathogenesis, therefore resistance to DON is considered an important
component of resistance against FHB [18]. As reported by several studies, one mechanism of resistance
to DON is the conversion of DON into the less toxic metabolites deoxynivalenol-3-O-glucoside
(D3G) [19–21]. In particular, in a wheat population segregating for Fhb1, lines containing the Fhb1
resistance allele efficiently conjugate DON to the less toxic D3G [19]. In this work, the authors reported
a good correlation between FHB resistance and DON conversion rate, expressed as [D3G]/[DON]
ratio. This hypothesis was recently questioned by Gunnaiah et al. [22], whose study showed that DON
resistance is not a major mechanism of FHB resistance associated with Nyubai Alleles of Fhb1.
The co-occurrence of DON and D3G in durum wheat harvested in Northern Italy was recently
reported [23], showing a diffuse contamination of most samples with both compounds present at
significant levels.
The present work is aimed at the study of the DON-to-D3G conversion ability of wheat lines (four
durum wheat genotypes and one soft wheat genotype) under controlled greenhouse conditions.
In particular, the soft wheat line Sumai-3 was chosen as reference standard based on its well-known
resistance towards FHB [24–26], while durum wheat lines (Kofa, Svevo, Neodur and Claudio) were
chosen on account of their technological performances and because have been widely used in the most
relevant durum breeding programs.
In a first trial, plants have been treated with F. graminearum and with DON under controlled
growing conditions and samples have been analyzed for free and masked mycotoxins content. Then,
those lines that had showed strong differences in the first trial were further considered in a second
trial, just focusing on the DON-treatment at anthesis.
2. Results and Discussion
2.1. Set up of the First Trial
Two different trials were performed within this study, following the general scheme reported in
Figure 1. The first trial involved four genotypes of Triticum durum (Kofa, Svevo, Claudio, Neodur) and one
genotype of T. aestivum (Sumai-3), selected on the basis of their resistance towards Fusarium head blight
(FHB) under in-field conditions and their genetic background. In particular, the DON detoxification ability
related to FHB resistance was largely studied in soft wheat [27], while very few studies only reported the
occurrence of D3G in durum wheat under natural infection conditions, so far [23].
We decided to compare contamination data obtained upon fungal conidia inoculation and
DON-treatment, in consideration of the possible different effects pointed out by these treatment.
In particular, the inoculation with F. graminearum at the flowering stage (Zadoks 60) [28] easily
resembles the plant infection occurring in field, causing thus a similar plant-pathogen cross-talk.
On the other hand, the direct treatment with DON, although extremely simplified compared to the
natural phenomenon, allows to maximize those enzymatic mechanisms carried out by the plant to
limit the DON toxic action during fungal infection.
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Plants (n = 750) were split into three groups and underwent different treatments at the flowering
stage, namely inoculation with fungal conidia suspension, treatment with DON solution and
mock-treatment with distilled water (control group). Each group was sampled after five days and after
15 days from the treatment (see Figure 1a). Sampling times were chosen in order to highlight the DON
detoxification ability in the first phases after the fungal infection, since reports published until now
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Figure 1. Experiment set up: (a) first trial; (b) second trial.
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2.1.1. Fusarium graminearum Treated Samples
In the first trial, four selected durum wheat lines (Kofa, Svevo, Claudio and Neodur) and a soft
wheat line (Sumai-3) were inoculated with F. graminearum, following the scheme reported in Figure 1a.
Since also other trichothecenes could be present besides DON and D3G, acetylated-DON
derivatives as well as other type B and type A trichothecenes were also screened.
No detectable contamination was found in the control spikes, thus ensuring the reliability of the
experiment, while all treated samples were found to be positive for both DON and D3G.
Acetylated-DON were found in most of the samples collected at S15d, while other type B and
type A trichothecenes were not detected at any stage. Since the fungal growth was not comparable
in the considered samples, the ergosterol content was used for data normalization. Ergosterol can be
efficiently used as fungal growth biomarker as the artificially inoculated fungal strain was the only
one responsible for the fungal biomass in the considered system.
Total contamination expressed as the sum of DON and analogues at S5d was in the range 4.8–17.4
mg/Kg, thus indicating a significant mycotoxin production already after five days from the fungal
inoculation. Besides Claudio that showed a significantly higher toxin amount, the other wheat lines
were found to be comparable in terms of total contamination. D3G was found in all the considered
samples at levels ranging from 0.2 to 4.4 mg/Kg, with an average [D3G]/[DON] ratio of about 0.3.
Since significant differences between lines were not outlined at this stage, results obtained at S15d
were better considered for the discussion.
Total contamination at S15d, expressed as the sum of DON, D3G and ADON, ranged from 49 to
168 mg/Kg, as reported in Table 1, thus indicating that the trend obtained at S5d stage was confirmed
also after 15 days from the fungal inoculation.
Table 1. Total contamination (TD) expressed as the sum of deoxynivalenol (DON), deoxynivalenol-3-O-
glucoside (D3G), acetyldeoxynivalenol (ADON) (mg/Kg) and ergosterol content determined in
F. graminearum treated wheat lines at S15d stage. Data are referred to the first trial, described in
Figure 1a.
Cultivars TD (mg/Kg) Ergosterol (mg/Kg)
Claudio 168 ± 34 22.0 ± 7.7
Neodur 90 ± 20 5.2 ± 1.8
Kofa 79 ± 5 4.0 ± 1.3
Svevo 129 ± 6 10.1 ± 0.7
Sumai-3 49 ± 6 2.5 ± 0.2
Among durum wheat varieties, Claudio and Svevo showed the highest contamination at S15d,
while concentrations found in Neodur and Kofa were comparable. According to the ergosterol content,
Claudio supported also the highest fungal growth compared to other lines.
Data, normalised on the ergosterol content and expressed as relative percentage of DON and D3G
found in the five biological replicates considered for both maturation stages, are reported in Figure 2.
At first, from the plot, Sumai-3 showed the lower toxin accumulation compared to the durum
wheat lines. This result is supported by a lower fungal growth compared to the other lines, measured
as ergosterol content (see Table 1). These data are in agreement with the literature, since Sumai-3 is
often reported as a highly resistant line towards FHB and DON accumulation [29,30]. Furthermore,
the strongest toxin accumulation after 15 days from the inoculum was recorded for Claudio cv. also in
this case in agreement with ergosterol data.
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Figure 2. DON, ADON and D3G amount found in F. graminearum treated samples collected at S5d and
S15d stages. Data referred to the first trial, described in Figure 1a.
Concentration ratio values obtained for durum wheat lines and expressed as the ratio between
D3G and DON concentrations, were statistically compared by ANOVA analysis followed by a post-hoc
Tuckey test; results are reported in Table 2. The sampling time was found significant for all the
considered samples (p = 0.000), thus indicating that the DON conversion starts after the treatment and
progressively increases during the maturation. Kofa and Svevo showed a good conversion rate (0.25
and 0.28, respectively), while [D3G]/[TDON] ratio was the lowest in Claudio (0.14).
Table 2. Conversion rate expressed as [D3G]/[TDON] (where TDON is the sum of DON, D3G and
ADON) found in durum wheat lines at S15d stage. Different letters indicate significantly different
values. Data are referred to the first trial, described in Figure 1a.
Cultivars
[D3G]/[TDON]
DON-Treated Samples F. graminearum Inoculated Samples
Claudio 0.292 b 0.144 b
Neodur 0.371 a 0.182 b
Kofa 0.407 a 0.252 a
Svevo 0.273 b 0.282 a
2.1.2. DON-Treated Samples
Besides fungal inoculation, wheat lines were also treated with DON, as already performed by
Lemmens et al. [19]. The use of a simplified system, although very far from the complicated cross-talk
phenomena occurring upon in field fungal inoculation, allows distinguishing the possible differences
in the transformation occurring in plants. Differently from Lemmens et al. [19], we decided to apply
an amount of DON 10-times lower (total amount: 80 μg) to better resemble the common conditions
experimented under in-field infection.
All the DON-treated and control spikes were separately analysed for DON and D3G content; each
analysis was performed in duplicate.
As already reported for F. graminearum treated plants, no detectable DON contamination was
found in the control spikes, while all DON-treated samples were found to be positive for both DON
and D3G. Data, expressed as concentration of DON and D3G found in the five biological replicates at
both maturation stages, are reported in Figure 3.
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Figure 3. DON and D3G concentrations found in DON-treated samples collected at S5d and S15d
stages. Data are referred to the first trial, described in Figure 1a.
As a general comment, all the conversion rates observed in the DON-treated samples were
extremely higher than those reported for plants treated with F. graminearum. This could be explained
considering two points: (a) at first, the toxin concentration levels reached in F. graminearum treated
samples are definitely higher than those obtained in the DON-treatment; (b) then, the fungal growth
under inductive conditions was strong, with severe pathogenesis symptoms. In consideration of these
conditions, it is reasonable to deduce that the detoxification occurred at a lower extent.
D3G was found to be higher or comparable to DON at S15d stage in all the considered lines, but
an important conversion was already noticed five days from the treatment (S5d).
The Sumai-3 line confirmed the strong DON-to-D3G conversion ability already 15 days from
the toxin treatment, being the ratio between D3G and total DON-related compounds (TDON) 0.731
at S15d.
Among durum wheat lines, Kofa showed the highest conversion ability, as reported in Table 2; on
the other hand, Svevo showed the lowest conversion rate. It should be noticed that DON concentration
was found higher than D3G only in Svevo samples.
As further observation, the total DON concentration at S15d was higher in Claudio and Svevo
than in Neodur and Kofa, thus suggesting that possible other conjugation mechanisms may be active
in plant.
In addition, differently from other lines, Svevo and Claudio also presented comparable total DON
concentration at S5d and S15d: also in this case, lower bioconversion ability could be considered as a
possible explanation.
Interestingly, our results clearly showed that D3G formation in planta already started five days
from the treatment.
Similarly to the results obtained for F. graminearum treated samples, Kofa was found to show the
highest conversion rate; on the contrary, Svevo showed a significantly higher conversion rate upon
fungal inoculation compared to what was observed upon DON-treatment. This fact could be due to
the absence of fungal growth, and should be carefully considered in further studies.
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2.2. Set up of the Second Trial
Starting from the results obtained in the first trial, a second experiment was set up. According to
the data obtained, Kofa and Svevo durum wheat lines showed the most different detoxification ability
and thus were selected for further investigation, in comparison to Sumai-3.
Plants (n = 600) were split into two groups and alternatively underwent DON-treatment and
mock-inoculation (control group) at the flowering stage (see Figure 1b).
DON-treated plants were compared to control group by collecting samples one day (Sd1),
two days (Sd2), and five days (Sd5) from the treatment, and at harvest. A recent study reported
that UDP-glucosyltransferase proteins in Sumai-3, involved in the DON detoxification process, are
over-expressed already 32–48 h from the fungal inoculation [29]; thus, short times after treatment
were considered to better understand the D3G formation at the early-stage. In addition, spikes at full
maturation were harvested and analysed to evaluate the final content of DON and D3G.
DON-Treated Samples
The general trend observed in the first trial was confirmed, although this time the conversion
rate at harvest was lower for the considered lines, as reported in Table 3. This fact may be due to the
inter-individual differences between plants and to the slightly different environmental conditions
not directly dependent from the controlled agronomical parameters (e.g., external climatic factors),
experimented in the greenhouse during the trials.
Table 3. Conversion rate expressed as [D3G]/[TDON] (where TDON is the sum of DON, D3G and
ADON) obtained at each sampling stage for the DON-treated lines considered in the second trial.
Sampling dates Kofa Svevo Sumai-3
Sd1 0.046 0.056 0.246
Sd2 0.391 0.154 0.655
Sd5 0.421 0.115 0.619
SH 0.530 0.312 0.843
Conversion rate values were statistically compared by ANOVA followed by post-hoc Tuckey test.
The sampling stage was found to be significant for all the considered lines (p = 0.000). D3G was
found in all the analysed samples already after 24 hours from the treatment, thus indicating that the
detoxification pathway is promptly active towards DON in plant. This fact is in agreement with the
expression data recently reported by Gottwald et al. [29] for FHB resistant soft wheat lines, among those
Sumai-3. In particular, the authors stated that the expression profiles of genes related to detoxification
processes in resistant genotypes are inducted in the early stage, while susceptible lines typically show
late inductions.
As reported in Table 3, Sumai-3 showed the highest conversion rate already after 24 h from the
treatment and its detoxification ability is confirmed as very high at harvest. Concerning durum wheat,
also in this second trial, Kofa showed a higher detoxification ability compared to Svevo already after
two days from the treatment (p = 0.003 at Sd2) and this difference became particularly evident at
harvest. The data here presented are clearly in agreement with Gottwald et al. [29], since Svevo, which




Sodium acetate, formic acid, methanol, hexane, ethyl acetate, bis-silyltrifluoroacetamide (BSTFA)
and acetonitrile were purchased from Sigma-Aldrich (Taufkirchen, Germany). All solvents were HPLC
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grade. Ultra-pure water was in-house produced by using a Milli-Q System (Millipore, Bedford, MA,
USA). The following mycotoxin standard solutions were purchased from RomerLabs (Tulln, Austria):
13C-Deoxynivalenol (internal standard, 25 mg/L in acetonitrile), D3G (50 mg/L in acetonitrile), mix A
+ B trichothecenes containing DON, NIV, T-2 and HT-2 (10 mg/L each in acetonitrile). All standard
solutions were stored at −20 ◦C and brought to room temperature before use. A working solution
(2.5 μg/mL) containing all the target mycotoxins was prepared in water/methanol (80/20, v/v) by
combining and properly diluting suitable aliquots of each standard. Ergosterol and cholestanol were
purchased from Sigma-Aldrich (Taufkirchen, Germany). F. graminearum strain was purchased from
Department of Agronomy (DiPSA) University of Bologna.
3.2. Wheat Lines Background Information
For this study, four durum wheat lines (Kofa, Svevo, Neodur and Claudio) and one soft wheat
genotype (Sumai-3) have been chosen.
Kofa, is a Southwestern United States cv. released by Western Plant Breeders (Arizona) obtained
from a population based on multiple parents (dicoccum alpha pop-85 S-1) mainly related to the
American and CIMMYT germplasm, with the inclusion of emmer accessions. Svevo, an Italian cv.
released by Società Produttori Sementi, has been obtained from the cross between a CIMMYT line
(pedigree rok/fg//stil/3/dur1/4/sapi/teal//hui) related to the cv. Yavaros, genetic background
(Jori/Anhinga//Flamingo), and the cv. Zenit originating from a cross between Italian and American
accessions (Valriccardo/Vic). Both Kofa and Svevo are well adapted to the Mediterranean climate
and can be classified as early-flowering genotypes in such conditions, and are susceptible to FHB.
Neodur (pedigree 184-7/Valdur//Edmore) is a late flowering variety cultivated in north Italy
carrying a major QTL for resistance against the soil-borne cereal mosaic virus. Claudio (pedigree
Sel.Cimmyt35/Durango//ISEA1938xGrazia) is a medium late variety widely cultivated in Italy and
France well known for its yield stability. Both Neodur and Claudio can be considered moderately
tolerant to FHB under Mediterranean growing conditions.
The four elite varieties of durum wheat (Svevo, Claudio, Kofa e Neodur) were selected for a
preliminary study on the ability to convert DON into D3G. Lines were initially chosen based on
the different susceptibility to DON accumulation and to FHB symptoms, Kofa and Svevo showing
medium susceptibility and Claudio and Neodur medium tolerance. Moreover, the selected lines well
represent the genetic diversity of the main ameliorated pool of durum wheat adapted to grow in the
Mediterranean area. The soft wheat cv. Sumai 3 was used as control for its known resistance ability
towards FHB (type II resistance, linked to the QTL QFhs.ndsu-3B).
3.3. Fusarium graminearum Strain Background Information
Fusarium graminearum strain F566 was used for plant inoculation; the strain was isolated from
wheat samples harvested in Northern Italy (Bologna area, Emilia Romagna region); the chemotype
was fully characterized as reported by Prodi et al. [30], as well as its aggressiveness [31]. The strain is
conserved in the Phytopatological Mycology Collection of the Department of Agricultural Sciences of
the University of Bologna.
3.4. Design of the Greenhouse Experiment
The artificial inoculation experiment on durum wheat plants has been carried out according to a
RCB (Randomized Complete Block) scheme within a greenhouse plant at Produttori Sementi S.p.A.
(Argelato, Bologna, Italy). All the plants were singularly sown and maintained at low temperature
(5 ◦C) for 30 days to mimic vernal conditions (vernalization), then they were transferred into the
greenhouse, fixing the ambient conditions in order to mimic first the spring period and then the
summer season. For the first experiment, four lines of durum wheat (Svevo, Claudio, Kofa e Neodur)
and one line of soft wheat chosen as a reference line for its resistance to FHB (Sumai 3) were selected.
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For each line, four groups were considered, each formed by five plants: at the flowering stage
(zadok 59–60) the first group was artificially inoculated with a F. graminearum inoculum, the second
group was contaminated with a DON solution, whereas the third group was considered as the control
one. All the contaminated groups, as well as the negative (not contaminated) control, were replicated
five times. The entire experiment was performed in triplicate in order to allow two different sampling
steps at two different maturation stages. Sampling steps were fixed from the inoculation step as
follows: after five days (S5d) and after 15 days (S15d). The total plant number was 750. The treatment
was performed on four spikelets in the central part of the spike: each spikelet was inoculated with
10 μL of a fungal conidia solution (1 × 105 conidia/mL) or with 20 μL DON standard solution (exact
title: 0.828 mg/mL). The control samples were mock treated with distilled water.
The second trial was focused on two lines of durum wheat (Svevo, and Kofa) and one line of soft
wheat (Sumai 3). In this case, four sampling steps at four maturation stages were considered. Sampling
steps were fixed from the treatment step as follows: after one day (S1d), after two days (S2d), after five
days (S5d) and at harvest (SH). The total number of plants was 600. The treatment with DON solution
was performed as above. Control plants were mock-treated with distilled water.
At each sampling stage, spikes were separately collected and milled, before LC-MS analysis.
For fungal contaminated samples, data were normalized on the amount of fungal biomass developed,
using ergosterol as fungal growth biomarker.
3.5. Free and Masked Mycotoxins Analysis
Samples were prepared according to Berthiller et al. [32] with slight modifications. Briefly, the
whole ears were finely grounded and mixed 0.5 g of grounded wheat was extracted for 90 min at
200 strokes/min on a shaker with 2 mL of acetonitrile/water (80/20, v/v) acidified with 0.1% of formic
acid. The extract was collected and centrifuged for 10 min at 1,4000 rpm at room temperature, then 1 mL
was evaporated to dryness under nitrogen. After addition of the internal standard (13C-DON, 20 μL),
the residue was dissolved in 1 mL of water/methanol (80/20, v/v) and analyzed by UPLC-ESI/MS.
The UPLC-ESI/MS analyses were carried out according to Dall’Asta et al. [23], using an Acquity
UPLC separation system (Waters Co., Milford, MA, USA) equipped with an Acquity Single Quadrupole
MS detector with an electrospray source. Chromatographic conditions were as follows: column,
Acquity UPLC BEH C18 (1.7 μm, 2.1 × 50 mm); flow rate, 0.35 mL/min; column temperature, 40 ◦C;
injection volume, 5 μL; gradient elution using 0.1 mM sodium acetate solution in water (eluent A) and
methanol (eluent B), both acidified with 0.2% formic acid. Gradient conditions: initial conditions were
set at 2% B for 1 min, then eluent B was increased to 20% in 1 min; after an isocratic step (6 min), eluent
B was increased to 90% in 9 min; after a 3 min isocratic step, the system was re-equilibrated to initial
conditions for 3 min. The total analysis time was 23 min. The ESI source was operated in positive
ionization mode. MS parameters were as follows: capillary voltage, 2.50 kV; cone, 30 V; source block
temperature, 120 ◦C; desolvation temperature, 350 ◦C; cone gas, 50 L/h; desolvation gas, 850 L/h.
Detection was performed using single ion monitoring mode and monitoring the [M + Na]+ ion, as
reported by Dall’Asta et al. [23].
Matrix-matched calibration curves (calibration range 100–2500 μg/kg) were used for target
analyte quantification. A good linearity was obtained for all the considered mycotoxins (r2 > 0.99).
For all the target compounds, limit of quantification (LOQ) and limit of detection (LOD) were lower
than 30 μg/kg and 10 μg/kg, respectively.
3.6. Ergosterol Extraction and Analysis
Lipid fraction was extracted from wheat by stirring 1 g of milled sample in 20 mL of n-hexane for
1 h at room temperature. After that, the extract was filtered on paper filter and dried under vacuum.
Lipid fraction, containing fatty acids and sterols, were dissolved in 1 mL of hexane, added of
0.3 mL of an internal standard solution (cholestanol, 100 μg/mL) and transesterified by adding 1 mL
of 5% KOH in methanol and shaking vigorously. The organic phase containing ergosterol was then
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purified on a silica gel cartridge eluting the fraction of interest with 3 mL of ethyl acetate, in accordance
with Annaratone et al. [33]. The residue was dissolved in 0.5 mL of hexane, with 50 μL of BSTFA added,
and reacted at 60 ◦C for 1 h. Analysis and quantification of ergosterol was performed by GC-MS,
injecting 1 μL of the obtained solution.
GC-MS analysis was performed on a 6890N gas chromatograph coupled to a 5973N mass selective
detector (Agilent technologies, Santa Clara, CA, USA), using a SLB-5MS capillary column (Supelco,
Bellefonte, PA, USA). The programmed temperature gradient was as follows: 240 ◦C for 3 min, then
increasing to 280 ◦C in 2 min and holding this final condition for 20 min. Injection was performed in
split mode. Data acquisition mode was SIM, monitoring 460.4 and 445.4 m/z for cholestanol (internal
standard) and 468.4 and 363.3 m/z for ergosterol detection.
4. Conclusions
The study presented herein showed for the first time the DON-to-D3G conversion ability of several
durum wheat lines in comparison to Sumai-3 soft wheat under greenhouse conditions. In addition, for
the first time, the D3G formation in plants already 24 h from the DON treatment and five days from
the fungal infection was reported. Among the considered lines, Claudio cv. supported the highest
fungal growth and the highest DON accumulation upon F. graminearum inoculation, showing also the
lowest [D3G]/[TDON] ratio. This result was further confirmed upon DON-treatment, thus suggesting
that low glycosylation ability is also related to a high susceptibility towards fungal infection and
toxin accumulation, at least under greenhouse conditions. Furthermore, Kofa cv. showed a good
glucosylation activity towards DON in both the assays and is a promising candidate for further studies
to better define the DON detoxification activity in durum wheat.
Data here represented support thus the hypothesis reported by Lemmens et al. [19]: the ability
to convert DON to D3G in these lines seems actually to be related to their resistance towards FHB.
The role played by D3G as DON detoxification products in durum wheat was demonstrated, thus
pinpointing as well the necessity for careful monitoring of this masked mycotoxin in durum wheat.
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Abstract: Thecorrelation of ATP citrate lyase (ACL) and acetyl CoA levels with trichothecene
production in Fusarium graminearum was investigated using an inhibitor (precocene II) and an enhancer
(cobalt chloride) of trichothecene production by changing carbon sources in liquid medium. When
precocene II (30 μM) was added to inhibit trichothecene production in a trichothecene high-production
medium containing sucrose, ACL expression was reduced and ACL mRNA level as well as acetyl CoA
amount in the fungal cells were reduced to the levels observed in a trichothecene trace-production
medium containing glucose or fructose. The ACL mRNA level was greatly increased by addition
of cobalt chloride in the trichothecene high-production medium, but not in the trichothecene
trace-production medium. Levels were reduced to those level in the trichothecene trace-production
medium by addition of precocene II (300 μM) together with cobalt chloride. These results suggest that
ACL expression is activated in the presence of sucrose and that acetyl CoA produced by the increased
ALC level may be used for trichothecene production in the fungus. These findings also suggest that
sucrose is important for the action of cobalt chloride in activating trichothecene production and that
precocene II may affect a step down-stream of the target of cobalt chloride.
Keywords: ATP citrate lyase; precocene II; acetyl CoA; trichothecene production; cobalt chloride;
sucrose; Fusarium graminearum
1. Introduction
Fusarium graminearum is a worldwide predominant plant pathogen that causes Fusarium
head blight of wheat and other grain cereals and produces trichothecene mycotoxins in infected
grains. Contamination of important cereal crops by trichothecenes, mainly deoxynivalenol and
nivalenol, is a serious human and livestock health concern and also has the potential to cause drastic
economic consequences [1]. Presently, the use of fungicide is the most effective method for controlling
contamination, but inhibition of fungal growth may lead to the spread of resistant fungal strains [2].
Therefore, it is critical to develop other effective means for controlling trichothecene contamination.
To determine the optimal target for developing an effective method, a better understanding of the
basic regulatory mechanisms for trichothecene production in the fungus is required.
Trichothecenes are biosynthesized from farnesyl pyrophosphate, which is produced via the
mevalonate pathway. Mevalonate, the key intermediate in the pathway, is biosynthesized from three
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acetyl CoA molecules. A number of Tri genes are responsible for trichothecene biosynthesis from
farnesyl pyrophosphate [3]. In F. graminearum, Tri6 encodes a key regulatory protein for trichothecene
biosynthesis [4,5]. The expression of Tri genes encoding trichothecene biosynthetic enzymes is under
the positive control of TRI6. TRI6 also up-regulates the expression of genes encoding enzymes involved
in the mevalonate pathway [6]. Therefore, the overall biosynthetic pathway from acetyl CoA to
trichothecenes is activated by TRI6. However, the upstream events that lead to TRI6 expression
have not yet been clarified.
Supply of acetyl CoA to the biosynthetic pathway may be necessary for trichothecene production,
but the mechanism by which acetyl CoA is supplied is not clear. Three pathways, in which acetyl
CoA synthetase, carnitine acetyltransferase, or ATP citrate lyase (ACL) is a key enzyme, are known
to produce acetyl CoA in the fungal cytosol [7]. Occurrence of ACL and carnitine acetyltransferase
activity was shown to be spread widely in filamentous fungi [8]. It has been shown that each subunit of
ACL of F. graminearum is encoded by two genes (ACL1 and ACL2) and deletion of ACL1 and/or ACL2
results in reduction of trichothecene production in the fungus [9]. It also has been shown that two
carnitine acetyltransferases (CAT1 and CAT2) are present in the fungus and deletion of CAT1 decreases
trichothecene production [10]. In our proteome analysis studies on the mode of action of precocene
II, a trichothecene production inhibitor, we found that ACL2 expression was reduced by precocene
II. In a microarray experiment with the Tri6 deletion mutant, ACL mRNA levels were not affected by
the deletion, suggesting that its expression is not under the control of TRI6 [5]. Although acetyl CoA
levels are thought to be a key factor for trichothecene production, the relationship of ACL expression
levels or acetyl CoA amounts with trichothecene production has not been investigated. Therefore, in
this study we investigated the relationship using factors that affect trichothecene production.
Carbon source is an important factor for trichothecene production in F. graminearum [11]. Sucrose
and some oligosaccharides containing a sucrose moiety are necessary for active production of
trichothecene. Other sugars, such as glucose or fructose, do not induce the production. The molecular
mechanism of sucrose for induction of trichothecene production is not clear. Precocene II and cobalt
chloride are known as a specific inhibitor and enhancer for trichothecene production of F. graminearum,
respectively [12,13]. Precocene II reduced the mRNA levels of Tri6, whereas cobalt chloride enhanced
levels. The target molecules of precocene II and cobalt chloride have not yet been elucidated.
In this paper, we describe the results of the proteome analysis and experiments designed to
investigate the correlation of the ACL expression level and acetyl CoA amount with trichothecene
production in F. graminearum using precocene II and/or cobalt chloride under different carbon sources.
2. Results and Discussion
2.1. Effects of Precocene II on ACL Expression
Fusarium graminearum MAFF101551 accumulates 3-acetyldeoxynivalenol (3-ADON) in its culture
supernatant in SYEP liquid medium containing sucrose as a carbon source. The production of 3-ADON
by the strain begins 2 days after cultivation and reaches a plateau at 4 days of cultivation in the
medium [12]. Precocene II, a constituent of essential oils, almost completely inhibited 3-ADON
production of strain MAFF101551 at a concentration of 30 μM without affecting fungal growth and
ergosterol production. Precocene II may affect a regulatory mechanism leading to expression of TRI6 in
the trichothecene production pathway in the fungus. To investigate the mode of action of precocene II,
proteome analysis by two-dimensional differential gel electrophoresis (2D-DIGE) was performed [14,15].
Strain MAFF101551 was incubated without or with precocene II (30 μM) for 2 or 4 days and the
proteins were extracted from the cells. Control and precocene II-treated samples were labeled with Cy3
(green) and Cy5 (red), respectively, and combined. The mixture was separated by two-dimensional gel
electrophoresis followed by fluorescent imaging (Figure 1). Green spots (decreased with precocene
II treatment) and red spots (increased with precocene II treatment), showing changes in abundance
greater than 1.2-fold, were clearly observed on the gels. Proteins in the spots were identified by
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MALDI-TOFMS analysis after in-gel tryptic digestion and by MASCOT research (Table 1). Among the
identified proteins, diphosphomevalonate decarboxylase (spot 11 on the sample gel from day 4), an
enzyme involved in the mevalonate pathway, was identified as a protein that had decreased expression
after precocene II treatment. Since expression of diphosphomevalonate decarboxylase is promoted by
TRI6, inhibition of TRI6 expression by precocene II may lead to a decrease of the protein expression
level. We also focused on the decrease of ACL (ACL2 encoded by FGSG_06039.3, [8]) expression (spot
5 on sample gels from days 2 and 4) because ACL was a key enzyme for acetyl CoA supply into the
cytosol as described above. The relationship of the other identified proteins listed in Table 1 with
precocene II’s function is currently under investigation.
















Figure 1. A two-dimensional differential gel electrophoresis (2D-DIGE) gel image of F. graminearum
proteome after precocene II treatment for 2 days (a) or 4 days (b). Green, red, and yellow spots indicate
proteins with decreased, increased, and unchanged abundance levels, respectively. Selected proteins
(>1.2 and <1.2 change in abundance; p < 0.05; n = 3) are numbered.
Table 1. Analysis of the effect of precocene II by 2D-DIGE.
Spot Protein
Fold change a




coverage (%)2 days 4 days
1 Formamidase −1.43 - 5.6 44.2 3.1 × 10−10 9 29
2 Serine carboxypeptidase −1.53 - 6.5 59.7 0.0019 5 10
3 Serine carboxypeptidase −1.54 - 5.1 63.6 0.029 6 13
4 Peroxidase catalase 2 −1.43 - 5.8 81.3 3.1× 10−11 11 17
5 ATP citrate lyase −1.27 −1.59 5.5 53.3 5.0 × 10−7 8 26
6 Pyruvate decarboxylase +1.60 +4.29 5.6 63.5 2.0 × 10−13 12 34
7 Glycolipid transfer protein +1.33 - 5.7 22.4 6.0 × 10−5 5 30
8 Cell division cycle protein 48 +1.35 +2.85 4.9 90.5 0.00087 6 11
9 Superoxide dismutase - −2.27 5.6 27.7 4.0 × 10−7 6 29
10 Kinesin heavy chain - −2.56 5.7 104.1 19 4 6
11 Diphosphomevalonate decarboxylase - −1.77 5.3 41.0 2.2 3 7
12 Enolase - +2.32 5.0 47.5 1.0 × 10−10 10 35
13 Carboxypeptidase S1 - +2.18 5.5 52.3 6.3 × 10−7 8 28
14 Acid phosphatase - +1.85 6.6 47.8 0.15 4 10
15 Alcohol dehydrogenase 1 - +2.39 7.6 42.0 0.0061 5 19
16 Aldehyde dehydrogenase - +1.60 5.4 53.9 1.0 × 10−12 11 32
17 40S ribosomal protein 50 - +2.34 4.8 31.8 3.1 × 10−10 8 30
18 Pyruvate kinase - +2.78 5.8 60.0 4.8 × 10−5 7 13
19 UDP glucose epimerase - +1.69 5.8 42.0 0.0051 5 20
a Normalized spot intensity: precocene II treated vs. untreated cells (average of triplicate gels from each of the three
independent cultures). b Theoretical pI (isoelectric point) was calculated from amino acid sequence.
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2.2. Effects of Carbon Sources on Acetyl CoA Amount and ACL2 mRNA Level
As reported by Jiao et al. [11], strain MAFF101551 produced a very small amount of 3-ADON in
GYEP or FYEP liquid medium containing glucose or fructose as a carbon source instead of sucrose in
SYEP medium at 3 and 7 days cultivation (Figure 2). We analyzed the levels of acetyl CoA and ACL2
mRNA in the fungal cells cultured in these three media. Analysis of acetyl CoA amount was performed
using the method by Ruijter et al. with some modification [16]. The acetyl CoA amount in the fungal
cells cultured in SYEP liquid medium was much higher than that in GYEP or FYEP medium at 3 days
of cultivation (Figure 3). A decrease of the acetyl CoA amount was observed after 7 days of cultivation
in SYEP medium. The fungal cells cultured in SYEP medium showed the highest ACL2 mRNA level
among the three media at 3 days of cultivation (Figure 4). However, after 7 days of cultivation, the
ACL2 mRNA level was nearly the same among all three conditions. These results suggest that the
acetyl CoA amount and ACL2 mRNA level correlate with trichothecene production of F. graminearum
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Figure 2. Effects of carbon sources on 3-acetyldeoxynivalenol production by F. graminearum. n = 3,
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Figure 3. Effects of carbon sources (a) and precocene II in SYEP medium (b) on acetyl CoA amount.
n = 3, ** p < 0.01, vs. control.
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Figure 4. Effects of carbon sources and precocene II on ACL2 mRNA level. n = 4 (3 days cultivation),
n = 3 (7 days cultivation), ** p < 0.01, vs. control.
2.3. Effects of Precocene II on Acetyl CoA Amount and ACL2 mRNA Level
The acetyl CoA amount in the fungal cells cultured in SYEP medium was strongly reduced
by addition of 30 μM precocene II at 3 days of cultivation (Figure 3), but it was not significantly
affected after 7 days of cultivation in SYEP medium. The ACL2 mRNA level observed in SYEP medium
was also reduced to the level detected in GYEP or FYEP by addition of precocene II at 3 days of
cultivation (Figure 4). In addition, precocene II did not have a strong effect on the transcription level of
ACL2 in GYEP or FYEP. These results suggest that precocene II may suppress the activation of ACL2
transcription and acetyl CoA production by sucrose.
2.4. Effects of Cobalt Chloride on Acetyl CoA Amount and ACL2 mRNA Level
The production of 3-ADON in strain MAFF101551 is known to be dramatically enhanced by
addition of 30 μM cobalt chloride in SYEP medium without any effect on fungal mycelial weight
and ergosterol amount [13]. Cobalt chloride strongly up-regulated transcription of Tri6 and genes
regulated by TRI6 as well as genes encoding ergosterol biosynthetic enzymes. Higher concentrations
(300 μM) of precocene II were necessary to almost completely inhibit 3-ADON production in SYEP
medium containing 30 μM cobalt chloride. In the presence of 30 μM of cobalt chloride and 300 μM
of precocene II, transcription of Tri6 was suppressed, but the transcription of ergosterol biosynthetic
enzyme genes was still up-regulated [13]. After addition of 30 μM cobalt chloride, the ACL2 mRNA
level in the fungal cells was enhanced in SYEP liquid medium, but not significantly affected in GYEP
medium (Figure 5). The acetyl CoA amount in the fungal cells was slightly increased by addition of
30 μM cobalt chloride in SYEP medium, but not in GYEP medium (Figure 6). Co-addition of 300 μM of
precocene II into SYEP medium containing 30 μM of cobalt chloride reduced the ACL2 mRNA level
and acetyl CoA amount to those observed in GYEP medium (Figures 5 and 6).
Based on our results, we propose a regulatory mechanism for trichothecene production (Figure 7)
whereby the expression of ACL and TRI6 is activated in the presence of sucrose, and the acetyl CoA
produced by the increased ALC levels may be used for trichothecene production in F. graminearum.
Sucrose is important for the action of cobalt chloride in activating transcription of ACL and Tri6,
which leads to promotion of trichothecene production. Precocene II may affect a step down-stream
of the target of cobalt chloride. F. graminearum can produce many secondary metabolites including
polyketides and terpens other than trichothecenes [17]. Since acetyl CoA is the key precursor common
to biosynthesis of polyketides and terpens produced by the fungus, increasing of acetyl CoA amount
134
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may affect their production. Therefore, the results obtained in this study may have a possibility to
provide clues for clarifying the regulatory mechanism of production of not only trichothecenes but
also other secondary metabolites produced by the fungus.




























Figure 5. Effects of cobalt chloride on ACL2 mRNA level. n = 4, ** p < 0.01, * p < 0.05, vs. control.
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Figure 7. Possible regulatory mechanism of trichothecene production by F. graminearum.
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3. Experimental Section
3.1. F. graminearum Culture Conditions and Analysis of 3-Acetyldeoxynivalenol
A Japanese isolate strain, Fusarium graminearum MAFF101551, described previously [13] was
used as a 3-acetyldeoxynivalenol producer. A spore suspension of the strain was prepared using
carnation leaf agar medium. After cultivation of the strain on the medium at 28 ◦C for 10 d, the leaf
was rinsed in 20% glycerol aqueous solution and the mixture was filtered with miracloth to obtain a
filtrate containing spores, which was stored at −80 ◦C and used as a spore suspension. Liquid medium
(5 mL) of SYEP (sucrose 5%, yeast extract 0.1%, polypeptone 0.1%), GYEP (D-glucose 5%, yeast extract
0.1%, polypeptone 0.1%), or FYEP (D-fructose 5%, yeast extract 0.1%, polypeptone 0.1%) was put
into test tubes (1.6 cm × 18 cm) and autoclaved. Autoclaved aqueous CoCl2 solution (5 μL) and/or
methanolic precocene II solution (15 μL) was added to the medium. Each tube was inoculated with
a spore suspension of the strain (1 × 105 spores/tube) and then incubated with continuous shaking
(300 rpm) at 26.5 ◦C for 2–7 d. The resulting culture broth was filtered to obtain the mycelia and filtrate.
The filtrate (1 mL) was extracted with 200 μL of ethyl acetate, the ethyl acetate solution was evaporated
to dryness, and the obtained residue was dissolved in 200 μL of 10% acetonitrile in water, which was
subjected to LC/MS analysis using a 2695 HPLC system (Waters, Milford, MA, USA) equipped with a
150 mm × 2 mm i.d. Capcell-Pak C18 column eluted with a gradient of 10%–80% acetonitrile in water
containing 10 mM ammonium acetate in 20 min. The flow rate was 0.2 mL/min and the retention time
of 3-acetyldeoxynivalenol was 9.4 min. MS analysis was done with a micromassZQ (Waters) by ESI, in
positive ion mode; spray chamber parameters: source temperature, 120 ◦C; desolvation temperature,
350 ◦C; cone, 30 V; desolvation gas, 600 L/h; cone gas, 50 L/h; capillary voltage, 2800 V. MS ions were
monitored in single-ion recording mode using the extracted ion m/z 339 (M + H)+.
3.2. 2D-DIGE Analysis
A spore suspension of the strain MAFF101551was inoculated into SYEP medium (5 mL) in a
test tube with or without precocene II (30 μM), and incubated with continuous shaking (300 rpm) at
26.5 ◦C for 2 d or 4 d. After incubation, mycelia were harvested and lyophilized. The dried mycelia
were ground in a mortar with a pestle in liquid nitrogen, and incubated in CelLytic Y Yeast Cell
Lysis/Extraction Reagent (600 μL, Sigma-Aldrich, St. Louis, MO, USA) containing 1 M DTT solution
(2 μL) and phosphatase inhibitor cocktail (2 μL, Sigma-Aldrich) for 30 min at room temperature to
extract total proteins. After centrifugation of the mixture at 15,000 g for 10 min at 4 ◦C, the supernatant
was mixed with acetone (800 μL) and incubated for 1 h at −80 ◦C. The obtained precipitates were
collected by centrifugation, washed with ethanol, and dissolved in 2D-DIGE lysis buffer (2 M thiourea,
7 M urea, 4% (w/v) CHAPS, 30 mM Tris-HCl, pH 8.5). Total protein contents were determined by the
Bradford assay using BSA as a standard.Main text paragraph
Precocene II-treated and control protein samples were quantified and labeled with NHS-Cy2,
-Cy3 and -Cy5 (GE Healthcare, Buckinghamshire, UK). Protein (50 μg) taken from precocene II-treated
or control samples were minimally labeled with 160 pmol of Cy3 or Cy5 in triplicate. An equal pool of
precocene II-treated and control samples were labeled with Cy2 (3.2 pmol/μg protein) and run as a
standard on all gels to aid in spot matching and cross-gel quantitative analysis. Protein labeling was
performed on ice in the dark for 30 min. Reactions were quenched by 10 min incubation with a 20-fold
molar excess of free lysine. The labeled samples were mixed and carrier Pharmalyte (pH 3–10, GE
Healthcare) was added to a final concentration of 2%.
The mixture was separated by isoelectric focusing in the first dimension using 24 cm pH 3–10 NL
(nonlinear) strip (GE Healthcare) and by SDS-PAGE in the second dimension using 10% SDS-PAGE gel
bonded to low-fluorescence glass plates. Gels were run in Ettan 6 gel tanks at 400 mA per gel at 20 ◦C
until the dye front had run off the bottom.
After 2DE, gels were scanned using a Typhoon™ 9400 variable mode imager (GE Healthcare)
and ImageQuant software (GE Healthcare). The photomultiplier tube voltage was adjusted for each
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dye channel for preliminary low-resolution scans to give maximum pixel values within 5%–10%
for each channel and below saturation, prior to the acquisition of 100 μm high-resolution images.
Images were cropped and analyzed using DeCyder™ V5.0 (GE Healthcare). Ratios of spot intensities
detected in precocene II-treated or control samples to those of corresponding spots in standard
sample were calibrated and obtained values were averaged across triplicates for each experimental
condition. Statistical analysis was performed to pick spots matching across all images, displaying a
≥1.2 average-fold increase or decrease in abundance between drug-treated and control samples and
with p values < 0.05 (Student’s t-test).
3.3. In-Gel Digestion and Protein Identification by Mass Spectrometry
Visible spots were excised from the CBB R250 (Nacalai tesque, Kyoto, Japan) -stained gels and
transferred into microcentrifuge tubes. Excised fragments were washed successively with water,
25 mM NH4HCO3, acetonitrile/25 mM NH4HCO3 (1:1) and acetonitrile. Destained gel fragments
were dried under vacuum with a centrifugal evaporator. Tryptic digestion was performed overnight
at 37 ◦C using 10 μL of 10 μg/mL trypsin (Roche, Basel, Switzerland) in 50 mM NH4HCO3, pH
7.8. The resulting tryptic fragments were extracted twice with 100 μL of acetonitrile/water (3:2)
containing 0.1% TFA, in an ultrasonic bath for 15 min. The supernatants were concentrated to 10 μL
in a centrifugal evaporator and passed through a Zip-Tip™ C18 (Millipore, Bedford, MA, USA). The
adsorbed peptides were eluted with 2.0 μL of acetonitrile/water (3:2) containing 0.1% TFA and 1%
α-cyano-4-hydroxycinnamic acid. The eluent was loaded onto a mass spectrometer sample plate. Mass
spectra were acquired on a Voyager-DE STR MALDI-TOF mass spectrometer (Applied Biosystems,
Foster City, CA, USA) operated in the reflectron-delayed extraction mode. Spectra were internally
calibrated using trypsin autodigestion products. MASCOT (Matrix Science, Boston, MA, USA) was
used to search databases. The expect value, number of matched peptides and percentage of sequence
coverage for each identified protein are listed in Table 1.
3.4. Analysis of Acetyl CoA
The strain MAFF101551 was incubated in liquid medium (5 mL), and the mycelia were obtained
and frozen by liquid nitrogen. The frozen mycelia were incubated for 30 min at −45 ◦C with a
solution of methanol (6 mL) and chloroform (10 mL) containing 3,4-dimethoxyaniline (1 μM) as the
internal standard. After adding an aqueous 5 mM triethanolamine solution (4 mL) to the mixture,
the mixture was incubated for 10 min at −45 ◦C and then shaken for 30 min at room temperature.
After centrifuging the mixture at 5000 g for 5 min at −10 ◦C, the upper layer was transferred to a
50 mL tube. The remaining lower layer was mixed with 5 mM triethanolamine (2 mL) and shaken.
After centrifuging the mixture at 5000 g for 5 min at −10 ◦C, the upper layer was transferred into
the 50 mL tube in which the first upper layer has been collected. The pooled upper layers were
shaken with diethyl ether (15 mL) and centrifuged at 5000 g for 5 min at −10 ◦C to obtain the lower
layer. After the solution was filtered and evaporated, the obtained residue was dissolved in 200 μL
of 25% methanol in water, which was subjected to LC/MS analysis under the same conditions as
3-acetyldeoxynivalenol was analyzed above mentioned except for the following ones. Isocratic elution
by solvent A (5 mM hexylamine in water whose pH was adjusted to 6.3 by acetic acid) from 0 to 2 min
and then gradient elution by changing the ratio of solvent A and solvent B (90% methanol in water
containing 10 mM ammonium acetate whose pH was adjusted to 8.5 by ammonia water) from 100:0 to
0:100 from 2–50 min were used for the HPLC elution. The retention time of acetyl CoA was 33.2 min.
MS ions were monitored in single-ion recording mode using the extracted ion m/z 810 (M + H)+.
3.5. RT-PCR Analysis
The strain MAFF101551 was incubated in liquid medium (5 mL) and mycelial cake was harvested
by filtration and lyophilized. Total RNA was extracted using a TRIzol plus RNA Purification Kit
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol. First-strand cDNA was
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prepared using the SuperScript III First Strand Synthesis System (Invitrogen) with random hexamer
primers, according to the protocol. The cDNA derived from 0.005 μg of total RNA was used as a
template. Real-time quantitative RT-PCR was carried out using the SYBR Green Master Mix (Applied
Biosystems, Foster City, CA, USA), in a final volume of 25 μL for each reaction, and an ABI PRISM
7300 thermal cycler (Applied Biosystems). Two-step PCR conditions were as follows: after an initial
incubation at 95 ◦C for 10 min, 40 cycles of 95 ◦C for 15 s and 60 ◦C for 1 min were performed.
The PCR primers for each gene were as follows: ACL2 5′-CGCCAACTACGGCGAGTAC-3′ and
5′-AGTTCGGGCGTAGTGGTAAGTC-3′: β-tubulin (control gene) 5′-CCTGACCTGCTCTGCCATCT-3′
and 5′-TGGTCCTCAACCTCCTTCATG-3′. The amount of each mRNA was normalized to the amount
of β-tubulin mRNA in each sample.
3.6. Data Analysis
Data are presented as the mean ± SD. Differences between groups were assessed with one-way
ANOVA followed by Dunnett’s test. Values of p < 0.05 were considered to be significant.
4. Conclusions
The relationship of ATP citrate lyase and acetyl CoA levels to trichothecene production in
F. graminearum was clearly observed in the trichothecene-production medium containing sucrose,
which suggested that up-regulation of expression of ATP citrate lyase by sucrose is a key event for
inducing the trichothecene biosynthesis.
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Abstract: The mycotoxin deoxynivalenol (DON), produced by several Fusarium spp., acts as a virulence
factor and is essential for symptom development after initial wheat infection. Accumulating evidence
shows that the production of this secondary metabolite can be triggered by diverse environmental
and cellular signals, implying that it might have additional roles during the life cycle of the fungus.
Here, we review data that position DON in the saprophytic fitness of Fusarium, in defense and in the
primary C and N metabolism of the plant and the fungus. We combine the available information in
speculative models on the role of DON throughout the interaction with the host, providing working
hypotheses that await experimental validation. We also highlight the possible impact of control
measures in the field on DON production and summarize the influence of abiotic factors during
processing and storage of food and feed matrices. Altogether, we can conclude that DON is a very
important compound for Fusarium to cope with a changing environment and to assure its growth,
survival, and production of toxic metabolites in diverse situations.
Keywords: trichothecene; oxidative stress; virulence factor; fungicides; primary metabolism
1. Introduction
Fusarium head blight (FHB) is an important disease of small-grain cereals that is caused by a
diverse set of Fusarium species. Although yield reduction is a serious consequence of Fusarium infection
in the field, the primary interest in FHB research is driven mainly by the ability of Fusarium to produce
mycotoxins that have toxic effects on plants, animals and humans [1,2]. Deoxynivalenol (DON) is one
of the most prevalent mycotoxins encountered in grain fields. Consequently, although it is not the
most toxic one, DON is considered to be the most economically important mycotoxin. DON belongs to
the structural group of trichothecenes all bearing a common tricyclic 12,13-epoxytrichothec-9-ene core
structure. Type A, B, C and D trichothecenes can be distinguished based on substitutions at position
C-4, C-7, C-8 and/or C15 [3]. DON belongs to the type B trichothecenes and is mainly produced by
Fusarium graminearum and F. culmorum, two important members of the FHB-causing species complex [4].
Historically, DON, also called vomitoxin, has been notorious because it provokes acute and chronic
disease symptoms in humans and animals that consume contaminated grains [5]. Its toxic effects
range from diarrhea, vomiting, gastro-intestinal inflammation, necrosis of the intestinal tract, the
bone marrow and the lymphoid tissues. It causes inhibition of protein, DNA and RNA synthesis and
inhibition of mitochondrial function. In addition, it has effects on cell division and membrane integrity
and induces apoptosis [6]. Only after its toxicity for mammals had been established, were dedicated
efforts initiated to unravel the conditions under which Fusarium species produce DON.
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Many environmental factors are reported to affect DON levels during the infection process [7,8].
For instance, humidity and intensive rainfall during and after anthesis result in increased DON
production and proliferated FHB symptoms [9–16]. Moreover, the weather conditions during the
vegetative growth of wheat are important parameters determining Fusarium and DON load, reflecting
the importance of survival of the primary inoculum present in soil and on crop debris during
winter [14]. Furthermore, FHB and DON are influenced by many agronomic and other anthropogenic
factors: no-, minimal-, or non-inversive tillage systems are beneficial for Fusarium [17]. Crop rotation,
nitrogen fertilization, and weed management shape the structure of the soil biota and influence
Fusarium survival [14,18,19]. Finally, the germplasm of the host has been shown to influence FHB and
DON synthesis for example by the ability of resistant genotypes to metabolize DON [20,21].
Although this information is very valuable, in most studies no mechanistic clues are provided
on how these factors affect the toxigenic machinery of the fungus. In addition, there are many other
abiotic factors affecting DON of which the physiological relevance is not always clear. Obviously,
a thorough insight into the functional rationale of DON production may provide hints towards an
adjustment of control measures in order to avoid DON presence in the field. Therefore, we have placed
the factors known to induce DON production in a relevant physiological frame, namely the different
phases in the life cycle of Fusarium during the growing season of wheat (Triticum sp.) as a model
host. Where possible we combine this information into working models that should be experimentally
validated to obtain a holistic view on DON production by Fusarium.
2. The Saprophytic Phase
2.1. Survival of the Fittest
During the saprophytic phase, F. graminearum can survive on dead organic matter to persist in the
absence of a living host, which is an important asset during the active invasion of hosts later on in the
season. Therefore, saprophytic fitness is a significant component of the overall pathogen vigor [22].
Strikingly, information on the role of DON during this saprophytic period is scarce, although it covers
a major part in the pathogen's life cycle and determines the primary inoculum load. Indeed, recently,
DON production during the saprophytic survival on wheat stubble has been shown to be correlated
with the aggressiveness of the isolates during their pathogenic phase [22].
The ability of most F. graminearum isolates to produce DON provides a dual advantage at the
saprophytic state in the competition for niches on crop residues and organic matter. Firstly, DON
is an antimicrobial metabolite that is effective against other eukaryotic soil organisms because of its
interference with protein biosynthesis [5]. Secondly, DON can affect the metabolite production of other
soil-residing fungi, such as Trichoderma sp., that are known for their strong outcompeting capacity
by mycoparasitism, orchestrated by chitinases and other degrading enzymes [23]. In co-inoculation
experiments, DON proved to repress the chitinase activity in T. atroviride [24], although a reduction in
the Trichoderma biomass due to DON production by F. graminearum could not be observed [25].
Despite the very limited amount of information on the role of DON during the saprophytic phase,
indirect evidence may come from comparative studies on the saprophytic survival of different Fusarium
species. Apparently, F. poae which is considered a weak pathogen, is a better saprophytic survivor that
outcompetes F. graminearum from soil and crop debris samples [26,27]. Since F. poae produces a more
toxic blend of mycotoxins than F. graminearum, comprised of both type A and type B trichothecenes,
it is tempting to speculate that this feature accounts for its better saprophytic survival capacity. The
remarkable omnipresence of F. poae in the subsequent growth phase on living plant tissue, may thus
originate from a “strength in numbers” strategy, originating from an inoculum build-up during the
saprophytic phase.
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2.2. Linkage between DON Production and Formation of Conidia and Ascospores
As the infection of F. graminearum is realized via production of conidia and ascospores, the
formation of these reproductive structures is a very important phase in the pathogen’s life cycle.
Recent research has shown that both DON production and conidia/ascospore formation are under
tight regulation by overlapping cellular factors [28], some of which are mentioned below. APSES
proteins are a conserved class of transcription factors regulating development, secondary metabolism
and pathogenicity [29,30]. Recently, FgStuA, a F. graminearum gene encoding a protein with high
homology to APSES transcription factors has been characterized. Using a knock-out approach, FgStuA
was shown to influence spore development and DON biosynthesis amongst other processes [31].
Several other regulatory cellular proteins such as the C-type cyclin like protein CID1, the ZIF1 b-zip
transcription factor and the Wor-1 like nuclear protein Fgp1 are all involved in sexual reproduction and
influence DON production [32–35]. These results highlight a tight link between reproductive fungal
development and secondary metabolite production.
3. DON in the Pathogenic Phase: A Lethal Weapon of a Hemibiotrophic Cereal Killer
3.1. Plant Defense: A Matter of Making the Good Choices at the Right Time
Plants are endowed with a sophisticated set of plant defense mechanisms that can be activated
upon pathogen infection. These defense responses can be divided into two main signaling pathways.
One pathway involves a prompt induction of reactive oxygen species (ROS) followed by the
accumulation of salicylic acid (SA), activating the plant’s defense machinery. This type of defense often
coincides with a programmed cell death (PCD)-type response and a hypersensitive response (HR)
that isolate the pathogen and deprive it from nutrients. This SA-type defense is generally accepted
to be efficient against biotrophic pathogens that need viable cells for survival. The other pathway
involves jasmonic acid (JA). This type of response is especially activated during the plant defense
against necrotrophic pathogens [36,37].
However, some pathogens, such as DON-producing Fusarium spp, are hemibiotrophic and have
both a biotrophic and a necrotrophic phase during the colonization of their host. Hence, in such
interactions, a coordinated and ordered expression of SA- and JA-dependent defense responses in
the plant is crucial to halt the fungus [38], but at the same time, it provides multiple opportunities for
interference by the pathogen.
3.2. DON and the Plant Defense Response: Hijacking the Plants Oxidative Armor
There is ample evidence suggesting that DON production during infection is a sophisticated
strategy of the fungus to circumvent and hijack the plant’s defense system. When a rain-splashed
conidium or wind-dispersed ascospore lands on the exposed vulnerable parts of a crop plant (glumae,
floral cavity, lemma, palea, or anthers) during or just after anthesis, it can germinate and penetrate
the plant [39]. An initial superficial and intercellular growth of the fungus is eventually followed by
the actual penetration of the plant, which involves the formation of infection cushions and foot-like
structures invaginating the host tissue [40,41]. In this first phase, the fungus grows biotrophically into
the intercellular spaces and the role of DON is assumed to be unimportant. Still, during this biotrophic
phase several reports describe Tri gene expression at the hyphal tip [42–44]. Recently, the ability of
very low DON concentrations to inhibit PCD has been illustrated [45] which could interfere with PCD,
thus disrupting the biotroph-type defense (Figure 1).
Afterward, the fungus switches to a more invasive intracellular growth, including necrosis and
cell death [40]. During this second necrotrophic infection phase, the production of the mycotoxin DON
becomes apparent and is necessary for the spread of the fungus in the rachis of wheat [46]. Previously,
studies have demonstrated that tri5 knockout mutants, which cannot produce DON because the
inactive Tri5 gene does not convert farnesyl pyrophosphate to trichodiene, are less virulent due to the
lack of spread in the rachis, implying that DON is crucial in ear colonization [42,47,48].
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Figure 1. Hypothetical model of the effect of DON during the biotrophic and necrotrophic phases of
F. graminearum infection of wheat, based on defense-related responses in wheat. The left part depicts
the biotrophic phase and the right and red parts indicate the necrotrophic phase of the fungus. Green
lines and arrows mark pathways of the fungus, whereas the blue lines reflect pathways of the plant.
DON: deoxynivalenol; DON-3G: DON-glucoside; DON-GSH: DON-gluthatione; JA: jasmonic acid;
PAO: polyamine oxidases; PCD: programmed cell death; PR: pathogenesis related; SA: salicylic acid;
Tri: trichothecenes.
The induction of cell death is a well-known defense strategy of plants against biotrophic but
not against necrotrophic fungi [49]. In this context, it is interesting that high DON concentrations
were shown to trigger H2O2 synthesis and subsequent cell death (Figure 1). Moreover, using an
in vitro approach, several research groups demonstrated that H2O2 is an efficient inducer of DON
production, especially when applied at early stages of spore germination [50–52]. Physiologically, these
observations indicate that if H2O2 is one of the first defense molecules encountered by the invading
Fusarium hyphae, it also establishes a positive feedback loop leading both to increased DON and H2O2
levels. Consequently, DON production by Fusarium in the necrotrophic infection phase may interfere
with the two-step defense response against hemibiotrophs, because it directs the plant towards an
oxidative burst which is not effective against necrotrophs. The eventual activation of H2O2-mediated
defense responses comprising phenolic acids, chitinases, glucanases and peroxidases [46], might come
too late or at the wrong time point for the plant to defend itself against the invasive necrotrophic
growth of F. graminearum. Indeed, it is generally recognized that both timing and localization of defense
or signaling compounds determine the outcome of a plant-pathogen interaction. The importance of
H2O2 in the induction of DON was confirmed by the effectiveness of anti-oxidative phenolic acids,
such as ferulic acid, to inhibit trichothecene accumulation at a transcriptional level in vitro [53–55].
In addition, in planta, the presence of ferulic acid in wheat cultivars correlated negatively with the
accumulation of DON during F. graminearum infection [56].
Finally, it seems that DON-producing Fusarium species also interfere with the plant defense
pathway further downstream of the oxidative burst. Indeed, SA can be used by F. graminearum as
a carbon source [36], which may result in reduced expression of the typical SA-dependent defense
genes such as pathogenesis-related protein 1 (PR1), nonexpressor of PR genes 1 (NPR1), and PR4,
possibly impeding the control of symptoms development [36]. Moreover, the production of other
defense-related compounds, such as PR10, chitinases, peroxidases, PR5, and PR10, is inhibited by
DON at later time points during infection [49].
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Nevertheless, DON is not essential in all F. graminearum plant interactions. For instance, although
eventually a high DON load is measured as well, the infection of barley and rice with F. graminearum
strains does not involve this mycotoxin [47,57,58].
3.3. Directing DON to the Vacuoles: Deprivation of the Pathogen of Its Virulence Factor
From the above, it is clear that DON is a powerful tool of F. graminearum to grow within the wheat
host. Nevertheless, the plant is endowed with detoxification mechanisms to dampen the detrimental
effects of the mycotoxin (for review [21]). Most important is the covalent binding of DON to hydrophilic
molecules, such as glucose and glutathione (γ-glutamyl-cysteinyl-glycine, GSH). Conjugated DON is
then transported via membrane-bound transporters to the vacuoles or apoplastic space [59,60]. The
detoxifying effect of the conjugation is beyond dispute, but intriguingly, glutathione, a product derived
from glyoxylate in the Calvin cycle, also plays an important role in modulating the redox status of
the host cell, which determines the outcome of plant-pathogen interactions. Hence, it is tempting
to speculate that through conjugation to DON, the fungus sequesters glutathione that affects the
antioxidative status and, consequently, the defense machinery of the host cell. Still, it is important to
notice that the oxidative status of plant cells is very complex with amongst others catalases, ascorbate
peroxidases, superoxide dismutases and NADPH oxidases establishing the oxidative equilibrium.
4. The Plant’s Primary Carbohydrate and Nitrogen Metabolism Feed into DON Production and
Fungal Growth
Although current research particularly focuses on downstream defense signaling, the energy
and carbon skeletons used in the defense reactions activated in wheat upon infection with Fusarium
require the redistribution of energy from the primary metabolism of the plant. Interestingly, pathogens
themselves seemingly also drain energy from the primary metabolism of the host to the advantage of
their own pathogenic growth and production of their virulence factors [61,62].
When a plant is attacked by a pathogen, the availability of ready-to-use energy, reducing agents,
and carbon skeletons is a prerequisite for optimal activation of defense. In many plant pathosystems,
photosynthesis, which generates ATP and NADPH, decreases at the site of infection, establishing
novel sink tissues [61]. Carbohydrate partitioning between source and sink tissues is a highly dynamic
process during the plant’s life cycle and the physiological balance can easily be disrupted. Because of
reduced photosynthesis, the plant will mobilize monosaccharides to the infection site by activating
membrane-bound invertases that cleave apoplastic sucrose, thus generating energy and carbohydrate
skeletons for diverse metabolic processes, including defense. However, sucrose is also an important
inducer of the Tri gene machinery. Especially Tri5 and Tri4, which are both involved in the initial
steps of trichothecene biosynthesis by converting farnesylpyrophosphate to trichodiene and the latter
to 15-decalonectrin, respectively, are strongly upregulated by sucrose, resulting in increased DON
biosynthesis [63].
In the F. graminearum-wheat interaction, several plant invertases are upregulated, indicating that
the fungus exploits sucrose not only as a trigger for DON biosynthesis, but also as a monosaccharide
source that can be used for its own growth [64]. However, the contributions to the metabolism of the
plant and of the fungus are difficult to distinguish. Indeed, pathogenic fungi also produce invertases
that can potentially disturb the source-sink balance and the repartitioning of the carbon sources in the
plant and, hence, affect the infection process.
The importance of nitrogen in plant defense is mainly situated at three levels. Firstly, nitrogen is
indirectly involved as an energy source. Inorganic nitrogen is usually taken up as NH4 or NO3 after
which it is incorporated into amino acids, such as glutamate, glutamine, asparagine, and aspartate
via glutamine synthase. Subsequently, these amino acids are transported or stored in the plant by the
glutamine-oxoglutarate aminotransferase (GOGAT) cycle. When the energy demand of the plant cells
increases, for example upon pathogen infection, these amino acids are diverted to the energy-generating
tricarboxylic acid (TCA) cycle, in part via the γ-aminobutyrate (GABA) shunt, leading to reducing
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equivalents and ultimately ATP [61,62]. Secondly, nitrogen is a main compound in the regulation of the
redox status of plant cells. Reactive nitrogen species, such as nitric oxide (NO), but also polyamines,
produced from the precursor L-arginine, can be directly involved in plant defense through HR
induction [65]. Moreover, N-containing glutathione is an important antioxidant alleviating oxidative
damage during an HR [66]. Thirdly, the plant’s nitrogen metabolism has been suggested to be involved
in the defense response through a pivotal mechanism of evasion or endurance [62]. During the evasion
process, implicated in a successful defense response against biotrophic pathogens, nitrogen is uploaded
in the phloem as asparagine or glutamine and transported away from the invaded area to deprive the
pathogen from the necessary nitrogen sources. During the endurance process nitrogen is remobilized
from noninfected tissues providing infected cells with sufficient nitrogen to keep them alive; a strategy
that is very efficient against necrotrophic pathogens [62].
Just as with the carbohydrate metabolism, pathogens, including DON-producing Fusarium species,
appear to hijack the primary nitrogen metabolism of the plant for their own benefit. For instance,
several pathogens can use the plant’s amino acids as N-sources. Moreover, upon infection with
F. graminearum, the primary GOGAT cycle appears to be redirected toward the production of ornithine
and arginine, resulting in the formation of polyamines [67] (Figure 2). Indeed, a metabolo-proteomics
approach revealed the induction of the agmatin-to-polyamine conversion [68]. As described above,
the accumulation of polyamines can lead to ROS through the formation of NO and the action of
polyamine oxidases [38,69], which could hypothetically contribute positively to the necrotrophic phase
of F. graminearum. Finally, in an in vitro study, polyamines have been shown to induce DON production
as well, further contributing to the fungus pathogenicity [70].
Figure 2. Hypothetical model of the interaction of DON with the primary metabolism of the host and
the pathogen. Green lines and arrows indicate pathways of the fungus, blue lines reflect pathways
of the plant. Bullet lines represent inhibitory actions. Agm: agmatine; αKG: α-ketoglutarate; DON:
deoxynivalenol; GABA: γ-aminobutyric acid; GDH: glutamate dehydrogenase; Gln: glutamine; Glu:
glutamate; Glx: glyoxylate; Gly: glycine; GOGAT: glutamine oxoglutarate aminotransferase; Orn:
ornithine; TCA: tricarboxylic acid.
Although evidence is scarce, DON may interfere with aspects of the primary metabolism of the
fungus itself. Although DON is considered to be a secondary metabolite, knocking out of the Tri5
gene has a very profound impact on the primary metabolism of the fungus leading to decreased
levels of glutamate and GABA and reduced glutamine synthase and GABA transferase activities [71].
Consequently the complete GABA shunt, TCA cycle, and polyamine metabolism are negatively
affected (Figure 2). Conversely, upon infection, the GABA shunt becomes activated in DON-producing
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F. graminearum strains, suggesting a replenishment of the TCA cycle during the interaction with a
host [72]. Moreover, metabolomic studies of wheat ears have revealed that the TCA cycle of the
host is disturbed as well upon infection with F. graminearum, resulting in an increased activity of
glutamate hydrogenase that converts α-ketoglutarate to glutamate although a direct link with DON
production was not investigated. Interestingly, in other pathosystems involving necrotrophic and/or
toxin-producing plant pathogens, a similar exhaustion of the TCA cycle of the host takes place,
suggesting this might be a conserved and effective virulence strategy [73,74].
5. Of Crops and Men: The DON Molecule and Man’s Chemical Warfare
Because Fusarium infects an important economic crop cultivated within an agro-ecosystem, the
plant-fungus interaction is more complex than in a natural ecosystem. Indeed, farmers interfere to
minimize the presence of DON and other mycotoxins in the crop. Whereas the effect of chemical
fungicides on fungal outgrowth is quite straightforward and generally results in reduced fungal load,
reports on the impact of fungicides on the production of fungal secondary metabolites, especially
mycotoxins, are rather inconsistent and fragmentary. Still, careful analysis of the information reveals
important insights into the function of DON in the reaction of fungi to fungicide applications.
The effect of the strobilurin fungicide azoxystrobin on DON production varies from an
increase [75–78] to a reduction [79] depending on environmental factors. Some other fungicides,
such as carbendazim and thiram, have been tested for their efficiency to reduce DON in grain samples,
but no clear effect was observed [80]. Nevertheless, the mycotoxin chemotype and the sensitivity
toward carbendazim fungicides correlated well. As such, most strains producing nivalenol (NIV) or
15-acetyl-deoxynivalenol (15ADON) were susceptible, whereas all carbendazim-resistant isolates were
3-acetyl-deoxynivalenol (3ADON) producers [81].
The most important fungicides currently used to control Fusarium are the azoles. A multi-year
and multi-location experiment carried out in Belgium illustrated that the effect of azole fungicides
with respect to DON depended on the DON concentration in the wheat host. In plants containing
low and high DON amounts, fungicide applications often resulted in an increase and a reduction
of DON load, respectively. These field trials also demonstrated that it was impossible to decrease
the DON levels by more than 75% of the control fields (Figure 3). This observation may imply that
highly contaminated fields, in which DON levels exceed the legislative values multiple fold, cannot be
rescued by fungicide applications.
Within the group of azole fungicides, field doses of tebuconazole [75,77,82–85], metconazole [79,82,85],
and prothioconazole [85] consistently reduced DON biosynthesis or content. In contrast, application of
another azole fungicide, propiconazole, either decreased or increased DON levels [76,85]. Intriguingly,
DON amounts are increased by application of a sublethal dose of prothioconazole, which is
meticulously regulated through the production of H2O2 as an oxidative stress response of the fungus.
Indeed, oxidative stress as a booster of toxigenic pathways is now considered a trait common to
various toxigenic fungi from different genera of the fungal kingdom [86]. Moreover, qRT-PCR analyses
have revealed that the expression of Tri4, Tri5, and Tri11 was higher in cultures of F. graminearum
isolates supplemented with sublethal concentrations of tebuconazole and propioconazole than that in
nontreated controls, although the fold change in the Tri transcript levels differed according to the type
of azole used [87].
Typically, azole sensitivity in fungi is modified by either point mutations in the cytochrome
P450 monooxygenase-encoding target gene CYP51 [88,89], overexpression of CYP51 [90], presence
of paralogous CYP51 genes [91], the presence of fungal drug transporters, belonging to the ABC or
MDR classes [92], or an altered composition of the sterol content [93]. However, considering the
effect of low fungicide levels on DON production, the question arises whether DON interferes with
the fungicide effectiveness. Indirect proof comes from in vitro fungicide assays with a tri5 knockout
mutant of F. graminearum. The overall fitness and fecundity of the mutant was comparable to that of
the parent strain; but, when homeopathic levels of azole fungicides were applied, only the mutant
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fungus promptly stopped growing [94]. Apparently, when a strain cannot produce its toxic secondary
metabolite DON, it becomes hypersensitive to azole fungicides. Additionally, when F. graminearum
strains were allowed to adapt to azole fungicides, they showed an increased production of the B-type
trichothecene NIV [95].
Figure 3. Percentage of reduced DON content after application of triazole fungicides at GS 39 and GS
55 on different wheat varieties in function of the DON content present in the untreated experimental
field trials. All data points are the result of four independent replications and experiments were carried
out at several locations in a three-year-experiment.
Although direct evidence on the role of DON in fungicide resistance is currently lacking,
Sacharomyces cerevisiae is known to be very resistant against DON because of the presence of multiple
ABC transporters that pump the mycotoxin out of the cell [96]. In addition, expression of ABC
transporters of the plant pathogen Mycosphaerella graminicola in an ABC transporter-lacking mutant
of S. cerevisiae clearly indicated a wide functional overlap between the ABC transporters induced by
azole fungicides and those by the A-type trichothecene diacetoxyscirpenol [97]. Finally, transcriptional
profiling of ABC transporters upon fungicide application points toward a mechanism alleviating the
impact of the fungicide [95]. Together, this fragmentary information seems to imply that the mycotoxin
production capacity and resistance against fungicides converge at the ABC efflux level or other MDR
pumps. It is not unlikely that (some) efflux pumps activated upon mycotoxin biosynthesis are also
activated during exposure to fungicides. Interestingly, at least one ABC transporter has been shown to
be important in the virulence of F. graminearum, but an effect on the mycotoxin efflux from the deletion
mutant was not reported [98].
6. Abiotic Factors Influencing DON Biosynthesis in the Field and during Storage
The impact of abiotic factors on mycotoxin production has recently been reviewed [7,8]. Therefore,
we highlight only new research findings that deal with environmental effects on DON biosynthesis.
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6.1. pH
Although it is currently unknown whether and how the pH fluctuates during a wheat infection
with Fusarium, it is well established that a low extracellular pH results in an increased trichothecene
production [99]. Tri gene expression is regulated by a zinc finger transcription factor FgPac1 at acidic
pH values [100], but the regulation at neutral or basic pH remains unclear. As information on the
extracellular pH during wheat infection by F. graminearum and during grain storage remains scarce, it
is very difficult to place the results on the pH effects in a physiological context. Probably, a dynamic
window of pH fluxes influences DON production during the infection process.
6.2. aw and Temperature
The availability of free water (aw) and the incubation temperature will determine whether there
will be an outgrowth of F. graminearum, especially during storage of wheat grains after harvest.
In addition, the toxigenic outcome of fungal growth also depends on the aw value and the temperature.
Indeed, high aw values increase DON production in contaminated wheat grain batches [101] as well as
elevating the incubation temperature from 15 ◦C to 30 ◦C [102]. Several reports also describe a clear
interaction between temperature and aw value [103].
6.3. Light
In plants, several important pathways follow a diurnal regulation based on the day/night regime.
Although fungi do not depend on photosynthesis for their energy supply, their secondary metabolism
is often fine-tuned by light. One of the most important light-regulatory protein complexes is the
velvet complex, comprising at least FgVe1 (VeA) and FgVeB. Although the velvet complex has been
elaborately investigated with regard to the switch between asexual and sexual phases of the fungus,
recent research highlights its significance in the regulation of the Tri gene machinery. By means of a
gene replacement strategy, VeA has been demonstrated to regulate trichothecene production at the level
of the biosynthetic genes Tri4 and Tri5 and the transcriptional regulator genes Tri6 and Tri10 [104,105].
Results with knockout mutants have revealed that FgVeB plays a role in the regulation of Tri5 and Tri6
as well [106].
6.4. Post-Harvest Anthropogenic Factors Influencing the DON Content
After harvest, grains are often stored for some time in silos before final use as animal feed or
human food. Although DON production during storage is, exceptions notwithstanding, rather rare,
effects of changed storage conditions on fungal outgrowth and DON production have been reported.
Modified storage atmosphere, chemical preservation systems, and biocontrol with lactic acid bacteria
have been proposed as antifungal measures [102]. Detailed insights into the effect of these measures on
DON production are still lacking. Chemical compounds, such as antioxidants and essential oils applied
during storage of wheat grains clearly have a very variable impact on the DON levels. In an experiment
in which wheat grains were inoculated with F. graminearum and subsequently treated with neutralized
electrolyzed water, the ROS present in the electrolyzed water reduced the fungal load in the wheat
commodities. However, at sublethal levels, this decrease in biomass coincided with an increase in DON
level. The ROS liberated from the electrolyzed water oxidatively stimulated the Tri gene machinery to
produce DON [94].
7. Conclusions and Challenges for the Future
In the present review, we gathered available data on diverse factors known to affect DON
production by Fusarium. We combined this information into hypothetical models on the effect of DON
on defense-related processes and the primary metabolism of wheat as a model host. Altogether, based
on the present literature, we claim that DON is a molecule that is crucial throughout the fungal life
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cycle. During saprophytic survival, DON might be involved in competition for niche. Furthermore,
DON production and conidia- and/or ascospore formation are tightly linked processes.
During the interaction with its host, it seems that Fusarium uses DON to disturb the defense system
at several critical time points of infection assuring successful colonization and symptom development
(Figure 1). Moreover, DON appears to be deployed to hijack the primary C and N metabolism of the
plant to improve fungal growth and production of virulence factors (Figure 2). Although parts of the
proposed models are still highly speculative and not supported by direct experimental evidence, we
hope they provide valuable working hypotheses for future research.
An additional challenge is to decipher the function of other type A and type B trichothecenes
produced by other members of the FHB disease complex. Is the importance of DON in the life cycle
of Fusarium spp. unique or can the functions be extrapolated to other mycotoxins? More generally,
searching for parallels between Fusarium and other toxin-producing plant pathogens might reveal
conserved infection strategies typical for this type of phytopathogens.
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Piotr Goliński 1,* and Maciej Gajęcki 2
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Abstract: Deoxynivalenol is also known as vomitoxin due to its impact on livestock through interference
with animal growth and acceptance of feed. At the molecular level, deoxynivalenol disrupts normal cell
function by inhibiting protein synthesis via binding to the ribosome and by activating critical cellular
kinases involved in signal transduction related to proliferation, differentiation and apoptosis. Because
of concerns related to deoxynivalenol, the United States FDA has instituted advisory levels of 5 μg/g
for grain products for most animal feeds and 10 μg/g for grain products for cattle feed. The aim of
the study was to determine the effect of low doses of deoxynivalenol applied per os on the presence
of this mycotoxin in selected tissues of the alimentary canal of gilts. The study was performed on
39 animals divided into two groups (control, C; n = 21 and experimental, E; n = 18), of 20 kg body
weight at the beginning of the experiment. Gilts received the toxin in doses of 12 μg/kg b.w./day
(experimental group) or placebo (control group) over a period of 42 days. Three animals from two
experimental groups were sacrificed on days 1, 7, 14, 21, 28, 35 and 42, excluding day 1 when only
three control group animals were scarified. Tissues samples were prepared for high performance liquid
chromatography (HPLC) analyses with the application of solid phase extraction (SPE). The results
show that deoxynivalenol doses used in our study, even when applied for a short period, resulted
in its presence in gastrointestinal tissues. The highest concentrations of deoxynivalenol reported in
small intestine samples ranged from 7.2 (in the duodenum) to 18.6 ng/g (in the ileum) and in large
intestine samples from 1.8 (in transverse the colon) to 23.0 ng/g (in the caecum). In liver tissues, the
deoxynivalenol contents ranged from 6.7 to 8.8 ng/g.
Keywords: deoxynivalenol; gastrointestinal tract; immature gilts; low doses; mycotoxicosis
1. Introduction
Toxigenic Fusarium species are common pathogens of wheat, triticale and other cereals
worldwide [1–3]. Many of them attack a range of plant parts and stages, such as seedlings, heads,
roots, stems and ears, resulting in severe reductions of grain yield, often ranging from 10% to 40% [4,5].
Consequently, when cereal plants are infected with fungi, there is a risk of grain contamination
with secondary metabolites, i.e., mycotoxins, and their subsequent transfer to feed and food [6,7].
A major problem associated with animal feed contaminated with mycotoxins is not acute disease,
but rather the ingestion of low levels of toxins, which may cause an array of metabolic, physiologic
and immunologic disturbances [8–10]. Major Fusarium toxins found under the climatic conditions
of Poland are deoxynivalenol, zearalenone, moniliformin and fumonisins detected in cereals during
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plant growth and vegetation [5,6,11,12]. The presence of deoxynivalenol (DON) in agricultural crops
is an increasingly common problem associated with the occurrence of Fusarium head blight (FHB)
infection not only under temperate weather conditions, possibly because of the extensive application
of “no-tillage farming”, changing climate patterns and simultaneously, enhanced cultivation of host
crops such as maize and wheat [13]. Numerous studies indicated that choosing a less susceptible
cultivar is a powerful tool to ensure a low DON concentration in cereal grain even under highly
infectious conditions. This strategy enables farmers to make use of the benefits of conservation tillage
and, simultaneously, produce high quality grain [14].
Structurally, DON is a polar organic compound with the IUPAC name: 12,13-epoxy-3α,7α,15-
trihydroxytrichothec-9-en-8-on [15,16]. The ketone position in C8 is a characteristic of the class B
trichothecenes, also the number and position of the hydroxyl and acetyl-ester groups can influence the
relative toxicity within cells. In addition, via the epoxy group, this toxin is able to bind to the large
subunit of eukaryotic ribosomes and interfere with peptidyl transferase, thus impairing initiation or
elongation of peptide chains [17,18]. DON relative capacity to interfere with protein synthesis has been
attributed to a combination of different factors: the rate of transport into cells, metabolism by cytosol
enzymes, changes in affinity to the active binding site or capacity to interfere with protein synthesis.
The intensity of DON toxic effects depends on the dose, species, duration of consumption, toxin
purity and the route of administration [19,20]. Data on genotoxic effects of trichothecenes are scarce
and these toxins are classified to group 3 (inadequate evidence) by the International Agency on Cancer
Research. Among various animal species, swine are known to be especially susceptible to DON and could
therefore serve as a model for human sensitivity to this mycotoxin. DON absorption in pigs is rapid,
reaching peak plasma concentrations within 15 to 30 min of dosing [18,21]. Up to 0.82 systemic absorption
was recorded in pigs administered DON orally. Transient tissue distribution of DON in pigs occurs with
an elimination half-life of 3.9 h and very limited accumulation in tissues. From numerous studies on
laboratory animals and cell lines it was concluded that low dose exposure upregulates expression of
cytokines, chemokines and inflammatory genes with a concurrent immune stimulation. In addition,
low to moderate dose acute oral exposure to trichothecenes causes vomiting, diarrhea, gastroenteritis,
anorexia, reduced weight gain, malabsorption of glucose, glutamine and 5-methyltetrahydrofolic acid,
oesophageal perforation, circulatory shock and can ultimately lead to death [22–24]. DON affects
the integrity of intestinal epithelium through alterations in cell morphology and differentiation in
the barrier function. In turn, high dose exposure promotes leukocyte apoptosis with a concomitant
immune suppression and severe damage to the lymphoid and epithelial cells of the gastrointestinal
mucosa resulting in hemorrhage, endotoxemia and shock [17,25–27]. Other targets include bone
marrow and thymus, which can contribute to generalized immunosuppression. Interestingly, these gut
effects can occur in animals exposed to trichothecenes via inhalation. The United States Food and Drug
Administration (USFDA) has established Advisory Levels for DON in grain and grain by-products
based on the intended use [18]. For beef, feedlot cattle older than 4 months and chickens it is 10 mg/kg
while for pigs and all other animal species it is 5 mg of DON per kg of fodder.
The gastrointestinal tract is the first barrier against feed contaminants as well as the first target
for mycotoxins. The intestine is a preferential immune site where immunoregulatory mechanisms
simultaneously defend the body against pathogens, but also maintain tissue homeostasis to avoid
immune-mediated pathology in response to environmental challenges [28]. However, the toxin has
been demonstrated to readily cross the epithelial barrier by a paracellular pathway [29]. Hence, the
purpose of the present study was to examine the effect of per os DON exposure at NOAEL (no observed
adverse effect level) doses on the absorption, accumulation and final presence of this toxin in tissues of
the gastrointestinal tract of gilts, i.e., the liver, the small and large intestine, using high performance
liquid chromatography tools.
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2. Results and Discussion
In the last two decades, many studies have described DON toxicity using diverse species as
models, where DON consumption was shown to affect numerous physiological functions such as food
intake, reproduction or immunity [30–32]. The presented experiment involved two groups of immature
gilts (with body weight of up to 20 kg), which were orally administered deoxynivalenol at 12 μg/kg b.w.
(group E, n = 18) or placebo (group C, n = 21) over a period of 42 days. The concentration of the toxin
in the small intestine, large intestine and liver tissues was chromatographically analyzed. Until now,
most performance and toxicological data in pigs have been obtained with medium to high doses of the
toxin, i.e., 2 to 10 mg/kg of feed [33,34]. A survey of 11,022 cereal samples from 12 European countries
showed that 57% were positive for DON, with 7% containing DON concentrations of 750 μg/kg or
greater. One of the most important physicochemical properties of DON is its ability to withstand high
temperatures, which poses a risk of its occurrence in feed and food [35]. Ipso facto, it is known that feed
and food processing may have no effect on DON concentrations in the final product. Additionally, it
seems possible that differences in the feed form could modulate the bioavailability of DON, as it could
affect the liberation of the toxin from the matrix and thereby influence residue concentration in the
animal tissue. In this study, the daily DON intake during the whole period of the experiment reflects
slight differences between animals because of DON doses converted into body weight and precisely
administered by a small portion of the feed matrix.
2.1. DON Residues in Small Intestine Tissues
The effect of feed contamination with low doses of DON on the presence of the toxin was
investigated in tissue preparations from the duodenum, jejunum and ileum. As described in Table 1,
in this experiment, diets significantly affect tissue concentrations of the toxin. Under individual
intoxication of DON with 12 μg/kg b.w. per day doses, the toxin content in small intestine tissues
ranged from 0.00 (terms I and II) to 18.60 ng/g (term VI) (Table 1). At terms I and II no mycotoxins
were detected in any samples analyzed. The highest DON concentrations were detected during terms
of slaughter IV–VI, at 7.20 ng/g for the duodenum, 9.20 ng/g for the jejunum and 18.60 ng/g for
the ileum samples, respectively. Only in the ileum samples the content of DON in diets for pigs
demonstrated linear dose relationships to tissue concentration. However, these relationships were
characterized by high inter-individual variation.
Table 1. Concentration levels of deoxynivalenol (DON) [ng/g] with determined homogenous groups
(α = 0.05) and the derived carry over factor of DON in the first section of gastrointestinal tract-small















7 (term I) 84 0 a ± 0 0 0 a ± 0 0 0 a ± 0 0
14 (term II) 168 0 a ± 0 0 0 a ± 0 0 0 a ± 0 0
21 (term III) 252 6.71 b ± 0.22 0.027 1.80 a,b ± 0.64 0.007 0 a ± 0 0
28 (term IV) 336 7.20 b ± 0.16 0.021 9.20 c ± 2.54 0.027 9.20 b ± 4.65 0.027
35 (term V) 420 4.24 b ± 1.57 0.010 4.54 b ± 0.95 0.011 11.19 b,c ± 2.40 0.027
42 (term VI) 504 6.13 b ± 2.13 0.012 8.06 c ± 1.08 0.016 18.60 c ± 4.26 0.037
Note: The same symbols for average values in a particular column indicate no statistically significant differences in
the level of DON concentrations within the analyzed samples (Tukey HSD test).
Dänicke and co-workers [36] indicated that only about 1% of ingested DON reaches the proximal
parts of the small intestine (duodenum and jejunum) in pigs with maximum DON contents of 1.3 mg/kg
freeze-dried ingesta when swine weighing 88 kg were fed 1.1 kg feed with a DON concentration of
4.2 mg/kg. However, also lower and fluctuating DON accumulations can lead to morphological
modifications of the intestinal epithelium after DON exposure in vivo [37]. In an experiment by Goyarts
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and co-workers [38], 15 min after per os exposure DON was found in all serum samples. This early
detection of DON in serum [39] showed that the absorption of DON was rapid and indicated that it
could start in the stomach or in the upper part of duodenum [40]. Presented arguments may explain
the observed gradual saturation of tissues, which eventually led to an increased DON concentration
in successive sections of the alimentary tract in proportion to the passing time. In turn, we would
also have to remember that these slight DON levels, while gradually saturating tissues did not
cause any increase in DON concentrations in earlier sections of the alimentary tract with the passage
of time. Such a situation could be attributed to the acquisition of food tolerance, consisting in the
inhibition of inflammation processes in the alimentary tract, particularly the ileum and the descending
colon [41]. This might be a certain “escape” mechanism of mycotoxins before the induction of the
local immune system, similarly as it is the case with Tregs induction by classical pathogens [42] during
chronic infections.
Using the obtained results, the carry-over factor was calculated as the quotient of toxin
concentration in the tissue (μg/kg) by toxin concentration in the diet (μg/kg), included as the total
administered doses in the defined term experiment, according to previous researchers [38,43,44]
The mean carry-over factors in the first and second terms amounted to 0, while the maximum
values in that period of time were observed in samples from terms III (for the duodenum–0.027),
IV (for the jejunum–0.027) and VI (for the ileum–0.037) (Table 1). For the duodenum and jejunum
specimens the median carry-over factors decrease with increasing proportions of exposure to DON
starting from term IV for the duodenum and term V for the jejunum. The summary carry-over factor
for the duodenum is higher than for the jejunum and ileum, respectively. In a study by Goyarts and
co-workers [38] the mean carry-over factor of DON and de-epoxy-DON, presented as the content of
both substances in the specimen divided by the toxin content in the diet, for all swine decreased in the
descending order from the bile (0.1046), kidneys (0.0151), liver (0.0057), serum (0.0023), muscle (0.0016)
to back fat (0.0002).
The percentage distribution of DON in analyzed small intestine tissues is shown in Figure 1.
Starting from date 3 the quantitative participation of the mycotoxin in different tissues changed. At
term III the highest DON concentration was detected in the duodenum, while at term IV the same
percentage of DON was recorded in the jejunum and ileum. At terms V and VI the highest DON
contents were detected in the ileum samples at a simultaneous similar participation of DON in the
duodenum and jejunum specimens.
Figure 1. The percentage distribution of DON in tissues of small intestine (duodenum, jejunum, ileum).
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2.2. DON Residue in Large Intestine and Liver Tissues
Using individual intoxication of DON the toxin was not detected in transverse and descending
colon tissues collected in the first three dates of the experiment (Table 2). Up to term IV of sample
collection the highest DON amounts were observed in the liver tissues (7.90 ng/g), and later in the
ascending and descending colon sections (terms V and VI). The concentration of DON for different
fragments of the gastrointestinal tract fell within the following ranges (in ng/g): for the liver from 6.70
(term VI) to 8.80 (term V), for the cecum from 0.0 (term I) to 20.5 (term V), for the transverse colon from
0.0 (terms I, II, III, V and VI) to 1.8 (term IV), and for the descending colon from 0.0 (terms I, II and
III) to 20.00 (term VI). Averaging the recorded DON concentrations in tissues from all study terms the
highest average level of the toxin was 8.70 ng/g in the cecum samples.
Table 2. DON concentration [ng/g] with determined homogenous groups (α = 0.05) and the resulting
carry-over factor of DON in the second section of the gastrointestinal tract, i.e., the large intestine, of





















7 (term I) 84 0 a ± 0 0 0 a ± 0 0 0 a ± 0 0 0 a ± 0 0
14 (term II) 168 3.70 a,b ± 0.47 0.022 2.50 a ± 0.17 0.015 0 a ± 0 0 0 a ± 0 0
21 (term III) 252 6.42 a,b ± 0.22 0.025 3.10 a ± 1.56 0.012 0 a ± 0 0 0 a ± 0 0
28 (term IV) 336 9.81 b ± 4.08 0.029 7.44 a ± 0.92 0.022 1.80 b ± 0.18 0.005 6.75 b ± 2.53 0.020
35 (term V) 420 9.29 b ± 2.54 0.022 20.52 b ± 5.77 0.049 0 a ± 0 0 10.92 b ± 2.62 0.026
42 (term VI) 504 23.00 c ± 4.89 0.046 16.09 b ± 3.57 0.032 0 a ± 0 0 20.00 c ± 3.27 0.040
Note: The same symbols for average values in a particular column indicate no statistically significant differences in
the level of DON concentrations within the analyzed samples (Tukey HSD test).
In a similar study the concentrations of DON decreased from bile > kidney > serum > liver =
muscle in an experiment, where pigs received diets containing 0%, 25% and 50% of contaminated
wheat containing 2.5 mg DON/kg [43].
The median carry-over factors for the large intestine samples showed significant differences.
The maximum stability for the observed indicator was found for the cecum samples. The higher values
of the carry-over factor were recorded in term VI for the cecum (0.046), term V for the ascending colon
(0.049), term IV for the transverse colon and term VI for the descending colon (0.040) (Table 2).
The summary carry-over factor for the cecum was higher than for the ascending, descending and
transverse colon, respectively. For the liver the median carry-over factors ranged from 0.013 to 0.081.
The decreasing factor values were only observed in these tissue samples during the experimental
periods (Table 3).
The percentage distribution of DON in the large intestine and liver tissue samples is shown in
Figure 2. From term II to term III the highest percentages of the toxin with a downward trend were
observed in the liver tissues, whereby starting from term IV the amounts of DON in the analyzed
samples indicate similar levels in all tissues.
The observed situation is confirmed by the results of the authors’ investigations [41], showing
that the action of DON is multifaceted, e.g., it is an inhibitory factor for mRNA expression processes
of the gene controlling the NOS-1 constitutive isomer and the NOS-2 inducible isomer. This causes
specific changes in the functioning of the alimentary tract in gilts due to a reduced amount of NO,
which is an inhibitor of neurotransmitters of the non-adrenergic and non-cholinergic systems [45,46].
As a consequence, low NO levels cause accelerated peristalsis of the oesophagus, stomach and
intestines, inhibit stomach accommodation processes (relaxation, absorption, adaptation and successive
contraction) and increased tension of intestinal sphincters, thus contributing to inhibition of gastric
emptying and transfer of digesta in the intestines [47], i.e., proliferation processes are activated [48].
All the presented situations are factors promoting enhanced biotransformation depending on energy
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resources of the organism [49], as well as better explain the cytotoxic properties of DON in the
colon [50], which cytotoxicity in small doses is lower [51].
Table 3. Concentration levels of DON [ng/g] with determined homogenous groups (α = 0.05) and the
derived carry over factor of DON in liver of gilts fed diets containing NOAEL concentrations of DON.
Days of the experiment Total doses [μg/kg b.w.]
DON amounts in liver [ng/g] ± standard deviation
Liver Carry over factor
7 (term I) 84 6.79 a ± 1.28 0.081
14 (term II) 168 7.51 a ± 0.74 0.045
21 (term III) 252 7.90 a ± 2.87 0.031
28 (term IV) 336 7.78 a ± 3.35 0.023
35 (term V) 420 8.80 a ± 3.69 0.021
42 (term VI) 504 6.70 a ± 4.28 0.013
Note: The same symbols for average values in a particular column indicate no statistically significant differences in
the level of DON concentrations within the analyzed samples (Tukey HSD test).
Figure 2. The percentage distribution of DON in large intestine (cecum, ascending colon, transverse
colon and descending colon) and liver samples.
Up to now, exposure of swine to low doses of deoxynivalenol was investigated in the
context of hematological, biochemical, immunological and histopathological parameters [9,52–54].
The toxicological principle of deoxynivalenol action may be similar in several organs, such as the
lungs, liver or kidneys, and the toxin may cause damage and increase cell death in porcine intestinal
cells, which is associated with metabolic stress [53]. Disturbed intestinal functions after DON ingestion
seem to be connected with the fact that intestinal epithelial cells can be exposed to high luminal DON
contents for a prolonged time following ingestion of contaminated feed [52,55]. An experiment on
the cytotoxic effect of DON on a porcine intestinal cell line (IPEC-J2) demonstrated that the minimal
effective dose to induce the cytotoxic effect was between 0.5 to 2.5 μM of DON solution in ethanol,
whereas at a concentration of 10 μM this toxin caused cell damage, including rounding of cells, autolysis
and cell loss from the monolayer. Such observations are confirmed by the currently unpublished
results of a our study, from which it results that these low DON doses are only slightly cytotoxic to the
local bacterial flora. It may be assumed that in the last segment of the large intestine (descending colon)
the cytotoxic activity of DON is increased, but only at low doses [51] and the activity of fecal enzymes
increases. In other words, a situation may occur promoting the occurrence of pathological changes in
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the final section of the porcine alimentary tract [56]. In addition, a significant decrease in ATP levels
was observed at 48 h in a dose-dependent manner. Experimental acute DON toxicity in pigs includes
digestive symptoms with emesis starting after 2 h following intravenous injection, together with
increased defecation and diarrhea [57]. DON at high doses exceeding causes jejunal lesions, diagnosed
after a 4-h exposure in an ex-vivo pig culture model including shortened and coalesced villi, lysis of
enterocytes, and edema [58]. Similarly, at 4 mg/kg diet DON may cause corrugation in the fundic
region of the stomach and after 5-week exposure to DON at 2.8 mg/kg diet, in the absence of body
weight modulation in pigs, significant histopathological changes were observed [59]. Additionally,
multifocal atrophy and villi fusion, apical necrosis of villi, cytoplasmatic vacuolation of enterocytes and
edema of the lamina propria were observed in the jejunum and ileum of pigs administered DON [60].
In another study, Pinton and co-workers showed that DON causes a dose-dependent translocation of a
pathogenic strain of Escherichia coli across the porcine IPEC-1 epithelial cell monolayers [61]. Similarly,
an increased translocation of Salmonella Thyphimurium was observed in porcine IPEC-J2 exposed to
low doses of DON [62].
Our experiments in combination with the results discussed above provide a significant contribution
to the knowledge on DON toxicity and distribution in individual tissues of the porcine alimentary tract.
This is the first report concerning quantitative analysis of deoxynivalenol in the gastrointestinal tract of
gilts after per os toxin application and may be an important addition to knowledge concerning the effect
of per os exposure to this toxin.
Summing up the presented results as well as studies conducted by other authors certain conclusions
may be drawn. Accumulation of low DON exposure doses in the final section of the alimentary tract
may contribute to specific situations, not necessarily pathological [48]. One of the may be connected
with the cytotoxic property of DON. As a consequence, the count of microbial pathogens decreases,
which constitute one of the proinflammatory factors in the large intestine [63]. On the other hand,
exposure of animal organisms to low doses of the mycotoxin is a factor inhibiting mRNA expression of
NOS controlling genes [41,46]. In this situation, we might propose a conclusion that low DON doses
(below NOAEL) may have a therapeutic effect [51].
3. Experimental Section
All of the experimental procedures involving animals were carried out in compliance with the
Polish legal regulations determining the terms and methods for performing experiments on animals
(opinion of the local Ethics Committee for Animal Experimentation No. 88/2009).
3.1. Experimental Animals
This part of the study was conducted at the Department of Veterinary Prevention and Feed
Hygiene, Faculty of Veterinary Medicine, the University of Warmia and Mazury in Olsztyn, Poland,
using 39 clinically healthy female gilts. The mean initial body weight was ±20 kg. The gilts were
housed in individual cages with an ad libitum access to water. The experimental diets were prepared
locally and formulated according to the energy and amino acid requirements for piglets. The feed used
in the present study was contaminated only with DON, which was confirmed by chromatography
analysis of the feed matrix.
3.2. Experimental Design
A total of 39 animals were divided into two groups: control (n = 21) and experimental (n = 18).
The animals from the experimental group were administered DON daily at a dose of 12 μg/kg body
weight per os for 42 days. Analytical samples of the mycotoxin were applied in gelatin capsules before
morning feeding. The animals from the control group were orally administered placebo (gelatin
capsules without mycotoxin) for the same period of time as the experimental group. Amounts of toxin
application were dependent on the body weight and updated weekly. Three animals from both groups
(experimental and control) were sacrificed on days 1, 7, 14, 21, 28, 35 and 42 (a total of 6 gilts on each
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day), excluding day 1 when only three control group animals were sacrificed. Every week tissue samples
were collected from the porcine gastrointestinal tract (the liver–left lobe, duodenum–first and middle
sections, jejunum–middle section, ascending colon–middle section, descending colon–middle section).
3.3. Chemicals
The deoxynivalenol standard and organic solvents (HPLC grade) were purchased with a standard
grade certificate from Sigma-Aldrich (Steinheim, Germany). All chemicals used for extraction and
purification of DON were purchased from POCh (Gliwice, Poland). Water for the HPLC mobile phase
was purified using a Milli-Q system (Millipore, Bedford, MA, USA).
3.4. Tissue Samples
Post-mortem samples of the following tissues: the duodenum, jejunum, ileum, cecum, ascending
colon, transverse colon, descending colon and the liver were collected after rinsing with phosphate
buffer. Pure tissues were stored at −80 ◦C until the shredding and extraction procedure.
3.5. Extraction and Purification Procedure
Tissue fragments (2 g) were homogenized twice with methanol, then centrifuged (4000 rpm) and
evaporated. The residue was diluted in 20 mL water and 20 mL 0.2 M CH3COONa and applied on
the top of immunoaffinity columns according to the manufacturer’s recommendations (IAC, VICAM,
Watertown, MA, USA). The toxin was eluted with a mixture of acetonitrile: water (82:12, v/v).
The eluate was evaporated to dryness at 40 ◦C under a stream of nitrogen. Dry residue was stored at
−20 ◦C until HPLC analyses.
3.6. HPLC Analysis of Deoxynivalenol
The chromatographic system consisted of a Waters 2695 high-performance liquid chromatograph
(Waters, Milford, CT, USA) with a Waters 2996 Photodiode Array Detector with a Nova Pak C-18
column (300 mm × 3.9 mm) for DON (λmax = 224 nm) analysis. Quantification of the toxin was
performed by measuring the peak areas at the retention time according to the relevant calibration
curve. The limit of detection was 0.001 μg/g for DON.
3.7. Statistical Analysis
Data on DON concentrations in various tissue samples were evaluated for statistically significant
differences employing the Tukey-test. Values are presented as medians and ranges. All statistical
analyses were conducted using the Statistica Package for Social Science program.
4. Conclusions
After 7-day exposure to DON (term I) among tissue samples the liver was the only organ where
DON could be detected. Median DON concentrations decreased in the order from the ileum >
duodenum > jejunum for the small intestine specimens and the cecum > ascending colon > liver >
descending colon > transverse colon for the large intestine and liver samples. Maximum carry-over
rates reached the following levels: 0.037 (term VI) for the ileum (the small intestine), 0.049 (term V) for
the ascending colon and 0.046 (term VI) for the cecum (the large intestine) and 0.081 (term I) for the
liver. In conclusion, the results show how dose and exposure time may affect the distribution of DON
in the gastrointestinal tract of gilts after per os toxin application.
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The effect of experimental long-term exposure to low-dose zearalenone on uterine histology in sexually
immature gilts. Exp. Toxicol. Pathol. 2012, 64, 537–542. [CrossRef]
10. Girish, C.K.; MacDonald, E.J.; Scheinin, M.; Smith, T.K. Effects of feedborne Fusarium mycotoxins on brain
regional neurochemistry of turkeys. Poult. Sci. 2008, 87, 1295–1302. [CrossRef]
11. Wegulo, S.N. Factors influencing deoxynivalenol accumulation in small grain cereals. Toxins 2012, 4,
1157–1180.
12. SCOOP. Collection of Occurrence Data of Fusarium Toxins in Food and Assessment of Dietary Intake by
the Population of EU Member States. Reports on Tasks for Scientific Cooperation. 2003. Available online:
http://ec.europa.eu/food/fs/scoop/task3210.pdf (accessed on 31 October 2013).
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Abstract: Deoxynivalenol (DON) frequently contaminates animal feed, including fish feed used in
aquaculture. This study intends to further investigate the effects of DON on carp (Cyprinus carpio L.)
at concentrations representative for commercial fish feeds. Experimental feeding with 352, 619
or 953 μg DON kg−1 feed resulted in unaltered growth performance of fish during six weeks of
experimentation, but increased lipid peroxidation was observed in liver, head kidney and spleen after
feeding of fish with the highest DON concentration. These effects of DON were mostly reversible by
two weeks of feeding the uncontaminated control diet. Histopathological scoring revealed increased
liver damage in DON-treated fish, which persisted even after the recovery phase. At the highest DON
concentration, significantly more fat, and consequently, increased energy content, was found in whole
fish body homogenates. This suggests that DON affects nutrient metabolism in carp. Changes of
lactate dehydrogenase (LDH) activity in kidneys and muscle and high lactate levels in serum indicate
an effect of DON on anaerobic metabolism. Serum albumin was reduced by feeding the medium
and a high dosage of DON, probably due to the ribotoxic action of DON. Thus, the present study
provides evidence of the effects of DON on liver function and metabolism.
Keywords: liver damage; oxidative stress; nutrient allocation; aquaculture
1. Introduction
Deoxynivalenol (DON) is a trichothecene mycotoxin that is commonly known to be produced by
Fusarium fungi, but also fungal species, such as Myrothecium, Cephalosporium, Verticimonosporium and
Stachybotrys [1]. The toxic effects of DON in mammals include diarrhoea, emesis and malabsorption
of nutrients [2–4]. A recommended guidance value for DON in compound feed stuff of 5 mg kg−1
DON was established by the European Commission (2006/576/EC) [5]. As far as it is known, fish feeds
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do not exceed this level, although recent research has shown that DON frequently can be observed in
fish feeds at concentrations of up to 825 μg kg−1 [6]. DON affects fish growth performance and health.
For example, exposure to DON resulted in the reduction of growth performance in salmonids [7,8].
These investigations on salmonids also showed that histopathological changes and lesions in the liver of
fish, including the altered appearance of hepatocytes, subcapsular edema and fat accumulation, occurred
upon feeding with DON-contaminated diets at concentrations of 1.4 mg kg−1 and higher [8]. Lipid
accumulation in liver tissue is a common problem in aquaculture and can be caused by parasites [9],
inadequate nutrition [10–12], pesticides [13–15] and toxins [16]. Evidence for changes of nutritional
status in fish has only been shown for rainbow trout treated with 2.6 mg kg−1 DON for 56 days [8],
whereby crude protein values were reduced by DON compared to control fish. The effects of DON on
the immune system of fish have only been shown for carp at even lower DON concentrations of 352 to
953 μg DON kg−1 feed [17].
In the last few years, many studies have been focused on fish health interactions with dietary
management. In aquaculture, fish nutrition is critical, and the applied feed contributes up to more
than 60% of the total production costs [18]. Thus, nutritional and economical optimization of dietary
compositions for certain fish species supports the expanding aquaculture sector. The utilization of
plant products in aquaculture feed has been increasing in the last few years tremendously, as the
supply of conventional feed sources, e.g., fish meal, is limited, and prices are consequently rising.
With increasing plant material utilization in aquaculture, the risk for feed borne exposure to DON
increases. Therefore, further understanding of dietary DON on the health and nutritional value of carp
(Cyprinus carpio), as an aquaculture species of high global relevance, is needed to guarantee fish health
and a safe product for human nutrition.
The aim of the present study was therefore the evaluation of various DON feed dosages on the
growth performance and health status of juvenile carp. The present study is a part of a feeding study
in which stress and immune responses already have been evaluated and published elsewhere [17].
The analyses reported in the present study were conducted on preserved samples from this trial, to
further elaborate the detrimental health effects of DON observed in the experiment. The main findings
reported in the previous study were that fish fed the diet containing DON showed reduced immune
parameters. The present study intended to investigate the effects of DON on liver condition and
metabolism more closely.
2. Results and Discussion
2.1. Composition of the Diet and Growth Performance
The experimental diets were prepared as shown in Table 1. The inclusion of ingredients has been
chosen to meet the nutritional requirements of carp [19]. The experimental diets differed only in their
DON content.
The nutritional compositions of experimental diets are given in Table 2, showing that no nutritional
differences between the diets occurred. The diets were formulated to be isonitrogenous (44.58%–45.91%
crude protein) and isocaloric (22.26–22.51 MJ kg−1 dry matter).
After four weeks of feeding, two tanks containing six fish each were sampled, whereas two
similar treated tanks containing 12 fish were fed the uncontaminated diet for a further two weeks and
sampled thereafter. The growth performance, serum parameters and biochemical composition of all
fish were analysed.
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Table 1. The ingredients (percent of inclusion) used for preparations of experimental fish diets.
DON, deoxynivalenol.
Ingredient Basal Feed Low DON Medium DON High DON
Fish meal 30.0 30.0 30.0 30.0
Blood meal 12.5 12.5 12.5 12.5
Casein 12.0 12.0 12.0 12.0
Dextrose 13.0 13.0 13.0 13.0
Potato starch 21.1 21.1 21.1 21.1
Fish oil 10.4 10.4 10.4 10.4
Vitamins1 0.5 0.5 0.5 0.5
Minerals1 0.5 0.5 0.5 0.5
DON (mg kg−1) 0 0.352 0.619 0.953
Notes: Vitamin and mineral mix (Spezialfutter Neuruppin-VM BM 55/13 no. 7318): vitamin A, 12,000 I.E.; vitamin
D3, 1,600 I.E; vitamin E, 160 mg; vitamin K3, 6.4 mg; vitamin B1, 12 mg; vitamin B2, 16 mg; vitamin B6, 12 mg;
vitamin B12, 26.4 μg; nicotinic acid, 120 mg; biotin, 800 μg; folic acid, 4.8 mg; pantothenic acid, 40 mg; inositol,
240 mg; vitamin C, 160 mg; antioxidants (BHT), 120 mg; iron, 100 mg; zinc, 24 mg; manganese, 16 mg; cobalt 0.8 mg;
iodine, 1.6 mg; selenium, 0.08 mg.
Table 2. The composition of the experimental fish feeds. The values are given as the means ± SD of
two independent determinations of the same feed batch. NFE, nitrogen-free extract.
Composition Basal Feed Low DON Medium DON High DON
Dry matter (% wet matter) 91.70 ± 0.01 91.58 ± 0.02 91.66 ± 0.05 91.68 ± 0.04
Crude protein (% dry matter) 44.58 ± 0.28 45.91 ± 0.17 45.14 ± 0.06 44.89 ± 0.48
Crude lipid (% dry matter) 14.61 ± 0.03 14.56 ± 0.07 14.63 ± 0.01 14.96 ± 0.20
NFE (% dry matter) 33.15 ± 0.36 32.13 ± 0.18 32.60 ± 0.01 32.47 ± 0.34
Crude ash (% dry matter) 7.66 ± 0.01 7.40 ± 0.03 7.64 ± 0.05 7.68 ± 0.05
Gross energy (MJ kg−1 dry matter) 22.51 ± 0.07 22.46 ± 0.01 22.26 ± 0.02 22.42 ± 0.01
Feeding carp the experimental diets at a restricted daily basis of 2% of body weight resulted in
increased fish body weights after four weeks (Table 3). Compared to the initial weight of fish, significant
weight gain was observed for the groups fed the DON-contaminated diets, but not for the control
group. However, individual specific growth rates (SGR), calculated as shown in Equation (1) were not
found to be different between treatment groups after four weeks of feeding (mean ± SEM: control fish:
1.31 ± 0.11; low dose: 1.13 ± 0.20; medium dose: 1.71 ± 0.31; high dose: 1.50 ± 0.06, respectively).
SGR = (ln final weight − ln initial weight)/days of experiments × 100 (1)
Table 3. The growth performance of experimental fish after four weeks of DON feeding; n = 12 each.
Growth Parameters Basal Feed Low DON Medium DON High DON
Initial Weight (g) 37.23 ± 6.31 36.36 ± 6.67 36.23 ± 8.00 34.46 ± 4.05
Final Weight (g) 48.38 ± 7.48 51.86 ± 5.50 52.71 ± 6.37 56.40 ± 10.63
Final Total Length (cm) 14.11 ± 0.61 14.64 ± 0.52 14.76 ± 0.66 14.62 ± 0.99
Final Condition Factor 0.016 ± 0.000 0.016 ± 0.000 0.016 ± 0.000 0.016 ± 0.000
Furthermore, condition factors were not different between treatment groups after four weeks of
feeding and also after recovery for additional weeks (Tables 3 and 4). The final weight of fish after
the recovery phase was also not significantly influenced by DON application (Table 4). Individual
specific growth rates were also not different between treatment groups after the recovery phase
(mean ± SEM: control fish: 1.26 ± 0.26; low dose: 1.62 ± 0.23; medium dose: 1.19 ± 0.30; high dose:
1.26 ± 0.25, respectively). However, the comparison of final weights to the initial weights at the start of
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the experiments showed a significant difference for the control group and the fish fed the low dose
diet, but not for the fish fed the higher DON doses.
Table 4. The growth performance of experimental fish after four weeks of DON feeding with an
additional two weeks of recovery; n = 12 each.
Growth Parameters Basal Feed Low DON Medium DON High DON
Initial Weight (g) 38.24 ± 5.51 33.46 ± 4.42 36.71 ± 5.01 38.18 ± 8.77
Final Weight (g) 65.58 ± 10.42 57.56 ± 8.36 50.99 ± 9.15 53.72 ± 9.83
Final Total Length (cm) 14.11 ± 0.61 14.64 ± 0.52 14.76 ± 0.66 14.62 ± 0.99
Final Condition Factor 0.015 ± 0.000 0.015 ± 0.000 0.015 ± 0.000 0.014 ± 0.000
Reduced intake of DON-contaminated feed leading to reduced weight gain was reported in
mice [20], but not in the present study. Thus, it is unlikely that feed deprivation was a factor in the
effects on carp metabolism, as fish were observed to ingest the entire feed ration. Nevertheless, Atlantic
salmon showed reduced weight gain after 15 weeks of feeding of 3.7 mg DON per kilogram of feed,
while rainbow trout revealed similar responses to 0.3 to 2.6 mg DON per kilogram of feed after 56 days
of feeding [7,8]. In contrast, a previous study on zebrafish showed that treatment of fish with feed-borne
DON concentrations of up to 3 mg per kilogram of feed did not result in effects on weight gain [21].
Thus, our results together with the study of Sanden et al. [21] suggest that weight gain is not a sensitive
parameter when the effects of DON are investigated in cyprinids.
2.2. Histology
Prussian blue staining in liver tissue did not result in extensive staining of macrophages in
liver tissues in the treated groups and in the control group. Therefore, results are not reported here.
PAS reaction was positive in the liver of all fish. However, PAS staining did not indicate significant
differences between control fish and DON-treated fish with respect to chrominance, RGBmax and
luminosity values (Table 5).
Table 5. The histological estimation of glycogen in PAS-stained liver sections of experimental fish after
four weeks of DON feeding; n = 6 each, calculated from five pictures from each slide.
Color Properties of Sections Basal Feed Low DON Medium DON High DON
Chrominance 50.1 ± 2.8 50.5 ± 1.2 46.7 ± 3.4 47.4 ± 3.0
RGBmax 135.1 ± 1.5 133.8 ± 2.4 129.9 ± 4.1 131.4 ± 2.4
Luminosity 23.7 ± 1.5 24.1 ± 0.9 23.1 ± 2.0 23.2 ± 1.7
However, the examination of haematoxylin and eosin (HE)-stained sections revealed significant
differences between the condition of the liver tissue of control fish and DON-treated fish (Table 6).
DON-treated fish showed significantly increased fat disposition (Figure 1) and severe hyperaemia,
whereas no significant difference was found when tissue lesions and the degree of vacuolization were
recorded. The observation of the dilatation of sinusoids revealed a significant difference between
control fish and fish treated with the low and medium DON diet. In rainbow trout fed 1.4 mg kg−1
DON for 15 weeks, congestion in liver tissue was observed [8].
In addition, feeding 2.6 mg kg−1 DON in the same study led to fatty infiltration in liver. Histological
changes, including fat deposition, have also been found in DON-treated carp in the present study.
Liver damage was probably caused by the occurrence of oxidative stress (as indicated by the lipid
peroxidation assay) together with apoptotic loss of cell integrity and disturbance of nutrient metabolism.
Liver damage also often leads to the occurrence of increased liver fat content, as is reported for fish
recovering from being fed the high-dose DON feed for four weeks (Table 6).
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Table 6. The histological condition of haematoxylin and eosin (HE)-stained liver tissue after DON
feeding and a two-week recovery phase (mean ± standard errors of six fish per treatment group; each
fish was analysed by using 10 fields taken from two slides (0 = no alterations, 1 = mild alterations,
2 = moderate alterations, 3 = severe alterations); means with the same letter (a and/or b) are not
significantly different from each other [significance tested with Mann-Whitney U-tests, p < 0.05)].
Histological Alteration Basal Feed Low DON Medium DON High DON
DON-treated:
Lesions 0.03 ± 0.03 0.20 ± 0.13 0.14 ± 0.05 0.35 ± 0.15
Fat aggregation 0.92 ± 0.07 a 1.57 ± 0.28 a,b 1.94 ± 0.25 b 1.80 ± 0.19 b
Hyperaemia 1.00 ± 0.12 a 2.02 ± 0.26 b 1.90 ± 0.26 b 1.90 ± 0.23 b
Vacuolization 1.17 ± 0.06 1.77 ± 0.32 1.84 ± 0.32 1.85 ± 0.20
Dilation of sinusoids 1.20 ± 0.16 a 1.87 ± 0.07 b 1.82 ± 0.13 b 1.60 ± 0.16 a,b
Recovery:
Lesions 0.02 ± 0.02 0.28 ± 0.15 0.12 ± 0.07 0.18 ± 0.09
Fat aggregation 0.50 ± 0.18 a 1.85 ± 0.26 b 1.47 ± 0.31 a,b 1.63 ± 0.29 b
Hyperaemia 1.26 ± 0.11 a 1.70 ± 0.17 a,b 1.37 ± 0.19 a,b 2.08 ± 0.23 b
Vacuolization 0.54 ± 0.22 1.45 ± 0.41 1.42 ± 0.38 1.48 ± 0.38
Dilation of sinusoids 1.44 ± 0.13 a 2.10 ± 0.12 b 1.78 ± 0.18 a,b 1.92 ± 0.11 a,b
Figure 1. Histological sections of liver tissue from control fish (A) and DON-treated fish [low dose (B),
medium dose (C) and high dose (D)].
2.3. Lipid Peroxidation
Measurement of lipid peroxidation indicated increased membrane damages in fish fed the diet
with the high-dose DON compared to control fish (Figure 2A). This was no longer observed after the
recovery phase of two weeks. A similar pattern was observed in spleen (Figure 2C). In contrast, lipid
peroxidation in trunk kidney was reduced in the group treated with the high dose DON feed after four
weeks of feeding and in all DON-treated fish after the recovery (Figure 2B).
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Lipid peroxidation in liver was enhanced in fish treated with the high-dose feed after four
experimental weeks and significantly reduced after the recovery phase compared to control fish
(Figure 3A). Lipid peroxidation in muscle samples showed no differences, due to DON treatment
(Figure 3B). Oxidative stress in these carp has already been indicated by the elevation of antioxidative
enzymes in erythrocytes [17] and probably also contributed to the damage to several organs of
DON-treated fish. Oxidative stress and lipid peroxidation due to the Fusarium toxins, deoxynivalenol
and zearalenone, have frequently been shown in mammalian cell cultures and farm animals [22–24].
Figure 2. Lipid peroxidation measured as malondialdehyde (MDA; ng mg protein−1) in different
tissues [(A) head kidney, (B) trunk kidney, (C) spleen] in experimental fish with four weeks of DON
feeding (DON-treated) and DON-fed fish with an additional two weeks of recovery (recovery); mean ±
SEM; means with the same letter (a and/or b) are not significantly different from each other (significance
tested with Mann-Whitney U-tests, p < 0.05).
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Figure 3. Lipid peroxidation measured as malondialdehyde (MDA; ng mg protein−1) in different
tissues [(A) liver, (B) white muscle] in experimental fish with four weeks of DON feeding (DON-treated)
and DON-fed fish with an additional two weeks of recovery (recovery); mean ± SEM; means with
the same letter (a and/or b) are not significantly different from each other (significance tested with
Mann–Whitney U-tests, p < 0.05).
2.4. Measurement of LDH Activity in Different Tissues
The activity of the lactate dehydrogenase (LDH) showed differences in the kidneys after four
weeks of DON feeding and also after additional two weeks of recovery but not in liver and spleen
(Table 7). During DON feeding LDH activity was increased in the kidneys of all DON-fed fish compared
to control fish which indicates increased anaerobic metabolism. However, a lower LDH activity in the
recovery phase was observed between fish fed the highest DON diet and the control fish. The significant
difference in LDH activity in muscle after four weeks of feeding the highest dose of DON was no
longer observable after the recovery of two weeks. The observation that lactate levels are not increased
in muscle samples although LDH activities are decreased in fish treated with the high dose DON
diet, supports the hypothesis that lactate is transferred from white muscle via the blood stream before
it accumulates.
2.5. Biochemical Body and Organ Composition
Investigation on whole body composition revealed that the fat content in whole body homogenates
of fish treated with the medium- and high-dose DON diet was increased compared to control fish
(Table 8), whereas in fish treated with the low dose DON diet, only a tendency for increased fat
content was found (p = 0.065). Still, a significant relationship between the toxin concentrations in
the experimental feeds and lipid content was found (Spearman correlation coefficient, 0.498, and
significance, p = 0.013).
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Table 7. Lactate dehydrogenase (LDH; mU mg protein−1) activity in tissue homogenates after DON
feeding and a two-week recovery phase; n = 6; mean ± SEM; means with the same letter (a and/or b)
are not significantly different from each other (significance tested with Mann-Whitney U-tests, p < 0.05).
LDH Activity Basal Feed Low DON Medium DON High DON
DON-treated:
head kidney 31.58 ± 4.77 a 71.55 ± 3.63 b 61.22 ± 5.11 b 51.89 ± 6.30 b
trunk kidney 34.34 ± 5.18 a 77.79 ± 3.95 b 66.23 ± 4.55 b,c 53.16 ± 6.84 a,c
spleen 2.64 ± 0.25 2.97 ± 0.47 2.90 ± 0.34 2.92 ± 0.43
liver 275.23 ± 61.86 370.96 ± 66.37 176.58 ± 40.47 264.67 ± 56.73
white muscle 38.28 ± 13.68 a 17.51 ± 5.77 a,b 20.86 ± 7.39 a,b 3.12 ± 1.81 b
Recovery:
head kidney 51.21 ± 4.97 a 52.54 ± 6.65 a 57.12 ± 9.96 a 13.34 ± 2.77 b
trunk kidney 54.58 ± 6.08 a 65.33 ± 6.10 a 60.70 ± 13.15a 19.89 ± 4.50 b
spleen 10.88 ± 0.99 9.74 ± 0.90 7.92 ± 0.59 12.96 ± 2.86
liver 496.02 ± 118.64 669.79 ± 113.86 510.05 ± 106.11 344.31 ± 89.97
white muscle 17.73 ± 4.85 12.35 ± 4.57 22.29 ± 3.90 25.91 ± 3.92
After two additional weeks of recovery, all DON-treated fish showed lower lipid levels than the
control fish (Table 9). These results were paralleled by significant differences in the energy content of
the whole body homogenates. After recovery, the ash contents of the whole body homogenates were
also found to be different in fish fed the high-dose DON diet compared to control fish (Table 9).
In the recovered fish, the ash content correlated with the lipid content negatively (Spearman
correlation coefficient, −0.568; significance, p = 0.002). Moreover, a significant relationship between
the toxin concentrations in the experimental feeds and the lipid and ash content was found (Spearman
correlation coefficient, −0.792 and 0.568, and significance, p < 0.000 and p = 0.007, respectively) in fish
after the recovery phase. This led to the investigation of similar parameters in samples of liver tissue
and white dorsal musculature to allow a possible explanation for these observations.
Impairment of the intestinal nutrient uptake by DON was reported for mammalian systems [25–27].
Since the liver is an important metabolic organ that processes nutrients from feed, one would expect
effects on the nutritional status of liver tissue if such impairment of intestinal nutrient uptake would
also be present in the experimental carp.
Therefore, the biochemical composition of liver tissue of carp was analysed. Dry matter values
of liver tissue were comparable to the values reported for other cyprinid species, such as freshwater
major carp, Catla catla [28]. No significant differences in the dry matter of DON-treated fish compared
to control fish were observed after four weeks of experiments, but an additional two weeks of recovery
led to significantly different dry matter incorporations between fish fed the low-dose DON feed and
the control fish (Table 10). Liver total lipid contents are higher than in the whole body homogenates.
This seems feasible, since liver in carp is known to be important for the storage of lipids. Moreover, in
fish treated with the highest concentration of DON, the lipid content in liver tissue was significantly
increased after the recovery phase compared to control fish. This is in contrast to the whole body lipid
levels of DON-treated fish after the recovery phase and indicates that liver damage was accompanied
by hepatic lipid accumulation, which also influenced the lipid balance of the entire body.
Table 8. The whole body composition of experimental fish two weeks after DON feeding (recovery
phase); n = 6; mean ± SEM; means with the same letter (a and/or b) are not significantly different from
each other (significance tested with Mann-Whitney U-tests, p < 0.05).
Whole Body Composition Basal Feed Low DON Medium DON High DON
Crude lipid content (% dry matter) 24.83 ± 1.85 a 29.33 ± 1.36 a,b 32.17 ± 0.95 b 30.33 ± 0.95 b
Crude ash (% dry matter) 8.56 ± 1.22 8.72 ± 0.19 8.03 ± 1.01 9.37 ± 0.34
Energy content (MJ kg−1 dry matter) 24.32 ± 0.47 a 25.27 ± 0.34 a,b 25.78 ± 0.25 b 25.25 ± 0.31 a,b
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Table 9. The whole body composition of experimental fish two weeks after DON feeding (recovery
phase); n = 6; mean ± SEM; means with the same letter (a and/or b) are not significantly different from
each other (significance tested with Mann-Whitney U-tests, p < 0.05).
Whole Body Composition Basal Feed Low DON Medium DON High DON
Crude lipid content (% dry matter) 33.17 ± 0.75 a 30.25 ± 0.48 b 29.60 ± 1.08 b 25.00 ± 2.71 b
Crude ash (% dry matter) 8.23 ± 0.35 a 8.46 ± 0.34 a,b 9.37 ± 0.34 a,b 9.98 ± 0.53 b
Energy content (MJ kg−1 dry matter) 25.63 ± 0.12 a 25.40 ± 0.19 a,b 25.02 ± 0.28 a,b 24.64 ± 0.23 b
Table 10. The composition of liver samples after four weeks of DON feeding and after the recovery
phase of two weeks; n = 6; mean ± SEM; means with the same letter (a and/or b) are not significantly
different from each other (significance tested with Mann-Whitney U-tests, p < 0.05).
Liver Composition Basal Feed Low DON Medium DON High DON
DON-treated:
Dry matter (% wet matter) 25.9 ± 0.8 22.9 ± 2.2 25.6 ± 0.8 27.0 ± 1.4
Total lipids (% wet matter) 15.0 ± 1.3 14.5 ± 1.2 16.2 ± 1.7 17.3 ± 1.7
Free glucose (mM g−1 wet matter) 1.16 ± 0.27 0.87 ± 0.14 1.19 ± 0.08 0.91 ± 0.19
Lactate (mM g−1 wet matter) 1.75 ± 0.48 3.05 ± 1.29 3.77 ± 2.03 3.56 ± 1.87
AST (U mg protein−1) 90.3 ± 18.2 60.2 ± 20.5 81.7 ± 8.2 89.1 ± 16.6
ALT (U mg protein−1) 1.43 ± 0.14 a 2.61 ± 0.98 a,b 2.95 ± 0.51 b 2.73 ± 0.49 a,b
Ascorbate (μM g−1 wet matter) 81.7 ± 15.7 63.5 ± 8.3 71.5 ± 14.8 54.3 ± 8.8
Recovery:
Dry matter (% wet matter) 25.1 ± 0.5 a 28.9 ± 1.4 a 27.5 ± 1.8 a,b 25.8 ± 1.7 a,b
Total lipids (% wet matter) 17.7 ± 1.2 a 19.2 ± 1.3 a,b 18.7 ± 0.8 a,b 23.6 ± 4.1 b
Free glucose (mM g−1 wet matter) 0.73 ± 0.10 0.96 ± 0.17 0.91 ± 0.12 0.99 ± 0.21
Lactate (mM g−1 wet matter) 1.36 ± 0.35 a 3.74 ± 1.13 a,b 6.48 ± 2.02 b 2.85 ± 0.80 a,b
AST (U mg protein−1) 98.5 ± 22.1 96.5± 27.5 81.7 ± 8.2 99.7 ± 10.8
ALT (U mg protein−1) 2.47 ± 0.23 2.88 ± 0.22 2.79 ± 0.11 3.03 ± 0.26
Ascorbate (μM g−1 wet matter) 51.8 ± 6.5 58.8 ± 7.0 64.9 ± 7.5 62.2 ± 7.6
Liver glucose levels were not significantly different between treatment groups. It was suggested
that amino acids are a superior energy sources to glucose for carp [29]. It has also been shown for carps
under starvation that the conversion of lipid to glycogen in liver tissue was accompanied by an increase
in blood glucose levels [30]. No changes of blood glucose (Table 11) and lipid (Table 10) in liver tissue
were observed in DON-treated fish, which suggests that blood homeostasis was not subjected to a
fasting-like status, due to an impairment of nutrient uptake in the intestine.
Liver glucose, lactate and ascorbate concentrations were not influenced by DON feeding and did
not correlate with toxin concentrations in the experimental feeds. Although ascorbic acid has been
shown to prevent the hemolytic action of DON on rat erythrocytes to some extent [22], ascorbate levels
in carp remained unchanged, which indicated that ascorbate alone is not sufficient to prevent damage
due to DON exposure. Liver alanine aminotransferase (ALT) activity was increased by treatment with
the medium-dose DON diet for four weeks compared to control fish, while the other DON-treated
groups showed no significant difference of this enzyme activity compared to the control group,
probably due to higher individual variation (coefficient of variance (CV) for control fish of 24.6 versus
CVs of 92.2, 42.3 and 51.0 for fish treated with the low-, medium- and high-dose, respectively, while
the CVs for all fish in the recovery phase ranged from 9.5 to 23.2). ALT activity also correlated with the
mycotoxin concentrations in feed (Spearman correlation coefficient, −0.409; significance, p = 0.047).
This indicates damage to liver tissue, as has already been observed in carp under chemical stress [31].
In contrast, aspartate aminotransferase (AST) activity was not significantly influenced by DON feeding,
which indicates that the rate of amino acid transformations via transamination is not influenced.
A considerable amount of the fish consists of white musculature, which shows low levels of
myoglobin and is mostly used for burst swimming [32]. Swimming performance is known to lead
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to the utilization of nutrients from blood circulation and white and red musculature [33]. Several
factors further influence the chemical body composition. For example, the genetic background of carp
determined the dry matter content of the fillet, as has been shown for different crossbreds of common
carp, accounting for 19% to 28% [34–36]. With respect to common mirror carps, a value for dry matter
of 22.0% was observed [36]. The dry matter of the carp used in our study corresponds to this value
and was only influenced by feeding the low-dose DON diet (Table 12).
As expected, the lipid content in carp muscle was found to be low in the present study, and it
was not influenced by DON feeding. Different crossbreds of common carp showed lipid contents in
the fillet of up to 9.9%, with mirror carps showing 2.4% lipid in fillet [36]. Low muscle lipid contents
ranging from 0.5% to 2.6% have also been noted by another study [34]. However, slightly higher
values, ranging from 2.9% to 5.2%, have been reported elsewhere [35,37]. Differences in the chemical
composition of carp musculature can be due to the influence of rearing conditions [38,39], the influence
of age [35,36,39] and differences in the composition of the diet [37,39–41], and these factors should be
considered when the values for the present study are compared to other studies. For example, in the
study of Steffens and Wirth [40], the addition of 10% different lipid sources in the diet led to 2.2 to 2.5%
lipid in dorsal muscle of carp, which corresponds to the values in the present study.
The significant difference in the dry matter of white muscle of fish fed the low-dose diet compared
to the control fish cannot be explained at the moment. Reductions of dry matter in the musculature
can be caused by the depletion of tissue nutrient contents, which are compensated for by increasing
the water content [29]. However, even after calculation of the dry weight lipid contents in white
muscle, the samples do not show a significant influence of DON. Thus, the reason for this observation
remains obscure.
Muscle glucose shows no differences of the DON treatment of fish. The glucose concentration in
red musculature has been reported to be rather independent of blood glucose levels [42], but the aerobic
glucose utilization was still assumed to be relying by approximately 30% on glucose in circulation.
In contrast, white musculature in fish is known to largely depend on anaerobic glycogenolysis for
energy liberation [43]. Lactate in carp white musculature ranged from four to 9 mM [44], even after
exhaustive exercise. The lactate levels in muscle tissue in the present study were a bit lower and were
not influenced by DON feeding. This might be due to the fact that even after severe hypoxic stress,
lactate did not accumulate in white muscle, but was probably transferred out of the tissue [45].
Ascorbate levels in white muscle samples strongly depend on the supply via the diet and have
been reported to be low in fish musculature [46]. This corresponds to the present study, although
higher values have been reported for carp previously [47]. This study also reported an influence of
the mycotoxin, sterigmatocystin, on ascorbate levels in the white musculature of carp, which was not
observed after DON feeding of carp in the present study. Similar to the ascorbate levels in liver tissue,
the lack of influence of DON on their concentration in muscle further indicates that ascorbate as an
endogenous antioxidant does not prevent the detrimental effects of DON on carp.
2.6. Serum Parameter
Our study demonstrates a large variation of biochemical serum parameters, which are known to
be affected by many endogenous and exogenous factors, such as age, health condition, nutrition or
stress, including chemical stress [48,49].
Glucose levels in the experimental fish in the present study were comparable to values for
unstressed carp reported previously [48,49]. Glucose concentrations in serum remained unchanged in
fish treated with DON for four weeks (Table 11). A direct influence of DON on glucose metabolism
has been shown in the human epithelial intestinal cell line, HT-29-D4, and in jejunum of chicken;
however, cholesterol metabolism remained unchanged in this cell line [26,27]. No evidence for a similar
impairment of glucose from the diet could be observed in the present study, although a possible
decrease in blood glucose might also have been compensated for in DON-treated fish. Similar to other
fish, carp are known to maintain blood glucose levels, even after prolonged starvation [29].
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Serum lactate levels in control fish are comparable to values in unstressed fish in other studies [49,50].
However, lactate values in DON-treated carp were considerably higher. This was probably caused by an
activation of gluconeogenesis to maintain levels of circulation glucose. Consequently, elevated serum
glucose levels can be caused [49], which has also been observed in fish recovering for the treatment with
the medium- and high-dose diet compared to the control fish (Table 11). Thus, it can be assumed that
DON affects anaerobic metabolism in carp muscle.
Table 11. The serum parameter in DON-treated fish and in fish after a recovery of two weeks; n = 6 per
group; mean ± SEM; means with the same letter (a and/or b) are not significantly different from each
other (significance tested with Mann-Whitney U-tests, p < 0.05).
Serum Parameters Basal Feed Low DON Medium DON High DON
DON-treated:
Free glucose (μM mL−1) 2.22 ± 0.22 2.37 ± 0.19 2.12 ± 0.09 2.53 ± 0.27
Lactate (μM mL−1) 8.04 ± 2.87 a 21.85 ± 5.78 a,b 20.50 ± 6.70 a,b 29.96 ± 8.44 b
LDH (mU mg protein−1) 15.7 ± 1.0 a 19.8 ± 1.8 a,b 18.6 ± 2.5 a,b 23.6 ± 2.1 b
SDH (mU mg protein−1) 11.2 ± 4.4 a,b 30.3 ± 4.8 a 23.1 ± 8.2 a,b 8.5 ± 2.1 b
AST (U mg protein−1) 7.1 ± 0.9 a 5.1 ± 0.2 a,b 4.8 ± 0.7 b 10.6 ± 3.8 a,c
ALT (U mg protein−1) 0.7 ± 0.2 a 0.7 ± 0.3 a 1.2 ± 0.6 a 0.2 ± 0.0 b
Total protein (mg mL−1) 23.05 ± 0.73 23.32 ± 0.64 26.22 ± 1.26 23.41 ± 0.78
Albumin (mg mL−1) 19.85 ± 1.49 a 15.14 ± 2.03 a,b 5.42 ± 2.40 b 6.92 ± 3.66 b
Recovery:
Free glucose (μM mL−1) 1.66 ± 0.12 a 2.78 ± 0.28 b 2.84 ± 0.33 b 2.77 ± 0.25 b
Lactate (μM mL−1) 4.12 ± 1.08 a 34.87 ± 12.74 b 39.70 ± 8.35 b 19.83 ± 3.70 b
LDH (mU mg protein−1) 14.8 ± 1.4 a 18.8 ± 1.0 b 17.4 ± 0.9 a,b 21.9 ± 1.6 b
SDH (mU mg protein−1) 32.4 ± 8.8 16.1 ± 3.5 20.3 ± 5.4 34.5 ± 11.7
AST (U mg protein−1) 6.4 ± 0.8 5.1 ± 0.2 4.8 ± 0.7 7.9 ± 2.6
ALT (U mg protein−1) 0.4 ± 0.1 a 0.6 ± 0.1 a 0.7 ± 0.2 a,b 1.1 ± 0.2 b
Total protein (mg mL−1) 21.89 ± 0.73 22.04 ± 0.39 21.47 ± 1.86 29.86 ± 0.57
Albumin (mg mL−1) 15.32 ± 1.50 17.22 ± 1.74 16.94 ± 3.75 22.45 ± 2.40
Table 12. The composition of samples from dorsal white musculature after four weeks of DON feeding
and after the recovery phase of two weeks; n = 6; mean ± SEM; means with the same letter (a and/or b)
are not significantly different from each other (significance tested with Mann-Whitney U-tests, p < 0.05).
Composition of White Muscle Basal Feed Low DON Medium DON High DON
DON-treated:
Dry matter (% wet matter) 22.4 ± 2.0 a 19.0 ± 0.7 b 20.9 ± 0.6 a,b 20.5 ± 0.4 a,b
Total lipids (% wet matter) 2.4 ± 0.4 2.2 ± 0.2 2.4 ± 0.1 2.1 ± 0.2
Free glucose (μM g−1 wet matter) 2.93 ± 0.39 3.30 ± 0.22 2.95 ± 0.29 2.76 ± 0.29
Lactate (mM g−1 wet matter) 3.54 ± 0.37 4.08 ± 0.29 4.56 ± 0.30 3.79 ± 0.21
Ascorbate (μM g−1 wet matter) 10.2 ± 0.5 10.0 ± 0.8 10.3 ± 0.5 9.5 ± 0.6
Recovery:
Dry matter (% wet matter) 19.6 ± 0.9 19.7 ± 0.3 21.2 ± 0.6 19.7 ± 0.5
total lipids (% wet matter) 2.2 ± 0.3 2.5 ± 0.2 2.6 ± 0.2 2.9 ± 0.6
Free glucose (μM g−1 wet matter) 3.33 ± 0.34 3.12 ± 0.18 3.89 ± 0.40 3.32 ± 0.48
Lactate (mM g−1 wet matter) 3.03 ± 0.11 3.41 ± 0.48 2.95 ± 0.22 2.94 ± 0.31
Ascorbate (μM g−1 wet matter) 9.7 ± 0.3 9.3 ± 0.5 9.1 ± 0.7 10.2 ± 0.7
Total protein content in all carp used in the present study was slightly lower in most cases
compared to previously reported values in other studies [33,49]. From this, it may be assumed that
in general, the nutritional status of the fish was sufficient, since serum total protein levels are known
to reflect the nutritional condition of carp [29]. The albumin concentration in the control group was
comparable to previously reported values [33]. Although the total protein content of serum remained
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unchanged by DON feeding, albumin concentrations were significantly reduced in fish fed the medium
dose and high dose diets for four weeks. This means that the ratio of albumin to total proteins in control
fish of more than 80% is reduced in DON-treated fish to 66%, 21% and 31% in fish treated with the
low-dose, medium-dose and high-dose diet, respectively. Which adaptations led to the maintenance of
total protein levels, although albumin levels were reduced by DON treatment, remains unknown and
should be investigated in future studies. Nevertheless, the effect on serum albumin levels was certainly
caused by liver impairment that occurred upon DON treatment. That trichothecenes, including DON,
are ribotoxic, targeting the 60S ribosomal subunit, and consequently, impairing protein synthesis and
transcription, which leads to apoptosis, has already been reported for leukocytes and other actively
proliferating eukaryotic cells of higher vertebrates [51].
In contrast to their activity in liver tissue (Table 10), the activities of AST and ALT in serum
were significantly reduced by DON feeding in the medium-dose group and the high-dose group,
respectively, compared to control fish (Table 11), and only ALT activity was increased in fish recovering
from receiving the high-dose DON diet. This indicates that the rate of amino acid transformation
via transamination is slowed down by DON. Lactate dehydrogenase (LDH) activity in serum was
found to be increased in fish fed the high-dose feed for four weeks and after two weeks of recovery
compared to control fish. Increased LDH in serum of carp, indicating membrane leakage in tissues, has
also been shown after exposure to toxic concentrations of pesticides [52]. This parallels the increased
lactate levels in DON-treated fish. SDH activity was increased in these fish compared to fish fed the
low-dose DON diet. Significant increases of AST, ALT and LDH activities have been observed in carp
that have been exposed to handling stress, regular exercise or toxic substances, such as microcystins
and cyanide [33,53–56]. Although correlations between the toxin concentrations in feed and AST
activities in serum were not significant in the present study during the feeding period, our results
showed a significant correlation of ALT, LDH or SDH with the toxin concentrations in the experimental
diets (Spearman correlation coefficient, −0.527, 0.466 and 0.475; significance, p = 0.012, 0.022 and
0.025, respectively). Moreover, after the same time period, albumin or lactate concentrations in serum
correlated with the toxin concentration in the experimental feeds (Spearman correlation coefficient,
−0.678 and 0.453; significance, p = 0.000 and 0.034, respectively). Similar results have also been
obtained for the recovery phase for the correlation of ALT and LDH with the toxin concentrations
previously applied (Spearman correlation coefficient, 0.433 and 0.555; significance, p = 0.034 and
0.005, respectively). Furthermore, glucose or lactate concentrations in serum correlated with the toxin
concentration in the experimental feeds (Spearman correlation coefficient, 0.592 and 0.487; significance,
p = 0.002 and 0.021, respectively). Thus, the activity of serum ALT and LDH together with lactate
concentrations seems to be a sensitive indicator of the fish responses to DON. The symptoms of
carp exposed to DON resemble the situation of freshwater snakehead fish, Channa punctatus, that
were treated with sublethal concentrations of a carbamate pesticide, leading to increases of LDH and
decreased SDH activity in several organs and hyperglycaemia and hyperlactaemia, which suggested
that anaerobic metabolism was favored [57].
3. Experimental Section
3.1. Preparation of Feeds and Husbandry
Ingredients were chosen so that no cereals were included in the experimental diets to exclude
cereal-based Fusarium toxin contamination of these diets. For the preparation of experimental feeds,
all ingredients listed in Table 1 were mixed thoroughly [17]. The feeds were artificially contaminated
by adding deoxynivalenol (DON, dissolved in ethanol; purity >98%, lot no. 011M4065V) to the fish
oil during the feed preparation process, achieving different concentrations (low dose, 352 μg kg−1,
medium dose, 619 μg kg−1, and high dose, 954 μg kg−1, final feed, respectively) [17]. The preparation
of the different diets was repeated three times in a pelletizer (L 14-175, Amandus Kahl, Reinbek,
Germany) to allow the homogenous distribution of ingredients. The manufactured 4-mm pellets
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were allowed to cool down to room temperature for two hours before storage at 4 ◦C until use.
The composition of the diets was analyzed by using standard methods. Experimental diets were
analyzed for dry matter (DM) (105 ◦C, until constant weight), crude ash (550 ◦C, 2 h.), crude fat (Soxtec
HT6, Tecator, Höganäs, Sweden) and crude protein content (N × 6.25; Kjeltec Auto System, Tecator,
Höganäs, Sweden). Nitrogen-free extract and fibres (NFE) are summarized as shown in Equation (2).
Nitrogen free extract + fibre, (NFE) = 100 − (% protein + % fat + % ash) (2)
Carp were raised from eggs in our facilities and used for the experiments at 12–16 cm in total
length. The fish were kept at a 16 h light/8 h dark photoperiod at 25 ± 0.2 ◦C (mean ± SD) and
acclimatized to the tanks that were integrated into a flow-through system providing 6 L fresh and
conditioned water per hour per tank prior to the experiments for three weeks.
3.2. Chemicals
All chemicals were obtained from Sigma-Aldrich (Buchs, Switzerland), unless indicated otherwise.
3.3. Experimental Feeding Design
The prepared pellets (4 mm in diameter) were given at 2% of body mass once every day to juvenile
carp, which were separated into four different feeding groups (control, low dose, medium dose and
high dose) with 6 fish each in quadruplicate 54-L tanks for each treatment. The maintenance of optimal
rearing conditions (dissolved oxygen, water temperature, pH, conductivity) was controlled during the
entire experiments [17]. All experimental procedures have been approved by the cantonal veterinarian
authorities of Basel-Stadt (Basel, Switzerland) under permission number 2410. Feed amounts per
tank were adjusted to the increased weight on a weekly basis. Uptake of feed was observed in all
groups within less than 30 min after offering the experimental diets. Fish were fed the experimental
diets for four weeks, and one half of the fish were sampled by using all fish from two tanks of each
treatment group. All remaining fish were fed the uncontaminated control diet for a further two weeks
before termination of the experiment, in order to investigate the possible reversal of the DON effects.
Sampling of fish included blood sampling, recording of weight and length, as well as sampling of
individual organs. The calculation of condition factors was achieved according to Equation (3).
Condition factor = weight/(length)3 (3)
3.4. Histological Determination of Glycogen and Histopathological Scoring
Histological assessments were conducted on liver (n = 6 fish per treatment level per sampling day).
Tissues were automatically processed (TP1020 tissue processor, Leica Microsystems AG, Switzerland),
and at least six sections per fish (3 μm-thick) were mounted on microscope slides and stained with
haematoxylin and eosin (HE). Additionally, sections were stained with PAS or Prussian blue to
analyze glycogen content and to detect changes in tissue iron content related to erythrocyte turnover.
For histopathological examination (Nikon Eclipse 400 microscope), sections were examined in detail
at 400× magnification. Quantitative analyses, as described below, were conducted on digital images,
which were taken with a Nikon DXM 1200 F digital camera and Nikons ACT-1 software V2.63.
Damage to liver tissue was estimated by histopathological scoring in 10 HE-stained sections per
fish using semi-quantitative assessments of the severity (0 = no alterations, 1 = mild alterations,
2 = moderate alterations, 3 = severe alterations) according to the suggestions of Zodrow et al. [58].
Glycogen content of 5 PAS-stained sections per fish was analyzed by determining the luminosity and
RGBmax. Luminosity can be deduced from the histogram settings in Adobe Photoshop. RGBmax was
achieved by lightening the green and blue channels in the RGB space. Chrominance was calculated by
subtracting the minimal RGB value (which was obtained by darkening the minimal tones) from the
RGBmax (Adobe® Photoshop® CS3 Extended version 10.1).
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3.5. Lipid Peroxidation Assay and LDH Activity Measurements
Tissue samples were homogenated in 19 volumes PBS containing 0.1% (w/v) butylated
hydroxytoluene (BHT), homogenized using an UltraThurrax (IKA Werke, Staufen, Germany) for
10 s and centrifuged for 10 min at 10,000× g at 4 ◦C (Centrifuge 5415R, Eppendorf, Basel, Switzerland).
The supernatant was used for the TBARs assay [59] with the following modifications. A volume
of 40 μL of supernatant was mixed with 200 μL TBARs solution [60], containing 3.75 mg mL−1
thiobarbituric acid (TBA), 20% (w/v) trichloric acid (TCA), 9.1 μL mL−1 hydrochloric acid (37%),0.06%
(w/v) BHT and 866.9 μL distilled water. Thereafter, samples were incubated at 70◦ C for 90 min,
cooled to room temperature and centrifuged at 16,000× g for 15 min at room temperature. In parallel,
standards containing 0 to 3200 nM malondialdehyde (MDA) were prepared. Optical densities of all
samples were read at 532 nm (Infinite M200, Tecan Group Ltd., Männedorf, Switzerland). Aliquots
of the tissue homogenate were also used for the lactate dehydrogenase (LDH) assay and protein
determinations. The latter were conducted using the bicinchoninic acid (BCA) assay (Sigma), according
to the manufacturer‘s protocol. The activity of LDH in tissue homogenates and serum samples was
measured according to Bergmeyer [61]. In short, 164 μL NADH solution (0.244 mmol L−1 in Tris-NaCl
solution (Tris, 81.3 mmol L−1; NaCl, 203.2 mmol L−1 pH 7.2)) were mixed with 33 μL pyruvate solution
(9.76 mmol L−1 in Tris-NaCl solution). The reaction was started by the addition of a 20 μL sample,
and an absorption decrease at a wavelength of 339 nm was recorded for 10 min (Infinite M200, Tecan
Group Ltd., Männedorf, Switzerland).
3.6. Nutrient Allocation in Fish
Fish from each group were killed by an overdose of anaesthetic, cut into small pieces with scissors
and blended. Homogenates were then dried at 105 ◦C for 24 h and dry mass was noted. Fat content in
dried homogenates was analysed in duplicate by petroleum ether extraction using a Soxhlet apparatus
(Soxtec System HT, Tecator, Sweden).
The nutritional status of snap-frozen liver and muscle samples was analysed using different
methods, as follows. To amounts of 100 to 250 mg, 1 mL distilled water was added. Liver samples
were homogenated with an UltraThurrax (IKA Werke, Staufen, Germany) for 10 s, and the muscle
samples were homogenized manually by using a glass potter (Wheaton™ Potter-Elvehjem Tissue
Grinders, purchased from Fisher Scientific, Reinach, Switzerland). For the determination of total
lipid content, samples were extracted with chloroform-methanol (2:1) containing 0.01% BHT as an
antioxidant, according to the method of Bligh and Dyer [62], followed by analyses of total lipids with
the sulfo-phospho-vanillin method [63]. A standard curve was prepared with olive oil dissolved
in ethanol.
The energy content of dried homogenates was analysed using an IKA C 200 bomb calorimeter.
By this method, the dried sample is wrapped in combustible paper and placed in a sealed iron bomb,
where its explosive combustion is unleashed by an electric flash, under an O2-saturated atmosphere.
The bomb is placed in a water bath, which absorbs the heat generated during the combustion; the
increase in the temperature of water relates to the heat generated during the combustion. The device is
calibrated with a standard compound, benzoic acid (energy released upon combustion: 26,460 Joules g−1).
Obtained values (in Joules g−1 dry matter) were converted to values relative to the fresh weight of fish
(% g fish−1).
3.7. Measurement of Ascorbate
Ascorbate concentrations were analyzed in medium samples and cell extracts according to the
method by Vislisel et al. [64]. Tissue samples were homogenized in 19 volumes of PBS, after which
methanol and diethylenetriaminepentaacetic acid (DTPA) were added to achieve final concentrations
of 60% (v:v) and 250 μM, respectively. Samples were centrifuged at 16,000 rpm for 2 min at 4 ◦C
(Centrifuge %427 R, Eppendorf, Basel, Switzerland). Samples of 40 μL from the supernatant were
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used for the assay. Ascorbate in the samples was first oxidized to dehydroascorbate by the addition of
40 μL tempol (4-hydroxy-2,2,6,6-tetramethyl-piperidinyloxy, 2.3 mM in 2 M sodium acetate buffer)
per well, followed by short shaking and the addition of 25 μL o-phenylenediamine (OPDA, 5.5 mM in
2 M sodium acetate buffer). Fluorescence emission values were recorded at 450 nm immediately using
a plate reader (Infinite M200, Tecan Group Ltd., Männedorf, Switzerland) with excitation at 345 nm.
Standard curves were prepared with ascorbate diluted to 14 different concentrations ranging from 0 to
150 μM using the methanol-water mixture containing DPTA.
3.8. Preparation of Serum Samples and Determination of Glucose and Lactate
Serum was immediately prepared from blood samples taken with heparinised syringes.
Serum samples were stored at −80◦C until analyses. Tissue homogenates were centrifuged at 10,000×
g for 10 min, and the supernatant was used for the analysis of glucose and lactate. Glucose was
analysed according to the glucose oxidase method. Therefore, samples were mixed with sodium
acetate buffer (2 M, pH 5.5) containing 0.1 mg mL−1 o-dianisidin, 4 U mL−1 glucose oxidase and 2.54
purpurgallin units of peroxidase (from horseradish) per mL. Plates were incubated at 37 ◦C for 30 min,
and the reaction was stopped by the addition of 100 μL 12 N sulphuric acid to each well. Optical
densities were read at 540 nm (Infinite M200, Tecan Group Ltd., Männedorf, Switzerland).
Lactate in serum and tissue samples was determined according to Maughan [65] using hydrazine
buffer (1.1 mM, pH = 9.0) and 227 μM NAD, and 125 U LDH from porcine heart per well. After incubation
for 30 min at room temperature, optical densities were measured at 339 nm and lactate concentrations were
calculated from a standard curve prepared with serial dilutions from a lactate standard (998 ± 6 mg L−1).
3.9. Measurement of Total Protein and Albumin in Serum
Total protein contents were analysed from a diluted serum sample using the bicinchoninic acid
(BCA) assay (Sigma), according to the manufacturer’s protocol. Albumin was determined using the
bromocresol green (BCG) method, as described by Doumas et al. [66], with the following modifications:
BCG was solubilised in 0.1 N NaOH and diluted with distilled water and succinate buffer (0.1 M,
pH 4.0) at a ratio of 1:3 (v/v). This BCG working solution was added to 25 mL of serum, followed by
incubation for 10 min at room temperature and measurement of optical densities at 628 nm (Infinite
M200, Tecan Group Ltd., Männedorf, Switzerland). A standard curve was prepared using essential
globulin-free bovine serum albumin.
3.10. Measurement of AST, ALT and SDH Activity
Activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) from samples
of 20 μL of serum or tissue homogenate were determined according to the modified methods described
by Casillas et al. [67] after incubation for 30 min at room temperature by monitoring NADH oxidation
at 339 nm (Infinite M200, Tecan Group Ltd., Männedorf, Switzerland). Sorbitol dehydrogenase (SDH)
activity in serum samples was measured as described by Bergmeyer [68] using fructose as the substrate.
Absorption changes at a wavelength of 339 nm were recorded for 10 min (Infinite M200, Tecan Group
Ltd., Männedorf, Switzerland).
3.11. Statistics
Data are presented as the mean ± standard error of the mean (SEM), unless indicated otherwise.
Coefficients of variance were calculated as shown in Equation (4).
Coefficient of variance (CV) = standard deviation/mean × 100 (4)
The effects of the treatments were determined by the comparison of treatment groups to controls
using non-parametrical Mann-Whitney U-tests (SPSS 9.0 for Windows). Relationships between
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parameters were evaluated using Spearman correlation tests. A p-value of <0.05 was accepted as being
statistically significant.
4. Conclusions
The histological alterations in carp livers of DON-treated fish suggest that the fish may face a
metabolic crisis caused by tissue damage. The results indicate that oxidative stress leading to lipid
peroxidation is involved in the detrimental effects of DON feeding. Taken together, the chemical body
composition of the experimental fish in the present study was influenced by the abovementioned
factors and gives strong evidence for an influence of DON on the nutritional status of carp. Similar
metabolic disorders, including impairment of hepatic metabolism of fats due to oxidative stress,
have also been observed in pesticide-treated carp [15]. Nevertheless, the specific biological action
and molecular action of DON on liver function in fish is still unclear and needs to be elucidated in
further studies.
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Abstract: Fusariotoxins such as fumonisin B1 (FB1) and deoxynivalenol (DON) cause deleterious
effects on the intestine of pigs. The aim of this study was to evaluate the effect of these mycotoxins,
alone and in combination, on jejunal explants from piglets, using histological, immunohistochemical
and ultrastructural assays. Five 24-day old pigs were used for sampling the explants. Forty-eight
explants were sampled from each animal. Explants were incubated for 4 hours in culture medium
and medium containing FB1 (100 μM), DON (10 μM) and both mycotoxins (100 μM FB1 plus 10 μM
DON). Exposure to all treatments induced a significant decrease in the normal intestinal morphology
and in the number of goblet cells, which were more severe in explants exposed to DON and both
mycotoxins. A significant reduction in villus height occurred in groups treated with DON and
with co-contamination. Expression of E-cadherin was significantly reduced in explants exposed
to FB1 (40%), DON (93%) and FB1 plus DON (100%). The ultrastructural assay showed increased
intercellular spaces and no junction complexes on enterocytes exposed to mycotoxins. The present
data indicate that FB1 and DON induce changes in cell junction complexes that could contribute to
increase paracellular permeability. The ex vivo model was adequate for assessing intestinal toxicity
induced by exposure of isolated or associated concentrations of 100 μM of FB1 and 10 μM of DON.
Keywords: Fusarium spp.; mycotoxins; gut; cell permeability; adherens junction
1. Introduction
Mycotoxins are secondary metabolites produced by several fungal genera. They act as natural
contaminants and are commonly found in grains and fresh foods of vegetable origin. It is estimated
that 25% of the grains worldwide are contaminated with these substances [1]. A survey including 7049
samples collected in Europe, Asia and Americas revealed that about 64% and 59% of raw materials and
finished feed samples contained fumonisins (FB) and deoxynivalenol (DON), respectively. The mean
levels were 1 mg/kg (maximum of 49 mg/kg) for DON and 2 mg/kg (maximum of 77 mg/kg) for FB [2].
The fumonisin B1 (FB1) corresponds to 70% of fumonisins and is produced by Fusarium verticillioides [3].
The toxicity of FB1 has been proved in several animal species, resulting in different effects such as acute
pulmonary edema in pigs, leukoencephalomalacia in horses, liver cancer in rats and esophageal cancer in
humans [4]. Data on the mechanisms of action of FB1 on the digestive system are scarce, and routes of
action on the intestinal epithelium are poorly understood. Exposure to FB1 induces a reduction in cell
number due to decrease in cell proliferation associated with increased apoptotic index, as well as a
decrease in transepithelial electrical resistance, indicating changes in intestinal integrity [5]. In vivo
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studies in piglets demonstrated that acute and chronic ingestion of feed contaminated with fumonisin
led to a significant increase in hepatic [6] and intestinal lesions such as atrophy and fusion of villi,
and decreased E-cadherin expression [7]. Piglets exposed to this mycotoxin showed higher bacterial
translocation to various organs [8], favoring the proliferation of opportunistic bacteria in the gut [9].
The fusariotoxin deoxynivalenol (DON) frequently contaminate corn and wheat, being a risk
to human and animal health [10–13]. Exposure of intestinal explants to DON causes morphological
changes in a dose-dependent manner, such as flattening of enterocytes; villi atrophy and increased
apoptotic index [14]. One effect of this mycotoxin on the intestine is the reduction in the expression
of proteins cell junctions as claudin-4 [15,16], E-cadherin and occludin [7], resulting in changes in
paracellular and transcellular permeability, favoring penetration of pathogens [13,15–17].
The ultrastructural evaluation may help in understanding the pathophysiology of injury; however
studies on the effects of mycotoxins on intestinal ultrastructure are scarce [18,19]. There is no data in the
literature on ultrastructural changes induced by exposure of the bowel to fumonisins and deoxynivalenol.
Health regulations only consider the effects of mono-contamination, but multi-contamination is a
phenomenon often observed in natural contamination of feed [6]. The available data indicate that
simultaneous intake of FB1 and DON induces an additive immunosuppressive effect as compared with
exposure to a single toxin [6,7]. The need for more research into additive, synergistic or antagonistic
effects in multi-contamination is necessary; however, in vivo studies are costly and involve bioethical
issues. Thus, the use of alternative models which mimic the organic systems of interest is extremely
interesting. The efficacy of ex vivo model for assessing the effects of exposure to DON on the intestine
has been proven in previous studies [14,20]. The model is also appropriate to examine the expression
of protein junctions of enterocytes [21]. Considering the need to broaden knowledge about the results
of interactions between multiple mycotoxins and the limited available data, the aim of this study
was to assess the effects of exposure to FB1 and DON, alone and in combination, with emphasis on
E-cadherin expression and ultrastructural changes, using the ex vivo model of intestinal explant.
2. Results
2.1. Histological Analysis
The main histological changes observed in the control group were edema of lamina propria,
mild cell degeneration and villi atrophy (Figure 1A). In explants exposed to FB1, flattening and focal
loss of apical enterocytes, moderate fusion and villi atrophy were observed (Figure 1B). In the group
treated with DON, the changes are similar to the FB1 group; however the intensity of the lesions was
more severe and a reduction in villi number was also verified (Figure 1C). Explants exposed to both
mycotoxins showed severe changes characterized by reduction in villi number, villi fusion and atrophy,
besides lysis of enterocytes (Figure 1D). A significant decrease in histological score was observed in all
explants treated with mycotoxins when compared to control group (Figure 1G). The reduction was
18.8%, 37% and 37.5% for exposure to FB1, DON and FB1 plus DON, respectively. The morphometric
analysis showed a significant decrease in villi height in the explants treated with DON and FB1 plus
DON (p ≤ 0.05) compared to the control group (Figure 1H).
The explants exposed to all treatments showed a significant change in the number of goblet cells
(p ≤ 0.05) in comparison to control explants. The reduction was more pronounced in the groups treated
with FB1 plus DON (98%) and DON (63.4%) (Figure 1I).
2.2. Expression of E-Cadherin
The immunohistochemical analysis was performed to evaluate the expression of the adherens
junction protein, E-cadherin. We observed a significant decrease in expression of E-cadherin in the
group treated with FB1 (40%) and DON (93%) compared to control (Figure 1E,F). The group treated
with both mycotoxins showed no immunostaining for E-cadherin.
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2.3. Ultrastructural Analysis
Cell viability and the integrity of the complex of enterocyte junctions in explants exposed to
fusariotoxins were evaluated by ultrastructural analysis. Control explants showed a continuous
monolayer of enterocytes lining the gut. The luminal membrane of enterocytes presented preserved
microvilli, while the apical membrane between adjacent intestinal cells formed intercellular junctions
and desmosomes (Figure 2A,B). The cytoplasm was homogeneous with no changes in organelles.
The nuclei contained a low concentration of heterochromatin and large, distinct nucleoli. Goblet
cells were observed between enterocytes, showing secretory granules throughout the length of the
villi. On the other hand, explants exposed to mycotoxins presented increased intercellular spaces,
decrease in the size and number of microvilli (Figure 2C,D). Junction complexes were not visualized
between the enterocytes. The nucleus showed marginated heterochromatin and occasionally apoptotic
corpuscles. The presence of cytoplasmic projections, vacuoles within the cytoplasm, cellular debris and
desquamated cells in the lumen were observed mainly in the explants incubated with DON (Figure 2E).
The group exposed to both mycotoxins showed so severe changes that impaired ultrastructural
evaluation. In this group we observed only cellular debris with no preserved enterocytes.
 
Figure 1. Effects of individual and combined exposition of jejunal explants to fumonisin and
deoxynivalenol on histology. Explants were exposed to culture medium ( ) or culture medium with
fumonisin B1 (FB1) ( ), deoxynivalenol (DON) ( ) or FB1 + DON (). (A) Control explants. Edema of
the lamina propria and mild villi atrophy (arrow); (B) FB1-exposed explant. Moderate fusion (arrow)
and villous atrophy; (C) DON-exposed explant. Severe loss of apical enterocytes, fusion and atrophy
(arrow); (D) FB1 + DON-exposed explant. Lysis of intestinal epithelium, villi atrophy, fusion (arrow)
and cell debris. HE. Bar 100 μm; (E) Control explant showing a strong and homogeneous E-cadherin
expression. Bar 20 μm; (F) DON-exposed explant showing reduced expression of E-cadherin. Bar
20 μm; (G) Tissue scores of pig intestinal explants exposed to FB1, DON and both mycotoxins; (H) Villi
height in pig intestinal explants treated with FB1, DON and FB1 + DON; (I) Number of goblet cells per
villus of pig intestinal explants treated with FB1, DON and FB1 + DON. Values are means with their
standard deviation of the mean represented by vertical bars (n 5 animals). Mean values with unlike
letters were significantly different (p ≤ 0.05). AU = Arbitrary Units.
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Figure 2. Effects of individual and combined exposition of jejunal explants to fumonisin and
deoxynivalenol on ultrastructure. (A) Control explant. Enterocytes with normal morphology of
microvilli and cytoplasm. Bar 500 nm; (B) Control explant. Enterocytes with junction complexes (arrow)
and glycogen granules scattered in the cytoplasm. Bar 2 nm; (C) FB1-exposed explant. Focal loss of
apical enterocytes (arrow head) and loss of microvilli (arrow). Bar 2 nm; (D) DON-exposed explant.
Increased intercellular space (arrow) and loss of junction complexes. Bar 5 nm; (E) DON-exposed
explant. Vacuoles within cytoplasm, membrane blebs and loss of apical enterocytes. Bar 10 nm.
3. Discussion
The integrity of the gut is dependent on the maintenance of various factors, including enterocyte
and mucus layer integrity, as well as preservation and functionality of epithelial junctions cells [21].
There is increasing evidence that the intestinal epithelium is repeatedly exposed to mycotoxins, and at
a higher concentration than other tissues [22]. The ingestion of fusariotoxins may induce changes on
intestinal morphology and local immunity [7] affecting the barrier function of the gut. The effects of
mycotoxins on gastrointestinal tract can diverge because the bioavailability of these fungal compounds
is very diverse and differs between animal species [22]. In this study, we used an ex vivo model
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to demonstrate that fusariotoxins alone or in combination induced significant morphological and
ultrastructural changes in jejunal explants from pigs.
The gut, as the first tissue to have contact with food contaminants, is considered a target organ
for the action of mycotoxins [23]. In this experiment, we verified that exposition to DON, FB1 or
both mycotoxins induced a significant decrease in intestinal score. Changes were more severe in
explants incubated with DON and DON plus FB1. The main histological changes were lysis of
enterocytes and villi atrophy and fusion. These histological findings are similar to those described in
pigs chronically fed with FB1 and DON [7,24–26], demonstrating that the ex vivo model is suitable for
assessing the effects of toxic substances on the intestine. It is interesting to observe that in both ex vivo
and in vivo models a good correlation was reported for histological changes and phosphorylation of
mitogen-activated kinases on intestine, even with differences in time of mycotoxin exposure (hours
and days, respectively) [20,26]. In explants the morphological changes induced by fusariotoxins are
more severe. Probably, the severity of the lesions on the explants is associated with a direct exposure
to the toxin, whereas in the in vivo model the bioavailability of mycotoxins differs. In addition, the
explants were submitted to a relative degree of hypoxia, a fact that can contribute to the intensity of
histological changes.
It is worth noting that even with a short period of incubation with mycotoxins both toxins
were able to cause significant injury on intestinal tissue. Deoxynivalenol induces a ribotoxic stress,
compromising protein synthesis and triggering apoptosis [27], which may explain the microscopic
changes observed in this study. Fumonisin leads to accumulation of sphinganine and sphingosine
products that are cytotoxic, pro-apoptotic and cell growth inhibitors [28].
Changes in villi height imply in reduced absorption of nutrients [22]. In this study we verified a
significant decrease in villi height in explants exposed to DON (24%) and DON plus FB1 (27%). Similar
results were reported in pigs fed chronically diets contaminated with DON [7]. The reduction in villi
height induced by DON is related to an increase in enterocyte apoptosis (data not shown). DON
induces phosphorylation of mitogen-activated protein kinases (MAPKs) resulting in cell apoptosis [26].
In addition, DON is also able to reduce cell proliferation in vitro [27].
Regarding the effects of FB1 on the intestine, the results are conflicting. Doses of 30 mg/kg and
2.8 mol/Kg caused villus atrophy and fusion [29]; however, ingestion of a single dose of 83 mg/kg
FB1 [3] or of 6 mg/kg chronically [7] induced no changes in villi height. In this study, explants exposed
to FB1 showed no significant changes in villi height (reduction of 16.4%) compared to control explants.
Goblet cell density reflects mucus production, an important protective intestinal barrier that prevents
adhesion of pathogens to enterocytes [30]. In this experiment, explants exposed to all treatments showed
a significant change in the number of goblet cells. We observed a reduction that was more severe in
DON and FB1 plus DON treatments. Chronic ingestion of FB1 induced no changes in globet cell density
in piglets (6 mg/Kg FB) [7], whereas in poultry (300 mg/kg) a significant increase was observed [31].
These differences are probably related to the doses of FB1 used. The explants were exposed to 100
μM, which is equivalent to a dose of 144 mg/kg of FB1. Also, pigs are much more susceptible to
fumonisins than poultry [22]. Reduction in the number of goblet cells after chronic exposure to DON
intestinal has already been reported in in vivo studies [7]. In a previous study, jejunal explants exposed
to DON and FB1 exhibited a significant increase in caspase-3 immunostaining, indicating cell apoptosis
(unpublished data). We hypothesize that the changes in goblet cell staining are also related to increased
apoptosis induced by mycotoxins exposition. On the other hand, changes in goblet cells staining could
be associated with two other mechanisms, expulsion of mucin granules and necrosis. DON induces a
ribotoxic stress [27] that results in decreased synthesis of proteins such as mucin, while FB1 induces
apoptosis by activation of the caspase-3 pathway [32]. The explants exposed to FB1 plus DON showed
a drastic reduction in the number of goblet cells suggesting an additive effect of these mycotoxins on
globet cells.
A decrease in the expression of proteins cell junction and the induction of apoptosis are some of the
factors associated with the deleterious effects of mycotoxins on the intestine [15]. Junction cell proteins
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as occludin, claudin and E-caderin have a fundamental role in maintaining epithelial architecture [33].
In this experiment we observed a decrease in E-cadherin expression, mainly in explants exposed to
DON and to both mycotoxins. It is known that pigs chronically fed diets contaminated with DON,
FB1 or FB1 plus DON present a significant decrease in E-cadherin and occludin expression [7]. In pigs’
intestinal cells exposed to DON, the changes in claudin-4 expression, a junction protein, were related
to phosphorylation of ERK 1/2, a mitogen activated protein kinase [16]. The molecular mechanisms
underlying FB1 exposition and changes in junction proteins remain to be investigated. The reduction
in the expression of E-cadherin reflects the ability of mycotoxins to alter epithelial integrity; however
future studies evaluating other proteins that comprise the junctional complex can establish the types
of changes on the epithelium and the courses of action of mycotoxins. A decreased expression of
E-cadherin is a factor that contributes to increased paracellular permeability and facilitates the invasion
of pathogens.
One of the aims of this study was to characterize the ultrastructural changes on the intestine
induced by DON and FB1 with emphasis on cell junctions. To the best of our knowledge, this is the first
study reporting the effects of DON and FB1 on intestinal ultrastructure. In this study we observed an
increase in intercellular spaces and disappearance of junction structures induced by both mycotoxins.
Increase in paracellular permeability has been reported in Caco-2 cells exposed to DON through
inhibition of protein synthesis [34]. In addition, IPEC cells incubated with FB1 showed a decrease in
transepithelial electrical resistance [5]. Our results indicate that DON and FB1 induce severe changes
in junction complexes and cell structure increasing intestinal permeability and decreasing intestinal
absorption. The ultrastructural findings observed on explants exposed to mycotoxins also strengthen
those observed on immunohistochemical evaluation of E-cadherin expression reinforcing the changes
on junction structures.
4. Material and Methods
4.1. Animals
Five piglets (Landrace × Large White × Duroc) of 24 days old (6.3 kg, ± 0.8) were used to collect
the explants. The animals were weaned at 21 days of age, and then subjected to a standard diet after
weaning in separate bays. At 24 days the piglets were euthanized with an intravenous injection of
sodium pentobarbital (40 mg/kg of body weight). The institutional Ethics Committee for Animal
Experimentation approved all animal procedures.
4.2. Culture of Explants and Exposure to FB1 and DON
The jejunum was chosen because in prior studies this region was shown to be more sensitive to
the effects of mycotoxins [16]. Fragments of 5 cm of medial jejunum were sampled immediately after
euthanasia, and washed with buffered saline (PBS) and opened longitudinally. The explants were
collected with the aid of a biopsy punch (8 mm) and placed in six-well plates (EasyPath, São Paulo,
Brazil), filled with 3 ml of agar and containing DMEM (GIBCO, NY, USA) plus fetal bovine serum
(10%), glutamine (0.2 mL/L), gentamicin (0.5 mg/mL) and penicillin/streptomycin (10 mL/L).
The explants were deposited with the mucosa facing upwards (3 explants/well) and incubated
at 37 ◦C in the presence of FB1 (F1147, Sigma-Aldrich, São Paulo Brazil) (100 μM) or DON (D0156,
Sigma-Aldrich, São Paulo, Brazil) (10 μM) alone and FB1 (100 μM) plus DON (10 μM) for four
hours. The doses used in this experiment are based in previous studies in vitro [35] and ex vivo [20]
that have shown toxic effects with these concentrations. The dose of FB1 (100 μM) corresponds to
an intake of 144 mg/kg of feed, while the dose of DON (10 μM) corresponds to an ingestion of
3 mg/kg of contaminated feed. From each animal 48 explants were sampled and submitted to the
different treatments (24 explants/animal were used for immunohistological analysis and the other
24 for ultrastructural analysis). A total of 240 explants were evaluated by immunohistological and
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ultrastructural methods. For each treatment three explants immersed in culture medium without
mycotoxins (control group) were incubated.
4.3. Histological and Morphometric Analysis
After the incubation period, explants were fixed in 10% buffered formalin solution, dehydrated in
increasing alcohols and embedded in paraffin. Sections of 5μm were stained with hematoxylin and eosin
(HE) for histological analysis. The histological changes were evaluated using an adapted tissue score [15]
in which the intensity and severity of lesions were considered. The maximum score (22 points) indicates
the overall integrity of the intestine. The criteria used to determine the score were morphology and
number of villi, morphology of enterocytes and microvilli, presence of cellular debris, interstitial edema,
lymphatic dilation and cellular necrosis. The lesion score was calculated by taking into account the degree
of severity (severity factor) and the extent of each lesion (according to intensity or observed frequency,
scored from 0 to 3). For each lesion, the score of the extent was multiplied by the severity factor.
To evaluate the density of goblet cells, sections were stained with alcian-blue. The number of
goblet cells was counted in 10 randomly villi, using a 10 × magnification. Goblet cells present in the
crypts were not counted. For morphometric evaluation the heights of 10 intestinal villi were measured
randomly with the aid of the Motic Image Plus 2.0 software using a 10 × magnification.
4.4. Immunohistochemical Analysis
The expression of E-cadherin was evaluated using specific monoclonal antibody (clone 4A2C7,
Zymed, Carlsbad, CA, USA) and the proportion of the intestinal section expressing E-cadherin was
estimated. Each sample was assessed as showing either normal or reduced staining. Normal staining
was considered when homogeneous and strong basolateral membrane staining of the enterocytes was
detected. Heterogeneous and weak staining was considered to indicate reduced expression. The results
are reported as the percentage of animals showing strong/homogeneous immunoreactivity to E-cadherin.
Tissue sections were deparaffinised with xylene and dehydrated through a graded ethanol series.
Heat-mediated retrieval was done by heating the sections immersed in citrate buffer (pH 6.0) in a
microwave oven (750 W) for 15 min. Endogenous peroxidase activity was blocked by incubation in
methanol-hydrogen peroxide solution. The sections were incubated overnight at 4 ◦C with the primary
antibody (diluted 1:50). The secondary antibody (Nichirei Biosciences, Tokyo, Japan) was applied followed
by the addition of a chromogen (3,3′-diaminobenzidine). Finally, tissue sections were counterstained
with hematoxylin and mounted on coverslips using a synthetic resin. All reactions were accompanied
with negative and positive controls of the reaction according to the manufacturer.
4.5. Ultrastructural Analysis
The explants exposed to the different treatments were submitted to transmission electron
microscopy. After the incubation period samples were fixed in Karnovsky modified solution and
post-fixed in 1% osmium tetroxide. After complete sequential dehydration, the samples were embedded
in epoxy resin and maintained for 3 days at 60 ◦C for polymerization. Ultrathin sections were stained
with uranyl acetate and lead citrate and analyzed by TEM (model FEI Tecnai 12).
4.6. Statistical Analysis
The data used for statistical analysis were represented as means with their standard deviation.
The experimental design used in the present study was entirely randomized with six replicates (each
explant representing one replicate). Oneway analysis of variance (ANOVA) followed by a multiple
comparison procedure (Tukey test) was used for statistical analysis. Data of the expression of E-cadherin
were subjected to Fisher's exact test. The lack of normality or homogeneity of goblet cell number leads to
the use of the non-parametric Kruskal-Wallis and Dunn tests. Differences were considered statistically
significant at p ≤ 0.05. Statistical analyses were performed with BioStat 5.0 (Belém, Pará, Brazil)
software package. Ultrastructure parameters were subjected to a descriptive analysis.
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5. Conclusions
In conclusion, results of the present study indicate that 10 μM of DON and 100 μM of FB1 alone
or in combination induce significant damage on intestinal tissue. An association between exposition
to these mycotoxins and reduced villi height, globet cell density, E-cadherin expression and junction
complexes was also demonstrated. Taken together, these results support that DON and FB1 could
increase enterocyte paracellular permeability and promote major changes on intestinal barrier function.
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Abstract: The aim of the study was to verify the hypothesis that intoxication with low doses of
mycotoxins leads to changes in the mRNA expression levels of nitric oxide synthase-1 and nitric
oxide synthase-2 genes in tissues of the gastrointestinal tract and the liver. The experiment involved
four groups of immature gilts (with body weight of up to 25 kg) which were orally administered
zearalenone in a daily dose of 40 μg/kg BW (group Z, n = 18), deoxynivalenol at 12 μg/kg BW (group
D, n = 18), zearalenone and deoxynivalenol (group M, n = 18) or placebo (group C, n = 21) over a
period of 42 days. The lowest mRNA expression levels of nitric oxide synthase-1 and nitric oxide
synthase-2 genes were noted in the sixth week of the study, in particular in group M. Our results
suggest that the presence of low mycotoxin doses in feed slows down the mRNA expression of both
nitric oxide synthase isomers, which probably lowers the concentrations of nitric oxide, a common
precursor of inflammation.
Keywords: mycotoxins; low doses; zearalenone; deoxynivalenol; gene expression; nitric oxide synthases
1. Introduction
The liver and intestinal mucosa are subjected to high antigen loads and highly varied antigen
molecules ingested with feed. Foodborne microorganisms colonize the digestive tract [1]. The intestinal
barrier function involves a series of mechanisms which control absorption through the mucous
membrane and prevent intestines against harmful substances. In a stable physiological state, small
numbers of antigens are transported across the intestinal barrier which can quickly identify and
eliminate foreign intruders that pose a health risk. Two types of immune responses are involved in
this process: innate (nonspecific) immunity which is the body’s first line of defense against infections
and adaptive (specific) immunity which is further subdivided into cellular and humoral immunity.
If the intestinal barrier function is disrupted by harmful substances ingested with food, such as
mycotoxins [2,3], other antigen molecules or microorganisms, the structural continuity of the mucous
membrane may be disrupted and the number of signaling molecules may be altered, leading to various
pathological states. In a normal host, equilibrium is restored when the pathological factor is eliminated,
but in susceptible hosts, intestinal permeability may be increased which, in extreme cases, can lead to
chronic inflammations [4].
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Nitric oxide (NO), first described as an endothelium-derived relaxing factor (EDRF), plays various
roles in basic life functions of an organism. NO is one of the smallest known biologically active
molecules. In stable physiological states, it acts as an intracellular signaling molecule, and at higher
concentrations, it plays the role of an autocrine and paracrine molecule which regulates the immune
response [5] or a factor which controls the peristalsis of the entire gastrointestinal tract [6]. NO levels
are determined by the activity of various nitric oxide synthase (NOS) isomers [7,8]. Three basic forms
of NOS have been identified to date: NOS-1, NOS-2 and NOS-3. They were previously classified as:
NOS-1–nNOS (neuronal NOS) or NOS-I; NOS-2–iNOS (inducible NOS) or NOS-II; and NOS-3–eNOS
(endothelial NOS) or NOS-III [6]. Mammalian cells contain two constitutive NOS enzymes—NOS-1
and NOS-3 which synthesize NO in response to an increase in calcium ion (Ca2+) concentrations inside
a cell [9]. In some cases, those enzymes can be activated independently in response to stress.
The activity of the inducible isoform of NOS-2 is not determined by intracellular concentrations
of Ca2+, but by calmodulin binding. Higher Ca2+ concentrations inside a cell increase calmodulin
levels and supports calmodulin binding with NOS-1 and NOS-3, leading to momentary intensification
of NO synthesis [10]. Unlike isoforms NOS-1 and NOS-3, NOS-2 can bind with calmodulin even at
low intracellular concentrations of Ca2+. NOS-2 activity is not affected by changes in Ca2+ levels,
which prolongs synthesis [11] and increases local NO concentrations in the cell in comparison with the
remaining NOS isoforms [12–14].
NOS-2 is found mainly in the central nervous system, peripheral nervous system, skeletal muscles,
pancreatic islets, endometrium and the macula densa. NOS-2 modulates the transmission of neural
signals, regulates nephron functions and controls gastrointestinal peristalsis [6]. NO produced by
NOS-2 also acts as a neurotransmitter, in particular in the non-adrenergic non-cholinergic (NANC)
nervous system. NOS-1 is activated in the first hours after cytokine release. Successive periods are
characterized by a predominance of NOS-2 which synthesizes significant amounts of NO [15].
NOS-2 is also observed in macrophages, cardiac muscle, liver, smooth muscles and vascular
endothelium where it is synthesized in response to endogenous and exogenous agents such as bacterial
lipopolysaccharides, pro-inflammatory cytokines (IL-1β, IL-4, IL-6, IL-8 and IL-10 INF-γ, TNF-α) [15] and
allergens [5,16,17], including zearalenone (ZEN), deoxynivalenol (DON) and mixtures thereof [18,19].
Mycotoxicosis caused by DON and/or ZEN reduced the number of mucus producing cells and
decreased glycocalyx secretion in pigs exposed to low doses of those mycotoxins [20]. Intoxication
with higher doses of ZEN alone exerted different effects by stimulating the activity of goblet cells and
mucinogen granules [21]. Maresca and Fantini [2] demonstrated that intestinal mucosa is also affected
by other mycotoxins which can contribute to inflammatory processes and uncontrolled proliferation of
mucosal cells. The mechanisms responsible for mycotoxins’ effects on mucus production have not yet
been identified. Trichothecenes and estrogenic hormones were found to inhibit protein synthesis, and
ZEN could be included in this group of mycotoxins [2].
The effects of ZEN and DON on local enteric immunity have not been investigated to date, but it
can be assumed that ZEN is a potential and DON is a definite immunosuppressive agent [2]. Those
mycotoxins participate in immunosuppressive processes that lead mainly to intestinal inflammations.
Hyperadditive synergistic interactions contribute to the above [22]. Some mycotoxins have direct
or indirect pro-inflammatory effects, and they exacerbate the existing inflammations [23]. They can
provoke inflammations indirectly by modifying intestinal permeability and contributing to antigen
transfer from the intestines, or directly by stimulating the release of pro-inflammatory cytokines from
the intestinal epithelium [23]. Expression levels, in particular the expression of NOS-2, should be
determined to evaluate the immunomodulative properties of the analyzed mycotoxins.
The objective of this study was to determine the effect of ZEN, DON and mixtures thereof,
administered at low doses to gilts, on the expression levels of NOS-1 and NOS-2 proteins in different
sections of the porcine gastrointestinal tract.
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2. Materials and Methods
All of the experimental procedures involving animals were carried out in compliance with Polish
legal regulations determining the terms and methods for performing experiments on animals (opinion
of the Local Ethics Committee for Animal Experimentation No. 88/N of 16 December 2009).
The experiment was conducted at the Department of Veterinary Prevention and Feed Hygiene,
Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Poland, on 75 clinically
healthy gilts with initial body weight of 25 ± 2 kg. The gilts were penned in groups with ad libitum
access to water. Administered feed was tested for the presence of mycotoxins: ZEA, α-ZEL and
DON. Mycotoxin levels in the diets were estimated by common separation techniques with the use of
immunoaffinity columns (Zearala-TestTM Zearalenone Testing System, G1012, VICAM, Watertown,
USA and DON-TestTM DON Testing System, VICAM, Watertown, USA) and high performance liquid
chromatography (HPLC) (Hewlett Packard, type 1050 and 1100) [24] with fluorescent and/or UV
detection techniques.
The animals were divided into three experimental groups (Z, D and M; n = 18 in each group)
and one control group (C; n = 21). Group Z animals were orally administered ZEN at 40 μg/kg
BW, group D animals were orally administered DON at 12 μg/kg BW, and group M animals were
orally administered a mixture of ZEN and DON (40 μg ZEN/kg BW + 12 μg DON/kg BW). Group C
pigs were fed a placebo. In all experimental groups, mycotoxins were administered at doses below
NOAEL values [22]. Both mycotoxins were synthesized and standardized by the Department of
Chemistry of the Poznań University of Life Sciences under the supervision of Professor Piotr Goliński.
The experiment covered a period of 42 days. Three animals from each experimental group were
sacrificed on days 1, 7, 14, 21, 28, 35 and 42 (a total of 12 gilts on each day), excluding day 1 when only
three control group animals were scarified.
2.1. Reagents
Analytical samples of the studied mycotoxins were administered per os daily in gelatin capsules
before the morning feeding. Mycotoxin samples were diluted in 300 μL 96% ethyl alcohol (96% ethyl
alcohol, SWW 2442-90, Polskie Odczynniki Chemiczne SA) to obtain the required doses (subject to
body weight). The resulting solutions were stored at room temperature for 12 h to evaporate the
solvent. The animals were weighed every seven days to update mycotoxin doses for each gilt.
2.2. mRNA Isolation and cDNA Synthesis
Tissue samples were collected from the porcine gastrointestinal tract (liver (L)—left lobe,
duodenum (DU)—first and middle sections, jejunum (J)—middle section, ascending colon (AC)—middle
section, descending colon (DC)—middle section) and rinsed in PBS. Tissue samples were placed in
RNAlater®solution (Invitrogen, Carlsbad, California, USA) to stabilize RNA. They were incubated
at 4 ◦C for 24 h and frozen at −80 ◦C. RNA was isolated from the porcine digestive tract with
the use of the Total RNA Mini Plus kit (A&A Biotechnology, Gdynia, Polska). Tissue samples of
200 g were weighed and homogenized in TissueLyser II (Qiagen, USA). Total RNA was extracted in
accordance with the manufacturer’s protocol. RNA concentrations and purity were determined in the
Nano Vue spectrophotometer (GE Health Care, Buckinghamshire UK). RNA quality was evaluated by
electrophoresis in 2% agarose gel. The resulting total RNA was dissolved in an aqueous solution and
stored at −80 ◦C until analysis by reverse transcription PCR (RT-PCR). RT-PCR was performed with
the use of Fermentas reagents (Lithuania). The volume of the RNA solution containing 5 μg of total
RNA was determined, and it was supplemented to 12.5 μg through the addition of RNase-free water
and 1 μg of Oligo(dT)18 (0.5 μg) primers (Fermentas, Lithuania). The resulting mixture was incubated
at −65 ◦C for 5 minutes and cooled on ice. 4 μL of 5 × RT buffer, 0.5 μL of 20U RNase inhibitor
(RiboLock™ RNase Inhibitor) (Fermentas, Lithuania), 2 μL of dNTP mix, 10 mM each (Fermentas,
Lithuania), and 1 μL of 200U reverse transcriptase (RevertAid™ Transcriptase) (Fermentas, Lithuania)
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were added. The resulting mixture was incubated at 42 ◦C for 60 min, and the reaction was terminated
at 70 ◦C for 10 min. The reverse transcription reaction was carried out in the Personal Mastercycler
Eppendorf thermocycler (Hamburg, Germany). The cDNA synthesis reaction mixture was used in
Real-Time PCR.
2.3. Real-Time PCR
Real-Time PCR was performed in the Genomics and Transcriptomics Laboratory of the
Department of Animal Anatomy, Faculty of Veterinary Medicine of the University of Warmia and
Mazury in Olsztyn. Real-Time PCR was carried out to determine the mRNA expression levels of NOS-2
and NOS-1 genes in reference to the GAPDH gene. Specific primers for the above genes were designed
in the Pick Primer Blast application based on the following sequences: NOS-2–NM_001143690.1,
NOS-1–XM_003132898.3 and GAPDH–NM_001206359.1 (Table 1). Reaction tubes were filled with
25 μL of the reaction mix, and the assay was performed in the 7500 Fast Real-Time PCR System
thermocycler (Applied Biosystems, Carlsbad, California USA) under the following conditions: initial
denaturation −10 min/95 ◦C, followed by 40 cycles: denaturation −15 s/95 ◦C, primer annealing
−1 min/60 ◦C. The following reagents were used: 12.5 μL of FastStart Universal SYBR Green Master
(Rox) (Roche, Vaud, Switzerland), 10.5 μL of nuclease-free water, 1 μL of cDNA, 1 μL of the primer
mix, 5 μM each (forward + reverse). All samples were analyzed in duplicates.









NOS-1 f: CCATGGCCGCCGATGTCCTCr: CGGTTGTCATCCCTCAGCCTGC 60
◦C 109 bp XM_003132898.3
NOS-2 f: CTCCAGGTGCCCACGGGAAAr: TGGGGATACACTCGCCCGCC 60
◦C 117 bp NM_001143690.1
GAPDH f: TTCCACCCACGGCAAGTTr: GGCCTTTCCATTGATGACAAG 60
◦C 69 bp NM_001206359.1
2.4. Statistical Analysis
The data were grouped based on: (i) the administered mycotoxins relative to experimental dates
and (ii) experimental dates relative to the analyzed mycotoxins. Differences between the administered
mycotoxins relative to experimental dates and differences between experimental dates relative to the
analyzed mycotoxins were analyzed. The results were processed statistically in the Statistica application.
Differences between groups (mycotoxin or date) were determined by ANOVA. The equality of group
variances was tested by the Brown-Forsythe test. When ANOVA revealed significant differences between
groups (P < 0.01—highly significant differences, 0.01 < P < 0.05—significant differences, P > 0.05—no
differences), Tukey’s HSD test was used to determine differences between specific groups.
3. Results
The results of statistical analysis of mRNA expression levels of NOS-1 genes in selected sections of
the porcine gastrointestinal tract and the liver on different days of the experiment relative to the GAPDH
gene are presented in Figure 1A–D. Differences at P < 0.05 were reported: on sampling date I—between
group M and group C in tissue J (Figure 1A), between groups Z and D and group C in tissue DC
(Figure 1B); on sampling date V—between group C and the remaining groups in tissue DC (Figure 1C);
on sampling date VI—between group C and the remaining groups in tissue J (Figure 1D). Differences at
P < 0.01 were observed only on date I between group D and group C in tissue J (Figure 1A).
The results of statistical analysis of mRNA expression levels of NOS-2 genes in selected sections
of the gastrointestinal tract and the liver of gilts intoxicated with mycotoxins on different days of
the experiment are presented in Figure 1E–F. Differences at P < 0.05 were reported between group Z
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and groups C and M on date VI in tissue DU (Figure 1E). Differences at P < 0.01 were observed on
date I between group Z and groups C and D, and between group M and groups C and D in tissue L
(Figure 1F).
 
Figure 1. The results of statistical analysis of mRNA expression levels of nitric oxide synthase (NOS)-1
and NOS-2 genes in selected sections of the porcine gastrointestinal tract and the liver on different
days of the experiment relative to the GAPDH gene are presented in: (A) Jejunum NOS-1 (sampling
date I); (B) Descending colon NOS-1 (sampling date I); (C) Descending colon NOS-1 (sampling date V);
(D) Jejunum NOS-1 (sampling date VI); (E) Duodenum NOS-2 (sampling date VI); (F) Liver NOS-2
(sampling date I).
The results of statistical analysis of mRNA expression levels of NOS-1 genes in selected sections
of the gastrointestinal tract and the liver of gilts intoxicated with mycotoxins in different groups
throughout the entire experiment are presented in Figure 2A–D. Differences at P < 0.05 were reported:
in group C in tissue DC between date I and dates IV and VI (Figure 2A); in group Z—in tissue DU
between dates I and V and between dates IV and VI (Figure 2B) and in tissue AC between date III and
dates IV and V (Figure 2C), in tissue DC between date IV and dates I and II (Figure 2A); in group D—in
tissue DC between date III and dates IV and V and between date II and dates IV and VI (Figure 2A), in
tissue L between dates II and V and between dates IV and VI (Figure 2D); in group M—in tissue DC
between dates I and VI (Figure 2A). Differences at P < 0.01 were observed: in group Z—in tissue DU
between dates IV and V (Figure 2B); in group D—in tissue DC between dates III and VI (Figure 1A)
and in tissue L between dates V and VI (Figure 2D).
The results of statistical analysis of mRNA expression levels of NOS-2 genes in selected sections
of the gastrointestinal tract and the liver of gilts intoxicated with myxotoxins in different groups
throughout the entire experiment are presented in Figure 2E–H. Differences at P < 0.05 were reported:
in group Z—in tissue DU between date VI and the remaining dates (Figure 2E), in tissue L between
dates VI and V (Figure 2F); in group M—in tissue DC between date II and dates III, IV and VI
(Figure 2G). Differences at P < 0.01 were observed: in all experimental groups in tissue J between
201
Toxins 2013, 5, 2281–2292
date IV and the remaining dates (Figure 2H); in group M—in tissue L between date II and dates I
and V (Figure 2F). A high number of differences were verging on the statistically significant level
(0.1 > P > 0.05), representing statistical tendencies.
 
Figure 2. The results of statistical analysis of mRNA expression levels of NOS-1 genes in selected
sections of the gastrointestinal tract and the liver of gilts intoxicated with mycotoxins in different groups
throughout the entire experiment are presented in: (A) Descending colon (NOS-1); (B) Duodenum
(NOS-1); (C) Ascending colon (NOS-1); (D) Liver (NOS-1); (E) Duodenum (NOS-2); (F) Liver (NOS-2);
(G) Descending colon (NOS-2); (H) Jejunum (NOS-2).
The results of statistical analysis of mRNA expression levels of NOS-1 and NOS-2 genes in selected
sections of the gastrointestinal tract and the liver of gilts intoxicated with mycotoxins on different
experimental dates (Figure 1A–F) point to a decreasing trend in the mRNA expression levels of NOS-1
genes (Figure 1A–D) in all experimental groups in comparison with group C, between group M and
groups Z and D, and between group Z and group D. A similar trend was noted in the mRNA expression
levels of NOS-2 genes (Figure 1E–F), but an increase in mRNA expression was noted in group D in a
comparison with group Z.
The values of NOS-1 gene expression in selected sections of the gastrointestinal tract and the liver
of gilts intoxicated with mycotoxins in different groups throughout the experiment (Figure 2A–D) were
not uniformly distributed, and the median for selected tissues in different groups was determined
at: in group C—0.012336 for DU, 0.001267 for J, 0.001316 for AC, 0.001425 for DC and 0.002838 for
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L; in group Z—0.001275 for DU, 0.000346 for J, 0.002249 for AC, 0.000795 for DC and 0.003281 for L;
in group D—0.002531 for DU, 0.000262 for J, 0.007142 for AC, 0.000940 for DC and 0.002988 for L;
in group M—0.001160 for DU, 0.000163 for J, 0.008002 for AC, 0.001026 for DC and 0.002392 for L.
The lowest quartile of gene expression values was observed on date VI in 7 cases (3 × in DC and L in
groups Z, D and M, and 1× in AC in group C) and on date IV in 6 cases (4 × in DU and 1 × in DC in
group C and in AC in group Z). The highest quartile of gene expression values was noted on date V in
6 cases (3 × in DU in groups C, Z and M, 2 × in L in groups D and M, 1 × in J in group D), on date III
in 5 cases (4 × in AC and 1 × in DC in group D) and on date I in 4 cases (2 × in J in groups Z and M
and 2 × in DC in groups C and M).
The values of NOS-2 gene expression in selected sections of the porcine gastrointestinal tract
and the liver across groups throughout the experiment (Figure 2E–H) were not uniformly distributed,
and the median for selected tissues in different groups was determined at: in group C—0.055680 for
DU, 0.416960 for J, 0.068257 for AC, 0.173322 for DC and 0.011045 for L; in group Z—0.041299 for
DU, 0.349643 for J, 0.105470 for AC, 0.204706 for DC and 0.006676 for L; in group D—0.037921 for
DU, 0.486018 for J, 0.062965 for AC, 0.109968 for DC and 0.009398 for L; in group M—0.021214 for
DU, 0.500869 for J, 0.077001 for AC, 0.158163 for DC and 0.009989 for L. The highest quartile of gene
expression values was noted: in DC on date II and in J on date IV in all groups, and in L in groups Z,
D and M on date V. The lowest quartile of gene expression values was observed: on date VI in 12 of 20
identified cases (3 × in J and DC in groups C, Z and M; 3 × in L in groups Z, D and M; 2 × in DU in
groups C and M, 1 × in AC in group Z); on date V in 4 cases (2 × in AC in groups Z and M, 1 × in DU
and 1 × in DC in group D). All median values of mRNA expression levels of NOS-2 genes were higher
than the median values of NOS-1 expression, excluding DU median values in group D.
4. Discussion
The presence of pathogens in digest can modulate the local immune response. The degree of
immunomodulation is determined by the dose of the pathogenic substance, such as a mycotoxin. On
the other hand, the clinical picture of intoxication does not reveal such a tendency, which is consistent
with the low dose hypothesis proposed by Vandenberg et al., [25]. The induction of regulatory T cells
(Treg) is observed. This mechanism is deployed by pathogens, and not only, is to escape the immune
response [26], and it observed during chronic and persistent infections. Very little is known about the
possible effects of mycotoxins which can be ingested in small doses with feed over prolonged periods
of time (monodiet) or on a regular basis.
Reactive oxygen species are activated before Treg induction [14]. They include NO, one of the
main signaling molecules in the immune system. NO is active at the place of release or it may be
transferred across mucous membranes into surrounding tissues. It is one of the most active smooth
muscle relaxants. NO is catalyzed from arginine by NOS. Its activity is strictly determined by its
concentrations at the site of the reaction which, in turn, are dependent on the expression levels of
specific NOS isomers. At high concentrations, NO exerts proinflammatory and cytotoxic effects directly
or indirectly via its active derivatives (nitrite, nitrogen trioxide, peroxynitrite, nitrosoperoxycarbonate).
At low, physiological concentrations, NO regulates homeostasis in circulatory, respiratory [27] and
immune systems and controls nerve conduction [28,29].
The results of our study investigating the mRNA expression levels of NOS-1 and NOS-2 genes in
gilts administered very low doses of individual mycotoxins (ZEN and DON) or the mycotoxin mix for
42 days are partially consistent with published data. Significant differences (at P < 0.05 and P < 0.01)
were observed in the mRNA expression levels of NOS-1 genes in selected sections of the porcine
gastrointestinal tract and the liver on different days of the experiment (Figure 1A–F), in particular in
tissues J and DC on dates I and VI. A decreasing trend in median values was reported in comparison
with group C and between groups administered DON. A similar trend was observed in the mRNA
expression levels of NOS-2 genes, but the noted values were significantly higher in comparison with
NOS-1 expression. A drop in the mRNA expression levels of both genes was observed in groups Z,
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D and M. This suggests that low doses of ZEN, DON or the mycotoxin mix in feed (below NOAEL
values) inhibit both NOS isomers, which probably lowers NO synthesis. The results shown in Figure 1
could suggest that ZEN was the inhibitory factor at the initial stage of the experiment, but the longer
the exposure to ZEN, the decrease in NOS-1 mRNA expression was leveled out, whereas the drop in
NOS-2 mRNA expression was more pronounced in group Z.
Similar statistical tendencies were noted with respect to the mRNA expression levels of NOS-1
and NOS-2 genes in selected sections of the gastrointestinal tract and the liver of gilts intoxicated with
mycotoxins in different groups throughout the entire experiment (Figure 2E–H). A decreasing trend
was intensified over time and in groups administered the mycotoxin/mycotoxins. The only exceptions
were tissue sections where significant differences were observed, mostly NOS-2 expression values in
tissues DU, J, AC and DC.
Our findings indicate that both mycotoxins inhibit the mRNA expression of genes controlling
constitutive isomer NOS-1 and inducible isomer NOS-2. It can be expected that low doses of ZEN or
DON administered with feed (below NOAEL value) over prolonged periods of time can modify
gastrointestinal functions due to a decrease in the concentrations of NO which inhibits NANC
transmitters [30,31]. Low levels of NO can probably speed up peristalsis in the esophagus, stomach
and intestines, inhibit gastric accommodation responses (receptive and adaptive relaxation, antral
contraction) and increase anal sphincter pressure, thus slowing down gastric emptying and digesta
passage through the intestines [6,32].
In consequence, decreased mRNA expression of the NOS-1 gene, released in the enteric nervous
system, should slow down intestinal peristalsis and sphincter function. A drop in the mRNA expression
of the NOS-2 gene should decrease intestinal permeability and inhibit bowel secretion [33]. The above
conclusions were formulated by directly extrapolating from the symptoms caused by high mycotoxin
doses to those caused by low doses. However, recent research findings provide evidence contrary to
this assumption (low dose hypothesis). The influence of very low doses (below NOAEL values) of any
hormonal agent which modulates tissue activity could be different. Undesirable hormonally active
substances [25] such as ZEN, which can act as a signaling molecule, could serve as an example.
Interestingly, a decrease in the mRNA expression of genes controlling both NOS isomerases was
particularly noted in distal sections of the digestive tract. The explanations can be provided for the
above observation. Firstly, mycotoxins have antibacterial properties, and they decrease the populations
of pathogenic microorganisms which are one of the key pro-inflammatory agents and which stimulate
NO production [34]. Secondly, when administered at low doses, the analyzed mycotoxins inhibit the
mRNA expression of both NOS genes, which could have therapeutic implications [31,35] at high levels
but not at physiological levels of NO. The presence of low doses of ZEN and DON (below NOAEL
value) in feed inhibits inflammatory processes in the digestive tract, in particular in tissues J, AC and
DC. The above could be attributed to the “escape” of signaling molecules from local and systemic
immune activation, similar to that observed when Tregs are induced by bacterial pathogens [26] in
chronic infections.
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intestine mucosa in gilts with zearalenone mycotoxicosis. Pol. J. Vet. Sci. 2005, 8, 301–307.
22. Boermans, H.J.; Leung, M.C.K. Mycotoxins and the pet food industry: Toxicological evidence and risk
assessment. Int. J. Food. Microbiol. 2007, 119, 95–102. [CrossRef]
23. Maresca, M.; Yahi, N.; Younès-Sakr, L.; Boyron, M.; Caporiccio, B.; Fantini, J. Both direct and indirect
effects account for the proinflammatory activity of enteropathogenic mycotoxins on the human intestinal
epithelium: Stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the
transepithelial passage of commensal bacteria. Toxicol. Appl. Pharmacol. 2008, 228, 84–92. [CrossRef]
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Abstract: The natural food contaminants, mycotoxins, are regarded as an important risk factor
for human and animal health, as up to 25% of the world’s crop production may be contaminated.
The Fusarium genus produces large quantities of fusariotoxins, among which the trichothecenes are
considered as a ubiquitous problem worldwide. The gastrointestinal tract is the first physiological
barrier against food contaminants, as well as the first target for these toxicants. An increasing number
of studies suggest that intestinal epithelial cells are targets for deoxynivalenol (DON) and other
Type B trichothecenes (TCTB). In humans, various adverse digestive symptoms are observed on
acute exposure, and in animals, these toxins induce pathological lesions, including necrosis of the
intestinal epithelium. They affect the integrity of the intestinal epithelium through alterations in cell
morphology and differentiation and in the barrier function. Moreover, DON and TCTB modulate the
activity of intestinal epithelium in its role in immune responsiveness. TCTB affect cytokine production
by intestinal or immune cells and are supposed to interfere with the cross-talk between epithelial
cells and other intestinal immune cells. This review summarizes our current knowledge of the effects
of DON and other TCTB on the intestine.
Keywords: barrier function; food-contaminant; immune response; intestinal lesions; mycotoxins
1. Introduction
Mycotoxins are structurally diverse fungal metabolites that can contaminate a variety of dietary
components consumed by animals and humans. It is estimated that 25% of the world’s crop production
is contaminated by mycotoxins during the pre-harvest period, transport, processing or storage [1].
The major mycotoxin-producing fungal genera are Aspergillus, Fusarium and Penicillium, mainly
producing aflatoxins, zearalenone, trichothecenes, fumonisins, ochratoxins and ergot alkaloids.
Among the mycotoxins produced by the Fusarium genus, the broad family of trichothecenes (TCT)
is extremely prevalent. They represent the most diverse chemical group of all the mycotoxins, and their
molecular weights range between 200 and 500 Da. All TCT possess a sesquiterpenoid structure with or
without a macrocyclic ester or an ester-ether bridge between C-4 and C-15. They contain a common
12,13-epoxytrichothecene group responsible for their cytotoxicity and a 9,10-double bond with various
side chain substitutions. The non-macrocyclic TCT constitute two groups: Type A, including T-2 toxin,
HT-2 toxin, neosolaniol and diacetoxyscirpenol (DAS), while the Type B group contains a ketone
and includes fusarenon-X (FUS-X), nivalenol (NIV) and deoxynivalenol (DON) and its 3-acetyl and
15-acetyl derivatives (3- and 15-ADON) (Figure 1). The number and position of the hydroxyl and
acetyl-ester groups can influence the relative toxicity within eukaryotic cells. Their relative capacity to
interfere with protein synthesis has been attributed to a combination of different factors: the rate of
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transport into cells, metabolism by cytosol enzymes, changes in affinity for the active binding site or
the ability to interfere with protein synthesis [2].
TCTB: Groups present in the R1, R2 and R3 position, respectively:
deoxynivalenol (OH, H, OH)
nivalenol (OH, OH, OH)
fusarenon-X (OH, OAc, OH)
3-acetyl deoxynivalenol (OAc, H, OH)
15-acetyl deoxynivalenol (OH, H, OAc)
Figure 1. Chemical structure of Type B trichothecenes. TCTB, Type B trichothecenes.
Deoxynivalenol and other Type B TCT (TCTB) are commonly found in cereals, such as wheat,
rye, barley, oats and corn, all over the world [2–4]. These toxins are resistant to milling, processing
and heating and, therefore, readily enter the food chain [5]. The total intake of DON in microgram per
kilogram of body weight per day has been estimated to reach from 0.78 in an African diet to 2.4 in
a Middle Eastern diet [6]. Intoxications following the consumption of foodstuffs contaminated with
TCT have occurred in both humans and animals, with large numbers of people and livestock being
affected [4]. Many outbreaks of acute human disease involving nausea, vomiting, gastro-intestinal
upset, dizziness, diarrhea and headache have been reported in Asia [7,8]. These outbreaks have been
attributed to the consumption of Fusarium-contaminated grains and, more recently, to the presence of
DON at reported concentrations of 3–93 mg/kg in grain for human consumption [6].
More than 40 countries have introduced regulatory or guideline levels for DON in food and feed.
In the USA, the Food and Drug Administration (FDA) has established an advisory level of 1 ppm
of DON for bran, flour and germ targeted for human consumption [9]. The European Commission
decided to limit the level of DON in food from 0.2 to 1.75 mg/kg for cereals and derived products,
depending on the exposed population, and in feed from 0.9 to 5 mg/kg for complementary and
complete feedstuffs, depending on the species [10,11].
Following the ingestion of contaminated food or feed, intestinal epithelial cells may be exposed to
high concentrations of toxicants, potentially affecting intestinal functions [12]. The intestinal epithelium
is a single layer of cells lining the gut lumen that acts as a selective filter, allowing the translocation of
essential dietary nutrients, electrolytes and water from the intestinal lumen into the circulation. It also
constitutes the largest and most important barrier to prevent the passage from the external environment
into the organism of harmful intraluminal substances, including foreign antigens, microorganisms
and their toxins [13]. The establishment of the epithelial monolayer by intestinal epithelial cells is
dependent upon a considerably high degree of intracellular and intercellular organization. Within
each epithelial cell, structural integrity is maintained by the presence of a complex cytoskeletal
network of microfilaments playing a crucial role in maintaining cellular polarity and in supporting
points of cell-cell contact. The interaction and contact between adjacent intestinal epithelial cells
of the monolayer is mediated by distinct junctions, including tight junctions, desmosomes and
adherens junctions [14]. The function as a selective permeable barrier places the mucosal epithelium
at the center of interactions between the mucosal immune system and luminal contents, which
includes dietary antigens and microbial products [15]. The intestine is a privileged immune site, where
immunoregulatory mechanisms simultaneously defend the body against pathogens, but also preserve
tissue homeostasis to avoid immune-mediated pathology in response to environmental challenges.
208
Toxins 2014, 6, 1615–1643
This review summarizes the consequences of exposure to DON and other TCTB on histopathological
intestinal lesions, on the potential disruption of the intestinal barrier function and on the active role of the
intestinal mucosa in immune responsiveness. We will focus on the data obtained in humans, laboratory
animals, poultry and pigs, as this latter species can be regarded as a good model for man [16,17].
2. DON and Other TCTB Reduce Growth
The reduction in weight gain as a consequence of reduced feed consumption is strongly associated
with the exposure of farm animals to DON, with pigs being one of the most sensitive species. Current
regulatory standards for DON in foods are based on its ability to cause growth suppression [18]. While
DON is considered one of the least lethal TCT, its anorexic and emetic potencies are equal to, or greater
than, those reported from the more acutely toxic TCT, such as T2-toxin [19]. Recently, the anorectic
potencies of TCTB were compared in mice, following intraperitoneal or oral exposure: NIV and FUS-X
were shown to have greater effects than DON, which had similar effects as 3- and 15-ADON [20]. The
ability of DON to induce anorexia may be the consequence of the dysregulation of various signaling
pathways. DON may act at different levels to induce impaired growth and weight gain, including
on neuroendocrine signaling, immune responses, growth hormone or a central neuronal network.
The involvement of neuroendocrine factors, such as serotonin, has been proposed [21,22]. Serotonin
is produced and released by the enterochromaffin cells in the gut, acts as a paracrine on the enteric
nervous system [23] and can affect the secretion of both anorexigenic or orexigenic hormones [24].
The impact of DON on immune responses can also affect feed consumption, because the activation of
proinflammatory cytokines is recognized as a cause of anorexia [24]. Indeed, these toxins induce several
suppressors of cytokine signaling (SOCS) [25] that impair growth hormone signaling by suppressing
two growth-related proteins, the hepatic insulin-like growth factor acid-labile subunit (IGFALS) and
insulin-like growth factor 1 (IGF1), as demonstrated in mice [25]. In this species, DON also induces
the release of the satiety hormones, peptide YY (PYY) and cholecystokinin (CCK), proposed as critical
mediators of DON-induced anorexia [26]. The impact of DON exposure on the central regulation of
energy balance has been studied in mice and pigs [27–29]. Recently, Girardet et al. [29] showed that in
addition to its peripheral action, DON can reach the brain after per os administration and act centrally
on the anorexigenic/orexigenic balance.
In conclusion, most data describing the effects of DON on food intake were obtained in mice or in
pig, and they point out both central and peripheral neuroendocrine control mechanisms. Neuroendocrine
factors and proinflammatory cytokines drive the anorexigenic effect of DON. Recent experiments obtained
only in rodent demonstrated that anorexia is induced rapidly within a few minutes following DON
ingestion. Complementary studies are needed to evaluate if the mechanisms involved in anorexia are
similar in rodents and other species.
3. DON and Other TCTB Affect Nutrient Absorption
The intestinal epithelium mediates the selective permeability from the intestinal lumen into the
circulation of essential dietary nutrients, electrolytes and water through two major routes: transcellular
permeability, generally associated with solute transport through the epithelial cells and predominantly
regulated by selective transporters for amino acids, electrolytes, short-chain fatty acids and sugars;
paracellular permeability, associated with transport via the space between epithelial cells and regulated
by intercellular membrane junctional complexes [13]. The intestinal epithelium is a recognized target for
NIV and FUS-X with acute effects, such as impaired sugar and electrolyte absorption [30]. The impaired
absorption of nutrients may participate in the effect of TCT on animal growth [31]. The impacts of
DON and other TCTB on nutrient absorption or transport at the intestinal level are summarized in
Table 1.
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3.1. Humans
In the human intestinal epithelial cell line, HT-29-clone D4, exposure to 10 μM of DON affects
the activities of intestinal transporters: inhibition of the D-glucose/D-galactose sodium-dependent
transporter (SGLT1), of the D-fructose transporter, glucose transporter-5 (GLUT5), and of active and
passive L-serine transporters has been observed. The transport of palmitate was increased, whereas
the uptake of cholesterol was not affected by the mycotoxin. At high concentrations (100 μM), SGLT1
activity was inhibited, whereas the activities of all the other transporters were increased [32].
3.2. Rodents
Exposure of mice to DON at 10 mg/kg for six weeks did not modulate the absorption of water,
L-leucine, L-tryptophan, iron or D-glucose. However, a slight, but significantly reduced, transfer
of glucose was observed. Furthermore, a significant decrease (up to 50%) in the transfer, as well
as tissue accumulation of 5-methyltetrahydrofolic acid in the jejunal segment was observed. These
findings indicate that subchronic ingestion of DON can impair the intestinal transfer and uptake of
nutrients [33].
Table 1. Effect of TCTB exposure on nutrient absorption. DON, deoxynivalenol; NIV, nivalenol;




Effects on nutrients absorption References
DON
Human HT-29
cell line (in vitro) 10 μM 48 h
Inhibition of D glucose/D galactose
transporters
[32]
Inhibition of D-fructose transporter
Inhibition of the active
L-serine transporter
Inhibition of active and passive
L-serine transport
Increase in palmitate transport
DON
Mouse (in vivo) 10 mg/kg feed 6- weeks
Reduced weight gain
[33]
Decreased transfer of glucose
Decreased jejunal transfer and tissue
accumulation of 5-methyltetrahydro folic acid
Poultry (ex vivo) 33 μM 30 min Inhibition of jejunalNa+-amino acid co-transport [34]
Poultry (ex vivo) 33 μM 30 and 45 min Decrease in jejunal glucose uptake [35]
NIV Poultry (ex vivo) 33 μM 30 min Decrease in jejunal glucose uptake [31]
15-ADON Poultry (ex vivo) 33 μM 30 min Decrease in jejunal glucose uptake [31]
FUS-X Poultry (ex vivo) 33 μM 30 min No obvious effect [31]
3.3. Farm Animals
Several studies have investigated the effects of DON on farm animals, with most of the data
obtained in chickens. The electrophysiological properties of chicken intestinal mucosa exposed to
DON were evaluated using isolated jejunum fragments in Ussing chambers [34]. Intestinal transport
was determined by changes in the short-circuit current (Isc), as a measure of ion transmembrane flux,
in the middle segment of the jejunum of broilers. The addition of D-glucose produced an increase in
the Isc, and this was reversed by different TCTB, including DON [31].
The Isc was decreased by the addition of L-proline on the luminal side of the isolated mucosa after
DON treatment, an effect that could be attributed to a strong inhibition of the L-proline/sodium-dependent
transporter by DON [34].
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Cotransporters are specialized membrane proteins using electrochemical gradients across
the membrane for transporting sugars, amino acids and ions. The inhibition of Na+ transport
and Na+-D-glucose co-transport are important mechanisms of DON toxicity in the intestine of
chickens [34,36,37]. Indeed, DON treatment (33.7 μM) decreased glucose uptake almost as efficiently
as phlorizin, a specific inhibitor of the sodium-dependent glucose cotransporter, SGLT-1 [35].
When comparing the different TCTB, the activity of the glucose co-transporter appears to be more
sensitive to DON, NIV and 15-ADON than to FUS-X in the jejunum of broilers [31].
In Ross broilers fed either a basal, low DON or high DON diet (0.26, 1.68 and 12.21 mg/kg of
DON, respectively), a progressive decrease in the relative density (weight:length) of the small intestine
with increasing time of exposure was observed, which could be correlated with a decrease in villus
height in the small intestine. The Isc of the jejunal epithelium was reduced in birds fed the high DON
diet [38]. Recently, morphometric analysis of duodenal sections of hybrid turkey poults, fed for three
weeks with DON at 5.2 mg/kg demonstrated a significant reduction in villus height and apparent
villus surface area [39]. Using a global transcriptomic approach, Dietrich et al. [40] identified, in the
jejunum of broilers fed for 23 days with DON at 2.5 or 5 mg/kg, a downregulation of genes involved
in the nutrient uptake into jejunal cells: SLC2A5, which facilitates glucose and fructose transport,
SLC27A4, involved in the palmitate transport and SLC16A1, involved in monocarboxylate uptake.
In conclusion, the data obtained by in vitro and ex vivo experiments performed in different
species (human, mouse and poultry) show that DON affects the absorption of amino acids and
sugars in intestinal epithelial cells. These studies indicate that DON affects key nutrients transporters.
The precise mechanisms of action of DON and other TCT is still unknown, but these toxicants could
act on the transporter proteins themselves and also on other constituents of the “transportsome”, such
as regulatory molecules or scaffold proteins.
4. DON and Other TCTB Induce Intestinal Lesions
Chronic exposure to TCTB induces digestive problems, reduced food intake and food refusal.
The most striking clinical sign is the alteration of growth performance, most often related to decreased
feed intake and decreased weight gain (Table 2). The reporting of intestinal lesions has been inconsistent
and not systematically correlated with the clinical signs. Animal species differ in their susceptibility
to these toxins. For example, as far as DON is concerned, the animal species can be ranked in the
following order: pigs > mice > rats > poultry ≈ ruminants [2].
Among different hypotheses, the interaction of mycotoxin-microbiota can be proposed to explain,
at least in part, the differences between species. The microbiota is thought to play important roles
in the maturation of the intestinal and immune systems, in the nutrition of the host and, finally, in
its protection against pathogenic micro-organisms and hazardous chemicals/xenobiotics, including
TCTB. Differences in the localization of the gut bacteria able to convert toxic DON into its non-toxic
de-epoxide metabolite, DOM-1, prior to or after the small intestine can have a major effect on the
bioavailability of ingested TCTB. On this basis, animals can be divided into two groups: polygastric
animals and birds with a high bacterial content located both before and after the small intestine; and
monogastric species (including humans, pigs and rodents) with a high bacterial content located only
after the small intestine, i.e., in their colon [41].
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3–5 weeks Edema and congestion [42–44]
0.7–5.8 mg/kg
4 weeks
Slight to moderate inflammation and
congestion of intestinal mucosa. Slight to
moderate degeneration of lymphoid cells in
Peyer’s patches and in lymph nodes
[45]
4 mg/kg Corrugations in the fundic region (stomach) [46]
2–3 mg/kg
4 weeks Corrugations in jejunum [47]
2.8 mg/kg Multifocal atrophy and villus fusion,Apical necrosis of villi,
[48,49]
5 weeks
Cytoplasmatic vacuolation of enterocytes,
Edema of lamina propria
Decrease in villus height
Decrease in the number of goblet cells in the




Alteration in villus architecture of the
jejunum (increased villus fusion and shorter
villus length).
Increased apoptosis score in jejunal epithelial
cells in association with higher number of









Histological scores of the jejunum
lower in animals fed DON + 15-ADON
compared to DON







Flattened and coalescent villi
Lyses of enterocytes
Interstitial edema and apoptosis
15-ADON >> DON = 3-ADON
[51]
The gut is identified as one of the target organs for TCTB, but no particular intestinal segment
appears more sensitive than others [52,53]. The difference in sensitivity between species may be
explained by differences in absorption, distribution, metabolism and elimination of DON [2]. The exact
mechanism of the cellular entry of TCTB is not well characterized, and one can speculate that
differences exist between species, leading to a differential sensitivity to these compounds. Moreover,
the biotransformation of TCT by the detoxifying enzymes in the liver is highly variable between
species. In the rat or pig liver, there is no de-epoxidation of DON, while these species are able to carry
out glucurono-conjugation.
4.1. Humans
Long-term exposure to Fusarium toxins has been associated with an increased incidence of
esophageal cancer in China. DON and also Fumonisin B1 were suspected to be a risk factor [54,55],
though the role of these toxins needs to be clarified [2].
4.2. Rodents
In mice, after two years of exposure to NIV at a 30 mg/kg dietary concentration, the survival
rate was generally higher in the NIV- treated animals than in the controls, where naturally occurring
tumors, mostly lymphomas, were observed. No intestinal lesions were observed after two years of
NIV exposure [56].
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In weaning rats, after 28 days of exposure to DON-contaminated feed at 10 mg/kg, a decreased
feed intake was observed, associated with a reduced weight gain. Lesions were observed in the
jejunum: the villus architecture was altered, with an increase in villus fusion and a shorter villus length.
The apoptotic score was increased in jejunal epithelial cells and associated with a greater number of
mitotic cells and crypt fission [50].
4.3. Pigs
Congestion and erosions of the gastric and intestinal mucosae have been described following
chronic DON exposure in pigs [42–45]. At 4 mg/kg of diet, DON may cause corrugations in the fundic
region of the stomach [46], which were also observed at the jejunal level with lower doses of toxin
(2–3 mg/kg diet) [47]. After five weeks of exposure to DON at 2.8 mg/kg of the diet, in the absence of
changes in the pigs’ body weight, significant histological changes were observed. Indeed, multifocal
atrophy and villus fusion, apical necrosis of villi, cytoplasmatic vacuolation of enterocytes and edema
of lamina propria were detected in the jejunum and ileum of DON-treated pigs [48]. A significant
decrease in villus height was observed in the jejunum, probably reflecting a change in the balance
between epithelial cell proliferation and apoptosis [49], while no difference in crypt depth was observed
in any intestinal region. The number of goblet cells that synthesize and secrete mucin, involved in
gut barrier function, decreased significantly in the jejunum and the ileum of piglets fed DON [49].
Similarly, a significant reduction in villus height and in the number of goblet cells was observed in pig
jejunal explants exposed to 10 μM DON for four hours [57]. When comparing the effects of DON and
its acetylated derivatives, Pinton et al. [51] observed that the reduction in villus height was greater in
animals receiving DON + 15-ADON than in the animals receiving feed contaminated only with DON.
The histological scores of the jejunum reflecting the main histological changes were lower in animals
fed with DON + 15-ADON compared with animals fed DON.
To conclude, comparable macroscopic lesions of the intestinal epithelium are observed in rodents
and pig exposed to TCTB. The exact mechanisms leading to these lesions are not characterized; it is
especially important to delineate the effect of DON on: (i) the alteration of intestinal epithelial cells;
(ii) the repair of these cells; and (iii) the coalescence and shortening of villi. Future research should
focus on the differential effects of TCT on the potential target cells in the intestinal epithelium (crypts
and stem cells vs. villus and differentiated cells). The effect of TCT on the factors that control the
balance between cell proliferation, differentiation and cell death should also be analyzed.
5. DON and Other TCTB Alter Intestinal Barrier Function
The toxicity of DON and other TCTB is partially explained by the ability of these compounds to
bind to eukaryotic ribosomes [58] and to rapidly activate the mitogen-activated protein kinases
(MAPKs) via a process termed the “ribotoxic stress response”. The MAPK cascades are central
signaling pathways that regulate a wide variety of stimulated cellular processes, including proliferation,
differentiation, apoptosis and stress response [59].
At present, the four different MAPK cascades identified are named according to their MAPK
components: extracellular signal-regulated kinase 1 and 2 (ERK1/2), c-Jun N-terminal kinase (JNK),
p38 and ERK5. Two possible upstream signal transducers for the DON-induced MAPK activation are
the double-stranded RNA-activated protein kinase (PKR) and the hematopoietic cell kinase (Hck), a
Src-family tyrosine kinase [24]. The consequence of this activation is an increase in proinflammatory
gene expression, and the downstream effects include anorexia, reduced weight gain, immune
stimulation, tissue injury and apoptosis. DON modulates cytokine and chemokine gene expression [60].
Highly dividing cells, such as intestinal epithelial cells or immune cells, are especially sensitive to
TCTB, and the exposure of intestinal epithelial cells to these toxins may alter their ability to proliferate
and to ensure a proper barrier function.
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5.1. Effects on Cell Proliferation and Differentiation
In order to maintain an effective barrier function, the intestinal epithelium rapidly regenerates
entirely in approximately one week, throughout life. Mature cells derived from intestinal stem cells
migrate upwards along the crypt-villus axis towards the tip of the villus, gradually differentiating
as they come closer to the tip [61]. Several studies have investigated the effects of mycotoxins on
intestinal epithelial cell proliferation and on intestinal morphology (Table 3).
5.1.1. Effects on Cell Growth
The effect of TCT on intestinal epithelial cell growth has mainly been studied in the two human
cell lines, Caco-2 and HT-29 [32,62,63]. When treated with a range of concentrations of DON (84 nM
to 84 μM), Caco-2 cells showed a reduction in protein synthesis, proliferation and survival [64].
Dividing Caco-2 cells were found to be more sensitive compared to differentiated cells [65]. The greater
sensitivity of proliferating cells is probably due to the capacity of the toxin to inhibit protein synthesis
and, subsequently, nucleic acid synthesis [66]. DON was also demonstrated to decrease the cell
proliferation in the porcine intestinal epithelial cell line, IPEC-1, whereas the acetylated derivatives
exhibited differential effects. Indeed, 3-ADON was less toxic and 15-ADON was equally toxic as
DON [51]. In the IPEC-J2 porcine intestinal epithelial cell line, the cytotoxicity of DON was correlated
with an increase in lactate dehydrogenase release and decrease in ATP content [67]. In the human
intestinal cell line HT-29, the cytotoxic effect of DON was not correlated with the induction of the
heat shock protein, Hsp 70, or with the generation of reactive oxygen species, but was associated
with a fragmentation of DNA and the activation of the apoptotic molecules, p53 and caspase-3 [68].
In intestinal cells from rat species (IEC-6 cell line), DON at 10 μM reduced the viability and induced
apoptosis, independently of any cell cycle arrest, but involving caspase-3 activation [69].











Increase in 4 kDa dextran permeability
Effect on the distribution pattern of claudin 1, 3






Decrease in transepithelial electrical resistance
(TEER)
Increase in 4 kDa dextran permeability
[50]








Dose dependent inhibition of cell viability
(IC50 = 10 μmol/L)
Time dependent:
Increase in total DNA damage
Increase in p53 protein level





24 h Decreased survival rate of 40% [64]
Human HT-29
cell line
0.13 to 0.7 μM
6 to 15 d
Decrease in brush border enzyme activity
Decrease in protein content
Decrease in transepithelial electrical resistance
(TEER)







Decrease in claudin-4 tight junction proteins





12 h Increase in E coli K12 translocation [72]
Human Caco-2
cell line
1.7 to 17 μM
24 h Decrease in claudin-4 tight junction proteins [73]
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10 to 50 μM
48 h
Decrease in TEER
Decrease in claudin-3 and 4 tight junction proteins
Increase in 4 kDa dextran permeability







10 to 30 μM
Decrease in TEER and increase in 4 kDa dextran
permeability
15-ADON >> DON > 3-ADON
[51]
24 to 48 h
Decrease in claudin-3 and -4 tight junction proteins
expression




2.5 to 10 μM 24 h
Decrease in cell viability
Increase of lactate dehydrogenase release






20 to 50 μM 2 h Increase in 4 kDa dextran permeability [71]
Porcine tissue
(jejunal explants)
1 to 10 μM 4 h Shortened and coalescent villi, lysis of enterocytes,edema [48]
As the intestine is potentially exposed to mixtures of mycotoxins [74,75], Alassane-Kpembi et al.
evaluated interactions caused by co-exposure to TCTB on proliferating Caco-2 cells [76]. Using the
MTT test and neutral red uptake, the authors observed that binary or ternary mixtures show synergistic
effects when toxins were at low concentrations (cytotoxic effect between 10% and 40%) and additive or
nearly additive effects at higher concentrations (cytotoxic effect around 50%).
5.1.2. Effects on Cell Differentiation
Using scanning electron microscopy, Kasuga et al. [62] demonstrated on differentiated Caco-2 cells
that the formation of the brush border and the expression of two membrane-associated hydrolases
related to enterocyte differentiation were affected by DON in a dose-dependent manner [62].
In broiler chicks, the ingestion of DON-contaminated feed produced an alteration in the small
intestinal morphology, especially in the duodenum and jejunum, where the villi were shorter and
thinner [77].
5.2. Effects on Barrier Functions
Polarized cells form strong barriers through the development of tight junctions between them.
The intercellular tight junction is the rate-limiting barrier in the paracellular pathway for permeation
by ions and larger solutes [78]. The investigations concerning the effects of TCTB on the intestinal
barrier functions are only just beginning.
5.2.1. Effects on TEER
The transepithelial electrical resistance (TEER) of cell monolayers can be considered a good
indicator of the degree of organization of the tight junctions within the cell monolayer and epithelial
integrity [79]. Several studies have investigated the effect of TCTB on the TEER of intestinal epithelial
cell lines (Table 3). In three different human intestinal epithelial cell lines, HT-29, Caco-2 and T84, DON
was found to induce a dose-dependent decrease in the TEER [32,62,63,71,72,80]. The same effect was
observed in the porcine intestinal epithelial cell lines IPEC-1 and IPEC-J2 [71,81]. Interestingly, IPEC-1
cells showed greater sensitivity to DON compared with Caco-2 [71]. Several hypotheses can explain
this higher sensitivity of IPEC-1 cells [71]. Firstly, Caco-2 cells were obtained from an adenocarcinoma,
whereas IPEC-1 cells were derived from normal newborn piglets [82]. Secondly, even if Caco-2 cells
express many morphological and biochemical characteristics of small intestine [83], they are derived
from the colon. By contrast, IPEC-1 cells were obtained from jejunum and ileum. Thirdly, these two
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cell lines are from different species (pig versus human), and among animal species, pig is the species
most sensitive to DON. However, it is difficult to assess the susceptibility of humans [2]. Interestingly,
a differential sensitivity to DON of the TEER of intestinal cells from the IPEC-J2 cell line has been
observed depending on the route of application. Indeed, following basolateral exposure, the TEER
was significantly decreased compared to apical exposure [81].
Differential effects were observed in the decrease of the TEER of IPEC-1 cells after a 24-h exposure
to 10 μM of DON or acetylated derivatives, and the toxins were ranked in the following order of
toxicity: 15-ADON >> DON > 3-ADON [51]. Similar data were obtained using human Caco-2 cells,
confirming the differential effects of toxins of a close chemical structure [84].
5.2.2. Effects on Intestinal Permeability
The observed reduction in the TEER induced by trichothecenes can be due to an alteration of the
tight junction barrier properties, but also to an effect on the plasma membrane, such as alterations
in transcellular ion transport [85]. It is thus of interest to determine the effect of these toxins on the
paracellular permeability of a tracer, such as lucifer yellow or dextran (Table 3).
Kasuga et al. [62] demonstrated a significant increase in the permeability of lucifer yellow in
human Caco-2 and human T84 cells treated with DON. Similarly, we observed that DON increased
the paracellular permeability of human Caco-2 cells and porcine IPEC-1 cells to 4 kDa dextran in a
time and dose-dependent manner [71]. Akbari et al. [70] observed during 24 h that DON induced the
dysfunction of the epithelial barrier of a Caco-2 cells by measuring the decline in impedance values.
DON and its acetylated derivatives exhibit differential effects on 4 kDa dextran permeability of IPEC-1
cells, and after a 24 h exposure to 10 μM of toxin, they were ranked in the following order of toxicity:
15-ADON >> DON > 3-ADON [51].
This effect of DON on paracellular permeability was confirmed in rats chronically exposed to
DON at 2 mg/kg of feed during 28 days. Pieces of jejunum mounted in an Ussing chamber showed a
decrease of the TEER associated with an increase of permeability to 4 kDa dextran [50]. In pig explants
mounted in Ussing chambers and exposed to DON ex vivo, we observed a two-fold increase in the
paracellular passage of FITC-dextran across intestinal tissue treated with 20 μM and 50 μM of DON,
when compared to untreated ones [71].
The numerous pores present in the basement membrane of the intestinal villi are essential for the
communication of enterocytes with cells in the lamina propria. An 11-week exposure of pigs to DON
at 2.2 to 2.9 mg/kg of feed led to an increase in the pore number in jejunum and potentially improved
the antigen sampling in the intestinal epithelium [86].
5.2.3. Effects on Bacterial Translocation
The impaired intestinal integrity could lead to the entry of luminal antigens and bacteria that
are normally restricted to the gut lumen by the intestinal barrier function (Table 3). We observed
that DON induces a dose-dependent translocation of a pathogenic strain of Escherichia coli across the
porcine IPEC-1 epithelial cell monolayers [71]. An increased translocation of Salmonella typhimurium
was observed in porcine IPEC-J2 exposed to low doses of DON, with undifferentiated cells being
more sensitive than the differentiated ones [87]. Maresca et al. [72] demonstrated that among other
mycotoxins, DON allowed the transepithelial passage of apically added non-invasive commensal
bacteria across human Caco-2 cell monolayers. However, in this case, no modification of paracellular
permeability evaluated by the TEER measurement or tracer flux was observed. Such an increase in the
bacterial passage through intestinal epithelial cells after DON treatment could have major implications
for human health in terms of sepsis and inflammation. In mice, DON-contaminated diet accelerates
S. enteritidis infection [88] and transiently increases the severity of reovirus infection [89].
5.2.4. Mode of Action
The mechanism underlying the trichothecene-induced impairment of the intestinal barrier function
has been poorly investigated. The effect of DON on bacterial translocation could be related to the
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ability of this toxin to specifically decrease the expression of claudin proteins. Indeed, we have observed
that, in porcine intestinal epithelial cell monolayers, the increased permeability was accompanied by
a specific reduction in the expression of claudins. This increased permeability was also noted in pig
explants treated with DON, and a reduction of claudin expression was described in the jejunum of piglets
exposed to DON-contaminated feed [71]. This reduction of epithelial integrity through inhibition of the
claudin-4 protein synthesis was observed in DON-exposed Caco-2 cells [73]. This decrease was not due to
diminished transcription or increased degradation and was also observed for a tight junction-independent
protein, i.e., intestinal alkaline phosphatase [73]. As well as claudins, E-cadherin also plays a fundamental
role in maintaining the epithelial architecture, and its expression is decreased in pig jejunal explants
exposed to 10 μM of DON for 4 h [57]. The MAPK signaling pathway could be involved in the regulation
of tight junction protein expression. Indeed, the ribotoxic stress induced by trichothecenes leads to
the activation of members of the family of Src tyrosine kinases implicated as upstream regulators of a
large number of intracellular signaling pathways [90]. They most likely represent critical signals that
precede MAPK activation and the induction of resultant downstream responses [91]. In our study, we
observed that the MAPK p44/42 ERK activation, induced by DON treatment, decreased the expression
of claudin in correlation with a reduction in the barrier function of the intestine evaluated by TEER and
paracellular permeability [92]. A recent study indicates that 6 h following the exposure of mice to 25 mg
DON/kg bw, the distribution pattern of claudins 1, 2 and 3 was affected. In addition, the increase in the
paracellular permeability, evaluated by the measure of FITC-dextran in the serum of mice, strengthened
the hypothesis that the tight junction protein network is a target of DON [70]. We proposed a potential
mechanism to explain the loss of the barrier function of intestinal epithelial cells following DON exposure,
mediated by MAPK and claudin. The correlation between claudin 4 decreased expression and the MAPK
activation was not observed in Caco-2 cells [73], suggesting a differential mechanism of action between
porcine untransformed and human transformed intestinal epithelial cell lines.
Recently, we showed that the differential effects of DON and its acetylated derivatives on the
intestinal barrier function were correlated, at the molecular level, with the exacerbated capacity of
15-ADON to activate MAPK ERK1/2, p38 and JNK, both in the intestinal cell line, explants and the
jejunum from exposed animals, at a lower dose than DON and 3-ADON, and to decrease the expression
of the tight junction proteins, claudin 3 and 4 [51].
DON cannot only interact with epithelial cells on the apical side during intestinal passage and
absorption, but following absorption in the stomach and upper small intestine, detectable concentrations
of DON can be found in blood serum, potentially exposing epithelial cells from their basolateral side.
Diesing et al. [81] demonstrated a differential decrease in the tight junction protein, claudin 3, in the
IPEC-J2 cell line, depending on the route of application, whereas the protein, ZO-1, was unaffected by
the treatment. In addition, using a comparative global genomic approach, they showed that the apical
and basolateral challenges to epithelial cell layers trigger different gene response profiles paralleled with
a higher susceptibility towards basolateral challenge. The genes regulated were involved in metabolism,
genetic or environment information processing and cellular processes [93].
The data summarized in this paragraph, obtained in different species (mouse, pig, human) and
using different models (cell cultures, explants, in vivo experiments) confirm that one of the main target
of DON in the intestine is the tight junction protein network. The modulation of claudin proteins
by DON correlated with the increased intestinal permeability observed in vitro, ex vivo and in vivo.
In terms of human or animal health, the consequences of the DON-induced increase in intestinal
permeability still have to be determined.
6. Genotoxic Effects of DON and Other TCTB
The data on the genotoxic effects of trichothecenes are scarce, and these toxins are classified in
Group 3 (inadequate evidence) by the International Agency on Cancer Research [94]. As far as the
intestine is concerned, the genotoxic potential of NIV and FUS-X were evaluated in vitro on the human
intestinal epithelial cell line, Caco-2. In differentiated post-confluent cells, a short exposure (3 h) to NIV
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or FUS-X did not cause any DNA damage, whereas DNA damage was observed after 24 h or 72 h [66].
In HT-29 cells exposed to DON, Bensassi et al. [68] demonstrated that the increase in DNA damage
was induced in a time-dependent manner. Interestingly, in mice exposed orally and intraperitoneally
to NIV (50% of the LD50), Tsuda et al. [95] observed that NIV was genotoxic in the gastrointestinal tract,
with the colon mucosa being preferentially damaged.
7. DON and Other TCTB Modulate the Intestinal Immune Response
The intestinal immune response involves the coordinated action of both immune (dendritic cells,
macrophages, lymphocytes) and non-immune cells, including epithelial cells. Monocytes, macrophages,
dendritic cells, as well as T- and B-lymphocytes can be cellular targets of DON and other TCT. Low to
moderate toxin concentrations upregulate the expression of cytokines, chemokines and genes, inducing
an inflammatory response, both transcriptionally and post-transcriptionally [60]. Not only immune
cells, but also intestinal epithelial cells produce cytokines, crucial for the recruitment and activation
of the immune system, including TGF-α, IL-1, IL-10, IL-15 and IL-18 [96]. Other cytokines, such as
IL-1-α or β, IL-6, IL-8, TNF-α, MCP-1, CCL20 and GM-CSF, are also expressed by normal epithelial
cells and are markedly upregulated in response to microbial infections. Intestinal epithelial cells also
drive the development of dendritic cells: they release thymic stromal lymphopoietin that inhibits IL-12
production by dendritic cells and TGF-β and retinoic acid involved in the development of tolerogenic
dendritic cells. In addition, thymic stromal lymphopoietin favors the release of a proliferation-inducing
ligand (APRIL) and the B-cell activation factor of the TNF family (BAFF) by intestinal epithelial
cell-conditioned dendritic cells and supports IgA class switching directly in the lamina propria [97,98].
7.1. DON and Other TCTB Induce Intestinal Inflammation
7.1.1. Modulation of the Cytokine Production in Intestinal Tissue by TCTB
The effect of DON or TCTB on cytokine production in intestinal tissue has been evaluated
in different studies (Table 4). The increase in the expression of IL-1β, IL-8, MCP1 and IL-6 in pig
intestinal loops exposed to Salmonella typhimurium was potentiated when DON was co-exposed with
the bacteria [87]. The consequence of the DON intake could be an increase in the susceptibility to
Salmonella typhimurium, with a subsequent potentiation of the inflammatory response in the gut.





In vitro approach: intestinal epithelial cell lines
DON
Human intestine 407
and Caco-2 cell lines
0–3.3 μM 12 h [94]
↗ IL-8 [72,80,99]0–10 μM, 12 h [64]
0–16.9 μM, 48 h [66]
Porcine IPEC-J2 cell line
0.5 μM, 48 h ↗ IL-1b, IL-6, IL-8,
[100]2 μM, 48 h
↘ IL-1a, MCP1
↗ IL-1a, IL-1b, IL-6, IL-8, TNFa, MCP1
Human intestine
407 cell line
24 h pre-exposure to
LPS endotoxin ↘ IL-8 [101]
1.7 μM, 12 h




10 μM, 24 h




(in vivo) 0–3.3 μM, 6 h ↗ IL-1b, IL-8, MCP1, IL-6 [87]
Broiler chickens (in vivo) 10 mg DON/kg, 35 d
↘ IL-1β, IFN-g, TGFBR1
[103]
→ TNF-α, IL-8, NF-κβ,
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In porcine jejunal explants, 10 μM of DON led to an increase in the expression of IL-6, IL-23
and IL-1β, but did not affect the expression of TGF-β and strongly repressed FoxP3 and RALDH1.
These data suggest that in this model, DON mainly drives the intestinal immune system towards a
Th17 response elicited by the Th17 helper lymphocytes, recently described as important mediators of
the mucosal immunity, the defense against extracellular pathogens and autoimmunity [102]. Besides
these direct effects, DON also potentiates the effects of pro-inflammatory stimuli, such as TLR-4 ligands,
lipopolysaccharide (LPS) and bacteria on immune cells [104–106]. Exposure to LPS is common and
can occur through infections, via gastrointestinal translocation of gut microflora, due to inflammatory
bowel diseases, or gut injury [107]. In mice, simultaneous exposure of subtoxic intravenous doses of
LPS and dietary DON caused a sequential elevation of IL1-β overexpression and severe apoptotic
depletion of lymphoid tissue [108,109]. However, such a mechanism needs to be demonstrated in
intestinal lymphocytes during dietary exposure to LPS and TCT.
A recent study demonstrated a downregulation of the expression of IL-1β, IFN-g and transforming
growth factor beta receptor I (TGFBR1) in broiler chickens fed for 35 days with DON at 10 mg/kg feed,
but no changes in TNF-α, IL-8 and NF-κB in the jejunum of the animals [103].
7.1.2. Modulation of the Cytokine Production in Intestinal Epithelial Cells by TCTB
DON provokes intestinal inflammation in vivo [110], which results from a direct effect on the
production of pro-inflammatory cytokines, especially IL-8, by intestinal epithelial cells. IL-8 is an early
marker of the inflammatory process and is a potent chemo-attractant for leukocytes and T-lymphocytes
underlying gut epithelial cells. IL-8 also enhances cell proliferation and controls the repair processes
during injury of the intestinal mucosa or cytotoxic stress [111]. Several studies have shown that DON
stimulates the secretion of IL-8 in various human intestinal epithelial cell lines [72,80,99]. Indeed, after
exposure of Caco-2 cells to DON, a dose-dependent increase in IL-8 secretion through an NF-kB activity
mechanism was observed. This effect was amplified upon pro-inflammatory stimulation, showing that
DON exposure could cause or exacerbate intestinal inflammation. Moreover, Maresca et al. [72] have
shown that direct IL-8 secretion from differentiated Caco-2 cells in response to DON is dependent on
the ribotoxic-associated activation of PKR, NF-kB and p38. By contrast, DON-induced IL-8 secretion
in human embryonic epithelial intestine 407 cells (Int407) was dependent on the activation of MAPK
ERK1/2, but not on the activation of p38. This difference is probably due to the maturation status
of the cells: differentiated mature Caco-2 cells vs. undifferentiated Int407 cells [99]. Moreover, DON
modulates the production of several pro-inflammatory cytokines following a 48-h treatment of IPEC-J2
cells. A 2-μM exposure upregulates IL-1α, IL-1β, IL-6, IL-8, TNFα and MCP1, whereas a 0.5-μM
exposure upregulates IL-1β, IL-6, IL-8 and downregulates IL-1 and MCP1 [100]. The consequence of
the production of pro-inflammatory cytokines is the modulation of the intestinal tight junction barrier,
potentially favoring an increased translocation of luminal antigens [112].
The detection of bacteria by intestinal epithelial cells, which induces IL-8 secretion, is known
to be mediated through the interaction of bacteria flagella with the cellular Toll-like receptor 5 [113].
An indirect pro-inflammatory effect of mycotoxins could result from an alteration of the intestinal
barrier function, allowing the transepithelial passage of non-invasive commensal bacteria. Indeed,
high doses of DON (around 100 μM) compromise tight junctions and allow the transepithelial passage
of apically added non-invasive commensal bacteria [72]. In the same study, the authors showed that
DON at 1 and 10 μM potentiates the effects of basolaterally added bacteria on the secretion of IL-8 by
human intestinal epithelial cells.
The inflammation processes act to maintain tissue homeostasis, but as some cytokines are potent
mediators of potentially damaging tissue responses, several mechanisms exist to ensure that the effects
of these cytokines are restricted [114]. Recently, DON exposure was demonstrated to suppress BAFF
gene expression via the induction of SOCS3 in human enterocytes. As TCT are ribosomal stress
agents, their ingestion could exert adverse effects on the regulation of BAFF, a vital cytokine for B-cell
development [115].
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Moon et al. [101] showed that human epithelial cells are less responsive to DON-induced
IL-8 production after pre-exposure to the endotoxin LPS. As the intestine of newborn infants
becomes established with the normal microflora, their epithelium can recognize the external bacteria
components. After further constitutive experience of the commensals and their endotoxins, the
epithelium becomes hypo-responsive to the normal microflora and controls its associated physiological
inflammation [116]. The mechanism of the hypo-production of IL-8 in intestinal epithelial cells
is the extended production of the DON-induced proliferator-activated receptor γ (PPAR-γ) after
pre-exposure to endotoxin. DON increased PPAR-γ gene expression, which was transiently maintained,
but endotoxin pre-exposure extends the duration of DON-induced PPAR-γ expression, thus sensitizing
cells to induce an extended PPAR-γ in response to DON treatment. Constitutively-expressed PPAR-γ
on the intestinal epithelial surface may trigger the tolerance to the normal microflora and its
associated inflammation [117]. For example, the impaired expression of PPAR-γ has been observed
in inflammatory bowel diseases. The results demonstrated by Moon et al. [101] suggest that there
is a potential risk of mucosal inflammation after DON exposure in young infants compared with
endotoxin-tolerant adults.
7.2. DON and TCTB May Interfere with the Intestinal Homeostasis
As described previously, epithelial cells act as initiators, mediators and regulators in innate
and adaptive immune responses, as well as in the transition from innate immunity to adaptive
immunity. Dendritic cells collaborate as sentinels against foreign particulate antigens by building a
transepithelial interacting cellular network. During inflammatory and immune responses, epithelial
cells express pattern-recognition receptors to trigger a host defense response and interact with dendritic
cells to regulate antigen sensitization and release cytokines to recruit effector cells [118]. Moreover,
macrophages and T-cells are also able to modulate dendritic cell functions [119]. The effects of TCTB
on the different cell types involved in gut homeostasis can explain various pathologies associated with
the ingestion of mycotoxin contaminated food.
Firstly, DON can potentiate the effect of IL1-β on IL-8 secretion and increase the transepithelial
passage of commensal bacteria [71,72]. IL-8 has been implicated in many chronic diseases, ranging from
inflammatory bowel disease [120,121] to rheumatoid arthritis [122]. Then, in addition to potentially
exacerbating established intestinal inflammation, this mycotoxin may thus participate in the induction
of sepsis and intestinal inflammation in vivo [72]. Indeed, inflammatory bowel diseases, such as Crohn’s
disease, are generally associated with the presence of adherent-invasive bacteria [123]. A hypothesis
would be that at least in some cases, the ingestion of food contaminated with mycotoxins could be
involved in inducing inflammatory bowel diseases [63,71,72].
The induction of proinflammatory cytokines, such as IL-6 by macrophages, plays a pivotal role,
as they are directly linked to the differentiation of B-cells and to the stimulation of IgA secretion [124].
Prolonged feeding of DON causes a dramatic elevation in total serum IgA in mice. Moreover, dietary
exposure to DON or NIV selectively upregulates membrane IgA-bearing cells in mouse Peyer’s
patches [124]. IL-6 is critical to mucosal IgA immunity based both on its differentiative effects on
IgA-committed B-cells and its production in the gut by macrophages and T-cells [125]. In vivo and
in vitro, DON upregulates the IL-6 expression that drives the differentiation of IgA-committed B-cells to
IgA secretion [126–128], mimicking the early stage of human IgA nephropathy. It will be interesting to
study the implication of TCT on the release of soluble molecules, such as thymic stromal lymphopoietin
(TSLP), retinoic acid and TNF-β by intestinal epithelial cells. Indeed, TSLP is shown to favor the
release of BAFF and APRIL by conditioned dendritic cells and induces IgA switching directly in the
lamina propria. The disruption of gut homeostasis induced by TCT could explain the modification of
mucosal IgA responses, as well as the diverse immune-mediated pathology observed in response to
these fungal toxins.
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8. Conclusions
The intestinal mucosa is the first biological barrier encountered by natural toxins, and consequently,
it could be exposed to high amounts of dietary toxins. An increasing number of studies demonstrate
that intestinal epithelial cells are targets for food contaminants, including mycotoxins [129–131].
In this review, we summarize the data concerning the ingestion of DON and other TCTB.
These toxins induce intestinal pathologies in humans and animals, including necrosis of the intestinal
epithelium. They also disturb the barrier function, potentially leading to the increased translocation of
pathogens and an increased susceptibility to enteric infectious diseases. DON modulates the immune
responsiveness of the intestinal mucosa, may interact in the cross-talk between epithelial cells and
intestinal immune cells and could represent a predisposing factor to inflammatory diseases [102,132].
In farm and laboratory animals, dietary exposure to DON decreases growth performances. This is due
to a local effect of the toxin altering the structure of the epithelium, reducing nutrient absorption by
the enterocytes and modulating hormone production by enterochromaffin cells. A central effect of
DON has also been described, involving the regulation of growth hormone production by inhibitors of
cytokine signaling and the direct action of the toxin on the central neuronal network.
One important research field for the future will concern the impact of DON and other TCTB on
the intestinal microbiota. Indeed, these toxins may directly target the microbiota [133]. In addition, the
mucosal exposure to ribotoxic stress and the subsequent inflammatory responses may alter bacterial
composition and, thus, reduce the microbial diversity.
As mentioned in this review, the effects of DON and other TCTB have been investigated in
different species, including man, laboratory animals, poultry and pigs. Among these species, pigs
are of particular concern for at least two reasons: (i) due to the cereal-rich diet, pigs can be exposed
to a high level of toxins; and (ii) the pig is one of the most sensitive species. In addition, because of
the similarities in the intestinal tract, pigs can be considered as a good model for humans. In this
species, several complementary approaches have been developed to investigate the effects of DON and
other TCTB on the intestine. In vivo trials and cell culture models were used to study the long-term
exposure to mycotoxins. Intestinal loops and explants enable multiple exposure conditions of the
entire intestinal tissue to be investigated, but these models are limited to short-term exposure. The
data obtained using these complementary approaches all show an impact of DON and other TCTB on
the intestine, confirming the validity of the pig to investigate the effect of these toxins. Surprisingly,
despite the available tool of this animal species, very few data have been obtained on the effect of DON
on the intestine of rodents. This might be due to the fact that they are not very sensitive to this toxin.
The concentrations of toxins used in the in vivo trials presented in this review are, most of the
time, in accordance with plausible levels of contamination. Similarly, in the different models of study
of the intestine, cell culture or explants, the range of concentration used (generally 5–30 μM) is in
accordance with these plausible levels [63]. Under these conditions of realistic exposure, TCTB produce
deleterious effects on intestinal morphology and/or function. As highlighted recently by Maresca [41],
the differences between the doses of DON affecting cell functions and the doses of DON susceptible to
being present [134] in relation to the actual provisional maximum tolerable daily intake represent a
low safety factor. Thus, DON can represent a risk to human health, mainly because of its effect on the
intestinal and immune systems.
The data presented in this review focused on the effects of DON on the intestine. Fusarium species
are able to synthesize, in addition to DON, other related toxins, among them the acetylated derivatives,
the toxicity of which has been mainly investigated through in vitro experiments. Masked forms of
mycotoxins, such as deoxynivalenol-3-β-D-glucoside (DON-3G), that result from the detoxification
metabolism in plants, are an emerging problem [135]. The occurrence and toxicity of this new
DON-metabolite are poorly documented, as well as its possible hydrolysis to the parent mycotoxin in
the intestine.
The toxicity of DON also needs to be addressed in the context of mycotoxin mixtures. Indeed, the
co-occurrence of mycotoxins is likely to arise due to at least three different reasons: (i) most fungi are
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able to produce a number of mycotoxins simultaneously; (ii) food commodities can be contaminated
by several fungi; and (iii) a complete diet is made up of various different food commodities [75].
Unfortunately, the toxicity of combinations of mycotoxins cannot always be predicted based upon
their individual toxicities. Recent data suggest that the type of interaction depends not only on the
type of toxin and their ratio, but also on the concentration of the toxin-mixture at a constant ratio [76].
More research is needed to understand the impact of mycotoxin combinations and to determine when
synergistic interactions occur. These data are needed to assess the health risk due to the exposure of
multi-mycotoxin contaminated food and feed [74].
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Abstract: Contamination of food and feed with mycotoxins is a worldwide problem. At present,
acute mycotoxicosis caused by high doses is rare in humans and animals. Ingestion of low to
moderate amounts of Fusarium mycotoxins is common and generally does not result in obvious
intoxication. However, these low amounts may impair intestinal health, immune function and/or
pathogen fitness, resulting in altered host pathogen interactions and thus a different outcome of
infection. This review summarizes the current state of knowledge about the impact of Fusarium
mycotoxin exposure on human and animal host susceptibility to infectious diseases. On the one hand,
exposure to deoxynivalenol and other Fusarium mycotoxins generally exacerbates infections with
parasites, bacteria and viruses across a wide range of animal host species. Well-known examples
include coccidiosis in poultry, salmonellosis in pigs and mice, colibacillosis in pigs, necrotic enteritis
in poultry, enteric septicemia of catfish, swine respiratory disease, aspergillosis in poultry and rabbits,
reovirus infection in mice and Porcine Reproductive and Respiratory Syndrome Virus infection in
pigs. However, on the other hand, T-2 toxin has been shown to markedly decrease the colonization
capacity of Salmonella in the pig intestine. Although the impact of the exposure of humans to Fusarium
toxins on infectious diseases is less well known, extrapolation from animal models suggests possible
exacerbation of, for instance, colibacillosis and salmonellosis in humans, as well.
Keywords: deoxynivalenol; fumonisin; Fusarium mycotoxins; human; infectious diseases; mouse;
pig; poultry; T-2 toxin; zearalenone
1. Introduction
Mycotoxins are toxic fungal metabolites that can contaminate a wide array of food and feed [1].
Mycotoxin-producing fungi can be classified into either field or storage fungi. Field fungi, such as the
Fusarium species, produce mycotoxins on the crops in the field, whereas storage fungi, such as the
Aspergillus and Penicillium species, produce mycotoxins on the crops after harvesting [2]. Fusarium fungi
have traditionally been associated with temperate climatic conditions, since they require somewhat
lower temperature for growth and mycotoxin production than, for example, the Aspergillus species [3].
The most toxicologically important Fusarium mycotoxins are trichothecenes (including deoxynivalenol
(DON) and T-2 toxin (T-2)), zearalenone (ZEN) and fumonisin B1 (FB1).
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Fusarium mycotoxins are capable of inducing both acute and chronic toxic effects. These effects
are dependent on the mycotoxin type, the level and duration of exposure, the animal species that
is exposed and the age of the animal [4]. Intake of high doses of mycotoxins may lead to acute
mycotoxicoses, which are characterized by well-described clinical signs [5,6]. Exposure of pigs to high
concentrations of DON causes abdominal distress, malaise, diarrhea, emesis and even shock or death.
Exposure of pigs to fumonisins can lead to pulmonary edema due to cardiac insufficiency. In horses
fumonisins can cause equine leukoencephalomalacia (ELEM) and target the brain [7]. Since these
high contamination levels are rare in modern agricultural practice [8], this review will not discuss
extensively their effect on animal or human health. Indeed, although the results of a global survey
indicate that the Fusarium mycotoxins DON, fumonisins, and ZEN respectively contaminated 55%,
54% and 36% of feed and feed ingredients in the period 2004–2011, the majority of samples was found
to comply with even the most stringent European Union regulations or recommendations on the
maximal tolerable concentration (Table A3) [8]. Therefore, this review will focus on the effect of low to
moderate doses of the major Fusarium mycotoxins.
Following oral intake of low to moderate amounts of these mycotoxins, the gastro-intestinal
epithelial cell layer will be exposed first [9]. The intestinal mucosa acts as a barrier, preventing the
entry of foreign antigens including food proteins, xenobiotics (such as drugs and toxins), commensal
microbiota and pathogens into the underlying tissues [9,10]. The mucosal immunity, which consists
of an innate and adaptive immune system, can be affected by Fusarium mycotoxins (Figure 1) [9,10].
An important component of the innate immune system are the intestinal epithelial cells, which are
interconnected by tight junctions, and covered with mucus, produced by goblet cells [11]. By measuring
the transepithelial electrical resistance (TEER), several in vitro and ex vivo studies indicate that DON
and FB1 are able to increase the permeability of the intestinal epithelial layer of human, porcine and
avian origin [12–14]. Also the viability and proliferation of animal and human intestinal epithelial
cells can be negatively affected by Fusarium mycotoxins [9,15–20]. Their effect on mucus production is
variable: co-exposure of low doses of DON, T-2 and ZEN reduces the number of goblet cells in pigs [21],
but ZEN given alone at higher doses increases the activity of goblet cells [22]. Several mycotoxins
are also able to modulate the production of cytokines in vitro and in vivo [9,23]. For example, DON
increases the expression of TGF-β and IFN-γ in mice and fumonisins decrease the expression of IL-8 in
an intestinal porcine epithelial cell line (IPEC-1) [9].
Fusarium mycotoxins can cross the intestinal epithelium and reach the systemic compartment [20,24],
affecting the immune system. Exposure to these toxins can either result in immunostimulatory or
immunosuppressive effects depending on the age of the host and exposure dose and duration [20,25].
Mycotoxin-induced immunomodulation may affect innate and adaptive immunity by an impaired
function of macrophages and neutrophils, a decreased T- and B-lymphocyte activity and antibody
production [23,25,26]. In addition to the effect of Fusarium mycotoxins on the animal or human host,
these mycotoxins may alter the metabolism of the pathogen, which may alter the outcome of the
infectious disease [27,28].
A wealth of research papers clearly indicate a negative influence of Fusarium mycotoxins on the
intestinal function and immune system. Since the intestinal tract is also a major portal of entry to many
enteric pathogens and their toxins, mycotoxin exposure could increase the animal susceptibility to
these pathogens. Furthermore, mycotoxin-induced immunosuppression may also result in decreased
animal or human host resistance to infectious diseases.
This review attempts to summarize the impact of Fusarium mycotoxin exposure on the animal and
human host susceptibility to infectious diseases. More specifically, the effect of Fusarium mycotoxins
on enteric, systemic and respiratory infectious diseases in livestock animals and animal models for
human diseases are highlighted.
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Figure 1. The effect of Fusarium mycotoxins on the intestinal epithelium. A variety of Fusarium
mycotoxins alter the different intestinal defense mechanisms including epithelial integrity, cell
proliferation, mucus layer, immunoglobulins (Ig) and cytokine production. (IEC: intestinal epithelial
cell) (based on [9]).
2. Effect of Fusarium Toxins on Parasitic Diseases
Coccidiosis
Intestinal protozoa, including the coccidia (Eimeria, Isospora, Cryptosporidium and Sarcosporidia)
and flagellates, are important infectious agents. Coccidiosis in poultry generally refers to the disease
caused by the Eimeria species, and is still considered one of the most important enteric diseases affecting
performance. These obligate intracellular parasites have an oral-fecal life cycle with developmental
stages alternating between the external environment and the host [29].
Seven species of Eimeria (E. acervulina, E. brunetti. E. maxima, E. mitis, E. necatrix, E. praecox and
E. tenella) are found in chickens [29]. The physical and biological characteristics, pathogenicity and
immunogenicity depend on the species. Immunity to Eimeria is complex, multifactorial and influenced
by both host and parasite [30].
Cell-mediated immunity, mainly evoked by the intraepithelial lymphocytes (IEL) and
lymphocytes of the lamina propria, is the major protective immune component against avian
coccidiosis [31,32]. The CD4+ T-lymphocytes, IEL and macrophages are involved in the response
against primary exposure to Eimeria [31], while CD8+ T-lymphocytes and IFN-γ are important in the
protective immune response against Eimeria infection [33]. Girgis et al. [34,35] showed a negative
impact of diets naturally contaminated with Fusarium mycotoxins on the cell-mediated immune
response against coccidiosis in broilers (Table A2). Following primary infection of broilers with Eimeria,
Fusarium mycotoxins decreased the percentage of CD4+ and CD8+ T-cells in the jejunal mucosa [35].
In addition, feeding on a mycotoxin-contaminated diet lowered the blood levels of CD8+ T-cells and
monocytes, which could suggest an increased recruitment at the intestinal site of coccidial infection or a
delayed replication necessary to replenish these subsets in the circulation [34,35]. Additionally, feeding
on a Fusarium mycotoxin-contaminated diet increased IFN-γ gene expression in the cecal tonsils
of Eimeria-challenged birds, however, without being linked to the apparent resistance to coccidial
infection in terms of changes in oocyst yield [34]. The cecal tonsils constitute a lymphoid tissue in
the cecum belonging to the gut-associated lymphoid tissue (GALT). Resistance to Eimeria infection is
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related to the expression of a set of interleukins rather than only IFN-γ and the up-regulation of the
gene may not necessarily be associated with functional secretion [34]. Furthermore, it was shown that
moderate levels of Fusarium mycotoxins negatively affect intestinal morphology and interfere with
intestinal recovery from an enteric coccidial infection, indicated by a lower villus height and apparent
villus area (Table A2) [36]. Although Girgis et al. [34,35] demonstrated that Fusarium mycotoxins
impair the Eimeria-induced immune response, no effect was seen on fecal oocyst counts. Similarly,
Békési et al. [37] showed no impact of a T-2 and ZEN-contaminated diet on Cryptosporidium baileyi
oocyst excretion in broilers.
Research investigating the influence of mycotoxins on the animal susceptibility to infectious
diseases focuses mainly on exposure to single major mycotoxins. Limited information about the
impact of mycotoxin co-occurrence and plant metabolites of mycotoxins on this interaction is
available. Nevertheless, Girgis et al. [34,35] showed that the combination of DON, 15-acetylDON
(15-AcDON), ZEN and fumonisins alters the Eimeria-induced immune response. Interestingly,
mycotoxin contamination of broiler feed may reduce the efficacy of the anti-coccidial treatment
with lasalocid [38].
To conclude, Fusarium mycotoxins negatively affect the innate and adaptive cellular immune
response against Eimeria, though without changing the oocyst yield. Further data of clinical coccidiosis
lesion scoring is still needed in order to evaluate the effect of Fusarium mycotoxins on the severity of
the disease.
3. Effect of Fusarium Toxins on Bacterial Diseases
3.1. Salmonellosis
Salmonellosis is an infection with the Gram-negative Salmonella bacterium, a facultative anaerobic,
facultative intracellular microorganism of the Enterobacteriaceae family. The host—Salmonella interaction
is complex, with a broad array of mechanisms used by the bacteria to overcome host defenses. Two
important disease manifestations are differentiated, i.e., gastroenteritis and enteric fever, caused by
nontyphoidal and typhoidal Salmonella serovars, respectively [39].
Nontyphoidal Salmonella strains, such as Salmonella serovar Typhimurium and Salmonella serovar
Enteritidis strains, infect a wide range of animal hosts, including pigs and poultry, without causing
clinical symptoms in these animals. Infection in slaughter pigs and poultry can cause meat and egg
contamination [39,40].
An infection with Salmonella generally occurs in three stages: the adhesion to the intestinal
wall, the invasion of the gut wall and the dissemination to mesenteric lymph nodes and other
organs. Via bacterial-mediated endocytosis, Salmonella invades the intestinal epithelial cells, after
which the bacterium becomes enclosed within an intracellular phagosomal compartment (the
Salmonella-containing vacuole (SCV)). After crossing the epithelial barrier, the bacterium is located
predominantly in macrophages in the underlying tissue [39].
Feeding pigs a Fusarium mycotoxin-contaminated diet influences the intestinal phase of the
pathogenesis of Salmonella Typhimurium infections as illustrated in Figure 2. Non-cytotoxic
concentrations of DON and T-2 enhance intestinal Salmonella invasion and increase the passage
of Salmonella Typhimurium across the epithelium (Table A1) [28,41]. Chronic exposure of
specific pathogen-free pigs to naturally fumonisin-contaminated feed had no impact on Salmonella
Typhimurium translocation [42]. Once Salmonella has invaded the intestinal epithelium, the innate
immune system is triggered and the porcine gut will start to produce several cytokines [28,43]. Both
Fusarium mycotoxins and Salmonella affect the innate immune system. Vandenbroucke et al. [27] showed
that low concentrations of DON could potentiate the early intestinal immune response induced by
Salmonella Typhimurium infection. Co-exposure of the intestine to DON and Salmonella Typhimurium
resulted in increased expression of several cytokines, for instance, those responsible for the stimulation
of the inflammatory response (TNF-α) and T-lymphocyte stimulation (IL-12) (Table A2). The authors
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suggested that the enhanced intestinal inflammation could be due to a DON-induced stimulation of
Salmonella Typhimurium invasion in and translocation across the intestinal epithelium [27].
 
Figure 2. The impact of deoxynivalenol and T-2 toxin on a Salmonella Typhimurium infection in pigs.
In vitro, deoxynivalenol (DON) and T-2 toxin (T-2) promote Salmonella invasion (1) and transepithelial
passage (2) of IPEC-J2 cell layer. Subsequently, the bacterium can spread to the bloodstream using the
host macrophage to establish the systemic infection. In vitro, DON and T-2 enhance Salmonella uptake
(3) in porcine alveolar macrophages. The Salmonella invasion of macrophages coincides with membrane
ruffling, caused by actin cytoskeletal changes. Activation of host Rho GTPases by the Salmonella
pathogenicity island (SPI)-1 type 3 secretion system (T3SS) effector proteins SopB, SopE, SopE2 and
SopD leads to actin cytoskeleton reorganization. After Salmonella internalization has occurred, the
bacterium injects the effector protein SptP which promotes the inactivation of Rho GTPases. The
bacterium can also modulate the actin dynamics of the host cell in a direct manner through the bacterial
effector proteins SipA and SipC. The mycotoxin DON enhances the uptake of Salmonella in macrophages
through activation of the mitogen-activated protein kinases (MAPK) extracellular signal-regulated
kinases (ERK1/2) pathway, which induces actin reorganizations and membrane ruffles. DON and T-2
do not affect intracellular bacterial proliferation (4) (based on [41,44]).
Fusarium mycotoxins also affect the systemic part of the Salmonella Typhimurium infection in
pigs. After the intestinal phase of the pathogenesis, Salmonella can spread to the bloodstream using the
host macrophage to establish the systemic infection. However, in pigs the systemic part of Salmonella
Typhimurium is poorly documented and colonization is mostly limited to the gastrointestinal tract [44].
After bacterial uptake by the macrophage, Salmonella can survive and even proliferate in this cell.
Exposure of macrophages to non-cytotoxic concentrations of DON and T-2 promotes the uptake of
Salmonella Typhimurium (Figure 2, Table A1). Salmonella entry in host cells involves a complex series
of actin cytoskeletal changes. Macrophage invasion coincides with membrane ruffling, followed by
bacterium uptake and formation of Salmonella-containing vacuole [41]. Vandenbroucke et al. [41]
showed in vitro that DON enhances Salmonella Typhimurium engulfment, since low concentrations of
DON modulate the cytoskeleton of macrophages through ERK1/2 F-actin reorganization resulting in
an enhanced uptake of Salmonella Typhimurium in porcine alveolar macrophages (PAM) (Figure 2,
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Table A1). Non-cytotoxic concentrations of the Fusarium mycotoxins DON and T-2 did not affect the
intracellular proliferation of Salmonella Typhimurium in porcine macrophages (Figure 2) [28,41].
In addition to the effects of Fusarium mycotoxins on the host susceptibility to a Salmonella
Typhimurium infection, these mycotoxins also modulate the bacterial metabolism. Although no
effect of DON or T-2 on the growth of Salmonella Typhimurium is detected, DON and T-2 modulate
the Salmonella gene expression [28,41]. The enhanced inflammatory effect following exposure to
DON is more likely a result of the toxic effect of the mycotoxin on the intestine than on the
bacterium [27]. Only high concentrations of DON increase the bacterial expression of regulators
of Salmonella pathogenicity island (SPI)-1 and SPI-2, respectively hilA and ssrA. SPI-1 consists of genes
coding for bacterial secretion systems necessary for invasion, while SPI-2 genes encode essential
intracellular replication mechanisms [41]. For T-2 the toxic effects on the bacterium itself are probably
more pronounced than the host cell-mediated effects resulting in a reduced in vivo colonization in pigs.
Low concentrations of T-2 cause a reduced motility of Salmonella and a general down regulation of
genes involved in Salmonella metabolism, genes encoding ribosomal proteins and SPI-1 genes [28].
Only limited information is available concerning the interaction between Fusarium mycotoxins
and Salmonella Typhimurium infection in other animals. The currently available publications mainly
focus on the interaction of T-2 and the systemic phase of a Salmonella Typhimurium infection.
In T-2-challenged broiler chickens and mice an increased level of Salmonella Typhimurium-related
organ lesions or mortality was seen (Table A2) [45–48]. Infection of mice with Salmonella Typhimurium
results in systemic infection and a disease similar to that seen in humans after infection with Salmonella
Typhi [49]. Increased mortality might be explained partly by the synergistic effects of bacterial
lipopolysaccharide (LPS) and T-2 during the late phase of murine salmonellosis [50]. In addition to
Salmonella Typhimurium, DON reduces the resistance to oral infection with Salmonella Enteritidis in
mice by promoting translocation of Salmonella to mesenteric lymph node (MLN), liver and spleen
(Table A2) [51].
Mouse and pig models are important animal models to investigate the impact of mycotoxins,
infectious diseases and their combination on animal health [52,53]. Infection of mice with Salmonella
Typhimurium is an important host–pathogen interaction model to investigate typhoid fever in humans.
Moderate to high concentrations of T-2 have shown to increase Salmonella-induced mortality [46,47,50].
The pig is very similar to humans in terms of anatomic and physiologic characteristics such as size,
digestive physiology, kidney structure and function, pulmonary vascular bed structure, coronary
artery distribution, respiratory rates, cardiovascular anatomy and physiology, and immune response,
and has been used to study various intestinal pathogens, including Salmonella and Escherichia coli [53].
The interaction between mycotoxins and Salmonella Typhimurium studied in a porcine model of
infection, gives us relevant information concerning the impact of this interaction on human intestinal
inflammation and immune response [27].
In conclusion, the exact outcome of co-exposure to Fusarium mycotoxins and Salmonella
Typhimurium is difficult to predict. Published data show an influence of mycotoxin exposure on
the bacterium, the host cells and the host–pathogen interaction. Depending on the characteristics of
the mycotoxin exposure, one of these effects will determine the outcome of the interaction between
Fusarium mycotoxins and Salmonella Typhimurium.
3.2. Colibacillosis
Escherichia coli is a Gram-negative, non-sporulating rod-shaped bacterium of the family
Enterobacteriaceae. Although this bacterium is considered to be a normal component of the intestinal
microbiota, it is frequently associated with both intestinal and extra-intestinal infections in humans and
animals. A certain number of these strains possess particular combinations of virulence factors which
enables them to cause disease. Clinical syndromes resulting from infection with these pathotypes
include enteric/diarrheal disease, urinary tract infections and sepsis/meningitis.
234
Toxins 2014, 6, 430–452
The pathogenesis of E. coli infections depends on the pathotype involved and may include
colonizing the intestinal mucosa, evasion of host defenses, multiplication, and induction of host
damage [54,55].
Fusarium mycotoxins may influence the pathogenesis of E. coli infections in different animal
species by stimulating intestinal colonization and translocation and negatively affecting the immune
response. Feeding a diet contaminated with a moderate level of FB1 to pigs enhanced intestinal
colonization and translocation of a septicemic E. coli (SEPEC) strain from the intestine to the systemic
compartment. FB1-treatment resulted in a higher bacterial translocation to the mesenteric lymph
nodes and lungs, and to a lesser extent to liver and spleen (Table A2) [56]. It was shown in vitro
that DON increased the translocation of SEPEC over the intestinal epithelial cell monolayer (IPEC-1)
(Table A1) [14].
Mycotoxins increase the calf susceptibility to shiga toxin or verotoxin-producing E. coli
(STEC)-associated hemorrhagic enteritis. Recently, Baines et al. [57] showed that exposing calves
of less than one month old to the combination of aflatoxin and fumonisins promoted STEC-associated
hemorrhagic enteritis (Table A2) [57].
Feeding a FB1-contaminated diet to pigs negatively affects the mucosal immune response against
an infection with enterotoxigenic E. coli (ETEC). Devriendt et al. [58] showed a prolonged intestinal
infection of E. coli in pigs administered fumonisins for 10 consecutive days and subsequently challenged
with E. coli (F4+ ETEC) (Table A2). Antigen-presenting cells (APCs) have an important role in
the mucosal immune system by connecting the innate and adaptive immune response, through
uptake of antigen in lamina propria, maturation and migration to GALT, and interaction with T
cells. FB1 negatively affected the function of intestinal APCs by a reduced up-regulation of the major
histocompatibility complex class II (MHC-II), cluster of differentiation (CD) 80/6 and IL-12p40 cytokine
gene expression [58]. This altered function of APCs could therefore influence the E. coli-induced
adaptive immune response [58,59]. Additionally, moniliformin and FB1 delayed systemic E. coli
(avian pathogenic E. coli, APEC) clearance in broilers and turkeys after intravenous administration
(Table A2) [60,61].
The results of these studies may also be valid for human infections since the gastro-intestinal tract
of pigs and humans are very similar [58]. Infant diarrhea caused by enteropathogenic E. coli (EPEC)
is known to be of major concern in developing countries and, for instance, enterohemorrhagic E. coli
(EHEC) infections are a major worldwide public health hazard.
3.3. Necrotic Enteritis in Broilers
Necrotic enteritis (NE) is a disease in broilers caused by Clostridium perfringens. This Gram-positive
spore-forming bacterium occurs naturally in the environment, feed and gastrointestinal tract of
chickens and other animals [62,63]. NE is a complex, multifactorial enteric disease with many known
and unknown factors influencing its occurrence and the severity of the outbreaks. The best-known
predisposing factor is mucosal damage caused by coccidial pathogens [64]. Only C. perfringens strains
expressing the NetB toxin are capable of inducing NE in broilers [65]. C. perfringens is auxotrophic
for several amino acids, thus availability of these amino acids would allow extensive bacterial
proliferation [63].
The intake of DON-contaminated feed is a predisposing factor for the development of necrotic
enteritis in broiler chickens due to the negative influence on the epithelial barrier, and to an increased
intestinal nutrient availability for clostridial proliferation. Recently, we [66] showed in an experimental
subclinical NE infection model that chickens fed a diet contaminated with DON for three weeks were
more prone to develop NE lesions compared to chickens on a control diet (Table A2). The negative
effects of DON on the small intestinal barrier can lead to an impaired nutrient digestion and leakage of
plasma amino acids into the intestinal lumen, providing the necessary growth substrate for extensive
proliferation of C. perfringens [66].
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3.4. Edwardsiella ictaluri Infection in Catfish
Edwardsiella ictaluri is a Gram-negative bacterium of the Enterobacteriaceae family. Bacillary
Necrosis of Pangasianodon (BNP) caused by E. ictaluri is the most frequently occurring infectious
disease in catfish [67]. Besides the Vietnamese freshwater production, also the American channel
catfish (Ictalurus punctatus) industry suffers massively from E. icatluri infections which have been
termed Enteric Septicemia of Catfish (ESC). BNP is characterized by multifocal irregular white spots
of varying sizes on several organs including liver, spleen and kidney [68]. ESC in channel catfish
may occur in an acute form characterized by enteritis and septicemia with rapid mortality, or in a
chronic form, which is characterized by meningoencephalitis, open lesions on the cranial region and
exophthalmia [69]. Mortality associated with the co-occurrence of Fusarium mycotoxins and E. ictaluri
is difficult to predict in juvenile channel catfish. T-2 increased E. ictaluri-associated mortality [70],
while moderate contamination of DON improved the survival of the channel catfish [71] (Table A2).
Mycotoxin sensitivity differs between fish species. Rainbow trout, for example, are extremely sensitive
to DON, while channel catfish are rather resistant [71,72]. Important data concerning the toxicity of the
mycotoxin on the bacterium are lacking. Further investigation of the interaction between Fusarium
mycotoxins and E. ictaluri will be necessary to evaluate the outcome.
3.5. Swine Respiratory Disease
Respiratory disease in pigs is often caused by the combined effects of multiple pathogens and
predisposing factors [73]. Primary infections with bacteria such as Actinobacillus pleuropneumoniae,
Mycoplasma hyopneumoniae, Bordetella bronchiseptica or viruses such as influenza virus and Porcine
Reproductive and Respiratory Syndrome Virus (PRRSV), can predispose pigs to secondary pathogens
such as Pasteurella multocida and Trueperella pyogenes [74]. Respiratory symptoms can vary depending
on the pathogens involved. M. hyopneumoniae is the principal etiological agent responsible for enzootic
pneumonia in pigs [75]. M. hyopneumoniae is an obligate symbiotic and host-specific bacterium, which
is lacking a cell wall. This pathogen affects the respiratory mucosal clearance system by disrupting the
celia on the epithelial surface and modulates the immune system of the respiratory tract. Consequently,
M. hyopneumoniae predisposes animals to concurrent infections with other respiratory pathogens [75].
Dietary exposure to fumonisins induces pulmonary edema and may facilitate M. hyopneumoniae
infection (Table A2) [76].
The progressive form of porcine atrophic rhinitis is often due to a combined infection with
B. bronchiseptica and toxigenic P. multocida [73,77]. Dietary exposure to FB1 of piglets infected with
both bacteria increases the risk of pneumonia and the severity of the pathological changes [73].
P. multocida type A is the most frequently occurring secondary pathogen that can cause pneumonic
pasteurellosis [78]. Halloy et al. [74] showed that inoculation of piglets with P. multocida combined with
an oral bolus of FB1 induced a cough and a lung inflammatory process characterized by an increased
number of total cells, macrophages and lymphocytes in broncheo-alveolar lavage fluid (BALF). Lung
lesions were more severe in these animals and consisted of subacute interstitial pneumonia [74].
4. Effect of Fusarium Toxins on Fungal Diseases
Aspergillosis
Aspergillus fumigatus is an ubiquitous saprophytic fungus found in soil, plant debris, and the
indoor environment, including hospitals. This fungus is also an opportunistic pathogen. Inhalation
of its conidia can cause life-threatening infections in the respiratory system of immunocompromised
animals and humans. Respiratory macrophages are the first line of defense against inhaled Aspergillus
conidia. T-2 impaired the phagocytotic activities of macrophages against A. fumigatus conidia in
chickens and rabbits (Tables A1 and A2) [79,80]. However, the pro-inflammatory response of
A. fumigatus infected chicken macrophages was increased by T-2 (Table A1) [80]. The effect of T-2 on
the innate immune response against Aspergillus conidia is dual, which suggests that depending on
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the characteristics of the mycotoxin exposure and the animal, one of these effects will determine the
outcome of this interaction.
5. Effect of Fusarium Toxins on Viral Diseases
5.1. Reovirus
Reovirus is a non-enveloped double-stranded RNA virus that has been isolated from the
gastro-intestinal tract and respiratory tract of both humans and animals [81,82]. Enteric reoviruses
cause mostly a mild and self-limiting infection [82]. Nevertheless, reovirus infections can be more
severe, affecting, for example, the central nervous system in mice and rats [81]. Viral arthritis is the
most frequent reovirus-associated disease in poultry, which is characterized by lameness and swellings
affecting primarily tarsometatarsal joints and the feet [83–85].
Fusarium mycotoxins negatively affect the intestinal virus clearance in mice. Li et al. [82,86]
showed that high concentrations of DON and T-2 suppress the host immune response to reovirus as
evidenced by the inability to clear the virus from the intestine as well as by increased fecal shedding
of the virus (Table A2). Trichothecene exposure increased the intestinal viral load, which could
increase inflammation and discomfort to the host during the infection process. The increased fecal
shedding could enhance virus dissemination among individuals [86]. Both mycotoxins decreased
the cell-mediated viral clearance by suppressing the gene expression of IFN-γ in Peyer’s Patches
(PP) [82,86]. DON enhanced Th2 cytokine expression prior to and after reovirus infection, which
potentiates the IgA and IgG responses to reovirus [82]. In contrast, T-2 suppressed reovirus-induced
immunoglobulin responses [86]. The lack of a similar effect of Th2 cytokines by T-2 suggests inherent
differences between both mycotoxins in their capacity to modulate cytokines during viral infection,
although both mycotoxins belong to the class of trichothecenes [86]. Nevertheless, the intestinal
clearance of reovirus was less efficient after T-2 exposure compared to DON [86]. Since reovirus
infection in mice is used as a model for several enteric and respiratory viral infections in humans and
other animals [81], these results could assume an impact of mycotoxins on host susceptibility to more
virulent viruses.
5.2. Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is an enveloped single-stranded
RNA virus belonging to the family Arteriviridae, within the order Nidovirales [87]. Currently, PRRS
is one of the most economic significant diseases in swine production [87,88]. The clinical symptoms,
respiratory or reproductive, vary with the viral strain, the immune status of the herd, and management
factors [88,89]. PRRSV is a highly infectious virus that replicates within the monocytes or macrophages
with the lung being a predominant site of viral multiplication [89]. Exposure of piglets to FB1 increased
the risk for PRRSV disease [90]. More severe histopathological lesions were observed when pigs
were exposed to FB1 and subsequently inoculated with PRRSV. The authors suggest that FB1 causes
immunosuppression, facilitating PRRSV to induce more severe lesions [89]. Given the importance of
PRRSV in worldwide swine production and the frequent occurrence of fumonisins, research should be
performed investigating this interaction also at lower doses of FB1.
6. Discussion
In recent years, research investigating the effects of Fusarium mycotoxins on the intestinal and
immune functions has made substantial progress. However, only limited information is available on the
interaction between mycotoxins and infectious diseases. The aforementioned literature data indicates
that Fusarium mycotoxins may influence the animal and human host susceptibility to enteric, systemic
and respiratory infectious diseases. Depending on host, pathogen and mycotoxin characteristics,
exposure to Fusarium mycotoxins can generally exacerbate infectious diseases. On the other hand,
T-2 has been shown to decrease the colonization capacity of Salmonella in the pig intestine. Fusarium
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mycotoxins may influence the host–pathogen interaction by negatively affecting the intestinal barrier
function and the innate and adaptive immune response [9,23,26]. Fusarium mycotoxins affect the
morphology and the barrier function of the intestinal layer [9], leading to increased translocation
of different bacterial species including Salmonella enterica and E. coli, to the systemic compartment.
The negative influence of these mycotoxins on the function of macrophages results in impaired
phagocytosis of bacterial and fungal pathogens. However, also the adaptive immune response is
targeted, demonstrated by the effect on gene expression of several cytokines, leading to an altered Th1
and Th2 response.
The economic impact of mycotoxins on animal production is generally considered to be mainly
due to losses related to direct effects on animal health and trade losses related to grain rejection [91].
It is clear, however, that the indirect influence of myocotoxins on animal health, by enhancing infectious
diseases, should also be taken into account. These effects, as reviewed here, occur even at low to
moderate mycotoxin contamination levels of feed [8]. Some publications showed that these effects can
even occur at contamination levels below the European guidance levels, suggesting that the legislation
may not cover all deleterious health effects of mycotoxins.
Fusarium mycotoxins have various acute and chronic effects on humans [92]. DON could
play a role in diseases such as inflammatory bowel disease (IBD) [20,93]. Taken into account
conditions such as environmental, socio-economic and food production, it seems plausible that the
risk for food-associated mycotoxin exposure is even higher in developing countries [94]. Besides the
risk for acute mycotoxicosis in developing countries [95], results obtained in animals suggest that
low to moderate concentrations of these mycotoxins could also influence human susceptibility to
infectious diseases.
The effect of multi-mycotoxin contamination and of less well-known or emerging mycotoxins
on the human or animal susceptibility to infectious diseases is rather unknown. Multi-mycotoxin
contamination of feed is frequently occurring, raising the question on the impact on animal toxicity of
this phenomenon [3]. Several in vitro and in vivo studies demonstrated an enhanced toxicity and more
severe immune suppression compared to single mycotoxin contamination [96–98]. In addition, plant
metabolites of mycotoxins may also be present in feed and are known as masked mycotoxins [99].
Fusarium fungi and infected plants may produce conjugated forms of, for instance, DON, such as
3-AcDON (3-acetylDON), 15-AcDON and DON-3G (DON-3-glucoside). Furthermore, mycotoxins
can also be conjugated by certain food-processing techniques. These conjugated forms could have a
direct toxic effect, or may be hydrolyzed to their precursor mycotoxin in the digestive tract of animals,
resulting in higher exposure levels [100–102]. The influence of mycotoxin co-occurrence and masked
mycotoxins on human and animal susceptibility to infectious diseases will be an important research
question in the future.
Global warming and increasing world population of humans are further important issues. Climate
changes may affect the global distribution of mycotoxigenic fungi and their mycotoxins [103,104],
but also the distribution of infectious diseases [105]. Livestock farming will remain an important
component of the global food supply in the future. Animal health, including the impact of mycotoxins
and susceptibility to infectious diseases, will be important future topics to produce enough safe food
for the entire human population.
In conclusion, Fusarium mycotoxins may alter the human and animal susceptibility to infectious
diseases by affecting the intestinal health and the innate and adaptive immune system. Further
research will be necessary to investigate the impact of mycotoxins on infectious diseases and to
develop practical, economically justified, solutions to counteract mycotoxin contamination of feed and
food, and its effects on human and animal health. Acknowledgments G. Antonissen was supported by
a PhD fellowship from Biomin GmbH, Herzogenburg, Austria.
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Abstract: Suspensions or solutions with 1% of Chinese galls (Galla chinensis, GC) or 1% of tannic
acid (TA), inhibited germination of conidia or mycelium growth of Fusarium graminearum (FG)
by 98%–100% or by 75%–80%, respectively, whereas dried bark from buckthorn (Frangula alnus,
FA) showed no effect at this concentration. In climate chamber experiments where the wheat
variety “Apogee” was artificially inoculated with FG and F. crookwellense (FCr) and treated with 5%
suspensions of TA, GC and FA, the deoxynivalenol (DON) content in grains was reduced by 81%,
67% and 33%, respectively. In field experiments with two commercial wheat varieties and artificial
or semi-natural inoculations, mean DON reductions of 66% (TA) and 58% (FA), respectively, were
obtained. Antifungal toxicity can explain the high efficacies of TA and GC but not those of FA. The
Fusarium head blight (FHB) and mycotoxin reducing effect of FA is probably due to elicitation of
resistance in wheat plants. With semi-natural inoculation, a single FA application in the first half of
the flowering period performed best. However, we assume that applications of FA at the end of ear
emergence and a treatment, triggered by an infection period, with TA or GC during flowering, might
perform better than synthetic fungicides.
Keywords: Fusarium graminearum (FG); antifungal; natural compound; phenolic; phytoalexin; elicitor;
deoxynivalenol (DON); forecasting; organic
1. Introduction
Contamination of food and feed with mycotoxins is a major concern for growers and industry in
small grain cereals and especially in maize production. Globally, Fusarium graminearum (FG) Schwabe
(teleomorph Gibberella zeae) is the most prevalent Fusarium head blight (FHB) causing fungus and
the main source of deoxynivalenol (DON) and zearalenone (ZEA) contamination of wheat [1], most
probably because of its high genetic diversity and an increasing surface of maize cropping. The key
factors of F. graminearum (FG) infections in wheat are maize or wheat as a previous crop, reduced or
zero tillage and susceptible wheat varieties [2,3]. The reasons for increasing cases of such high risk
situations are mostly of economical nature. In Switzerland, even by using the lowest susceptible wheat
variety and intensive mechanical maize residue mulching treatments, the DON contamination has not
often been reduced below the maximum limit of 1.25 mg kg−1 in unprocessed cereals [4] when wheat
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following grain maize was sown with reduced or zero tillage [5]. For control of FHB, the application
of a fungicide during wheat anthesis (growth stage [GS] 61–69; Zadoks [6]) is often recommended.
In field trials in the UK by Edwards and Godley [7], applications of the prothioconazole product
Proline® at GS 65 resulted in an FHB and DON reduction in wheat of nearly 60%. In own field trials
with artificial infections with F. culmorum and the application of triazole fungicides at GS 57 and 67,
we observed DON reductions of 29% and 71%, respectively [8]. Apart from the choice of product to
optimise the efficacy of a treatment, the timing of the application based on a forecasting system such
as FusaProg [9] is helpful for sufficient control of FHB.
In European countries, except UK, FHB and DON contamination in organic wheat production
is generally considered as less important as in conventional production [10–12]. With the trend to
reduced soil conserving tillage and expanding maize cropping in organic wheat production [13,14],
increasing problems must be expected and natural fungicides could help to reduce the risk of
mycotoxin contaminations [15]. Botanicals and other natural antifungal agents have been shown
to inhibit Phytophthora infestans, the cause of potato late blight [16–19], Microdochium majus, the cause
of snow mold in wheat [20] or to be effective against food contaminating fungi such as F. oxysporum,
Alternaria alternata und Aspergillus species [21]. With respect to choice of natural antifungal compounds,
botanicals used in Chinese medicine and known for antioxidant and antimicrobial activity could
be promising. For example, Rheum palmatum (RP) L. (Chinese rhubarb), Frangula alnus (FA) Mill.
(buckthorn bark) and Galla chinensis (GC; Chinese gallnuts) are all rich in tannins and other phenolic
compounds [19,20,22,23]. Tannins and tannic compounds are used in dietary and medicinal herbs with
antioxidant and antimicrobial activity and have also been considered to prevent cancer [24–26]. As early
as in 1913, Knudson [27] reported that tannic acid (TA; C76H52O46) is even at low concentrations toxic
to a large number of fungi. Furthermore, strong inhibition was also observed towards bacteria [28,29].
Antibiotic phenolic compounds were found in many plants and play constitutively or induced by
elicitors a crucial role in the defense of plant diseases [30]. Examples of such induction of antibiotic
phenolics in wheat are seed treatments with Chitosan®, a product based on chitin, and silicon [31,32].
Seed treatments with Chitosan® reduced seed borne FG incidence by more than 50% whereas silicon
sprayed on wheat plants induced the formation of phenolics which in turn reduced powdery mildew
(Erysiphe graminis) incidence on wheat leaves.
The main objective of this study was to evaluate the potential of TA and the botanicals GC, RP
and FA to reduce head blight caused by FG and the DON concentration in integrated and organic
wheat production. The particular aims were to investigate the effect of the antifungal botanicals
(ABs): (1) on in vitro conidia germination and mycelial growth; (2) on FHB in wheat through FG and
F. crookwellense (FCr) as well as DON and nivalenol (NIV) contamination in climate chamber; and (3) in
field experiments from 2006 to 2010.
2. Results and Discussion
2.1. Isolate Specific Inhibition of Conidia Germination with TA
Based on re-isolations of Fusarium species from wheat grains of our first field experiment, we
realised that we did not investigate four isolates of FG as originally planned, but with three FG and one
FCr isolate. Since the FCr isolate is of Swiss origin and a potent NIV producer, we decided to continue
with this combination of strains and both Fusarium species. The mean rates of conidia germination of
the three FG isolates FG0407, FG0410, FG9915 and the FCr isolate FCr9703 (all single conidia) in the
control treatment with water were 86%, 79%, 82% and 97%, respectively. With 0.19% Pronto® Plus
(PrP), zero germination was observed from the isolates FG0407 and FG0410 and low germination rates
of 7% and 1% for FG9915 and FCr9703, respectively. Corrected for a germination rate of 100% of the
isolates in the control treatments, the effective concentration for 50% inhibition (EC50) through TA at
0.125%, 0.25%, 0.5% and 1% was calculated. The EC50 with TA and the three FG isolates varied little
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between 0.43% and 0.46%. The EC50 for the FCr isolate was 0.55%, making it slightly, but nonetheless,
significantly (p < 0.05) higher (Figure 1).
The EC50 with TA for the FG and FCr isolates was about 10 times higher than those reported for
Colletotrichum lindemuthianum with extracts of cascalote (Ceasalpinia cacalaco) [33]. Cascalote is also a
source for phenolics such as gallic and tannic acid. However, for Microdochium majus and suspensions
with 0.1%–1.0% GC, similar efficacies as with TA and FG were observed [20].
2.2. Inhibition of Conidia Germination of FG0407 with TA and Botanicals
Based on the results and the narrow EC50 band for all isolates, we subsequently restricted the
comparison of the conidia inhibiting effect of the three ABs and TA to one isolate, FG0407. Although
it is not known whether all four isolates would react similar to FG0407, this isolate proved to be
pathogenic and toxigenic in preliminary climate chamber trials. An application of PrP at 0.19%
completely inhibited the germination of FG0407 (data not shown). Complete inhibition was also
observed with TA and GC at 1%. Almost no effect was observed with the RP and the FA extracts at 1%.
Elevated concentrations with 10% RP or FA reduced the germination rate down to about 20% or 80%,
respectively (Figure 2).
 
Figure 1. In vitro experiment: isolate specific inhibition of conidial germination with tannic acid (TA):
concentration of TA needed for 50% inhibition (EC50) of conidia germination from three Fusarium
graminearum (FG) and one F. crookwellense (FCr) isolate/s. Mean values of the germination of each
60 conidia and the standard error of means. A “*” indicates a significant difference from the other
isolates, according to a one way analysis of variance (ANOVA) and a Holm-Sidak post hoc test
at p < 0.05.
2.3. Inhibition of Mycelial Growth of FG0407 with TA and Botanicals
Application of 2 mL of 1% TA and 1% GC suspensions in agar in Petri dishes significantly
(p < 0.001) inhibited the mycelium growth of FG0407 by 80% or by 73%, respectively. A slight but
not significant inhibition (13%) resulted with the RP treatment and almost none was observed after a
treatment with FA (Figure 3).
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Figure 2. In vitro experiment: conidia germination of FG0407 with various concentrations of TA
and botanicals. Solutions or aqueous extracts of TA and the botanicals Galla chinensis (GC), Rheum
palmatum (RP) and Frangula alnus (FA) were applied. The control treatment with water was set to
100% germination. Each data point represents the relative mean of the germination of 90 conidia. Bars
indicate the standard error of mean.
Figure 3. In vitro experiment: mycelial growth of FG0407 with TA and botanicals. Solutions of TA
and suspensions of 1% of GC, RP and FA were applied on agar (2 mL suspension per Petri dish). The
control treatment with water was set to 100% radial growth. For treatments labeled with the same
letter, mean values are not statistically different (p < 0.05) according to a Tukey test.
In preliminary trials, we observed that agar solidification was not successful when concentrations
of TA greater than 0.5% were incorporated. Therefore, all antifungal agents, including TA solutions,
botanicals and PrP were applied onto the surface of the already solidified agar. The aqueous solutions
were absorbed by the agar or were forced to evaporate in an air stream at room temperature. Certainly,
with this procedure adapted for TA and our ABs, a direct comparison with other investigations
employing agar incorporated agents is not possible. With our approach we can only estimate the EC of
the agents needed to sufficiently reduce mycelial growth. Still, the primary aim of this experiment
was to compare the effect of the selected agents and not to determine absolute values for toxic
concentrations. If we assume that the 2 mL 1% GC poured on 20 g agar in our experiment (~45%
256
Toxins 2014, 6, 830–849
inhibition of FG) is distributed in the agar, the concentration corresponds approximately to those of
0.1% GC incorporated in agar for an assay with M. majus (~70%) [20]. Hence, we assume that the
experimental set-ups are comparable. Nevertheless, a direct comparison is doubtful since different
fungal species were investigated. This might explain the contrasting results with RP in the current
study and those from an investigation with P. infestans: in our experiment with 1% RP, hardly no effect
was observed, whereas in the study by Hu et al. [17], concentrations of 0.4% RP incorporated into the
agar completely inhibited mycelial growth of P. infestans [17].
2.4. Climate Chamber Experiment—Reduction of Disease Severity and Mycotoxins in Artificially
Inoculated Wheat
In these experiments, the effect of antifungal agents was examined on the artificially inoculated
wheat cultivar “Apogee”. A mixture of the same isolates as in vitro was used for the inoculation. Since
the preparations with TA and the botanicals were acid, a tap water and acidified tap water control
were used (Table 1).
Table 1. Description of treatments in climate chamber experiments with the spring wheat cultivar
“Apogee” and in field experiments with the winter wheat cultivars “Runal” and “Levis”. Type of







Concentration pH Type of experiment
before after % ±0.2 A B
1 Tap water(control 1) Water × - - 7.8 × ×
2 Acidifiedwater (c. 2) ac-Water × - - 4.0 × -
3 Tannic acid TA b i. × - 5 3.8 × ×
4 Tannic acid TA a i. - × 5 3.8 × -
5 Tannic acid TA b+a i. × × 5 3.8 × ×
6 Galla chinensis GC b+a i. × × 5 3.9 × ×
7 Rheumpalmatum RP b+a i. × × 5 5.0 × ×
8 Frangula alnus FA b+a i. × × 5 5.2 × ×
9 Pronto® Plus PrP b i. × - 0.375 8.2 × ×
b i./a i.: before/after inoculation; b+a i.: application one day before and after inoculation; pH: pH of water,
suspensions with botanicals and PrP.
The artificial inoculation had a strong effect on all evaluated parameters. The best effect on disease
inhibition and DON reduction was achieved with PrP resulting in a complete elimination of symptoms
and 98% less DON compared with the control treatment (Figure 4). A significant effect (p < 0.05) was
also observed with TA applications before and after inoculation (TA b+a i.) with a reduction of the
disease severity from 59% down to 12% (Figure 4A). All botanicals, with the exception of FA and the
treatment with TA before infection, reduced the DON contamination in the grains significantly by 67%
to 80% (Figure 4B). An even stronger effect was observed for the yield and the thousand kernel weight
(TKW). The “TA b+a i.” treatment performed as excellent as PrP and gave a 77%–80% higher yield
compared with the control treatments (Figure 4C,D). There was a strong correlation between disease,
yield, TKW and DON (Table 2). In fact, the Spearman correlation coefficients between disease and
DON were as high as 0.948 (r2 = 0.90) (Table 2). Such strong relationships were also reported for the
incidence of F. poae in grains and the NIV content in field experiments with artificial inoculations of
different cultivars [34]. In the current study, the correlation between disease severity and NIV was
substantially lower but still very high (r2 = 0.77). The NIV and AcDON contents were analysed only in
one of the two climate chamber experiments. In this experiment, the r2 for DON and AcDON was
0.89, a strong indication that AcDON was produced by the FG isolates. Between NIV and DON, the r2
was still remarkable with 0.57. Therefore, it can be assumed that NIV was produced by an important
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fraction of FG isolates and not only by the FCr isolate as originally expected. In these climate chamber
experiments, the amount of harvested seed was only sufficient to analyse the mycotoxins but not to
perform a seed health test.
Figure 4. Climate chamber experiment: Effect of treatments with TA, GC, RP, FA and Pronto Plus® (PrP)
on: (A) disease severity (% area with FHB symptoms); (B) deoxynivalenol (DON) content; (C) yield
of three heads; and (D) thousand kernel weight (TKW) of the spring wheat cultivar “Apogee” after
artificial inoculation with a mixture of three F. graminearum (FG) and one FCr isolate/s. Data are pooled
results from two experiments with four replicates of each treatment. For treatments labeled with the
same letter, mean values are statistically not different according to a Tukey test (p < 0.05). Error bars
indicate the standard error of mean. Treatment abbreviations are as in Table 1.
In contrast to other studies showing good efficacies against potato late blight under field
conditions [19], no significant effect was observed with buckthorn bark (FA) in the “Apogee”
experiments. However, this result was not surprising since there was no effect of FA on in vitro FG
conidia germination or on mycelial growth (Figures 2 and 3). Nevertheless, the good efficacy obtained
with Chinese rhubarb (RP b+a i.), which showed little effects in vitro, but an in vivo performance
that was comparable with the gallnut suspension (GC b+a i.) with strong effects in vitro, was not
expected. One possible reason for this phenomenon could be an elicitation of defense mechanisms.
For example, in experiments with RP and FA against downy mildew (Plasmopara viticola) on grapes
(Vitis vinifera), a strong induction of resveratrol and other stilbenoids (polyphenols) was found [35].
In these experiments, TA and GC completely inhibited infections by P. viticola, but they did not induce
the production of stilbenoids.
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Table 2. Climate chamber experiment: Correlation between disease severities (% area with FHB
symptoms), yield and mycotoxin contamination with data from two experiments with the spring
wheat cultivar “Apogee”. Analysis for nivalenol (NIV) and acetylated deoxynivalenol (Ac-DON) were
conducted only in the second experiment. The Spearman correlation coefficients were all with p < 0.001;
coefficients with r > 0.8 are indicated in bold.
Parameter TKW (n = 72) Disease severity
(n = 72) DON (n = 72) NIV (n = 36) AcDON (n = 36)
Yield 0.660 −0.737 −0.637 −0.560 −0.675
TKW - −0.919 −0.932 −0.664 −0.814
Disease
severity - - 0.948 0.877 0.907
DON - - - 0.752 0.941
NIV - - - - 0.786
2.5. Field Experiments with Artificial Inoculation—Reduction of FHB and Mycotoxins in Wheat
In 2006 and from 2008 to 2010, field experiments with artificial inoculations were performed with
the two winter bread wheat cultivars “Runal” and “Levis”. Artificial inoculations were in general
conducted near mid anthesis (GS 63–65) together with applications for FHB control one day before
and/or after the fungal inoculation. For logistic reasons, however, both cultivars were inoculated at
the same day.
All treatments with antifungal compounds caused significant effects on FHB disease symptoms
on wheat heads, yield and mycotoxin accumulation. The fungicide PrP showed the best performance
and resulted in the highest yield (p < 0.05) with a mean increase of 37% for both cultivars compared
with the water control throughout the four experimental years (Figure 5C). With the botanicals and TA,
yield increases of 13%–23% (TA a+b i.) were achieved. With respect to FHB on heads (disease severity;
Figure 5A), DON and NIV (Figure 5B,D), the TA treatment “TA b+a i.” was as effective as PrP.
The higher yield caused by the synthetic fungicide could be explained by its broad spectrum
for disease control. Apart from the excellent performance of TA and GC under field conditions, the
efficacy of buckthorn bark (FA) was also highly remarkable, since preparations of FA were not only
ineffective in the in vitro experiments but also in the climate chamber experiments with the cultivar
“Apogee” (Figure 4). This finding may be explained by induction of self defense mechanisms with
production of phenolic compounds as observed in the mentioned experiment on downy mildew of
grapes [35] or with Chitosan® which reduced seed-borne FG by inducing the formation of phenolic
acids and lignin [29]. The function of induced or constitutive phenolic compounds in disease resistance
has been described for diverse pathogen-host interactions [30,36] and phenolic compounds may also
play a role as resistance factors in the FHB wheat interaction [37]. The assumed lack in induction of
FHB resistance in the cultivar “Apogee” through FA could be based on its overall high susceptibility
to various diseases and a deleted QTL region of the chromosome 3BS FHB [38].
High correlations were observed for FHB severity on heads versus yield, FHB severity versus DON
and versus NIV content as well as for yield versus DON and versus NIV content (Table 3). The high
correlation between DON and NIV (r = 0.893) together with that between the FG incidence in grains
and NIV indicates that NIV was also produced by the poly conidia FG isolates and not only by FCr.
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Figure 5. Field experiments with artificial inoculation: Effect of treatments with TA, GC, FA and PrP:
(A) on the area of heads with FHB symptoms (disease severity); (B) on DON content; (C) on yield; and
(D) on NIV content of the winter wheat cultivars “Runal” and “Levis” after artificial inoculation with a
mixture of three FG and one FCr isolate/s. Data are pooled results from field experiments located at
Zurich-Reckenholz in 2006 and from 2008 to 2010 (for choice of years, see Experimental Section). Bars
with means of 16 values (four years and four replicates) and standard error of means. For treatments
labeled by the same letter, mean values are statistically not different according to Tukey test (p < 0.05).
Table 3. Field experiments with artificial inoculations in 2006, 2007, 2009 and 2010 (for choice of years,
see Experimental Section 3.6): Correlation between yield, FHB (% area with symptoms on heads) and
mycotoxin concentrations. Spearman correlation coefficients for 178 observations and symbols for
significance, NS: not significant, * = p < 0.05, ** = p < 0.01, and *** = p < 0.001. Coefficients with r > 0.8
are indicated in bold. ZEA: zearalenone.
Parameter Disease severity FG incidence FCr incidence DON ZEA NIV
Yield
−0.868 −0.680 −0.168 −0.814 −0.112 −0.836
*** *** * *** NS ***
Disease severity
(FHB)
- 0.703 0.117 0.879 0.333 0.849
*** NS *** *** ***
FG incidence
- - 0.228 0.775 0.348 0.637
- - ** *** *** ***
FCr incidence
- - - 0.254 0.133 0.370
- - - ** NS ***
DON
- - - - 0.475 0.893
- - - - *** ***
ZEA
- - - - - 0.316
- - - - - ***
2.6. Field Experiments with Semi-Natural Inoculation—Reduction of FHB and Mycotoxins in Wheat
In commercial wheat fields with maize as the pre crop and zero or reduced tillage situations,
DON values exceeded often the EU limit of 1.25 ppm in unprocessed cereals, even when growing
varieties with low FHB susceptibility [5]. Field experiments with semi-natural inoculation represent an
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approach to mimic conditions as in commercial wheat fields. Such a field experiment was conducted in
2010. Our DON forecasting system FusaProg [9] was employed in order to optimise the timing of the
applications. In the first half of wheat flowering, the system forecasted FG infection periods for 6 and
7 June 2010. Therefore, the treatments were applied as soon as possible on 7 and 8 June 2010. In the
second half of the flowering period, no additional infection periods were registered. The fungicide
PrP significantly increased the yield of “Levis” but not that of “Runal” (Figure 6A,B). For “Runal”, all
treatments except those with application of GC (1) and FA (2) significantly reduced the DON content
(Figure 6C). For Levis, all treatments significantly reduced the DON content (Figure 6D). The good
efficacy of a single application FA (FA (1); Figure 6C,D) on “Levis” and on “Runal” can again be best
explained with the induction of plant defense mechanisms [35]. Differences in the efficacy between the
two cultivars might be a result of different defense induction abilities of cultivars and/or effects of the
growth stage as it has been reported in other investigations with the crops wheat and grapevine [29,37].
 
Figure 6. Field experiment with semi-natural inoculation (2010): Effect of treatments with TA, GC, FA
and PrP on (A,B) yield and (C,D) DON content, in the winter wheat cultivars “Runal” and “Levis”.
(1): application on 7 June 2010; (2): applications on 7 and 8 June 2010. Data from field experiment
at Zurich Reckenholz with infections originating from FG/FCr infected maize stubbles. Bars with
mean values and standard error of means. For treatments labeled by the same letter, mean values are
statistically not different according to Tukey test (p < 0.05).
3. Experimental Section
3.1. Fungal Isolates, Growth Conditions and Antifungal Agents
For in vitro, in vivo and field experiments, three isolates of FG, FG9915 (CBS 121291; CBS:
Centraalbureau voor Schimmelcultures), FG0407 (CBS 121296), FG0410 (CBS 121292) and one isolate
of FCr, FCr9703 (CBS 121293), were used. All isolates originate from wheat grains from eastern and
midland regions of Switzerland. Starter cultures and fungal inoculum was produced in 9 cm diameter
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Petri plates containing autoclaved (20 min, 121 ◦C) potato dextrose agar (PDA; 39 g L−1, CM0139;
Oxoid Ltd., Hampshire, UK). After inoculation, plates were incubated for 6–7 days at 19 ± 1 ◦C with a
photoperiod of 12 h dark/12 h near-ultraviolet light. Conidia suspensions for in vitro tests, artificial
infections in climate chambers and in the field were obtained by washing off the conidia from the
cultures with deionised water with 0.125‰ Tween®20 (Sigma Aldrich, Buchs, Switzerland). Conidia
concentrations were measured and adjusted to the desired concentration.
The following ABs were used: dried bark of FA (Frangulae corticis sicc norm), dried root of RP
(Rhei radix pulv) both from Hänseler AG (Herisau, Switzerland), powder of GC galls (origin: Sichuan,
China; purchased from Berg-Apotheke, Zurich, Switzerland) and the polyphenol TA (tannic acid
powder, puriss; Sigma Aldrich). The plant material was finely ground with a centrifugal mill (mesh
size 0.08 mm; Retsch ZM 200, Schieritz & Hauenstein AG, Arlesheim, Switzerland). The selection of
the ABs was based on promising botanicals from earlier experiments, including investigations with
Phytophthora infestans and Microdochium majus [17–20]. According to the results, GC was one of the best
performing botanicals. In China, GC galls from Rhus chinensis Mill., induced by larvae of the aphid
Melaphis chinensis, serve as raw material for industrial production of TA, hence, this compound was
also integrated in the experiments of this study [17]. This high molecular weight polyphenolic has a
broad field of applications and, for example, is used in human medicine for inhibition of melanogenesis
in melanoma cells [39] and also for antidiarrheal effects [40]. The fungicide Pronto Plus® (PrP; active
ingredients 25.5% spiroxamine, 13.6% tebuconazole) was integrated to compare the efficacy of the
antifungal agents with good performing synthetic fungicides to control FG in wheat [7].
3.2. Isolate Specific Inhibition of Conidia Germination with TA
Microscope slides (76 mm × 26 mm) were placed in Petri plates onto moistened (2 mL sterile
deionised water) filter papers (diameter 8.5 cm, Nr. 591, Schleicher & Schuell, München, Germany)
and three water agar plugs (1 cm diameter) were placed on each slide. Each treatment consisted of
two Petri plates, resulting in a total of six agar plugs. One droplet of 15 μL TA with concentrations
of 0.125%, 0.25%, 0.5% and 1% were pipetted onto each agar plug and were allowed to evaporate for
20 min in a sterile bench. Sterile, deionised water served as the control treatment. Subsequently, for
each isolate, one droplet consisting of 15 μL of the conidial suspensions with 3.3 × 104 conidia mL−1
was applied to the plugs. Petri plate lids were closed and plugs were incubated for 24 h at 10 ◦C
and 70% relative humidity (RH) in the dark. Conidia were killed and stained with one drop of a
solution with 0.19% PrP and 0.5% cotton blue. The germination rate was assessed on each plug with
the aid of a light microscope (400 magnification) by determining the ratio of germinated conidia from
a total of 30 conidia within three different visual fields. A conidium was assigned as germinated when
the germination tube was longer than the width of the conidium. Based on the results from the five
concentrations with six agar plugs, the concentration for a 50% inhibition of the germination of the
conidia (EC50) was calculated with the software ED50plus v1.0 [41]. The experiment was conducted
twice and the results from the two experimental runs were pooled.
3.3. Inhibition of Conidia Germination of FG0407 with TA and Botanicals
Using a single conidium isolate of FG0407, we examined the efficacy of the ABs and the fungicide
PrP. Preliminary trials showed that germinating conidia are hardly visible on agar containing powder
particles. Hence, for this experiment, aqueous extracts of the botanicals were used as opposed to
suspensions from botanicals in the in vivo and the field experiments. For each of the three botanicals,
10 g powder were suspended in 100 mL autoclaved deionised water and stirred for 3 h at ambient
temperature. The aqueous extracts were subsequently filtered using fluted filters (diameter 15 cm,
520 A 1/2, Schleicher & Schuell).
TA and GC were tested at 0.125%, 0.25%, 0.5% and 1% (w/v). RP and FA were tested with aqueous
extracts of 0.5%, 2.5%, 5% and 10% (w/v). The elevated concentrations for RP and FA were used, since
in preliminary trials almost no effect was observed with RP and FA at 1%. Sterile, deionised water
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served as the control treatment. For each treatment, the conidia germination rate was determined as
described above. The germination rate of the control treatment was set to 100% and the results from
the other treatments were adjusted correspondingly. The experiment was repeated three times and the
results from the three experimental runs were pooled.
3.4. Inhibition of Mycelial Growth of FG0407 with TA and Botanicals
Schott flasks with autoclaved PDA medium were placed in a water bath (60 ◦C) and while stirring
amended with streptomycin sulphate (0.1 g L−1). For each Petri plate, 20 g of agar was poured into
Petri plates. After one to two days, 2 mL water (control), water with 1% powder of ABs or with TA
were evenly spread over the agar surface with a sterilized spreader rod. Subsequently, the Petri dishes
were opened and placed into a sterile bench for 2–3 h until the weight of the agar was reduced back
to 20 g. For each treatment, five Petri plates were used. Using a cork borer, mycelial plugs (diameter
0.5 cm) were cut from the margin of seven day-old colonies of a single conidium isolate of FG407.
For each PDA plate, one plug was placed in the center with the mycelial side facing the agar. Plates
were incubated in the dark at 24 ± 1 ◦C and 70% RH for six days. Subsequently, radial growth was
determined by measuring the diameter of the fungal colony at two positions (smallest and largest
diameter) and calculating the average of both values. Data are presented as percentage growth of the
aqueous controls. The experiment was conducted two times and the results were pooled.
3.5. Climate Chamber Experiment—Reduction of Disease Severity and Mycotoxins in Artificially
Inoculated Wheat
For these experiments, poly conidia isolates of FG0407, FG0410, FG9915 and FCr9703 were used.
Suspensions with powder of the ABs GC, RP and FA were applied to wheat plants without any
filtration. The methods for cultivation of the spring wheat cultivar “Apogee” (Triticum aestivum L.),
inoculation of fungi, disease assessment and harvest were conducted according to Vogelgsang et al. [42].
One modification to this protocol was that for inoculation, the pots were transferred for 24 h in a
walk-in climate chamber at 19–20 ◦C with 90% RH, followed by 48 h with 85% RH and a dark and
light period of 9 h and 15 h, respectively. In addition, the TKW of harvested grains was assessed using
a “Contador” seed counter (Baumann Saatzuchtbedarf, Waldenburg, Germany). The experimental
set-up was a randomised complete block design. Each treatment consisted of eight pots (handled
as four replicates with each two pots) with three wheat plants in each pot. “Apogee” is a full dwarf
hard red spring wheat developed for life support system in space and is highly susceptible towards
FHB [38,43].
The botanical powders were suspended in water with 0.1‰ Greemax® (surfactant and adhesive
emulsifier; Madora GmbH, Lörrach, Germany) [44] and stirred at room temperature for 2–3 h. All
preparations and the water controls were applied with 37.5 mL per pot. TA and botanicals were applied
with 5% suspensions, PrP with 0.375%. Two water controls with Greemax® (0.1‰) amended tap water,
whereof one was acidulated with acetic acid to pH 4.0, were used (see Table 1). For application of the
botanicals, the pots were placed on a turntable and the heads of the wheat plants were sprayed from all
sides until run-off. After application, the wheat heads were allowed to dry during 2 h. Visual disease
assessments were conducted three times within 7–14 days post-inoculation by counting spikelets
from all heads in each pot with symptoms and estimating the percentage of the diseased area. The
experiment was conducted twice and the results were pooled.
For determination and quantification of mycotoxins, liquid chromatography tandem mass
spectrometry (LC-MS/MS) analysis was used. 10 g wheat flour was placed in a 100-mL flask and
40 mL of an acetonitrile/acetone/water mixture 50:25:25 (v/v) (all organic solvents from Scharlau
Multisolvent, Sentmenat, Spain; water from Gradient A10, Millipore, Bedford, MA, USA) were added.
Closed flasks were manually agitated until no larger wheat flour aggregates were visible. The extraction
was conducted on a rotary shaker (Bühler SM-30, Hechingen, Germany) for 2 h (180 rev min−1). Flour
and solvent mixture were separated over a folded filter (Whatman 595 12 , Dassel, Germany), and the
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extract was collected in a 22-mL vial with a solid screw cap (Supelco, Bellefonte, PA, USA). Matrix
components including lipids or fat were removed by cleaning 1 mL of extract over a 3 mL cartridge
(Isolute, Uppsala, Sweden) filled with 0.15 g of celite (Fluka, 545 coarse, Buchs, Switzerland)/alox
(Fluka, for chromatography, Buchs, Switzerland) 1:1 (w/w), wetted and precleaned with 2 mL of the
same solvent mixture used for extraction. The resulting extract was collected in a 5-mL Reacti-vial
(Supelco). After percolation of 1-mL extract, the cartridge was rinsed with 2 mL of solvent mixture
and emptied by use of vacuum. The final volume of the cleaned extract (3 mL) was reduced at 40 ◦C to
0.4 mL with compressed air and transferred into a 2 mL high-performance liquid chromatography
(HPLC)-vial. The Reacti-vial was rinsed with 0.4 mL water/methanol 90:10 during 10 s by the aid
of a vortex (Scientific Industries, Bohemia, NY, USA) and transferred to the HPLC-vial as well. The
final volume of the extract was adjusted with water/methanol 90:10 to 1 mL. The samples were
stored in the dark at room temperature and were processed within 48 h. The LC-MS/MS analysis
was performed on a Varian 1200-L system (Varian Inc., Walnut Creek, CA, USA). The analytes DON,
NIV, acetylated-deoxynivalenol (Ac-DON: sum of 3-Ac- DON and 15-Ac-DON (all from R-Biopharm,
Darmstadt, Germany) and ZEA (Sigma-Aldrich, St. Louis, MO, USA) were separated on a Polaris
C18-A column (50 mm × 2.0 mm, 3 μm; Varian Inc., Walnut Creek, CA, USA). Operating the mass
spectrometer in negative atmospheric pressure chemical ionization (APCI) mode, the analytes NIV,
DON, Ac-DON and ZEA were detected with the next elution gradient: 0 min: 5% B (95% A); 1
min: 5% B; 4 min: 30% B; 5 min: 100% B; 12.5 min: 100% B; 13 min: 5% B; 20 min: 5% B. Eluent
A consisted of water/methanol 95:5 (v/v) and eluent B of water/methanol 5:95 (v/v); both were
buffered with 5 mL 1 M ammonium acetate per Liter (Fluka, Puriss P.A., Buchs, Switzerland). Each
analyte was detected with two transitions (qualifier and quantifier) in multiple reactions monitoring
(MRM). Analyte identification was confirmed using chromatographic retention time, correct mass
of the mother ion, correct mass of the two daughter ions and agreement of the ratio of qualifier to
quantifier with the calibration (±10%). For quantification, the method of matrix matching calibration
was implemented to correct for eventual ion suppression. Recoveries for low (0.5 mg kg−1) and high (2
mg kg−1) spiked blank samples (n = 4) were between 86%–126% and 78%–107%, respectively. Method
precision was in the range of 2%–12%, whereas instrument precision was between 2% and 10%. The
limit of quantification for DON ranged between 0.09 mg kg−1 and 0.126 mg kg−1, for ZEA between
0.008 mg kg−1 and 0.021 mg kg−1 and for NIV between 0.058 mg kg−1 and 0.185 mg kg−1, depending
on the sample series analyzed.
3.6. Field Experiments with Artificial Inoculation—Reduction of FHB and Mycotoxins in Wheat
Field experiments were conducted from the harvest years 2006–2010 with the two Swiss winter
wheat cultivars “Runal” and “Levis”. According to the Swiss national catalogue, the resistance for
FHB of these bread wheat cultivars is considered to be “medium” and “medium to poor”, respectively.
The field experiments were carried out on the experimental farm of the Research Station Agroscope
in Zurich-Reckenholz, Switzerland. The experiments comprised seven treatments (Table 1) with
four replications each, using a Latin square design. The size of individual plots was 6.5 m × 2.6 m.
Each plot was divided in two subplots for the two varieties sown in bands. Husbandry management
was standard for the farm, except that no fungicides were applied.
For inoculation of the wheat plants, a suspension with a mixture of the four poly conidia isolates,
FG0407, FG0410, FG9915 and FCr9703, was used. The suspension contained 2 × 105 conidia mL−1
with equal amounts of each isolate and 0.125‰ Tween 20. The conidia mixture and a water control
with 0.125‰ Tween 20 were applied from both sides along the field with a volume of 750 L ha−1
using a knapsack sprayer (width 1.5 m, 3 bar, Birchmeier M125, Birchmeier Sprühtechnik AG, Stetten,
Switzerland). The inoculation was conducted at mid-anthesis (GS 63–65). The date for this growth
stage varied considerably throughout the years: For example, in 2006, this stage was reached on 12
June, whereas in 2007 it was reached on 21 May. Wheat was inoculated from both sides along the
plots, directing the spray towards wheat heads. Water and suspensions with ABs (GC, RP, FA) and
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TA were applied one day before the fungal inoculation and depending on weather conditions, again
one or two days after the inoculation. For the application of TA, PrP and water, spray nozzles from
TeeJet® XR11002 (4.0 bar, 450 L ha−1) and for GC, RP and FA, spray nozzles from Floodjet® (1.5 bar,
450 L ha−1) were used. Weather data were obtained from the MeteoSwiss operated weather station
located at Zurich-Reckenholz.
Visual disease assessment from 4 × 10 randomly selected wheat heads within an individual
plot was conducted in the field during two occasions between 14 and 25 days post-inoculation by
counting spikelets with typical FHB symptoms and estimating the percentage of the diseased head
area. Plots were combine-harvested when the cultivars reached GS 92 (caryopsis hard). Processing of
the harvested samples, the procedure of a seed health test to determine the percentage incidence of
FHB causing species and the preparation of samples for the analysis of toxins was done according to
Vogelgsang et al. [42]. The method for the analysis of toxins was conducted as described above.
In 2007, there were no treatments with GC and RP in our field experiment with artificial infections
and due to technical problems, the inoculation of wheat during anthesis was not possible. Hence, due
to the resulting lack of orthogonally to the other years, the data of this experiment were not used for
the analysis.
To determine the correlation of the field data with artificial inoculations, the results of 2007 were
used but not those of 2008, because in 2008, the overall incidence by Fusarium species in wheat grains
was close to 100% and hence, no seed health test was conducted.
3.7. Field Experiments with Semi-Natural Inoculation—Reduction of FHB and Mycotoxins in Wheat
To evaluate the performance of the ABs under conditions that mimic cropping of wheat without
tillage after maize, Fusarium infected maize stubbles were applied in experimental field plots in 2010
after wheat emergence. The stubbles were inoculated in mid-November 2009 with FG/FCr suspensions
of 1 × 106 conidia mL−1, and stored in plastic boxes permeable to air in a greenhouse with an average
temperature of 10 ◦C. The incubated stubbles were distributed in the field plots at the end of November
2009 (2–3 maize stalk pieces at about 0.5 kg m−2). Based on the indication of FG infection periods
by FusaProg [9], the treatments were applied on 7 June or 7 and 8 June 2010, respectively (Figure 6).
With the exception of the inoculation, all procedures and assessments of parameters were conducted
as in the field experiment with artificial inoculations.
3.8. Statistical Analysis
For all experiments except for the one with semi-natural inoculations, results from the
experimental runs were pooled in case of equal variances. In case of a failed normality or variance tests,
data were arcsine, log or square root transformed before analysis of variance (ANOVA). Apart from
one-way ANOVAs analysing the effect of one treatment factor only, two-way and three-way ANOVAs
were also conducted for experiments where other factors than the botanicals were important (e.g.,
wheat cultivar and year). When the overall effect of the tested factor was significant in ANOVA, an
all-pairwise multiple comparison procedure according to Holm-Sidak (α = 0.05) was employed. In
order to specify the differences between treatments or years, a Tukey post hoc test (α = 0.05) was
used. The variances of data from field experiments with artificial inoculations were not equal due
to substantial year effects. Nevertheless, we conducted a three way ANOVA and a Tukey test since
our experiments were orthogonal and the p value for the factor treatment was <0.0001 for all four
criteria. In addition, separate mean values for the cultivars “Runal” and “Levis” and the corresponding
standard error of means were calculated. For these ANOVAs, the open source “R” software version
3.0.1 (16 May 2013) was utilized. For calculation of Spearman correlations coefficients and for plotting
of graphs from untransformed data, SigmaPlot version 11.0 (Systat Software) was used.
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4. Conclusions
The overall aim of this study was to investigate possibilities to control FHB in wheat with
substances having no negative effects on humans, animals and the environment. The obtained results
prove that TA and the botanicals, GC and FA can substantially reduce FHB severity and mycotoxin
contents under field conditions. In several experiments, the efficacy was even close to that observed
with a synthetic fungicide.
In contrast to TA and GC, FA showed almost no fungal toxic effects in vitro. However, FA, being
not effective in vitro, demonstrated great field performance in reducing the DON content in kernels by
up to 71% under semi-natural inoculation conditions. The effectiveness of FA can best be explained by
resistance inducing effects.
With a better understanding of the interactions between FA and wheat, such as the type and
the dynamic of potentially induced compounds, the efficacy could be improved further. In addition,
an optimized application strategy could be developed. The elicitor FA might be applied at the end
of ear emergence. Subsequently, by using a forecasting system, which predicts FHB infection by FG
and DON contamination, a second treatment with an antifungal product including TA or GC could
be applied during flowering. With such an approach, it might be possible to obtain FHB and DON
reductions as good as those from the best commercial fungicides.
Certainly, FHB in small-grain cereals can only be controlled with an integrated approach,
employing crop rotation, tillage and proper choice of cultivars. However, data from our field
experiments suggest that TA, GC and FA do have a high potential and thus could provide an excellent
contribution to the production of safe small-grain cereals with acceptable toxin contents in low-input
farming systems.
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Abstract: Deoxynivalenol (DON, vomitoxin) is a type-B trichothecene mycotoxin produced by several
field fungi such as Fusarium graminearum and Fusarium culmorum and known to have various toxic
effects. This study investigated the effect of the bread making process on the stability of DON in
common bread and wheat germ-enriched bread using naturally contaminated ingredients at the level
of 560 μg/kg. The concentration of DON and its evolution during bread making were determined
by immunoaffinity column cleanup followed by liquid chromatography with diode array detection
(HPLC-DAD). During the bread making process, DON was reduced by 2.1% after fermentation and
dropped by 7.1% after baking, reaching a maximum reduction of 19.8% in the crust as compared
with a decrease of 5.6% in the crumb. The addition of 15% wheat germ to the dough did not affect
DON stability during bread making, showing an apparent increase of 3.5% after fermentation and a
reduction by 10.2% after baking.
Keywords: deoxynivalenol; bread making; wheat germ
1. Introduction
Wheat bread is a staple food prepared by baking a dough of flour and water usually leavened
with yeast, which is widely consumed around the world [1]. In Spain, the mean consumption of bread
accounts for 86 g/day [2]. Wheat germ is a component of wheat kernel with high nutritional value for
the concentration of α-tocopherol (vitamin E), vitamins of group B, dietary fiber, polyunsaturated fats,
proteins of high nutritive value, minerals and phytochemicals (i.e., flavonoids). Consequently, wheat
germ has been used as a flavoring ingredient in the manufacture of enriched breads available in the
marketplace, increasing the nutritional value as well as extending shelf-life due to the natural content
of organic acids and antifungal compounds such as lectin wheat germ agglutinin [3,4]. For all these
reasons wheat germ and its derivatives are attractive and promising functional ingredients.
Deoxynivalenol (DON, vomitoxin) is a type-B trichothecene mycotoxin produced by several field
fungi, including Fusarium graminearum and Fusarium culmorum, that cause a wide range of toxic effects
in animal and humans [5,6]. Among the trichothecenes DON is the most frequently occurring toxin,
and is found worldwide, particularly in cereal crops such as wheat and their products like flour, bread
and germ [7–9]. To reduce the dietary exposure to DON, maximum limits have been set in flour
(750 μg/kg) and bread (500 μg/kg) by the European legislation [10], and a temporary tolerable daily
intake (TDI) of 1 μg/kg body weight was established.
The bread making process consists of three major stages: mixing, fermentation and baking. The
fermentation and baking conditions vary considerably throughout the world, resulting in different
effects on DON levels in final baked bread [11]. Bakery processing has been reported to reduce
overall DON contamination [12–15], while others suggested that DON is highly stable during this
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process [16,17]. Similarly, Samar et al. [13] reported reductions in DON content during the fermentation
phase, whereas Valle-Algarra et al. [14] did not observe any changes and Young et al. [18] even showed
an increase of DON in the leavened products. These discrepancies may be due to several reasons such
as the activity of baker’s yeast, which may produce a reduction of DON levels attributed to mycotoxin
degradation or yeast absorption [13]. Then, the addition of wheat germ to the bread dough recipe may
reduce the degradation rate of DON by affecting the baker’s yeast, as wheat germ is known to have
natural antifungal compounds. In a recent review, it is concluded that the description of DON behavior
during the bread making process is very difficult, since complex physico-chemical modifications occur
during the process [19].
In summary, results of bread making studies on the stability of DON have been conflicting, and
the effect of wheat germ addition on the mycotoxin level during bread making has not been studied.
Therefore, the aims of the present work were to evaluate the stability of DON during bread making
and to estimate the effect of wheat germ addition on the DON levels during the fermentation and
baking phases of the bread making process.
2. Results and Discussion
The analytical method used for DON quantification in bread products, based on water extraction,
immunoaffinity column cleanup and high performance liquid chromatography (HPLC) coupled with
diode array (DAD) detection, was successfully validated down to 70 μg/kg. The method provided
good recoveries for DON of 96.2%, and the study of intra-day precision in terms of repeatability
obtained RSDr values of 4.5%, in accordance with the validation criteria [20].
Results of DON reduction during the different stages of bread making process are shown in
Table 1. In common bread (Figure 1a), DON level in the staring material (560 μg/kg on a dry matter
basis) was negligibly reduced by 2.1% during the fermentation step at 30 ◦C for 90 min and lowered
by 7.1% after baking at 190 ◦C during 20 min. Evolution of DON levels in wheat germ-enriched
bread (Figure 1b) showed an apparent increase by 3.5% after fermentation (from 560 to 580 μg/kg
on a dry matter basis) followed by a reduction of 10.2% after baking. Therefore, the bread making
process resulted in low reduction rates for DON in both bread types, which were non-significant as
compared to the initial levels (P > 0.05). Consequently, the addition of 15% wheat germ did not exert
any noticeable effect on the stability of DON during yeast fermentation and baking.
Extra care should be exercised regarding the compliance with maximum limits established by
Commission Regulation (EC) No. 1881/2006, depending whether analytical results are expressed on a
fresh basis or on a dry matter basis. Actually, the DON level in common bread was 356 μg/kg on a
fresh basis, below the maximum limit set at 500 μg/kg, but amounted to 520 μg/kg when calculated
on a dry matter basis (moisture content was 31.5%) (Table 1).
The distribution pattern of DON in the crumb and the crust also evolved in a similar manner in
common and enriched bread. Thus, DON reduction in finished common bread was 5.6% and 19.8% in
the crumb and the crust, respectively, amounting to 7.1% and 17.9% in enriched bread. The greatest
reductions of DON in both bread types were observed in the crust, the outer part of bread which
supports the highest temperatures, although the differences were not significant (P > 0.05).
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Table 1. Effect of fermentation and baking on the reduction of deoxynivalenol (DON) levels in common
bread and enriched bread with 15% wheat germ.
Sample
Common bread Wheat-germ enriched bread
DON μg/kga % loss DON μg/kg % loss
Dough before
fermentation 560 ± 54 - 560 ± 62 -
Dough after
fermentation 548 ± 56 2.1 580 ± 30 +3.5
Baked bread 520 ± 10 7.1 503 ± 25 10.2
Bread crumb 529 ± 74 5.6 520 ± 26 7.1
Bread crust 449 ± 45 19.8 460 ± 4 17.9
Note: a: results expressed on a dry matter basis, as mean ± standard deviation (n = 2 assays).
(a) (b) 
Figure 1. (a) Common bread and (b) enriched bread with 15% wheat germ.
According to the literature review, the main factors affecting the variability of the fate of DON
during the bread making process include the preparation of the batter (ingredients and additives,
mixing time), the fermentation step (yeast, incubation temperature and time), and the heating operation
(oven-type, baking temperature and time). Some discrepancy of DON retention during baking bread
may also result from uncertainty of the analytical method for DON. Thus, several studies have reported
varying reductions in DON levels during bread making. Previous research showed DON overall
reduction rates of 38%–44% [12], 48% [14], and 33%–58% [15]. On the other hand, other researchers
reported that DON is highly stable during bread making [16,17]. These discrepancies may be due in
large part to the analytical methods used, the concentration and source of toxin (natural vs. spiked),
and the experimental conditions employed [21,22]. Thus, it has been reported that the ingredients
used [23], the oven technology (commercial or home-made) [19,24] and the fermentation and baking
conditions [14] influence on the reduction of DON level observed during bread making. On the other
hand, Sugita-Konishi [17] reported that the DON level in flour was not reduced by bread making but
that rather the biological toxicity was significantly reduced as determined by cytotoxicity bioassay.
Bakery processing has been reported to produce a thermal degradation of DON during bread
making. For instance, the average reduction in DON concentration after baking (70 min at 195–235 ◦C)
was 47.2% for bread baked in an industrial oven and 48.7% for bread baked in a log fire oven [25].
As reviewed by Kushiro [22], during baking or heating, DON is partially degraded to DON-related
chemicals. Likewise, it is suggested that some DON reductions may be due to binding or the inability
to extract the toxin from the matrix using current analytical techniques. Our results showed DON
reductions up to 10.2% by baking at 190 ◦C for 20 min, which increased up to 19.8% in the crust that
reached higher temperatures. Numanoglu et al. [26] indicated that the temperatures recorded in the
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crust and crumb of maize bread during baking were 100 ◦C and 150 ◦C, respectively, and thermal
degradation of DON only initiated at 150 ◦C.
DON reduction during bread making may occur not only in the bakery due to thermal
decomposition, but also during the fermentation step. Thus, yeast fermentation has been reported
to produce a reduction of DON levels, which was attributed to mycotoxin degradation or yeast
absorption. The fermentation stage during bread making produced DON reductions between 0% and
25% in dough fermented at 30 ◦C for 60 min, whereas there was a maximum 56% reduction when the
dough was fermented at 50 ◦C [13]. In our study, yeast fermentation at 30 ◦C for 90 min produced
minor changes of DON levels in the fermented dough, even an apparent increase of 3.5% in wheat
germ-enriched bread. This is in agreement with Young et al. [18] who observed an increase in DON
levels in yeast doughnuts, explained by the contamination of wheat with a DON precursor, which was
possibly converted to DON by the active yeast.
3. Experimental Section
3.1. Bread Making and Sampling
According to a typical baker recipe, two different types of bread were manufactured at the pilot
plant of the Veterinary Faculty of Zaragoza (Spain): common bread and enriched bread with 15% of
wheat germ. For each type of bread (common and enriched) there were two bread making assays
carried out in different times. Each assay consisted of 1.0 kg of dough that yielded 6 bread pieces
of approximately 150 g. Therefore, for each bread type there were a total of two analytical samples
(n = 2 assays) at each processing step: dough before fermentation (50 g each), dough after fermentation
(50 g each), baked bread (50 g pooled from two bread pieces), bread crumb (50 g pooled) and bread
crust (50 g pooled). For statistical purposes, each result in Table 1 is the mean ± standard deviation
(n = 2 assays). The bread making process showed good repeatability between the two assays as
indicated by adequate values of relative standard deviation (%RSD) calculated from Table 1. The mean
%RSD was 7.3% and individual RSD values depending on sample type ranged from 0.9% to 14%.
The bread formulas were as follows: (i) common bread made with 1000 g wheat flour, 550 mL
tap water, 16 g sodium chloride, and 40 g of commercial baker’s yeast (Saccharomyces cerevisiae), and
(ii) enriched bread made with 850 g wheat flour, 150 g wheat germ, 550 mL tap water, 16 g sodium
chloride, and 40 g of commercial baker’s yeast. A continuous high-speed mixer was used to prepare
the batter by adding 450 mL pre-warmed water (37–40 ◦C) and mixing for 3 min, followed by the
addition of baker’s yeast dissolved in 100 mL pre-warmed water and mixing for another 8 min. Dough
was settled at room temperature for 15 min, and then fermentation was carried out during 90 min in a
camera at 30 ◦C and 80% relative humidity. Finally, the raised dough was baked in an oven at 190 ◦C
for 20 min to obtain the bread.
DON levels were determined at each step of the bread making: dough before fermentation,
dough after fermentation, and baked bread. For each bread several slices were cut and samples were
taken from the crumb and the crust. The wheat flour and wheat germ used as main ingredients were
naturally contaminated with DON and produced a concentration of 560 μg DON/kg dry matter in the
starting material (dough before fermentation).
3.2. Reagents and Apparatus for DON Analysis
HPLC grade acetonitrile and methanol were purchased from Lab-Scan (Dublin, Ireland).
Ultrapure water was obtained from a Milli-Q Plus apparatus from Millipore (Milford, MA, USA). The
immunoaffinity columns DonStar™ were supplied by Romer Labs (Union, MO, USA). Deoxynivalenol
standard solution at 100 μg/mL in acetonitrile was provided by Sigma (St. Louis, MO, USA) and
stored at −21 ◦C. Reagents for phosphate-buffered saline solution (PBS) were obtained from Panreac
(Barcelona, Spain).
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The LC system consisted of an Agilent Technologies (Santa Clara, CA, USA) 1100 high
performance liquid chromatograph coupled to an Agilent diode array detector (DAD) at 220 nm
for the determination of DON. The LC column was Ace 5 C18, 250 mm × 4.6 mm, 5 μm particle size
(Advanced Chromatography Technologies, Aberdeen, UK). The mobile phase consisted of a mixture
of water/acetonitrile/methanol (90:5:5, v/v/v) at a flow rate of 1.0 mL/min.
3.3. Analysis of DON in Dough and Bread Samples
For the determination of DON in dough and bread samples, five grams were extracted with
40 mL of Milli-Q water using an Ultraturrax homogenizer for 3 min. After the extraction, the solution
was filtered with Whatman #4 filter paper, and the extract collected for further cleanup by DonStar™
immunoaffinity columns according to the manufacturer’s instructions. Briefly, 2 mL of the filtered
extract were passed through the column at a flow-rate of 1 drop/second, followed by a washing with
5 mL PBS pH 7. DON was then eluted with 3 × 0.5 mL methanol and collected in a clean vial. The
eluted extract was evaporated to dryness under nitrogen stream at 50 ◦C and redissolved with 400
μL of the HPLC mobile phase. One hundred μL was injected into the LC-DAD system by full loop
injection system. Quantification of DON was performed by measuring peak areas at DON retention
time, and comparing them with the relevant calibration curve. To facilitate the comparison of the DON
levels in the different samples taken during the bread making process, results were expressed on a dry
matter basis. For this purpose, a sample of 5 g was heated in an oven at 130 ◦C for 2 h. After cooling,
the moisture content was determined by weight loss and the mycotoxin content expressed on a dry








)/( μμ = (1)
Average moisture contents were 41.8% for dough before fermentation, 41.7% dough after
fermentation, 31.5% bread, 40.7% crumb, and 16.4% crust.
3.4. Statistical Analyses
Results from mycotoxin analyses were subjected to descriptive and comparative statistics
according to Sachs [27]. DON levels determined before and after each processing step of the bread
baking assays and between different sample types (bread crumb, crust) were statistically evaluated
by the one-way analysis of variance (ANOVA at P = 0.05) procedure using the statistical software
StatView SE + Graphics (Abacus Concepts, Berkeley, CA, USA). Fisher PLSD test was used when
significant differences were found among means.
4. Conclusions
Mycotoxins are considered to be very stable molecules but because of their toxic effects,
information about their stability in thermal processes and potential inactivation procedures is needed.
This study concluded that DON was stable during the bread making process and remained stable
in the enriched bread with 15% wheat germ. The fermentation step (30 ◦C for 90 min) and the oven
baking (190 ◦C for 20 min) resulted in non-significant losses of DON from the initial dough. Quite
different results concerning the fate of DON during bread making have been reported in the literature
to date. The discrepancies between the findings reported in these different studies may be due in large
part to the analytical methods employed, the differences in the experimental conditions employed and
the concentration and source of toxin.
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Abstract: The trichothecene mycotoxin deoxynivalenol (DON) is a well known and common
contaminant in food and feed. Acetylated derivatives and other biosynthetic precursors can occur
together with the main toxin. A key biosynthetic step towards DON involves an oxidation of
the 8-OH group of 7,8-dihydroxycalonectrin. Since analytical standards for the intermediates
are not available and these intermediates are therefore rarely studied, we aimed for a synthetic
method to invert this reaction, making a series of calonectrin-derived precursors accessible. We
did this by developing an efficient protocol for stereoselective Luche reduction at C8. This
method was used to access 3,7,8,15-tetrahydroxyscirpene, 3-deacetyl-7,8-dihydroxycalonectrin,
15-deacetyl-7,8-dihydroxycalonectrin and 7,8-dihydroxycalonectrin, which were characterized using
several NMR techniques. Beside the development of a method which could basically be used for all
type B trichothecenes, we opened a synthetic route towards different acetylated calonectrins.
Keywords: dihydroxycalonectrins; trichothecenes; DON; Luche reduction; scirpene
1. Introduction
Trichothecene based mycotoxins are common and widespread contaminants in food and feed.
They can affect human and animal health by causing several acute and chronic symptoms after
uptake [1]. Toxicity studies showed that the primary mode of action of trichothecenes is inhibition of
eukaryotic protein synthesis [2–4]. When consumed in contaminated foods, trichothecenes can act as
neurotoxin, immunosuppressive or nephrotoxin [5–7].
The polarity of trichothecenes depends on the number of hydroxyl groups (ranging from 1 to 5)
and their esterification status. So far, more than 200 different trichothecenes have been reported,
which are produced by different genera such as Fusarium, Myrothecium, Stachybotrys, Cephalosporium,
Trichoderma and Trichothecium [8]. Generally, they are divided into four different groups (A–D), all
containing a tricyclic 12,13-epoxytrichothec-9-ene core structure [9]. Type A toxins are compounds
with at least one hydroxyl group, either no oxygen substituent at C8 or an ester functionality. In
contrast, type B trichothecenes feature a carbonyl functionality at C8. The most prominent toxins of
the two classes mentioned above are T-2 toxin (type A), nivalenol (NIV, type B) and deoxynivalenol
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(DON, type B). From the biosynthetic point of view type A and type B trichothecenes are derived
from the same precursors (Scheme 1) and most of the responsible genes are already described in the
literature [10].
 
Scheme 1. .Biosynthetic pathway of Type A and Type B trichothecenes (modified from [10]). F.
graminearum (Fg) and F. sporotrichioides (Fs) gene products catalyzing the reactions are indicated.
The oxidoreductase step leading to the C8 keto group is still uncharacterized. Our recent
findings [11] showed the occurrence of pentahydroxyscirpene (PHS), a NIV derivative with
an OH function at C8 which was isolated in substantial amounts (10%–20%) together with
NIV after fermentation and also in artificially inoculated wheat. Other results showed the
occurrence of 7,8-dihydroxycalonectrin [12–15] alone or in combination with 15-deacetyl-7,8-
dihydroxycalonectrin [16] or 3,7,8,15-tetrahydroxyscirpene [17]. Since these compounds are all
supposed to be toxin precursors, the findings suggest that there are even more acetylated forms
and derivatives of trichothecene precursors that might also be present in contaminated grain, but
which are not studied due to lack of standards. Therefore, we have focused on developing a reliable
method to make this substance class accessible.
2. Synthetic Approach
2.1. General Aspects
The most obvious synthetic way to access 7,8-dihydroxycalonectrin derivatives and other
trichothecenes with a C8 hydroxy group is the selective reduction of the C8 carbonyl function.
One common characteristic of naturally occurring compounds like trichothecenes is a very well
defined stereochemistry with a lot of chiral information. For example, DON has seven stereogenic
centers, which influences the synthetic introduction of a new stereocenter in a very unpredictable
way. Introducing a new hydroxyl group in position 8 would therefore lead to a mixture of
3,7,8,15-tetrahydroxyscirpene with its undesired isomer (Scheme 2).
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Scheme 2. Desired and undesired isomer of 3,7,8,15-tetrahydroxyscirpene via reduction of
deoxynivalenol (DON).
To avoid formation of the undesired isomer and suppress side reactions of the hydride reagent,
we choose to utilize the Luche reduction to achieve a very selective method for the reduction of DON.
2.2. Luche Reduction
The Luche reduction [18–20] can be used to convert α, β-unsaturated ketones into allylic alcohols
using CeCl3, NaBH4 and methanol as solvent. The main role of cerium(III) chloride is to coordinate
with the alcohol solvent, making its proton more acidic which can then be abstracted by the carbonyl
oxygen of the ketone. After addition of NaBH4 it also reacts with the cerium activated alcohol
forming a series of alkoxyborohydrides (Scheme 3). Since alkoxyborohydrides are “hard reagents”
their formation results in a selective 1,2-hydride attack on the protonated carbonyl group which leads
to the desired reaction. In addition the use of CeCl3 offers the possibility of coordinating [21] with
the C7 hydroxy group, which results in a shielding of the backside of deoxynivalenol (Scheme 3).
Due to this shielding effect, the desired frontside hydride attack should be more favored. The last
point which might have an influence on the reaction, is the oxygen in the pyran ring of DON. Since
this oxygen is located next to the reaction site, it is possible, that a coordination between the activated
borohydride species and the oxygen is taking place (Scheme 3), which would lead to an even more
targeted reduction.
Scheme 3. Mechanism of alkoxyborohydride formation, shielding and coordination.
3. Results and Discussion
3.1. Method Development
Since DON and its acetylated derivatives are very expensive we decided to use (+)-carvone
(Scheme 4) as a cheap and readily available mimic for method evaluation. Although the steric
information is quite simple compared with deoxynivalenol, it provides a good model for method
278
Toxins 2014, 6, 325–336
optimization. Therefore, the lowest possible concentration of all involved reagents as well as the
estimation of possible side reactions was examined, in order to avoid needless loss of starting material.
In addition 13 was used as stability test for the epoxy group, 14 as stability estimation for acetyl groups
and 15 as mimic for the coordination effect in deoxynivalenol.
Scheme 4. (+)-Carvone and its possible reaction products as model for deoxynivalenol.
For these experiments we used CeCl3·7H2O as it is significantly better soluble in methanol than
the anhydrous form. After some tests with varying equivalents, the reactions with 1 equivalent NaBH4
and 0.5 equivalents CeCl3·7H2O for 1 equivalent carvone turned out to be superior to other ratios,
allowing full stereoselective conversion without too much decomposition. With these conditions we
were able to perform the reaction from carvone to (+)-cis-carveol in 30 min with an isolated yield
of 92%. All attempts with lower reagent concentrations ended up with bad conversions (7%–13%
of starting material left after 24 h), more byproducts (>10%) and elongated reaction times (>24 h).
Stability testing regarding the epoxy group as well as the stability of the acetyl mimic under reaction
conditions revealed slow decomposition over time which rose to 16% within 2 h.
3.2. Synthesis of 3-ADON, 15-ADON, 3,15-diADON and Their Reduction
3-ADON was obtained from BOKU, Dept. for Agrarbiotechnology (IFA-Tulln) and was
spectroscopically pure (NMR, Figure S1) in accordance with existing literature [22]. The synthetic
route towards the different acetylated DON derivatives was carried out by deprotection of 3-ADON
via NaOMe/MeOH followed by Steglich esterification [23] to obtain 15-ADON and 3,15-diADON
simultaneously (Scheme 5).
All synthesized DON derivatives were reduced applying an optimized Luche protocol (See
3.3. Reduction Protocol) leading to the desired 7,8-dihydroxycalonectrin derivatives in moderate to
good yields.
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Scheme 5. Synthetic approach towards the different DON derivatives including reduction under Luche
conditions (NaBH4, CeCl3) to the corresponding calonectrins. (* = yield as sum of both products).
3.3. Reduction Protocol
All Luche reductions towards the different derivatives were done with 0.05–0.30 mmol of DON
or its corresponding acetylated form as starting material. The general procedure therefore was: Toxin
(1.00 equ.) was dissolved in 1 mL MeOH and CeCl3·7H2O (0.50 equ. in 1 mL MeOH) was added.
NaBH4 (1.00 equ.) was dissolved in 1 mL MeOH and added with moderate speed (dropwise, but fast
to prevent rising pressure due to H2 formation). We recommend preparation of a stock solution of
CeCl3·7H2O and NaBH4 as it is easier to deal with the low substance amounts. In case of NaBH4 the
solution should be prepared just in time and used quickly to avoid evolving hydrogen. After addition
of all reagents, the reaction was stirred at room temperature until TLC revealed conversion of the
starting material. The mixture was concentrated without heating under reduced pressure to avoid
decomposition and directly subjected to column chromatography.
3.4. Spectroscopic Investigation
To ensure that the desired stereochemistry of the product was achieved as well as for a full
characterization including proof of stereochemistry, all products were investigated via several NMR
techniques. In case of 7,8-dihydroxycalonectrin which is already well characterized in the literature,
we obtained the identical spectroscopic information as published [22] by recording 1H and 13C spectra.
In the case of the other three products we also recorded COSY, HSQC, HMBC and NOESY spectra to
achieve a complete characterization (Figure 1, Table 1).
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Table 1. 1H NMR data (in methanol-d4) including chemical shifts, (multiplicity) and [coupling
constants] of the isolated products. Multiplicities are abbreviated as s (singlet), d (doublet), t (triplet),
q (quartet), m (multiplet), and b (broad signal). R' and R are referring to the methyl signal of the
attached acetyl substituent in position 3 (R') and 15 (R).
Product 2 (d) 3 (dt) 4α (dd) 4β (dd) 7β (d) 8β (d) 10 (dq) 11 (d)
(5) 3.38 [4.5] 4.31 [10.7, 4.5] 2.21 [14.6, 4.5] 1.97 [14.6, 10.7] 4.43 [4.7] 3.91 [4.7] 5.57 [5.6] (b) 4.40 [5.6]
(7) 3.68 [4.4] 5.05 [11.1, 4.4] 2.48 [15.0, 4.4] 2.04 [15.0, 11.1] 4.40 [5.0] 3.91 [5.0] 5.54 [5.5, 1.4] 4.33 [5.5]
(8) 3.41 [4.4] 4.30 [11.1, 4.4] 2.49 [14.6, 4.4] 1.97 [14.6, 11.1] 4.45 [5.6] 3.92 [5.6] 5.57 [5.8, 1.4] 4.64 [5.8]
(9) 3.72 [4.4] 5.05 [11.2, 4.4] 2.68 [15.1, 4,4] 1.95–2.15(m) 4.42 [5.2] 3.91 [5.2] 5.53 [5.9, 1.5] 4.57 [5.9]
Product 13a (d) 13b (d) 14 (s) 15a (d) 15b (d) 16 (s) 3 R' (s) 15 R (s)
(5) 3.02 [4.4] 3.16 [4.4] 1.14 3.64 [12.6] 3.88[12.6] 1.84 — —
(7) 3.08 [4.1] 3.20 [4.1] 1.17 3.67 [12.6] 3.90[12.6] 1.84 — 2.10
(8) 3.04 [4.4] 3.18 [4.4] 1.15 4.34 [12.6] 4.38[12.6] 1.85 2.04 —
(9) 3.09 [4.3] 3.22 [4.3] 1.18 4.37(s), 2H 1.85 2.04 2.10
Figure 1. (a) Systematic numbering of trichothecenes; (b) Selected COSY and HMBC correlations of 5
(R = R' = H), 7 (R = H, R' = Ac) and 8 (R = Ac, R' = H); (c) Selected NOESY correlations within the 2D
(left) and 3D (right, optimized geometry, Figure S30, Tables S1,2) structure of 5.
4. Experimental Section
4.1. General
Thin layer chromatography (TLC) was performed over silica gel 60 F254 (Merck). All
chromatograms were visualized by heat staining using ceric ammonium molybdate/Hanessian’s
stain [24] in ethanol/sulfuric acid. Chromatographic separation was done on silica gel 60 (40–63 μm,
Merck, Darmstadt, Germany) using a SepacoreTM Flash System (Büchi, Switzerland). 1H and 13C
NMR spectra were recorded on an Avance DRX-400 MHz spectrometer as well as at a Bruker DPX-200
spectrometer (Bruker, Karlsruhe, Germany). Data were recorded and evaluated using TOPSPIN 1.3
(Bruker Biospin, Karlsruhe, Germany). CD spectra were recorded using a JASCO J-815 CD spectrometer
(JASCO, Easton, MD, USA), and can be found in the supporting information. All chemical shifts are
given in ppm relative to tetramethylsilane. The calibration was done using residual solvent signals [25].
Multiplicities are abbreviated as s (singlet), d (doublet), t (triplet), q (quartet) and b (broad signal).
3-ADON was obtained from University of Natural Resources and Life Sciences, Vienna, Dept. for
Agrobiotechnology (IFA-Tulln) and was used after 1H NMR purity check [22]. All other chemicals
were purchased from Sigma-Aldrich (Schnelldorf, Germany).
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4.2. Deoxynivalenol (2)
3-ADON (85.6 mg, 0.25 mmol) was dissolved in 5 mL dry methanol and NaOMe (13.7 mg,
0.25 mmol) was added to the reaction. After 1.5 h TLC revealed full conversion of the starting material
and the reaction mixture was concentrated to 1 mL. Finally the solution was directly purified by the
use of column chromatography (CHCl3:MeOH = 9:1) which yielded deoxynivalenol (79.0 mg, 95%) as
white solid. The reaction product was proved to be identical to an authentic sample by TLC and thus
was used for the next step.
4.3. 15-ADON (3) and 3,15-diADON (4)
DON (79.0 mg, 0.27 mmol) was dissolved in 50 mL dry dichloromethane. Pyridine (1 mL) and
4-DMAP (app. 10 mg) were added followed by the dropwise addition of acetic anhydride (27.2 mg,
0.27 mmol). The reaction was stirred overnight, treated with 20 mL HCl (2 N) and extracted 3 times
with 50 mL dichloromethane. After drying with Na2SO4, filtration and evaporation of the solvent the
remaining residue was subjected to column chromatography (CHCl3:MeOH = 95:5) to yield 15-ADON
(42.0 mg, 47%, Figures S2,S3) and 3,15-diADON (23.5 mg, 23%, Figures S4,S5) as white solid. Total
yield = 70%, 93% conversion. 15-ADON (3): 1H NMR (200 MHz, CDCl3) δ = 6.61 (dq, J = 5.7, 1.6 Hz,
1H), 4.89 (d, J = 5.7 Hz, 1H), 4.83 (d, J = 1.6 Hz, 1H), 4.52 (dt, J = 10.2, 4.7 Hz, 1H), 4.24 (s, 2H), 3.78
(d, J = 1.8 Hz, 1H), 3.63 (d, J = 4.5 Hz, 1H), 3.13 (d, J = 4.3 Hz, 1H), 3.08 (d, J = 4.3 Hz, 1H), 2.22 (dd,
J = 14.8, 4.7 Hz, 1H), 2.08 (dd, J = 14.7, 10.4 Hz, 1H), 1.88 (s, 3 H), 1.87 (s, 3H), 1.07 (s, 3H); 13C-NMR (50
MHz, CDCl3) δ = 199.6 (s), 170.3 (s), 138.8 (d), 135.6 (s), 80.7 (d), 73.5 (d), 70.1 (d), 68.9 (s), 65.5 (s), 62.2
(t), 51.4 (s), 47.4 (t), 46.3 (s), 43.3 (t), 20.7 (q), 15.4 (q), 13.8 (q). 3,15-diADON (4): 1H NMR (200 MHz,
CDCl3) δ = 6.56 (dq, J = 5.8, 1.4 Hz, 1H), 5.20 (dt, J = 10.9, 4.6 Hz, 1H), 4.80 (d, J = 2.0 Hz, 1H), 4.69
(d, J = 5.8 Hz, 1H), 4.27 (d, J = 12.1 Hz, 1H), 4.20 (d, J = 12.1 Hz, 1H), 3.89 (d, J = 4.3 Hz, 1H), 3.80 (d,
J = 2.0 Hz, 1H), 3.14 (d, J = 4.3 Hz, 1H), 3.09 (d, J = 4.3 Hz, 1H), 2.31 (dd, J = 15.2, 4.8 Hz, 1H), 2.15 (dd,
J = 15.2, 10.9 Hz, 1H), 2.12 (s, 3H), 1.88 (s, 3 H), 1.87 (s, 3H), 1.08 (s, 3H); 13C-NMR (50 MHz, CDCl3)
δ = 199.3 (s), 170.3 (s), 170.2 (s), 138.4 (d), 135.6 (s), 78.9 (d), 73.4 (d), 71.1 (d), 70.1 (d), 64.9 (s), 62.1 (t),
51.5 (s), 47.4 (t), 45.8 (s), 40.3 (t), 21.0 (q), 20.6 (q), 15.3 (q), 13.6 (q); 1H NMR data consistent with the
ones reported in literature [26,27].
4.4. (+)-cis-Carveol (11) (Large Scale Luche Reduction)
(+)-Carvone (10) (3.00 g, 20.0 mmol) and CeCl3·7H2O (1.86 g, 5.0 mmol) were dissolved in 150 mL
MeOH and cooled to 0 ◦C. NaBH4 (0.76 g, 20.0 mmol) was dissolved in 100 mL MeOH and added within
5 mins to the reaction solution via a dropping funnel. After complete addition of the NaBH4-solution
the cooling bath was removed and the reaction continued. TLC control (hexane:EtOAc = 5:1) after
30 min revealed complete conversion of the starting material and the reaction was treated with 50 mL
2N HCl and extracted three times with 100 mL Et2O. The organic phase was dried over Na2SO4, filtered
and the solvent was removed under reduced pressure. Column chromatography (hexane:EtOAc = 5:1)
yielded 2.79 g (92%, Figures S6,S7) of a slightly yellow oil which was consistent with literature NMR
data [28,29] for (+)-cis-carveol. 1H NMR (200 MHz, CDCl3) δ = 5.35 (b, 1H), 4.62 (b, 1H), 4.08 (b, 1H),
3.77 (b, 1H), 1.50 – 2.30 (m, 11H), 1.40 (dt, J = 12.2, 10.0 Hz, 1H); 13C-NMR (50 MHz, CDCl3) δ = 148.7
(s, C=), 136.6 (s, C=), 123.3 (d, =CH), 108.8 (t, =CH2), 70.3 (d, CH), 40.7 (d, CH), 37.8 (t, CH2), 31.0
(t, CH2), 20.3 (q, CH3), 19.0 (q, CH3).
4.5. Conversion of 3-ADON (1) to 15-Deacetyl-7,8-dihydroxycalonectrin (7) and
3,7,8,15-Tetrahydroxyscirpene (5)
3-ADON (1.00 equ.) was dissolved in 1 mL MeOH and CeCl3·7H2O (0.50 equ. in 1 mL MeOH) was
added. NaBH4 (1.00 equ.) was dissolved in 1 mL MeOH and added with moderate speed (dropwise,
but fast enough to prevent rising pressure due to H2 formation). After completion the reaction was
stirred until TLC revealed conversion of the starting material. The mixture was concentrated without
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heating under reduced pressure and subjected directly to column chromatography (DCM:MeOH = 9:1)
to yield 10.6 mg (58%, Figures S13–S17) of 15-deacetyl-7,8-dihydroxycalonectrin. In order to obtain
3,7,8,15-tetrahydroxyscirpene (5), the whole reaction was repeated and evaporated to dryness. After
uptake in 3 mL dry MeOH, K2CO3 (2.00 equ.) was added and the reaction stirred until TLC indicated
the deprotection of the acetyl group in position 3. The reaction mixture was concentrated to 1 mL
and purified via column chromatography (CHCl3:MeOH = 9:1) to yield 13.6 mg (26% for two steps,
Figures S8-S12) of 3,7,8,15-tetrahydroxyscirpene. 3,7,8,15-Tetrahydroxyscirpene (5): 1H NMR (400
MHz, methanol-d4) δ = 5.57 (bd, J = 5.6 Hz, 1H), 4.43 (d, J = 4.7 Hz, 1H), 4.40 (d, J = 5.6 Hz, 1H), 4.31 (dt,
J = 10.7, 4.5 Hz, 1H), 3.91 (d, J = 4.7 Hz, 1H), 3.88 (d, J = 12.6 Hz, 1H), 3.64 (d, J = 12.6 Hz, 1H), 3.38 (d,
J = 4.5 Hz, 1H), 3.16 (d, J = 4.4 Hz, 1H), 3.02 (d, J = 4.4 Hz, 1H), 2.21 (dd, J = 14.6, 4.5 Hz, 1H), 1.97 (dd,
J = 14.6, 10.7 Hz, 1H), 1.84 (s, 3 H), 1.14 (s, 3H); 13C-NMR (100 MHz, methanol-d4) δ = 140.0 (s, C-9),
124.3 (d, C-10), 81.1 (d, C-2), 72.9 (d, C-11), 72.2 (d, C-8), 72.0 (d, C-7), 69.8 (d, C-3), 66.5 (s, C-12), 62.3 (t,
C-15), 48.6 (s, C-6), 48.5 (s, C-13), 47.7 (s, C-5), 45.8 (t, C-4), 20.8 (q, C-16), 16.2 (q, C-14). The signal at 48.5
(C-13) is not visible in the 13C spectra, but could be located in the correlated spectra. HRMS (APCI+):
m/z calcd for (5) [M + Na+]: 321.1309; found: 321.1305. 15-Deacetyl-7,8-dihydroxycalonectrin (7): 1H
NMR (400 MHz, methanol-d4) δ = 5.54 (dq, J = 5.5, 1.4 Hz, 1H), 5.05 (dt, J = 11.1, 4.4 Hz, 1H), 4.40 (d,
J = 5.0 Hz, 1H), 4.33 (d, J = 5.5 Hz, 1H), 3.91 (d, J = 5.0 Hz, 1H), 3.90 (d, J = 12.6 Hz, 1H), 3.68 (d, J = 4.4
Hz, 1H), 3.67 (d, J = 12.6 Hz, 1H), 3.20 (d, J = 4.1 Hz, 1H), 3.08 (d, J = 4.1 Hz, 1H), 2.48 (dd, J = 15.0,
4.4 Hz, 1H), 2.10 (s, 3H), 2.04 (dd, J = 15.0, 11.1 Hz, 1H), 1.84 (s, 3 H), 1.17 (s, 3H); 13C-NMR (100
MHz, methanol-d4) δ = 172.6 (s, acetyl C=O), 140.4 (s, C-9), 123.7 (d, C-10), 79.9 (d, C-2), 73.0 (d, C-3),
72.9 (d, C-11), 72.1 (d, C-8), 71.7 (d, C-7), 66.1 (s, C-12), 62.1 (t, C-15), 48.7 (t, C-13), 48.5 (s, C-6), 47.1
(s, C-5), 42.6 (t, C-4), 20.9 (q, acetyl CH3), 20.8 (q, C-16), 15.9 (q, C-14). HRMS (APCI+): m/z calcd for
(7) [M + Na+]: 363.1414; found: 363.1409.
4.6. Reduction of 15-ADON (3) and 3,15-diADON (4) to 3-Deacetyl-7,8-dihydroxycalonectrin (8) and
7,8-Dihydroxycalonectrin (9)
Toxin (1.00 equ.) was dissolved in 1 mL MeOH and CeCl3·7H2O (0.50 equ. in 1 mL MeOH) was
added. NaBH4 (1.00 equ.) was dissolved in 1 mL MeOH and added with moderate speed (dropwise,
but fast to prevent rising pressure due to H2 formation). After completion the reaction was stirred
until TLC revealed conversion of the starting material. The mixture was concentrated without heating
under reduced pressure and directly subjected to column chromatography (DCM:MeOH = 97.5:2.5
for 7,8-dihydroxycalonectrin and DCM:MeOH = 9:1 for 3-deacetyl-7,8-dihydroxycalonectrin)
to yield the desired products in 55% (7,8-dihydroxycalonectrin, Figures S23,S24) and 65%
(3-deacetyl-7,8-dihydroxycalonectrin, Figures S18–S22). 7,8-Dihydroxycalonectrin (9): 1H NMR (200
MHz, methanol-d4) δ = 5.53 (dq, J = 5.9, 1.5 Hz, 1H), 5.05 (dt, J = 11.2, 4.4 Hz, 1H), 4.52 (d, J = 5.9 Hz,
1H), 4.42 (d, J = 5.3 Hz, 1H), 4.40 (s, 2H), 3.91 (d, J = 5.3 Hz, 1H), 3.72 (d, J = 4.4 Hz, 1H), 3.22 (d, J = 4.3
Hz, 1H), 3.09 (d, J = 4.2 Hz, 1H), 2.68 (dd, J = 15.1, 4.1 Hz, 1H), 1.95-2.15 (m, 1H), 2.10 (s, 3H), 2.04
(s, 3H), 1.85 (s, 3 H), 1.18 (s, 3H); 13C-NMR (50 MHz, methanol-d4) δ = 172.6 (s), 172.4 (s), 141.9 (s),
122.1 (d), 80.1 (d), 72.9 (d), 72.3 (d), 71.4 (d), 71.3 (d), 66.3 (s), 65.4 (t), 47.8 (s), 46.8 (s), 43.0 (t), 21.2 (q),
20.9 (q), 20.8 (q), 15.8 (q, C-14). 1 Signal missing due to solvent overlap. HRMS (APCI+): m/z calcd
for (9) [M+Na+]: 405.1520; found: 405.1515. 3-Deacetyl-7,8-dihydroxycalonectrin (8): 1H NMR (400
MHz, methanol-d4) δ = 5.57 (dq, J = 5.8, 1.4 Hz, 1H), 4.64 (d, J = 5.8 Hz, 1H), 4.45 (d, J = 5.6 Hz, 1H),
4.38 (d, J = 12.6 Hz, 1H), 4.34 (d, J = 12.6 Hz, 1H), 4.30 (dt, J = 11.1, 4.4 Hz, 1H), 3.92 (d, J = 5.6 Hz, 1H),
3.41 (d, J = 4.4 Hz, 1H), 3.18 (d, J = 4.4 Hz, 1H), 3.04 (d, J = 4.4 Hz, 1H), 2.49 (dd, J = 14.6, 4.4 Hz, 1H),
2.04 (s, 3H), 1.97 (dd, J = 14.6, 11.1 Hz, 1H), 1.85 (s, 3 H), 1.15 (s, 3H); 13C-NMR (100 MHz, methanol-d4)
δ = 172.5 (s, acetyl C=O), 141.5 (s, C-9), 122.6 (d, C-10), 82.0 (d, C-2), 72.0 (d, C-11), 71.5 (2 x d, C-7,
C-8), 69.6 (d, C-3), 66.8 (s, C-12), 65.4 (t, C-15), 48.8 (s, C-13), 47.8 (s, C-6), 47.3 (s, C-5), 46.0 (t, C-4), 21.2
(q, acetyl CH3), 20.8 (q, C-16), 16.0 (q, C-14). HRMS (APCI+): m/z calcd for (8) [M + Na+]: 363.1414;
found: 363.1411. NMR data for 7,8-dihydroxycalonectrin and 3-deacetyl-7,8-dihydroxycalonectrin
were found in accordance with the 1H chemical shifts reported in literature [22].
283
Toxins 2014, 6, 325–336
5. Conclusions
This paper presents a reliable, mild, fast and tolerant method for the stereoselective reduction
of the carbonyl group in deoxynivalenol and its acetylated derivatives. Although the method was
optimized for deoxynivalenol, it is likely to be applicable to nivalenol, its acetylated derivatives and
other type B trichothecenes in a similar way. The isolated yields of the method were satisfying and
further improvements towards better yields of the presented method might be difficult to achieve due to
the instability of several functional groups (epoxy, acetyl) with prolonged reaction time. Nevertheless,
we expect the method to also be applicable on masked forms of mycotoxins thereby providing a
valuable tool for synthetic conversion of different mycotoxin standards.
In addition to the reduction itself, four different calonectrin derivatives were synthesized and
characterized using several NMR techniques. By using NOESY (Nuclear Overhauser Enhancement
SpectroscopY) we were able to prove the stereochemistry of all reaction products. The value of the
compounds itself is difficult to estimate—although they are supposed to act as precursors for the
biosynthesis of DON, their natural occurrence is reported rarely in literature. Nonetheless, the protocol
presented can be readily applied for the synthesis of this class of compounds and therefore opens the
door for their use as reference material as well as for investigations on the biologic pathway towards
type B trichothecenes.
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